AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 5, 1999

REGISTRATION NO. 333-86361


SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


AMENDMENT NO. 2

TO

FORM S-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

IMMERSION CORPORATION
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

            DELAWARE                           3577                          94-3180138
(STATE OR OTHER JURISDICTION OF    (PRIMARY STANDARD INDUSTRIAL           (I.R.S. EMPLOYER
 INCORPORATION OR ORGANIZATION)       CLASSIFICATION NUMBER)            IDENTIFICATION NO.)

2158 PARAGON DRIVE
SAN JOSE, CALIFORNIA 95131
(408) 467-1900
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF
REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)

LOUIS B. ROSENBERG
CHIEF EXECUTIVE OFFICER
IMMERSION CORPORATION
2158 PARAGON DRIVE
SAN JOSE, CALIFORNIA 95131
(408) 467-1900
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
OF AGENT FOR SERVICE)

COPIES TO:

     BRUCE SCHAEFFER, ESQ.                          LAIRD H. SIMONS, III, ESQ.
       TOM FURLONG, ESQ.                          KATHERINE TALLMAN SCHUDA, ESQ.
     PAMELA B. BURKE, ESQ.                         CYNTHIA E. GARABEDIAN, ESQ.
GRAY CARY WARE & FREIDENRICH LLP                        FENWICK & WEST LLP
      400 HAMILTON AVENUE                              TWO PALO ALTO SQUARE
PALO ALTO, CALIFORNIA 94301-1825                   PALO ALTO, CALIFORNIA 94306
         (650) 328-6561                                   (650) 494-0600

APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC:

As soon as practicable after the effective date of this Registration Statement.

If any of the securities being registered on this Form are being offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, as amended (the "Securities Act"), check the following box. [ ]

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. [ ] __________

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. [ ] __________

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration number of the earlier effective registration statement for the same offering. [ ] __________

If delivery of the prospectus is expected to be made pursuant to Rule 434, check the following box. [ ]

CALCULATION OF REGISTRATION FEE

----------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------
                                                        PROPOSED MAXIMUM      PROPOSED MAXIMUM
                                    AMOUNT TO BE       OFFERING PRICE PER    AGGREGATE OFFERING        AMOUNT OF
                                     REGISTERED              SHARE                 PRICE          REGISTRATION FEE(1)
----------------------------------------------------------------------------------------------------------------------
Common Stock ($0.001 par
  value)......................       4,250,000               $11.00             $53,762,500             $14,946
----------------------------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------------------------

(1) Previously paid in connection with the filing of Immersion's Registration Statement on Form S-1 (File No. 333-86361) on September 1, 1999.

THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE SECURITIES ACT OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATE AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING PURSUANT TO SAID
SECTION 8(A), MAY DETERMINE.




THE INFORMATION IN THIS PRELIMINARY PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. WE MAY NOT SELL THESE SECURITIES UNTIL THE REGISTRATION STATEMENT FILED WITH THE SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER TO SELL THESE SECURITIES, AND IT IS NOT SOLICITING AN OFFER TO BUY THESE SECURITIES, IN ANY STATE WHERE SUCH AN OFFER OR SALE IS NOT PERMITTED.

SUBJECT TO COMPLETION, DATED OCTOBER 5, 1999

PROSPECTUS

4,250,000 SHARES

IMMERSION.LOGO
COMMON STOCK

This is an initial public offering of common stock by Immersion Corporation. The estimated initial public offering price is between $9.00 and $11.00 per share.


We have applied to have our common stock approved for quotation on the Nasdaq National Market under the symbol IMMR.

                                                                 PER SHARE           TOTAL
                                                                 ---------           -----
Initial public offering price...............................         $                 $
Underwriting discounts and commissions......................         $                 $
Proceeds to Immersion Corporation, before expenses..........         $                 $

Immersion Corporation and the selling stockholders have granted the underwriters an option for a period of 30 days to purchase up to 637,500 additional shares of common stock.


INVESTING IN THE COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. SEE "RISK

FACTORS" BEGINNING ON PAGE 7.


Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

HAMBRECHT & QUIST

BEAR, STEARNS & CO. INC.

ROBERTSON STEPHENS

, 1999


COVER PAGE ART

[Art: Rendition of a human hand reaching
out to touch a computer cursor]

Headline Above the Illustration: "Engaging the Sense of Touch'

FIRST GATE FOLD (LEFT)

[Art: Windows desktop with Yahoo home page and a smaller simulated Web page advertisement for tennis racquet]

Headline Above the Desktop Illustration: "Immersion TouchSense Technology Provides realistic Sensations For More Natural Interaction, Enhanced Productivity And A More Engaging Experience."

Smaller Text Below the Headline But Above the Desktop Illustration: "With Immersion TouchSense technology, it's now possible to deliver tactile feedback through an enhanced computer mouse."

[Surrounding the Yahoo home page, a series of call-outs describing how Immersion technology adds feel to particular aspects of the home page:

Call-out from Web page "Search" button: Web page buttons have dimensionality that can be felt as well as seen, making them easier to activate.

Call-out from hyperlink: "Like a Magnet, the cursor snaps to links on a Web page, enabling faster and easier navigation."

Call-out from menu: "Feeling the cursor click over each item in a pull-down menu improves accuracy, resulting in fewer incorrect selections."

Call-out from lower-right corner of Web page window: "Resize the window by pulling the edge and feel it stretch."

Call-out from folder icon: "Feel the cursor engage an icon with a tactile snap.


Drag an icon and feel its weight."

Call-out from simulated Web page advertisement for tennis racquet: "Enhancing online experiences. TouchSense technology lets users feel physical sensations such as textures, surfaces, springs, liquids, and vibrations. This simulated advertisement is an example of how shopping online can be enhanced by interacting with TouchSense authored attributes that let users feel the physical characteristics of products prior to purchase."

[Art: At lower middle of left gate-fold, a gamepad with the caption "HammerHead Fx"

Headline at bottom of page (below desktop on either side of gamepad): "Computer game enthusiasts can experience unprecedented realism."

SECOND GATE FOLD (RIGHT)

[Art: At top of page, a photo of feel-enabled mouse with the caption "Logitech WingMan Force Feedback Mouse"]

Text in middle of page:

"Adding realistic physical sensations to medical training. Immersion TouchSense technology enables doctors and students to practice surgical procedures in training environments that feel real.

For example, as the user manipulates the Endoscopic Sinus Surgery Simulator (pictured below), the computer tracks the position and orientation of the device. As the user interacts with the virtual organs and tissue, simulated physical sensations create the feeling of operating on an actual patient.


Patented technology makes it possible. More than just a pointer, a TouchSense enabled mouse delivers compelling physical sensations to the user that correspond to on-screen events. The mouse incorporates magnetic actuators, a specialized microprocessor, and advanced sensors. Our patented distributed processing architecture is optimized to handle the continuous stream of rapid calculations that are required to generate the tactile forces the user feels.
The result is an immediate, realistic experience.

Improving educational resources. TouchSense technology can help demonstrate principles of physics and other sciences. Students can use computers to experience hands-on manipulation of forces such as gravity, friction, inertia, and magnetism."

[Art: At middle right of page, a photo of an apple and a ruler]

[Art: At bottom left of page, a photo of a stethoscope, a sinus surgery simulator and a globe with a caption by the globe "Compress an Object and feel it flex"]

[Art: At bottom right of page, a drawing of molecules]

INSIDE BACK PAGE

[Art: At top left of page: a photo of a feel-enabled steering wheel with the caption "WingMan Formula Force"]

Text on right side of page:

Customers and Licensees

Anko

ACT Labs

HT Medical

InterAct

KYE/Mouse Systems

LMP

Logitech

Microsoft

Mad Catz

Padix

Picker

Quantum3D

Sysgration

Thrustmaster

Text in middle of page:

Evolving the games industry. From flight simulation to action games, our TouchSense technology helps create more compelling, realistic interactions. The vibrations of turbulence in flight, the recoil from a weapon, and the impact of hitting a wall are all sensations that users can feel. Action games can be energized by jolts and blasts. Driving games can add the roughness of the road and the force of moving around tight turns. Whether using a mouse, a joystick, or a steering wheel, computer game enthusiasts can experience unprecedented realism.

A powerful patent portfolio. With 37 patents issued and another 125 applications pending, Immersion technology applies to broad market opportunities. The customers and licensees listed to the right are using Immersion TouchSense technology to develop devices that provide tactile feedback.

[Art: At bottom left of page, a photo of a force feedback joystick with the caption "WingMan Force"]


[Art: At center bottom of page: a picture of Immersion logo, which is an artist's representation of a hand with the caption "Immersion"]

Small text on bottom right of page:

(C)1999 Immersion Corporation. HammerHead FX is a product of InterAct Accessories and 3Dfx Interactive. Immersion and the Immersion logo are trademarks of Immersion Corporation. Logitech, the Logitech logo, and the Logitech products referred to herein are either the trademarks or registered trademarks of Logitech. Yahoo! and the Yahoo! logo are trademarks of Yahoo! Inc. All other trademarks are the property of their respective owners. All rights reserved.


TABLE OF CONTENTS

                                                              PAGE
                                                              ----
Prospectus Summary..........................................    4
Risk Factors................................................    7
Forward-Looking Statements..................................   17
Use of Proceeds.............................................   17
Dividend Policy.............................................   17
Capitalization..............................................   18
Dilution....................................................   19
Selected Consolidated Financial Data........................   20
Management's Discussion and Analysis of Financial Condition
  and Results of Operations.................................   21
Business....................................................   31
Management..................................................   43
Certain Transactions........................................   52
Principal Stockholders......................................   54
Description of Capital Stock................................   57
Shares Eligible for Future Sale.............................   60
Underwriting................................................   62
Legal Matters...............................................   64
Experts.....................................................   64
Where You Can Find Additional Information...................   64
Index to Consolidated Financial Statements..................  F-1


All brand names and trademarks appearing in this prospectus are the property of their respective holders.

3

PROSPECTUS SUMMARY

You should read this summary together with the more detailed information, our financial statements and the related notes and the risks of investing in our common stock discussed under "Risk Factors" before making an investment decision. Except as otherwise noted, all information in this prospectus assumes the conversion of all outstanding shares of preferred stock into common stock, no exercise of the underwriters' over-allotment option and our reincorporation in Delaware prior to the date of this prospectus.

IMMERSION CORPORATION

Immersion Corporation develops and licenses technologies that enable users to interact with computers using their sense of touch. Our TouchSense feel technology enables computer peripheral devices such as mice and joysticks to deliver compelling tactile sensations that correspond to on-screen events. We are the leading provider of such technology to consumer markets and have licensed our intellectual property to more than 16 companies, including Microsoft, Logitech and InterAct. We hold 37 U.S. patents covering various aspects of our hardware and software technologies and have over 125 patent applications pending in the U.S. and abroad. Our objective is to proliferate our feel technology across markets, platforms and applications so that feel becomes as common as graphics and sound in the modern computer interface.

Early computers had crude user interfaces that only displayed text and numbers. In the 1980s, computers began to use graphics and sound to engage users' perceptual senses more naturally, leading to the popularization of the video game, the graphical user interface and the Web. While most modern computers realistically present information to the senses of sight and sound, they still lack the ability to convey content through the sense of touch.

We develop and license affordable technologies that allow computer users to touch and feel computer content. Our patented designs incorporate specialized hardware elements such as motors, control electronics and mechanisms into computer peripheral devices. Driven by sophisticated software algorithms, these hardware elements direct tactile sensations to the user's hand. We offer a complete technical solution to our licensees and to software programmers and Web developers. Our technologies comply with leading hardware and software standards including Universal Serial Bus (USB) and Microsoft's DirectX application programming interface.

In 1996, we introduced I-FORCE, our feel technology designed for entertainment peripherals such as joysticks, steering wheels and gamepads. I-FORCE has gained acceptance in the computer entertainment market, in which licensees such as Logitech, Microsoft and InterAct are currently manufacturing and selling hardware products incorporating I-FORCE technology.

To target the mainstream computing market, we have developed FEELit, a hardware and software solution designed for feel-enabled cursor control products such as mice and trackballs. Our first FEELit licensee, Logitech, has announced that it will begin shipping feel-enabled mice in late 1999. Logitech currently plans to include copies of our FEELit Desktop and FEELtheWEB software with each of its feel-enabled mice. FEELit Desktop, which works with Windows 98- compatible software, automatically adds feel to many of the basic Windows controls, such as icons, menus and buttons. FEELtheWEB, which works with Internet Explorer and Netscape Navigator, automatically adds feel to the standard interface elements of Web pages, such as hyperlinks, check boxes and menus.

We currently concentrate our marketing, research and development and business development activities on licensing our TouchSense feel technology in the computer entertainment and mainstream computing markets. We have historically derived the substantial majority of our revenues and will continue to derive revenues from commercial and government development contracts and product sales, including sales of three dimensional digitizing products, medical simulation products and industrial products.

4

At June 30, 1999, we had an accumulated deficit of approximately $6.3 million. Logitech accounted for 19% of our total revenues for the six months ended June 30, 1999 and 11% of our total revenues in 1998. The U.S. Government accounted for 11% of our total revenues for the six months ended June 30, 1999, 10% of our total revenues in 1998, 24% of our total revenues in 1997 and 16% of our total revenues in 1996.

Key elements of our strategy are to:

- pursue a royalty-based licensing model;

- facilitate development of feel-enabled hardware products;

- expand software support for our feel technology;

- utilize the Internet to create market demand for feel-enabled products;

- expand market awareness of our technologies and brands;

- secure licensees in new markets for feel technology; and

- continue to develop and protect our intellectual property.

We were incorporated in California in May 1993 and reincorporated in Delaware prior to the date of their prospectus. Our headquarters are located at 2158 Paragon Drive, San Jose, California 95131, and our telephone number is
(408) 467-1900. Our website address is www.immersion.com. Information contained on our website is not part of this prospectus.

THIRD QUARTER REVENUE

For the three months ended September 30, 1999, we had total revenues of approximately $2.1 million. These revenues consisted of approximately $700,000 in royalty revenue, $1.1 million in product sales and $300,000 in development contracts and other revenues.

5

THE OFFERING

Common stock offered by us................     4,250,000 shares



Common stock to be outstanding after this
offering..................................    15,441,856 shares

Use of proceeds........................... For working capital and other general corporate purposes.

Proposed Nasdaq National Market symbol.... IMMR


The number of shares of common stock to be outstanding after this offering is based on 11,191,856 shares outstanding as of September 30, 1999. This number excludes 4,379,465 shares of common stock issuable upon exercise of stock options outstanding as of September 30, 1999 with a weighted average exercise price of $3.18 per share and 498,593 shares of common stock issuable upon exercise of warrants outstanding as of September 30, 1999 with a weighted average exercise prices of $2.72. This number also excludes 15,594 shares of common stock available for future issuance under our 1997 Stock Option Plan and 500,000 shares reserved for sale under our 1999 Employee Stock Purchase Plan.

SUMMARY CONSOLIDATED FINANCIAL INFORMATION
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

The pro forma numbers in the consolidated balance sheet data reflect the automatic conversion of all shares of preferred stock into common stock upon the closing of this offering. The pro forma as adjusted numbers in the consolidated balance sheet data reflect the receipt of the net proceeds from the sale of the 4,250,000 shares of common stock offered by us at an assumed initial public offering price of $10.00 per share and after deducting the estimated underwriting discounts and commissions and estimated offering expenses.

                                                                              SIX MONTHS ENDED
                                               YEAR ENDED DECEMBER 31,            JUNE 30,
                                             ----------------------------    ------------------
                                              1996      1997       1998       1998       1999
                                             ------    -------    -------    -------    -------
CONSOLIDATED STATEMENT OF OPERATIONS DATA:
  Revenues.................................  $2,737    $ 4,332    $ 5,021    $ 2,177    $ 3,503
  Costs and expenses.......................   2,846      4,909      6,868      3,125      5,687
  Operating loss...........................    (109)      (577)    (1,847)      (948)    (2,184)
  Net loss.................................     (81)      (527)    (1,673)      (869)    (2,118)
  Basic and diluted net loss per share.....  $(0.03)   $ (0.17)   $ (0.43)   $ (0.23)   $ (0.42)
  Shares used in calculating basic and
     diluted net loss per share............   2,825      3,162      3,909      3,839      5,003
  Pro forma basic and diluted net loss per
     share.................................                       $ (0.19)              $ (0.21)
  Shares used in calculating pro forma
     basic and diluted net loss per
     share.................................                         8,630                10,134

                                                                       JUNE 30, 1999
                                                            -----------------------------------
                                                                                    PRO FORMA
                                                            ACTUAL    PRO FORMA    AS ADJUSTED
                                                            ------    ---------    ------------
CONSOLIDATED BALANCE SHEET DATA:
  Cash and cash equivalents...............................  $2,204     $2,204        $40,729
  Working capital.........................................   3,339      3,339         41,864
  Total assets............................................   9,706      9,706         48,231
  Redeemable convertible preferred stock..................   1,479         --             --
  Total stockholders' equity..............................   7,370      8,849         47,374

6

RISK FACTORS

Any investment in our common stock involves a high degree of risk. You should consider the risks described below carefully and all of the information contained in this prospectus before deciding whether to purchase our common stock. If any of the following risks actually occurs, our business, financial condition and results of operations would suffer. In this case, the trading price of our common stock could decline, and you might lose all or part of your investment in our common stock.

THE MARKET FOR OUR TECHNOLOGIES IS AT AN EARLY STAGE AND, IF MARKET DEMAND DOES NOT DEVELOP, WE MAY NOT ACHIEVE OR SUSTAIN REVENUE GROWTH

The consumer market for feel technology is at an early stage, and if we and our licensees are unable to develop consumer demand for our licensed products we may not achieve or sustain revenue growth. To date, consumer demand for our technologies has been limited to the computer gaming market, and sales of feel-enabled products in that market began only in late 1996. We anticipate that the first FEELit computer mouse will be introduced this year, and it may not achieve commercial acceptance or generate royalty revenue for us. In addition, software developers may elect not to create additional games or other applications that support our feel technology. Even if our technologies are ultimately widely adopted by consumers, widespread adoption may take a long time to occur. The timing and amount of royalties that we receive will depend on whether the products marketed by our licensees achieve widespread adoption and, if so, how rapidly that adoption occurs. We expect that we will need to pursue extensive and expensive marketing and sales efforts to educate prospective licensees and consumers about the uses and benefits of our technologies and to persuade software developers to create software that utilizes our technologies.

WE HAVE AN ACCUMULATED DEFICIT OF $6.3 MILLION AS OF JUNE 30, 1999, WILL EXPERIENCE LOSSES IN THE FUTURE AND MAY NOT ACHIEVE OR MAINTAIN PROFITABILITY

Since 1997, we have incurred losses in every fiscal quarter, and we expect losses through at least 2000. We will need to generate significant revenue to achieve and maintain profitability. We may not achieve, sustain or increase profitability in the future. We anticipate that our expenses will increase substantially in the foreseeable future as we:

- attempt to expand the market for feel-enabled products;

- increase our sales efforts;

- continue to develop our technologies;

- pursue strategic relationships; and

- protect and enforce our intellectual property.

If our revenues grow more slowly than we anticipate or if our operating expenses exceed our expectations, we may not achieve or maintain profitability.

OUR HISTORICAL FINANCIAL INFORMATION DOES NOT REFLECT OUR PRIMARY BUSINESS STRATEGY FOR ACHIEVING REVENUE GROWTH

We cannot predict our future revenues based on our historical financial information. Historically, we derived the substantial majority of our revenues from commercial and government development contracts related to feel-enabling technology and product sales, including sales of three dimensional digitizing products, medical simulation products and industrial products. The majority of our historical product sales resulted from sales of products that did not utilize the Company's feel technology but utilized related advanced computer peripheral technologies. We currently concentrate our marketing, research and development activities on licensing our feel technology in the computer entertainment and mainstream computing markets. We anticipate that

7

royalty revenue from licensing our technologies will constitute an increasing portion of our revenues. Accordingly, our historical results should not be relied upon as an indicator of our future performance.

WE DO NOT CONTROL OR INFLUENCE THE MANUFACTURE, PROMOTION, DISTRIBUTION OR PRICING OF OUR LICENSED PRODUCTS BY OUR LICENSEES UPON WHOM WE ARE DEPENDENT TO GENERATE ROYALTY REVENUE

Our primary business strategy is to license our intellectual property to companies that manufacture and sell feel-enabled products. The sale of those products generates royalty revenue for us. In the six months ended June 30, 1999, 18% of our total revenues were royalty revenues, and we expect royalty revenue will be an increasing portion of our total revenues in the future. However, we do not control or influence the manufacture, promotion, distribution or pricing of our licensed products by our licensees. As a result, products incorporating our technologies may not be brought to market, achieve commercial acceptance or generate meaningful royalty revenue for us. For us to generate royalty revenue, our licensees must manufacture and distribute feel-enabled products in a timely fashion and generate consumer demand through marketing and other promotional activities. Feel-enabled products are generally more difficult to design and manufacture than products that are not feel-enabled, and these difficulties may cause product introduction delays. If our licensees fail to stimulate and capitalize upon market demand for products that generate royalties for us, our revenues will not grow. Peak demand for products that incorporate our technologies, especially in the gaming market, typically occurs in the third and fourth calendar quarters as a result of increased demand during the year-end holiday season. If our licensees do not ship licensed products in a timely fashion or fail to achieve strong sales in the second half of the calendar year, we would not receive related royalty revenue.

IF INDUSTRY LEADERS DO NOT ADOPT OUR TECHNOLOGIES, WE MAY NOT ACHIEVE REVENUE GROWTH

An important part of our strategy is to penetrate new markets by targeting licensees that are leaders in those markets. This strategy is designed to encourage other participants in those markets to also adopt our technologies. If industry leaders in new markets do not adopt our technologies, our technologies may not achieve widespread market acceptance and this would significantly impair our ability to sustain or achieve revenue growth. In addition, if a high profile industry participant adopts our technologies for one or more of its products but fails to achieve revenue or market penetration with those products, other industry participants' perceptions of our technologies could be adversely affected. Likewise, if a market leader adopts and achieves success with a competing technology, our revenue growth could be limited and other potential licensees may not license our technologies.

BECAUSE LOGITECH IS CURRENTLY OUR ONLY LICENSED MANUFACTURER OF FEEL-ENABLED MICE, OUR ROYALTY REVENUE FROM FEEL-ENABLED MICE WILL BE SIGNIFICANTLY REDUCED IF LOGITECH DOES NOT EFFECTIVELY MANUFACTURE AND MARKET OUR PRODUCTS

Logitech is currently the only licensed manufacturer of feel-enabled mice. If Logitech does not manufacture, market and distribute its feel-enabled mouse product, our royalty revenue from feel-enabled mice would be significantly reduced. In addition, a lack of market acceptance of the Logitech feel-enabled mouse might dissuade other potential licensees from licensing our technologies for feel-enabled mice and other products.

IF WE FAIL TO PROTECT AND ENFORCE OUR INTELLECTUAL PROPERTY RIGHTS, OUR ABILITY TO LICENSE OUR TECHNOLOGIES AND TO GENERATE REVENUES WOULD BE IMPAIRED

Our business depends on generating revenues by licensing our intellectual property rights and by selling products that incorporate our technologies. If we are not able to protect and enforce those rights, our ability to obtain future licenses and royalty revenue could be impaired. In addition, if a court were to limit the scope of, declare unenforceable or invalidate any of our

8

patents, current licensees may refuse to make royalty payments or may themselves choose to challenge one or more of our patents. Also it is possible that:

- our pending patent applications may not result in the issuance of patents;

- our patents may not be broad enough to protect our proprietary rights;

- our patents could be challenged and potentially invalidated by one or more third parties, which could result in our loss of the right to prevent others from exploiting the inventions claimed in those patents; and

- effective patent protection may not be available in every country in which our licensees do business.

We also rely on licenses, confidentiality agreements and copyright, trademark and trade secret laws to establish and protect our proprietary rights. It is possible that:

- laws and contractual restrictions may not be sufficient to prevent misappropriation of our technologies or deter others from developing similar technologies;

- "shrinkwrap" and "clickwrap" license agreements upon which we rely to protect some of our software may not be enforceable under the laws of all jurisdictions;

- other companies may claim common law trademark rights based upon state or foreign laws that precede federal registration of our trademarks;

- current federal laws that prohibit software copying will provide only limited protection from software pirates, and effective trademark, copyright and trade secret protection may be unavailable or limited in some foreign countries; and

- policing unauthorized use of our products and trademarks would be difficult, expensive and time-consuming, particularly overseas.

IF WE ARE UNABLE TO DEVELOP NEW LICENSING ARRANGEMENTS, OUR REVENUES MAY NOT GROW

Our revenue growth depends on our ability to enter into new licensing arrangements. Our failure to enter into new licensing arrangements will cause our operating results to suffer. Particularly with respect to those licenses that involve the implementation of our hardware components or software solutions, we face numerous risks in obtaining new licenses on terms consistent with our business objectives and in maintaining, expanding and supporting our relationships with our current licensees. These risks include:

- the lengthy and expensive process of building a relationship with potential licensees;

- the fact that we may compete with the internal design teams of potential licensees;

- difficulties in persuading consumer product manufacturers to work with us, to rely on us for critical technology and to disclose to us proprietary product development and other strategies; and

- difficulties in persuading potential licensees to bear the development costs necessary to incorporate our technologies into their products.

9

OUR QUARTERLY REVENUES AND OPERATING RESULTS ARE VOLATILE, AND IF OUR FUTURE RESULTS ARE BELOW THE EXPECTATIONS OF PUBLIC MARKET ANALYSTS OR INVESTORS, THE PRICE OF OUR COMMON STOCK IS LIKELY TO DECLINE

Our revenues and operating results are likely to vary significantly from quarter to quarter due to a number of factors, many of which are outside our control and any of which could cause the price of our common stock to decline. These factors include:

- the establishment or loss of licensing relationships;

- the timing of our expenses, including costs related to acquisitions of technologies or businesses;

- the timing of introductions of new products and product enhancements by our licensees and their competitors;

- our ability to develop and improve our technologies;

- our ability to attract, integrate and retain qualified personnel; and

- seasonality in the demand for our licensees' products.

Accordingly, we believe that period to period comparisons of our operating results should not be relied upon as an indicator of our future performance. In addition, because a high percentage of our operating expenses is fixed, a shortfall of revenues can cause significant variations in operating results from period to period.

THE HIGHER COST OF FEEL-ENABLED PRODUCTS MAY INHIBIT OR PREVENT OUR TECHNOLOGIES FROM ACHIEVING MARKET ACCEPTANCE

Feel-enabled products are more expensive than products that are not feel-enabled. The greater expense of products containing our technologies may be a significant barrier to their widespread adoption and sale in consumer markets.

IF OUR TECHNOLOGIES ARE UNABLE TO GAIN MARKET ACCEPTANCE BEYOND THE PERSONAL COMPUTER GAMING PERIPHERALS MARKET, OUR REVENUE GROWTH WILL BE LIMITED

Substantially all of our royalty revenue is derived from the licensing of I-FORCE, our portfolio of feel technology for personal computer gaming peripherals such as joysticks and steering wheels. The personal computer gaming peripherals market is a substantially smaller market than either the mouse market or the dedicated gaming console market and is characterized by declining average selling prices. If we are unable to gain market acceptance beyond the personal computer gaming peripherals market, we may not achieve revenue growth.

COMPETITION IN THE COMPUTER PERIPHERALS MARKET COULD LEAD TO REDUCTIONS IN THE SELLING PRICE OF LICENSED PRODUCTS, WHICH WOULD REDUCE OUR ROYALTY REVENUE

The computer peripherals market in which our licensees compete is highly competitive and is characterized by rapid technological change, short product life cycles, cyclical market patterns, a trend of declining average selling prices and increasing foreign and domestic competition. We believe that competition among computer peripheral manufacturers will continue to be intense, and that competitive pressures will drive the price of our licensees' products downward. Any reduction in our royalties per unit that is not offset by corresponding increases in unit sales will cause our revenues to decline.

A SMALL NUMBER OF LICENSEES ACCOUNTS FOR A LARGE PORTION OF OUR ROYALTY REVENUE

We derived 93% of our royalty revenue for the six months ended June 30, 1999 from three of our licensees. We expect that a significant portion of our total revenues will continue to be derived

10

from a limited number of licensees, including Logitech. If any of this limited group of licensees fails to achieve anticipated sales volumes for their products that incorporate our technologies or fails to pay our royalties in a timely manner, our results of operations may be adversely affected.

BECAUSE OUR TECHNOLOGIES MUST WORK WITH MICROSOFT'S OPERATING SYSTEM SOFTWARE, OUR COSTS COULD INCREASE AND OUR REVENUES COULD DECLINE IF MICROSOFT MODIFIES ITS OPERATING SYSTEM SOFTWARE

Our hardware and software technology is currently compatible with Microsoft's operating system software, including DirectX, Microsoft's entertainment applications programming interface. If Microsoft modifies its operating system, including DirectX, we may need to modify our technologies and this could cause delays in the release of products by our licensees. If Microsoft modifies its software products in ways that limit the use of our other licensees' products, our costs could be increased and our revenues could decline.

WE DEPEND ON KAWASAKI LSI TO PRODUCE OUR I-FORCE AND FEELIT MICROPROCESSORS AND MAY LOSE CUSTOMERS IF KAWASAKI LSI DOES NOT MEET OUR REQUIREMENTS

Kawasaki LSI is the sole supplier of our custom I-FORCE and FEELit microprocessors which we develop, license and sell to support the requirements of our feel technology in gaming and PC peripheral products. Because Kawasaki LSI manufactures and tests our processors, we have limited control over delivery schedules, quality assurance, manufacturing capacity, yields, costs and misappropriation of our intellectual property. Any delays in delivery of the processor, quality problems or cost increases could cause us to lose customers and could damage our relationships with our licensees.

IF WE ARE UNABLE TO CONTINUALLY IMPROVE, AND REDUCE THE COST OF, OUR TECHNOLOGIES, COMPANIES MAY NOT INCORPORATE OUR TECHNOLOGIES INTO THEIR PRODUCTS, WHICH COULD IMPAIR OUR REVENUE GROWTH

Our ability to achieve revenue growth depends on our continuing ability to improve, and reduce the cost of, our technologies and to introduce these technologies to the marketplace in a timely manner. If our development efforts are not successful or are significantly delayed, companies may not incorporate our technologies into their products and our revenue growth may be impaired.

THREE KEY MEMBERS OF OUR MANAGEMENT TEAM HAVE RECENTLY JOINED US AND THEY MAY NOT BE EFFECTIVELY INTEGRATED INTO OUR COMPANY, WHICH COULD IMPEDE THE EXECUTION OF OUR BUSINESS STRATEGY

Our Chief Financial Officer, Vice President of Marketing and Vice President of Business Development each joined us in July or August 1999. Accordingly, each of these individuals has limited experience with our business. Our success will depend to a significant extent on the ability of our new officers to integrate themselves into our daily operations, to gain the trust and confidence of other employees and to work effectively as a team. If any of them fails to do so, our ability to execute our business strategy would be impeded.

THIRD-PARTY CLAIMS OF INFRINGEMENT OF THEIR PROPRIETARY RIGHTS COULD RESULT IN EXPENSIVE, TIME-CONSUMING LITIGATION, WHICH COULD ADVERSELY AFFECT OUR BUSINESS

Any intellectual property litigation, whether brought by us or by others, could result in the expenditure of significant financial resources and the diversion of management's time and efforts. In addition, litigation in which we are accused of infringement may cause product shipment delays, require us to develop non-infringing technology or require us to enter into royalty or license agreements even before the issue of infringement has been decided on the merits. If any litigation were not resolved in our favor, we could become subject to substantial damage claims from third parties and indemnification claims from our licensees. We and our licensees could be enjoined from the continued use of the technology at issue without a royalty or license agreement. Royalty or license agreements, if required, might not be available on acceptable terms, or at all. If a third party

11

claiming infringement against us prevailed and we could not develop non-infringing technology or license the infringed or similar technology on a timely and cost-effective basis, our expenses would increase and our revenues could decrease.

We attempt to avoid infringing known proprietary rights of third parties. We have not, however, conducted and do not conduct comprehensive patent searches to determine whether aspects of our technology infringe patents held by third parties. Third parties may hold, or may in the future be issued, patents that could be infringed by our products or technologies. Any of these third parties might make a claim of infringement against us with respect to our products and technologies. Between May 1995 and June 1999, we received letters from four companies, several of which have significantly greater financial resources than we do, asserting that some of our technologies, or those of our licensees, infringe their intellectual property rights. Although none of these matters has resulted in litigation to date, any of these notices, or additional notices that we could receive in the future from these or other companies, could lead to litigation. We might also elect to enforce our patents and other intellectual property rights against third parties, which could result in litigation.

COMPETITION FROM PRODUCTS THAT DO NOT INCORPORATE OUR TECHNOLOGIES COULD LEAD TO REDUCED PRICES AND SALES VOLUMES OF OUR LICENSED PRODUCTS, WHICH COULD LIMIT OUR REVENUES OR CAUSE OUR REVENUES TO DECLINE

Our licensees may seek to develop products that are based on alternative technologies that do not require a license under our intellectual property. We did not invent the concept of force feedback, a field in which there is a substantial history of prior art. Several companies currently market products that incorporate more expensive variations of feel technology for scientific and industrial use and may shift their focus to consumer markets if those markets continue to grow. These or other potential competitors may have significantly greater financial, technical and marketing resources. If existing or potential licensees do not license technology or intellectual property from us, our revenue growth could be limited or revenues could decline.

COMPETITION TO OUR I-FORCE AND FEELIT MICROPROCESSORS MAY LEAD TO REDUCED PRICES AND SALES VOLUMES OF OUR MICROPROCESSORS

To date, the market for our I-FORCE and FEELit microprocessors has been small. If the market grows, we expect more companies to compete in this market. Increased competition could result in significant price erosion, reduced revenues or loss of market share, any of which would have an adverse effect on our business and operating results. Currently, semiconductor companies, including Intel and Mitsubishi, manufacture products that compete with our microprocessors. Although the products of these semiconductor companies have not been optimized specifically for feel technology, in the future, Intel, Mitsubishi or other companies may elect to enter the market for optimized feel microprocessors. These companies may have greater financial, technical, manufacturing, distribution and other resources, greater name recognition and market presence, longer operating histories, lower cost structures and larger customer bases than we do. Accordingly, we may not be able to compete successfully against either current or future competitors.

BECAUSE WE HAVE A FIXED PAYMENT LICENSE WITH MICROSOFT, OUR ROYALTY REVENUE IN THE PERSONAL COMPUTER JOYSTICK AND STEERING WHEEL GAMING MARKET MIGHT DECLINE IF MICROSOFT DOMINATES THAT MARKET

Under the terms of our present agreement with Microsoft, Microsoft receives a perpetual license under our patents for its present generation of feel-enabled joystick and steering wheel peripheral products targeted at the personal computer market, and for a future replacement version of these joystick and steering wheel products having essentially similar functional features. Instead of an ongoing royalty on Microsoft's sales of licensed products, the agreement provides for payment of a fixed amount regardless of Microsoft's sales volume. At the present time, we do not have a

12

license agreement with Microsoft for products other than joysticks and steering wheels. Microsoft has a significant share of the market for feel-enabled joysticks and steering wheels for personal computers. In the event that Microsoft increases its share of this market, our royalty revenue from other licensees in this market segment might decline. Microsoft has significantly greater financial, sales and marketing resources, as well as greater name recognition and a larger customer base, than our other licensees.

WE MIGHT BE UNABLE TO RECRUIT OR RETAIN NECESSARY PERSONNEL, WHICH COULD SLOW THE DEVELOPMENT AND DEPLOYMENT OF OUR TECHNOLOGIES

Our ability to develop and deploy our technologies and to sustain our revenue growth depends upon the continued service of our executive officers and other key personnel and upon hiring additional key personnel. We intend to hire additional sales, support, marketing and research and development personnel in the remainder of calendar 1999 and in 2000. Competition for these individuals is intense, and we may not be able to attract, assimilate or retain additional highly qualified personnel in the future. In addition, our technologies are complex and we rely upon the continued service of our existing engineering personnel to support licensees, enhance existing technology and develop new technologies.

WE HAVE EXPERIENCED RAPID GROWTH AND CHANGE IN OUR BUSINESS, AND OUR FAILURE TO MANAGE THIS AND ANY FUTURE GROWTH COULD HARM OUR BUSINESS

We are increasing the number of our employees rapidly. Our business may be harmed if we do not integrate and train our new employees quickly and effectively. We also cannot be sure that our revenues will continue to grow at a rate sufficient to support the costs associated with an increasing number of employees.

Any future periods of rapid growth may place significant strains on our managerial, financial, engineering and other resources. The rate of any future expansion, in combination with our complex technologies, may demand an unusually high level of managerial effectiveness in anticipating, planning, coordinating and meeting our operational needs as well as the needs of our licensees.

PRODUCT LIABILITY CLAIMS, INCLUDING CLAIMS RELATING TO ALLEGED REPETITIVE STRESS INJURIES, COULD BE TIME-CONSUMING AND COSTLY TO DEFEND, AND COULD EXPOSE US TO LOSS

Claims that consumer products have flaws or other defects that lead to personal or other injury are common in the computer peripherals industry. If products that we or our licensees sell cause personal injury, financial loss or other injury to our or our licensees' customers, the customers or our licensees may seek damages or other recovery from us. Any claims against us would be time- consuming, expensive to defend and distracting to management and could result in substantial damages and damage our reputation or the reputation of our licensees or their products. This damage could limit the market for our licensees' feel-enabled products and harm our results of operations.

In the past, manufacturers of peripheral products, such as computer mice, have been subject to claims alleging that use of their products has caused or contributed to various types of repetitive stress injuries, including carpal tunnel syndrome. We have not experienced any product liability claims to date. Although our license agreements typically contain provisions designed to limit our exposure to product liability claims, existing or future laws or unfavorable judicial decisions could limit or invalidate the provisions.

13

IF WE FAIL TO DEVELOP NEW OR ENHANCED TECHNOLOGIES FOR NEW COMPUTER APPLICATIONS AND PLATFORMS, WE MAY NOT BE ABLE TO CREATE A MARKET FOR OUR TECHNOLOGIES AND OUR ABILITY TO GROW AND OUR RESULTS OF OPERATIONS MIGHT BE HARMED

We expect to develop new or enhanced technologies and to license technologies for new applications and new platforms. These initiatives may not be favorably received by consumers and could damage our reputation or our brand. Expanding our technology could also require significant additional expenses and strain our management, financial and operational resources. The lack of market acceptance of these efforts or our inability to generate additional revenues sufficient to offset the associated costs could harm our results of operations.

WE MAY ENGAGE IN FUTURE ACQUISITIONS THAT DILUTE STOCKHOLDER VALUE, DIVERT

MANAGEMENT ATTENTION OR CAUSE INTEGRATION PROBLEMS

As part of our business strategy, we have in the past acquired, and might in the future acquire, businesses or intellectual property that we feel could complement our business, enhance our technical capabilities or increase our intellectual property portfolio. If we consummate acquisitions through an exchange of our securities, our stockholders could suffer significant dilution. Acquisitions could create risks for us, including:

- unanticipated costs associated with the acquisitions;

- use of substantial portions of our available cash, including the proceeds of this offering, to consummate the acquisitions;

- diversion of management's attention from other business concerns; and

- difficulties in assimilation of acquired personnel or operations.

Any future acquisitions, even if successfully completed, might not generate any additional revenue or provide any benefit to our business.

YEAR 2000 COMPLIANCE COSTS AND RISKS ARE DIFFICULT TO ASSESS AND COULD RESULT IN DELAY OR LOSS OF REVENUES, DAMAGE TO OUR REPUTATION AND DIVERSION OF DEVELOPMENT RESOURCES

Many computer programs and embedded date-reliant systems use two digits rather than four to define the applicable year. Programs and systems that record only the last two digits of the calendar year may not be able to distinguish whether "00" means 1900 or 2000. If not corrected, date-related information and data could cause these programs or systems to fail or to generate erroneous information.

To the extent that any third-party product with which our technology is associated is not Year 2000 compliant, our reputation may be harmed. Our revenue and operating results could become subject to unexpected fluctuations if our licensees encounter Year 2000 compliance problems that affect their ability to distribute licensed products. In addition, a delay or failure by our critical suppliers to be Year 2000 compliant could interrupt our business.

WE MAY NOT BE ABLE TO RAISE ADDITIONAL CAPITAL IN THE FUTURE, WHICH COULD LIMIT OUR ABILITY TO GROW

We may in the future be required to raise additional funds through public or private financing, strategic relationships or other arrangements. We cannot be certain that any financing will be available on acceptable terms, or at all, and our failure to raise capital when needed could limit our ability to expand our business. In addition, an equity financing may be dilutive to the holders of our common stock, and debt financing, if available, may involve restrictive covenants. Moreover, strategic relationships, if necessary to raise additional funds, may require that we relinquish valuable rights.

14

OUR STOCK MAY BE VOLATILE AND YOU MAY NOT BE ABLE TO RESELL YOUR SHARES AT OR ABOVE THE INITIAL PUBLIC OFFERING PRICE.

There has been no public market for our common stock prior to this offering. The initial public offering price for our common stock will be determined through negotiations between the underwriters and us. The market price of our common stock after the offering may vary from the initial public offering price. If you purchase shares of our common stock, you may not be able to resell those shares at or above the initial public offering price. In addition, the stock market has experienced extreme volatility that often has been unrelated or disproportionate to the performance of particular companies. These market fluctuations may cause our stock price to decline regardless of our performance. You should read the "Underwriting" section on page 62 for a more complete discussion of the factors to be considered in determining the initial public offering price of our common stock.

OUR EXECUTIVE OFFICERS, DIRECTORS AND MAJOR STOCKHOLDERS WILL RETAIN SIGNIFICANT CONTROL OVER US AFTER THIS OFFERING, WHICH MAY LEAD TO CONFLICTS WITH OTHER STOCKHOLDERS OVER CORPORATE GOVERNANCE MATTERS

We anticipate that our current directors, officers and more than 5% stockholders will, as a group, beneficially own approximately 46% of our outstanding common stock after this offering. Acting together, these stockholders would be able to significantly influence all matters that our stockholders vote upon, including the election of directors and mergers or other business combinations, which could have the effect of delaying or preventing a third party from acquiring control over or merging with us.

PROVISIONS IN OUR CHARTER DOCUMENTS AND DELAWARE LAW COULD PREVENT OR DELAY A

CHANGE IN CONTROL, WHICH COULD REDUCE THE MARKET PRICE OF OUR COMMON STOCK

Provisions in our certificate of incorporation and bylaws may have the effect of delaying or preventing a change of control or changes in our management. These provisions could limit the price that investors might be willing to pay in the future for shares of our common stock. These provisions include, among others:

- the division of our board of directors into three separate classes;

- the ability of our board of directors to issue up to 5,000,000 shares of preferred stock, and to determine the prices, rights, preferences, privileges and restrictions, including voting rights, of those shares without any further vote or action by the stockholders;

- advance notice requirements for stockholders to nominate directors and bring stockholder proposals to a vote; and

- the inability of stockholders to act by written consent.

Furthermore, because we are incorporated in Delaware, we are subject to the provisions of Section 203 of the Delaware General Corporation Law. These provisions prohibit stockholders owning 15% or more of the outstanding voting stock from consummating a merger or combination between us and another corporation unless:

- 66 2/3% of the shares of voting stock not owned by the large stockholders approve the merger or combination; or

- The board of directors approves the merger or combination or the transaction that resulted in the large stockholders which own 15% or more of our outstanding voting stock.

15

MANAGEMENT COULD SPEND THE PROCEEDS OF THIS OFFERING IN WAYS WITH WHICH OUR STOCKHOLDERS MAY NOT AGREE

We plan to use the proceeds from this offering for working capital and other general corporate purposes. We may use the proceeds in ways with which you do not agree or that prove to be disadvantageous to our stockholders. We may not be able to invest the proceeds of this offering, in our operations or external investments, to yield a favorable return.

THERE ARE A LARGE NUMBER OF SHARES THAT MAY BE SOLD IN THE MARKET FOLLOWING THIS OFFERING, WHICH MAY DEPRESS THE MARKET PRICE OF OUR COMMON STOCK

Sales of substantial numbers of shares of our common stock in the public market after this offering, or the perception that sales may be made, could cause the market price of our common stock to decline. In addition, the sale of these shares could impair our ability to raise capital through the sale of additional equity securities. Based on shares outstanding as of September 30, 1999, following this offering, we will have 15,441,856 shares of common stock outstanding or 15,579,086 shares if the underwriters' over-allotment is exercised in full. 8,875,526 shares will become available for sale 180 days following the date of this prospectus upon the expiration of lock-up agreements, subject to the restrictions imposed by the federal securities laws on sales by affiliates. Hambrecht & Quist LLC, however, may waive the lock-up restrictions at its sole discretion.

16

FORWARD-LOOKING STATEMENTS

This prospectus, including the sections entitled "Prospectus Summary," "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Business," contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. These risks and other factors include those listed under "Risk Factors" and elsewhere in this prospectus. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," the negative of these terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially. In evaluating these statements, you should specifically consider various factors, including the risks outlined under "Risks Factors." These factors may cause our actual results to differ materially from any forward-looking statement.

Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. We are under no duty to update any of these forward-looking statements after the date of this prospectus to conform our prior statements to actual results or revised expectations.

USE OF PROCEEDS

We estimate that our net proceeds from the sale of the 4,250,000 shares of common stock offered by us will be approximately $38,525,000, at an assumed initial offering price per share of $10.00 and after deducting the estimated underwriting discounts and commissions and estimated offering expenses.

The principal purposes of the offering are to obtain additional working capital, establish a public market for our common stock and facilitate our future access to public capital markets. We currently expect to use the net proceeds from this offering for working capital and other general corporate purposes. We have not yet determined our expected use of these proceeds, but we currently anticipate that we will incur at least $3.5 million in research and development expenses and $6 million in sales and marketing expenses through the end of the year 2000. Actual expenditures may vary substantially from these estimates. The amounts and timing of our actual expenditures will depend upon numerous factors, including the status of our development efforts, marketing and sales activities and the amount of cash generated by our operations. We may find it necessary or advisable to use portions of the proceeds for other purposes. We may also use a portion of the net proceeds to acquire or invest in complementary businesses or products or to obtain the right to use complementary technologies. We have no current commitments or agreements with respect to any acquisition or investment. Pending these uses, we intend to invest the net proceeds in short-term, investment-grade, interest-bearing securities.

DIVIDEND POLICY

We have never declared or paid cash dividends on our capital stock. We currently expect to retain earnings, if any, to finance the growth and development of our business. Therefore, we do not anticipate paying cash dividends on our common stock in the foreseeable future. The decision whether to pay dividends will be made by our board of directors from time to time in light of conditions then existing including, among other things, our results of operations, financial condition and capital expenditure requirements.

17

CAPITALIZATION

The following table sets forth our capitalization as of June 30, 1999. The pro forma information reflects the conversion of all outstanding shares of our preferred stock into 5,131,100 shares of common stock upon the closing of the offering. The pro forma as adjusted information reflects the sale of shares of common stock offered by us at an assumed initial public offering price of $10.00 per share and after deducting the estimated underwriting discounts and commissions and estimated offering expenses. The common stock outstanding as of June 30, 1999 excludes:

- 5,991,973 shares reserved for issuance under our stock option plans, of which 3,344,329 shares were subject to outstanding options, with a weighted average exercise price of $1.13 per share;

- 498,593 shares subject to outstanding warrants, with a weighted average exercise price of $2.72 per share; and

- 500,000 shares reserved for issuance under our 1999 Employee Stock Purchase Plan.

                                                                        JUNE 30, 1999
                                                              ---------------------------------
                                                                                     PRO FORMA
                                                              ACTUAL    PRO FORMA   AS ADJUSTED
                                                              -------   ---------   -----------
                                                                       (IN THOUSANDS)
Redeemable convertible preferred stock, $0.001 par value;
  863,778 shares designated, 863,771 shares issued and
  outstanding, actual; none authorized, issued or
  outstanding, pro forma or pro forma as adjusted...........  $ 1,479    $    --      $    --
                                                              -------    -------      -------
Stockholders' equity:
  Convertible preferred stock, $0.001 par value; 10,215,716
     shares authorized, actual; 4,267,329 shares issued and
     outstanding, actual; 5,000,000 shares authorized and
     none issued or outstanding, pro forma or pro forma as
     adjusted...............................................    6,955         --           --
  Common stock, $0.001 par value; 100,000,000 shares
     authorized and 5,901,405 shares issued and outstanding,
     actual; 100,000,000 shares authorized, pro forma and
     pro forma as adjusted; 11,032,505 shares issued and
     outstanding, pro forma; 15,282,505 shares issued and
     outstanding, pro forma as adjusted.....................    7,947     16,381       54,906
Warrants....................................................      893        893          893
Deferred stock compensation.................................   (2,075)    (2,075)      (2,075)
Accumulated other comprehensive loss........................       --         --           --
Note receivable from stockholder............................      (17)       (17)         (17)
Accumulated deficit.........................................   (6,333)    (6,333)      (6,333)
                                                              -------    -------      -------
     Total stockholders' equity.............................    7,370      8,849       47,374
                                                              -------    -------      -------
          Total capitalization..............................  $ 8,849    $ 8,849      $47,374
                                                              =======    =======      =======

18

DILUTION

Our pro forma net tangible book value as of June 30, 1999 was $4,008,000, or $0.36 per share of common stock. Pro forma net tangible book value per share represents the amount of our total tangible assets (total assets excluding purchased patents and technology) less the amount of our total liabilities and divided by the total number of shares of common stock outstanding after conversion of all outstanding shares of preferred stock into common stock. Taking into account the sale of the 4,250,000 shares of common stock offered by us at an assumed initial public offering price of $10.00 per share and after deducting the estimated underwriting discounts and commissions and estimated offering expenses and receipt of the net proceeds, our adjusted pro forma net tangible book value as of June 30, 1999 would have been approximately $42,533,000, or $2.78 per share. This represents an immediate increase in net tangible book value of $2.42 per share to existing stockholders and an immediate dilution of $7.22 per share to the new investors. The following table illustrates this per share dilution:

Assumed initial public offering price per share.............           $10.00
  Pro forma net tangible book value per share as of June 30,
     1999...................................................  $0.36
  Increase in net tangible book value attributable to new
     investors..............................................   2.42
                                                              -----
As adjusted pro forma net tangible book value per share
  after the offering........................................             2.78
                                                                       ------
Dilution per share to new investors.........................           $ 7.22
                                                                       ======

The following table sets forth, on a pro forma basis as of June 30, 1999, the difference between the number of shares of common stock purchased, the total consideration paid and the average price per share paid by the existing stockholders and by the new investors purchasing shares in this offering, at an assumed initial public offering price of $10.00 per share and before deducting the estimated underwriting discounts and commissions and estimated offering expenses:

                             SHARES PURCHASED        TOTAL CONSIDERATION      AVERAGE
                           ---------------------    ----------------------   PRICE PER
                             NUMBER      PERCENT      AMOUNT       PERCENT     SHARE
                           ----------    -------    -----------    -------   ---------
Existing stockholders....  11,032,505      72.2%    $ 8,590,000      16.8%    $ 0.78
New investors............   4,250,000      27.8      42,500,000      83.2     $10.00
                           ----------     -----     -----------     -----
          Total..........  15,282,505     100.0%    $51,090,000     100.0%
                           ==========     =====     ===========     =====

The above tables exclude 6,491,973 shares of common stock reserved for issuance under our stock option and stock purchase plans, of which 3,344,329 shares were subject to outstanding options as of June 30, 1999 with a weighted average price of $1.13 per share, and 498,593 shares of common stock were subject to outstanding warrants with a weighted average price of $2.72 per share. New investors will experience further dilution if any additional shares of our common stock are issued upon the exercise of these options or warrants.

19

SELECTED CONSOLIDATED FINANCIAL DATA

The following selected consolidated financial data should be read in conjunction with "Management's Discussion and Analysis of Financial Condition and Results of Operations" and with the consolidated financial statements, related notes and other financial information included in this prospectus. The selected consolidated statement of operations data for the years ended December 31, 1996, 1997 and 1998 and the consolidated balance sheet data as of December 31, 1997 and 1998 are derived from the audited consolidated financial statements included elsewhere in this prospectus. The selected consolidated balance sheet data as of December 31, 1996 are derived from audited consolidated financial statements not included in this prospectus. The selected consolidated financial data as of and for the years ended December 31, 1994 and 1995 are derived from unaudited financial statements not included in this prospectus. The consolidated statement of operations data for the six months ended June 30, 1998 and 1999 and the consolidated balance sheet data as of June 30, 1999 are derived from unaudited consolidated financial statements included elsewhere in this prospectus. We believe that the unaudited consolidated financial statements contain all adjustments necessary to present fairly the information included in those statements, and that the adjustments consist only of normal recurring adjustments. Historical results are not necessarily indicative of the results to be expected in the future, and results of interim periods are not necessarily indicative of results for the entire year.

                                                                                            SIX MONTHS
                                                   YEAR ENDED DECEMBER 31,                ENDED JUNE 30,
                                         -------------------------------------------    -------------------
                                          1994     1995     1996     1997     1998        1998       1999
                                         ------   ------   ------   ------   -------    --------   --------
CONSOLIDATED STATEMENT OF OPERATIONS
  DATA:
  Revenues:
    Royalty revenue....................  $   --   $   --   $   --   $   14   $   321     $    8    $   622
    Product sales......................     444    1,068    2,022    2,908     3,725      1,604      2,133
    Development contracts and other....     117      285      715    1,410       975        565        748
                                         ------   ------   ------   ------   -------     ------    -------
         Total revenues................     561    1,353    2,737    4,332     5,021      2,177      3,503
                                         ------   ------   ------   ------   -------     ------    -------
  Costs and expenses:
    Cost of product sales..............     210      540      947    1,186     1,507        641        970
    Sales and marketing................      87      224      422      658       656        361        459
    Research and development...........     216      393      710    1,515     1,817        833      1,057
    General and administrative.........      55      267      766    1,550     2,677      1,269      1,548
    Amortization of intangibles and
      deferred stock compensation......      --       --        1       --       211         21        463
    In-process research and
      development......................      --       --       --       --        --         --      1,190
                                         ------   ------   ------   ------   -------     ------    -------
         Total costs and expenses......     568    1,424    2,846    4,909     6,868      3,125      5,687
                                         ------   ------   ------   ------   -------     ------    -------
  Operating loss.......................      (7)     (71)    (109)    (577)   (1,847)      (948)    (2,184)
  Other income.........................       2       14       28       50       174         79         66
                                         ------   ------   ------   ------   -------     ------    -------
  Net loss.............................  $   (5)  $  (57)  $  (81)  $ (527)  $(1,673)    $ (869)   $(2,118)
                                         ======   ======   ======   ======   =======     ======    =======
  Basic and diluted net loss per
    share..............................  $(0.01)  $(0.02)  $(0.03)  $(0.17)  $ (0.43)    $(0.23)   $ (0.42)
                                         ======   ======   ======   ======   =======     ======    =======
  Shares used in calculating basic and
    diluted net loss per share.........   2,653    2,468    2,825    3,162     3,909      3,839      5,003
                                         ======   ======   ======   ======   =======     ======    =======
  Pro forma basic and diluted net loss
    per share..........................                                      $ (0.19)              $ (0.21)
                                                                             =======               =======
  Shares used in calculating pro forma
    basic and diluted net loss per
    share..............................                                        8,630                10,134
                                                                             =======               =======

                                                                 DECEMBER 31,
                                                ----------------------------------------------    JUNE 30,
                                                 1994      1995      1996      1997      1998       1999
                                                ------    ------    ------    ------    ------    --------
CONSOLIDATED BALANCE SHEET DATA:
  Cash and cash equivalents...................  $  156    $   37    $  324    $  490    $2,592     $2,204
  Working capital.............................     149       779     1,151     2,080     3,975      3,339
  Total assets................................     308       963     1,562     2,900     5,959      9,706
  Redeemable convertible preferred stock......      --        --        --     1,471     1,476      1,479
  Total stockholders' equity..................     157       876     1,383       944     3,773      7,370

20

MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion and analysis in conjunction with our consolidated financial statements and the notes thereto beginning on page F-1 of this prospectus and the Selected Consolidated Financial Data above. Except for historical information, the discussion in this prospectus contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences include the risks discussed in the section titled "Risk Factors."

OVERVIEW

Immersion was founded in 1993 to develop technologies that help improve human to computer interaction. Historically, we have derived most of our revenue from sales of products and from development contracts. We began generating royalty revenue in the first quarter of 1997 and anticipate that royalty revenue will become an increasing percentage of our total revenues.

We began developing feel-enabled computer peripherals in 1993. In 1995, we introduced our Impulse Engine line of high-end feel-enabled devices for industrial, research and education markets. We manufacture and sell these products directly to our customers. In 1996, we introduced I-FORCE, our first branded portfolio of feel technology for consumer markets. We license I-FORCE, generally on a per unit royalty basis, to computer gaming peripheral manufacturers. Also in 1996, the first computer joystick incorporating I-FORCE was introduced.

We introduced FEELit, a technology for feel-enabled cursor control products, such as mice and trackballs, in 1997. In 1998, we licensed FEELit to Logitech, which has announced its intention to ship the first FEELit mouse in late 1999.

We have developed a custom processor for feel-enabled products that is manufactured by Kawasaki LSI, and we began selling this processor in September 1998. In addition to selling the processors ourselves, we granted Kawasaki LSI a limited royalty-bearing license to sell these processors to our customers.

We currently sell products in the industrial and professional markets. We developed our first three dimensional digitizer product in 1994 and currently sell this product under the name MicroScribe-3D. We began developing our Softmouse product for the geographic information systems market in 1994. This mouse product is sold to original equipment manufacturers. We began developing technology and products for the medical market in 1993. We derive revenues from selling medical training and simulation products. In June 1999, we also began to license technologies for the medical training and simulation market.

We have entered into numerous contracts with government agencies and corporations since 1993. Government contracts help fund advanced research and development, are typically less than two years in duration, are usually for a fixed price or for our costs plus a fixed fee, and allow the government agency to license the resulting technology for government applications specifically excluding any commercial activity. Corporate contracts are typically for product development consulting, are for a fixed fee and are also less than two years in duration.

Logitech accounted for 19% of our total revenues for the six months ended June 30, 1999 and 11% of our total revenues in 1998. The U.S. Government accounted for 11% of our total revenues for the six months ended June 30, 1999, 10% of our total revenues in 1998, 24% of our total revenues in 1997 and 16% of our total revenues in 1996.

Since inception, we have completed a number of acquisitions of patents and technology. We capitalize the cost of patents and technology and license agreements, except for amounts relating to acquired in-process research and development for which there is no alternative future use. As of June 30, 1999, we had capitalized patents and technology of $4.8 million, net of accumulated

21

amortization of $426,000. We are amortizing these patents and technology over the estimated useful life of the technology of nine years.

In the quarter ended March 31, 1999, we expensed $1.2 million of acquired in-process research and development related to five development projects. The first of these projects is a flexible force feedback development environment that allows developers to choose the level of complexity/functionality that fits their needs. At the time of acquisition, the development was 81% completed and the estimated cost to complete this development was $438,000. Management expects to ship products using this software beginning in June, 2001. The second of these projects, a three-degree-of-freedom joystick, gives the operator smooth, intuitive movement and feedback along three axes-roll, pitch and yaw-using brushless motor and encoder technology. At the time of acquisition, the development was 36% completed and the estimated cost to complete this development was $109,000. Management expects products based on this technology to become available in December 2000. The third of these projects is a six degree-of-freedom hand controller, a small back drivable robot that moves in six degrees of freedom, three linear positions and attitudes. At the time of acquisition, the development was 70% completed and the estimated cost to complete this development was $88,000. Management expects to complete development of a product based on this technology and begin shipping it in fiscal 2000. The fourth project is a Flight Yoke, which provides the intuitive motion and feel of an airplane control yoke. It translates in and out to control the pitch, rotates for roll control, and provides the corresponding feel along these axes of motion. At the time of acquisition, the development was 49% completed and the estimated cost to complete this development was $175,000. Management expects that licensees will ship licensed products using this technology in fiscal 2001. The fifth development project is a device which allows the user to reach inside the computer monitor and feel three-dimensional objects. At the time of acquisition, the development was 11% completed and the estimated cost to complete this development was $248,000. Management expects that a product based on this technology will become available for sale in fiscal 2000.

We will begin to benefit from the acquired research and development of these products once they begin shipping. Failure to reach successful completion of these projects could result in impairment of the associated capitalized intangible assets and could require us to accelerate the time period over which the intangibles are being amortized, which could have a material adverse effect on our business, financial condition and results of operation. Significant assumptions used to determine the value of in-process research and development including the following: (i) forecast of net cash flows that were expected to result from the development effort using projections prepared by us and the seller's management; (ii) the portion of the projects completed estimated by considering a number of factors, including the costs invested to date relative to total cost of the development effort and the amount of progress completed as of the acquisition date, on a technological basis, relative to the overall technological achievements required to achieve the functionality of the eventual product. The technological issues were addressed by engineering representatives from both us and the seller, and when estimating the value of the technology, the projected financial results of the acquired assets were estimated on a stand-alone basis without any consideration to potential synergistic benefits or "investment value" related to the acquisition. As there were no existing products acquired, separate projected cash flows were prepared for the existing and the in-process projects.

These projected results were based on the number of units sold times the average selling price less the associated costs. After preparing the estimated cash flows from the products being developed, a portion of these cash flows were attributed to the existing technology, which was embodied in the in-process product lines and enabled a quicker and more cost-effective development of these products. When estimating the value of the in-process technologies, a discount rate of 30% was used. The discount rate considered both the status and risks associated with the cash flows at the acquisition date. Projected revenues from the in-process products are expected to begin in 2000 and 2001 as the products are completed and begin to ship. Initial annual

22

revenue growth rates after introduction are projected to exceed 50% and decline to less than 15% by 2005. Gross margins from these products are anticipated to be consistent with the gross margins from its other products.

We record revenue from product sales upon shipment. We recognize fixed-fee contract revenue under the cost-to-cost percentage-of-completion accounting method based on the actual physical completion of work performed and the ratio of costs incurred to total estimated costs to complete the contract. We recognize allowable fees under cost-reimbursement contracts as costs are incurred. Losses on contracts are recognized when determined. Revisions in estimates are reflected in the period in which the conditions become known. We recognize royalty revenue based on royalty reports or related information received from the licensee.

Our cost of product sales consists primarily of materials, labor and overhead. There is no cost of sales associated with royalty revenue or development contract revenue. Our research and development expenses are comprised primarily of headcount and related compensation and benefits, consulting fees, costs of acquired technology, tooling and supplies and an allocation of facilities costs. Our sales and marketing expenses are comprised primarily of employee headcount and related compensation and benefits, advertising, trade shows, brochures, travel and an allocation of facilities costs. Our general and administrative expenses are comprised primarily of employee headcount and related compensation and benefits, legal and professional fees, office supplies, recruiting, travel and an allocation of facilities costs.

We recorded deferred stock compensation of $2.3 million during the six months ended June 30, 1999 from the issuance of warrants for services and from employee stock options. We are amortizing the deferred stock compensation over the terms of the related option agreements, which range up to four years.

HISTORICAL RESULTS OF OPERATIONS

The following table sets forth our statement of operations data as a percentage of total revenues.

                                                                                   SIX MONTHS
                                                      YEAR ENDED DECEMBER 31,    ENDED JUNE 30,
                                                      -----------------------    --------------
                                                      1996     1997     1998     1998     1999
                                                      -----    -----    -----    -----    -----
Revenues:
  Royalty revenue...................................     --%     0.3%     6.4%     0.4%    17.8%
  Product sales.....................................   73.9     67.1     74.2     73.7     60.9
  Development contracts and other...................   26.1     32.6     19.4     25.9     21.3
                                                      -----    -----    -----    -----    -----
          Total revenues............................  100.0    100.0    100.0    100.0    100.0
                                                      -----    -----    -----    -----    -----
Costs and expenses:
  Cost of product sales.............................   34.6     27.4     30.0     29.4     27.7
  Sales and marketing...............................   15.4     15.2     13.1     16.6     13.1
  Research and development..........................   25.9     35.0     36.2     38.2     30.2
  General and administrative........................   28.0     35.8     53.3     58.3     44.2
  Amortization of intangibles and deferred stock
     compensation...................................     --       --      4.2      1.0     13.2
  In-process research and development...............     --       --       --       --     34.0
                                                      -----    -----    -----    -----    -----
          Total costs and expenses..................  103.9    113.4    136.8    143.5    162.4
                                                      -----    -----    -----    -----    -----
Operating loss......................................   (3.9)   (13.4)   (36.8)   (43.5)   (62.4)
Other income........................................    1.0      1.2      3.5      3.6      1.9
                                                      -----    -----    -----    -----    -----
Net loss............................................   (2.9)%  (12.2)%  (33.3)%  (39.9)%  (60.5)%
                                                      =====    =====    =====    =====    =====

23

COMPARISON OF SIX MONTHS ENDED JUNE 30, 1998 AND 1999

Total Revenues. Our total revenues increased by 61% from $2.2 million for the six months ended June 30, 1998 to $3.5 million for the six months ended June 30, 1999. Royalty revenue increased by $614,000 from $8,000 to $622,000 due to higher sales by our I-FORCE licensees. Product sales increased by $529,000 from $1.6 million to $2.1 million primarily due to increased sales of industrial and professional products. Development contracts and other revenue increased by $183,000 from $565,000 to $748,000 due to new government and commercial contracts entered into in mid-1998 which were in progress during 1999.

Cost of Product Sales. Cost of product sales increased from $641,000 for the six months ended June 30, 1998 to $970,000 for the six months ended June 30, 1999. Cost of product sales as a percentage of product sales increased from 40% for the six months ended June 30, 1998 to 46% for the six months ended June 30, 1999. The increase in cost of product sales as a percentage of product sales was primarily due to increased sales of our processor, which has a lower margin than other products.

Sales and Marketing. Sales and marketing expenses increased by 27% from $361,000 for the six months ended June 30, 1998 to $459,000 for the six months ended June 30, 1999 primarily as a result of increased headcount and related compensation and benefits. We expect sales and marketing expenses to increase significantly in absolute dollars due to planned growth of our sales and marketing organization. These planned increases include higher employee headcount and related compensation and increased advertising and marketing expenses.

Research and Development. Research and development expenses increased by 27% from $833,000 for the six months ended June 30, 1998 to $1.1 million for the six months ended June 30, 1999. Research and development expenses increased due to increases in employee headcount and related compensation of $182,000, and an increase of $28,000 in consulting services. We believe that continued investment in research and development is critical to our future success, and we expect these expenses to increase in absolute dollars in future periods.

General and Administrative. General and administrative expenses increased by 22% from $1.3 million for the six months ended June 30, 1998 to $1.5 million for the six months ended June 30, 1999. The increase was primarily the result of increased compensation and benefits. We expect that the dollar amount of general and administrative expenses will increase in the future as we incur the significant additional costs related to being a public company.

Amortization of Intangibles and Deferred Stock Compensation. Amortization of intangibles and deferred stock compensation increased $442,000 from $21,000 for the six months ended June 30, 1998 to $463,000 for the six months ended June 30, 1999.

In-Process Research and Development. During the six months ended June 30, 1999, we incurred a charge of $1.2 million dollars for in-process research and development resulting from the acquisition of technology from Cybernet Haptic Systems.

Other Income. Other income consists primarily of interest income, dividend income and capital gains from cash and cash equivalents and short-term investments. Other income decreased from $79,000 for the six months ended June 30, 1998 to $66,000 for the six months ended June 30, 1999 primarily due to a decrease in cash and cash equivalents and short-term investments.

Income Taxes. We have not recorded provisions for income taxes other than minimum state taxes because we have experienced net losses since our inception.

COMPARISON OF YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998

Total Revenues. Our total revenues increased 58% from $2.7 million in 1996 to $4.3 million in 1997 and an additional 16% to $5.0 million in 1998. The increase from 1996 to 1997 was primarily the result of an $886,000 increase in product sales, principally from our MicroScribe-3D and

24

industrial products, and a $695,000 increase in development contract revenue, relating primarily to an increase in government contract revenue. The increase from 1997 to 1998 was principally the result of an $817,000 increase in product sales, primarily from our MicroScribe-3D and industrial products, and a $307,000 increase in royalty revenue due to increased sales by our I-FORCE licensees in 1998. The increase in product sales and royalty revenue was partially offset by a $435,000 decrease in contract revenue.

Cost of Product Sales. Cost of product sales were $947,000 in 1996, $1.2 million in 1997 and $1.5 million in 1998. Cost of product sales as a percentage of product sales was 47% in 1996, 41% in 1997 and 40% in 1998. Cost of product sales as a percentage of product sales decreased from 1996 to 1997 and 1998 primarily due to increased sales of higher margin industrial products and manufacturing efficiencies resulting from higher unit sales.

Sales and Marketing. Sales and marketing expenses increased 56% from $422,000 in 1996 to $658,000 in 1997 and remained constant at $656,000 in 1998. The increase from 1996 to 1997 was primarily a result of increased employee headcount and related compensation and benefits.

Research and Development. Research and development expenses increased 113% from $710,000 in 1996 to $1.5 million in 1997 and by 20% from 1997 to $1.8 million in 1998. The increase from 1996 to 1997 was due to a $436,000 increase in employee headcount and related compensation, a $262,000 increase in consulting services and an increase of $103,000 in supplies. The increase from 1997 to 1998 was principally due to an increase in employee headcount and related compensation.

General and Administrative. General and administrative expenses increased 102% from $766,000 in 1996 to $1.6 million in 1997 and by 73% from 1997 to $2.7 million in 1998. The increase from 1996 to 1997 was due to an increase of $309,000 in employee headcount and related compensation expenses and an increase of $290,000 in legal and professional fees. The increase from 1997 to 1998 was principally due to an increase in employee headcount and related compensation and benefits.

Amortization of Intangibles and Stock Compensation. Amortization of intangibles and stock compensation expense was $211,000 in 1998, representing amortization of licenses and patents acquired in 1998.

Other Income. Other income consists primarily of interest income, dividend income and capital gains from cash and cash equivalents and short-term investments. Other income was $28,000 in 1996, $50,000 in 1997 and $174,000 in 1998. These increases were due to increases in cash and cash equivalents and short-term investments in each of those years.

QUARTERLY RESULTS OF OPERATIONS

The following table presents certain unaudited consolidated statement of operations data for our six most recent quarters. This information has been derived from our unaudited consolidated financial statements. In our opinion, this unaudited information has been prepared on the same basis as the annual consolidated financial statements and includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the information for the quarters presented. This information should be read in conjunction with the consolidated financial

25

statements and related notes included elsewhere in this prospectus. Historical results for any quarter are not necessarily indicative of the results to be expected for any future period.

                                                                           THREE MONTHS ENDED
                                                   ------------------------------------------------------------------
                                                   MARCH 31,   JUNE 30,   SEPT. 30,   DEC. 31,   MARCH 31,   JUNE 30,
                                                     1998        1998       1998        1998       1999        1999
                                                   ---------   --------   ---------   --------   ---------   --------
                                                                             (IN THOUSANDS)
Revenues:
  Royalty revenue................................   $    5      $    3     $   --      $  313     $   481     $  141
  Product sales..................................      720         884        980       1,141       1,085      1,048
  Development contracts and other................      314         251        251         159         310        438
                                                    ------      ------     ------      ------     -------     ------
         Total revenues..........................    1,039       1,138      1,231       1,613       1,876      1,627
                                                    ------      ------     ------      ------     -------     ------
Costs and expenses:
  Cost of product sales..........................      293         348        431         435         494        476
  Sales and marketing............................      136         225        175         120         187        272
  Research and development.......................      379         454        445         539         458        599
  General and administrative.....................      561         708        756         652         752        796
  Amortization of intangibles and deferred stock
    compensation.................................        2          19         29         161         118        345
  In-process research and development............       --          --         --          --       1,190         --
                                                    ------      ------     ------      ------     -------     ------
         Total costs and expenses................    1,371       1,754      1,836       1,907       3,199      2,488
                                                    ------      ------     ------      ------     -------     ------
Loss from operations.............................     (332)       (616)      (605)       (294)     (1,323)      (861)
Other income.....................................       24          55         56          39          40         26
                                                    ------      ------     ------      ------     -------     ------
Net loss.........................................   $ (308)     $ (561)    $ (549)     $ (255)    $(1,283)    $ (835)
                                                    ======      ======     ======      ======     =======     ======

Royalty revenue in the quarter ended December 31, 1998 increased to $313,000 from no revenue in the quarter ended September 30, 1998. This increase resulted from nine new products introduced for the 1998 holiday season by our licensees. Royalty revenue in the quarter ended June 30, 1999 decreased to $141,000 from $481,000 in the quarter ended March 31, 1999. This decline was due primarily to a decrease in revenues from our licensing partners following the holiday season. Development contracts and other revenue in the quarter ended March 31, 1999 increased to $310,000 from $159,000 in the quarter ended December 31, 1998. This increase was partially due to a new government contract signed in late 1998, which began generating revenue in the quarter ended March 31, 1999. Sales and marketing expenses decreased from $175,000 in the quarter ended September 30, 1998 to $120,000 in the quarter ended December 31, 1998 due primarily to the absence of any significant trade show expenses in the quarter ended December 31, 1998. Sales and marketing expenses increased from $120,000 in the quarter ended December 31, 1998 to $187,000 in the quarter ended March 31, 1999 due primarily to the trade show expense of a game developer conference we attended in March 1999. Research and development expenses decreased in the quarter ended March 31, 1999 due to a temporary drop in the number of employees and a reduction in consulting expenses. General and administrative expenses decreased from $756,000 in the quarter ended September 30, 1998 to $652,000 in the quarter ended December 31, 1998. The decrease was primarily due to a $52,000 decrease in legal fees and a $41,000 decrease in consulting fees.

Because our historical financial information does not reflect our primary business strategy for the future, we cannot forecast future revenues based on historical results. We base our expenses in part on future revenue projections. Most of our expenses are fixed in nature, and we may not be able to reduce spending quickly if revenue is lower than we have projected. We expect that our business, operating results and financial condition would be harmed if revenues do not meet expectations.

26

Our revenues and operating results are likely to vary significantly from quarter to quarter due to a number of factors, many of which are outside our control and any of which could cause the price of our common stock to decline. These factors include:

- the mix of product sales, development contracts and royalty revenue;

- the establishment or loss of licensing relationships;

- the timing of our expenses;

- the timing of announcements and introductions of new products and product enhancements by our licensees and their competitors;

- our ability to develop and improve our technologies;

- our ability to attract, integrate and retain qualified personnel;

- costs related to acquisitions of technologies or businesses; and

- seasonality in the demand for our licensees' products.

Because a high percentage of our operating expenses is fixed, a shortfall of revenues can cause significant variations in operating results from period to period.

LIQUIDITY AND CAPITAL RESOURCES

Since inception, we have funded our operations primarily from the sale of preferred stock. As of June 30, 1999, we had an accumulated deficit of $6.3 million and working capital of $3.3 million, including cash and cash equivalents of $2.2 million.

Net cash used in operating activities for the six months ended June 30, 1999 was $195,000, primarily attributable to a net loss of $2.1 million, largely offset by non-cash charges, including a $1.2 million in-process research and development charge and $257,000 of amortization expense in connection with our acquisition of Cybernet. In 1998, net cash used in operating activities was $1.8 million, primarily attributable to a net loss of $1.7 million, an increase of $592,000 in accounts receivable and an increase of $186,000 in inventories. In 1997, net cash used in operating activities was $237,000, primarily attributable to a net loss of $527,000, largely offset by an increase in accounts payable of $189,000. In 1996, net cash use in operating activities was $208,000, attributable primarily to a net loss of $81,000, an increase of $131,000 in accounts receivable and an increase of $94,000 in inventories, offset by an increase of $75,000 in accrued liabilities.

Net cash used in investing activities for the six months ended June 30, 1999 was $345,000, and primarily consisted of $476,000 of purchases of property and other assets, offset by $201,000 from sales of short-term investments. In 1998, net cash provided by investing activities was $237,000, attributable to $3.8 million from sales of short-term investments primarily offset by $2.9 million of purchases of short-term investments and $434,000 for purchases of patents and technology. In 1997, net cash used in investing activities was $1.2 million, and was attributable to $1.5 million of purchases of short-term investments and $205,000 of purchases of property, offset by $538,000 from sales of short-term investments. In 1996, net cash used in investing activities was $107,000, and was attributable to $325,000 of purchases of short-term investments and $181,000 of purchases of property, offset by $399,000 from sales of short-term investments. In order to improve our rate of return on cash and still provide short-term liquidity, we periodically purchase or sell short-term investments which typically include interest bearing investment grade securities with a maturity of greater than 90 days and less than one year.

Net cash provided by financing activities for the six months ended June 30, 1999 was $152,000, and consisted primarily of net proceeds of $151,000 from the exercise of stock options. In 1998, net cash provided by financing activities was $3.7 million and was attributable primarily to net proceeds of $5.4 million from the sale of preferred stock, offset by the repurchase of $1.8 million of stock. In 1997, net cash provided by financing activities was $1.6 million and was attributable primarily to the proceeds of $1.5 million from the sale of preferred stock. In 1996, net cash provided by financing

27

activities was $596,000 and was attributable primarily to net proceeds of $590,000 from the sale of preferred stock.

We believe that the net proceeds of this offering, together with our cash, cash equivalents and short-term investments, will be sufficient to meet our working capital needs for at least the next 12 months. We anticipate that capital expenditures for the last six months of 1999 and for the full year ended December 31, 2000 will be approximately $1.0 million. Thereafter, we may require additional funds to support our working capital requirements or for other purposes and may seek to raise additional funds through public or private equity financing or from other sources. Additional financing may not be available at all or, if available, may not be obtainable on terms favorable to us. In addition, any additional financing may be dilutive. Although there are no present understandings, commitments or agreements with respect to any acquisition of other businesses, products or technologies, from time to time in the ordinary course of business, we evaluate potential acquisitions of businesses, products or technologies that are complementary to those of our business and may in the future use a portion of our cash to acquire or invest in complementary businesses or products or obtain the right to use complementary technologies.

QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Sensitivity. Our operating results have not been sensitive to changes in the general level of U.S. interest rates, particularly because most of our cash equivalents are invested in short-term debt instruments. If market interest rates were to change immediately and uniformly by 10% from levels at June 30, 1999, the fair value of our cash equivalents would not change by a significant amount.

Foreign Currency Fluctuations. We have not had any significant transactions in foreign currencies, nor did we have any significant balances that were due or payable in foreign currencies at June 30, 1999. Therefore, a hypothetical 10% change in foreign currency rates would not have a significant impact on our financial position and results of operations. We do not hedge any of our foreign currency exposure.

RECENT ACCOUNTING PRONOUNCEMENTS

In June 1997, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 130, Reporting Comprehensive Income, which requires an enterprise to report, by major components and as a single total, the change in its net assets during the period from nonowner sources. Accumulated other comprehensive income at December 31, 1998 is comprised of unrealized gains on short-term investments of $1,000. The FASB also issued SFAS No. 131, Disclosures About Segments of an Enterprise and Related Information, which establishes annual and interim reporting standards for an enterprise's business segments and related disclosures about its products, services, geographic areas and major customers. We currently operate in one reportable segment under SFAS No. 131.

In June 1998, the FASB issued SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. This statement requires companies to record derivatives on the balance sheet as assets or liabilities measured at fair value. Gains or losses resulting from changes in the values of those derivatives would be accounted for depending on the use of the derivative and whether it qualifies for hedge accounting. SFAS No. 133 will be effective for us beginning in 2001. We believe that this statement will not have a significant impact on our financial condition and results of operations.

YEAR 2000

Many currently installed computer systems and software products are coded to accept only two digit entries in the date code field. As a result, software that records only the last two digits of the calendar year may not be able to distinguish whether "00" means 1900 or 2000. This may result in software failures or the creation of erroneous results.

28

We have reviewed the current versions of our products to determine Year 2000 readiness. Based on our review and the results of our tests, we believe that our products, when configured properly and used in accordance with our instructions, will function properly during the transition and into the next century. We have not tested and do not plan to test the Year 2000 compatibility of prior versions of our products that have not been sold within the last two years. These products are functionally similar to current products that we have tested and determined are Year 2000 compliant. Accordingly, based on this review, we do not believe that there will be any material Year 2000 failures associated with prior versions of our products.

We have tested third-party software that is used with our products. Despite testing by us and by customers, and assurances from developers of products sold to operate with our products, these products may contain undetected errors or defects associated with the Year 2000 date functions. In addition, because our products are used in complex computer environments, they may directly or indirectly interact with a number of other hardware and software systems with uncertain results. We are unable to predict to what extent our business may be affected if our products or technologies should experience Year 2000 related problems. Known or unknown errors or defects that affect the operation of our products could result in delay or loss of revenues, diversion of development resources, damage to our reputation or increased service and warranty costs, any of which could harm our business.

Our internal systems include our information technology systems and non-information technology systems. We have completed an initial assessment of our information technology systems and non-information technology systems. We have purchased the majority of our software and hardware within the last 24 months. Purchases have mostly been the latest software versions and the latest commercially available hardware. To the extent that we have not tested the technology provided by third-party vendors, we are seeking assurances from these vendors that their systems are Year 2000 compliant and anticipate completing this assessment by November 30, 1999. Vendors of the majority of our software and hardware have represented the Year 2000 compliance of such products. Based on our review to date, we have determined that our telephone voice messaging systems will require an upgrade to be Year 2000 compliant. We are not currently aware of any material operational issues associated with preparing our information technology systems and non-information technology systems for the Year 2000. However, we may experience unanticipated problems or additional costs caused by undetected errors or defects in the technology used in our internal information technology systems and non-information technology systems.

We have identified our significant suppliers and service providers to determine the extent to which we are vulnerable to their failures to address Year 2000 issues. Many of these suppliers have indicated through publicly available information or through its Web site that the supplier believes its applications are Year 2000 compliant. We are seeking written assurances from all our significant suppliers and anticipate completing this assessment by November 30,1999. We have not yet received any public or written assurances from Kawasaki LSI. We are continuing to monitor the progress of third parties that are critical to our business. We cannot be certain that the representations of these third parties are accurate or that they will reach Year 2000 compliance in a timely manner. If we determine that the progress of specific suppliers or service providers toward Year 2000 compliance is insufficient, we intend to change to other suppliers and service providers that have demonstrated Year 2000 readiness. We may not find alternative suppliers or service providers. In the event that any of our significant suppliers or significant service providers do not achieve Year 2000 compliance in a timely manner, and we are unable to replace them with alternate sources, our business would be harmed.

In addition, governmental agencies, utility companies, third-party service providers and others outside of our control might not be Year 2000 compliant. The failure by these entities to be Year 2000 compliant could result in a systemic failure beyond our control, for example, a prolonged

29

telecommunications or electrical failure. We believe the primary business risks, in the event of these failures, would include:

- loss of telecommunication tools to support our licensees;

- lost revenue;

- increased operating costs; and

- claims of mismanagement, misrepresentation or breach of contract.

To date, we have not incurred any material costs directly associated with our Year 2000 compliance efforts, except for compensation expense associated with our salaried employees who have devoted some of their time to our Year 2000 assessment and remediation efforts. We do not expect the total cost of Year 2000 problems to be material to our business, financial condition and operating results. We have and will continue to expense all costs arising from Year 2000 issues, funding them from working capital.

30

BUSINESS

OVERVIEW

We develop and license technologies that enable users to interact with computers using their sense of touch. While today's standard user interfaces incorporate advanced graphics and sound capabilities, computers still lack the ability to present information that users can feel. Our TouchSense feel technology enables computer peripheral devices such as mice and joysticks to deliver compelling tactile sensations that correspond to on-screen events. We are the leading provider of such technologies, and have licensed our intellectual property to more than 16 companies, including Microsoft, Logitech and InterAct. We hold 37 U.S. patents covering various hardware and software solutions and have over 125 patent applications pending in the U.S. and abroad. We also manufacture and sell specialized peripheral devices in industrial, medical and scientific markets. Our objective is to proliferate our feel technology across markets, platforms and applications so that feel becomes as common as graphics and sound in the modern user interface.

INDUSTRY BACKGROUND

Early computers had crude user interfaces that only displayed text and numbers. These machines, commonly known as "green screen" computers, were effective at processing data but did not communicate information in an engaging and intuitive manner. As a result, computing was used primarily in selected scientific and business applications. In the early 1980s, computers began to use graphics and sound to engage users' perceptual senses more naturally. Graphics technologies brought pictures, charts, diagrams and animation to the computer screen. Audio technologies enabled sound and music.

By the late 1980s, graphics and audio technologies had spread to consumer markets, initially through computer gaming applications. By the early 1990s, the penetration of graphics and sound into consumer markets had expanded beyond gaming into mainstream productivity applications, largely due to the introduction of the Windows 3.0 graphical user interface. By the late 1990s, the proliferation of graphics and audio content helped transform the Internet into a highly interactive and popular medium for communication, commerce and entertainment.

The evolution from alphanumeric characters to the modern user interface is widely considered to be one of the great advances in computing. By presenting content in ways that engage the senses more fully, computers were "humanized," becoming more personal, less intimidating and easier to use. These improvements helped expand the audience for computer technologies, encouraging people to use software for business, home and entertainment applications. Today, graphics and audio technologies are standard features of most computer systems.

While most modern computers realistically present information to the senses of sight and sound, they still lack the ability to convey content through the sense of touch. The absence of touch is a substantial barrier to making computer use more natural and intuitive. For example, current computing environments do not allow online shoppers to feel physical attributes of products prior to purchase and do not permit students to feel physical concepts like gravity and magnetism. Software designers strive to develop compelling applications for users to see and hear, but do not provide applications that users can feel. As a result, software is not as engaging and informative as it would be if tactile sensations were conveyed.

The absence of touch and feel in modern computers also limits user productivity. The Windows interface, for example, is based on a physical metaphor: users must move the cursor on a screen to drag, drop, stretch and click. However, users must manipulate graphical elements without the benefit of tactile feedback. As a result, using a cursor is visually taxing. Selecting an icon, clicking on a hyperlink or grabbing the edge of a window are common tasks that would be easier to perform if users could feel the engagement of their cursor with the intended target.

31

Like sight and sound, touch is critical for interacting with and understanding our physical surroundings. Technology that brings the sense of touch to computing has the potential to further humanize the computer and increase the ease, usefulness and enjoyment of computing.

OUR SOLUTION

We develop and license affordable technologies that allow computer users to touch and feel computer content. In diverse applications like computer gaming, business productivity, medical simulation and surfing the Web, our technologies enable software applications to engage a user's sense of touch through common peripheral devices such as mice, joysticks, steering wheels and gamepads.

Our hardware and software technologies work together to enable peripheral devices to present touch and feel sensations. Our patented designs include specialized hardware elements such as motors, control electronics and mechanisms, which are incorporated into common peripheral devices such as mice and joysticks. Driven by sophisticated software algorithms, these hardware elements direct tactile sensations corresponding to on-screen events to the user's hand. For example, when a feel-enabled mouse is used to lift a "heavy" object within the computer application, software directs the mouse's motors to apply resistance to that motion to create a realistic simulation of weight. By contrast, when the cursor is moved against a "soft" object, the motors apply gradations of force to simulate the soft compliance of the object.

Key benefits of our solution include:

Complete Solution. We offer a complete technical solution to peripheral device manufacturers and to software and Web developers. Our technologies allow manufacturers to design high-quality feel-enabled peripheral devices such as mice, joysticks, steering wheels and gamepads at a reasonable cost and in a reasonable time frame. Our software automatically enables users to feel the basic user interface features of software applications running on Windows 98 without additional developer support. Our software also enables users to feel basic Web page features represented through standard Hypertext Markup Language (HTML), Java and ActiveX protocols. In addition, we provide authoring tools that permit software developers to quickly design and incorporate custom feel sensations into their own applications.

Compatible with Industry Standards. We have designed our hardware and software technologies to be compatible with leading hardware and software standards. Our technologies operate across multiple platforms and comply with such standards as DirectX, Microsoft's entertainment application programming interface, and USB (Universal Serial Bus).

Cost-Effective Solution. We have developed component technologies that permit peripheral device manufacturers to design and manufacture feel-enabled peripheral devices more cost effectively than would otherwise be possible. We have also developed and licensed sophisticated software drivers and firmware that permit our licensees to avoid substantial development costs and accelerate product introduction.

Presents Information to the Sense of Touch. It is difficult to communicate physical properties such as texture, compliance, weight and friction solely through words or pictures. Our technologies allow computer users to use their sense of touch to perceive these physical properties in a way that is instantly understandable and intuitively accessible. Our technologies significantly improve the ability of software to communicate to users the physical features of a product, the physical properties of a scientific or engineering principle or the physical response of an object in a simulated gaming environment.

32

Improves User Productivity in Cursor Manipulation Tasks. Computer users routinely select items on the screen using a cursor. This task involves precisely positioning a cursor on a desired target like a menu or a hyperlink, and then pressing a button to indicate that the target should be selected. With a traditional mouse, users can confirm only through visual feedback that the correct item has been selected. This task demands significant visual attention, slows execution and distracts the user from other activities. With a feel-enabled mouse, the user can feel each encounter between the cursor and an item on the screen. For example, the edge of a window feels like a groove carved into a desktop; when the cursor slides into the groove, users feel a distinct physical engagement. Users interpret these sensations intuitively because of their similarity to real-world encounters. When selecting icons, scrolling through a menu or clicking on a hyperlink on a Web page, the ability to feel the encounter greatly facilitates interaction.

LOGO

Increases Satisfaction and Enjoyment of the Computing Experience. By engaging the user's sense of touch, our technologies have the potential to make a variety of software applications more interesting, engaging and satisfying. Products incorporating our intellectual property have already gained acceptance in the computer gaming market, and we believe that our technologies will increase user satisfaction across many additional applications, including business productivity, engineering, education and e-commerce.

Enhances the Effectiveness of Simulation and Training Applications. Some computer applications, such as medical training, require realism to be effective. Companies and institutions have begun to replace traditional means of surgical training with more accessible and versatile simulation systems for training doctors to perform surgical procedures. Our technologies increase the effectiveness of these systems by providing tactile feedback that simulates what a doctor would feel when performing an actual procedure. Our technologies are used in training systems for laparoscopic surgery, endoscopic surgery and catheter insertion.

STRATEGY

Our objective is to proliferate our TouchSense feel technology across markets, platforms and applications so that feel becomes as common as graphics and sound in the modern computer interface. We intend to maintain and enhance our position as the leading provider of feel technology in consumer markets by employing the following strategies:

Pursue A Royalty-Based Licensing Model. We believe that the most effective way to proliferate our feel technology is to license our intellectual property to computer peripheral device manufacturers. We have licensed our intellectual property to manufacturers of joysticks and steering wheels targeted at game consumers and have recently licensed our intellectual property to Logitech for the manufacture of feel-enabled computer mice. We have also licensed our intellectual property to companies that make industrial products, such as medical simulation hardware and arcade systems. We intend to expand the number and scope of our licensing relationships and expect that licensing royalties will constitute an increasingly significant portion of our revenues in the future.

33

Facilitate Development of Feel-Enabled Products. We will continue to devote significant resources to facilitate development by our manufacturing licensees of feel-enabled products. We offer complete design packages that include sample hardware, software, firmware and related documentation, and offer our technical expertise on a consulting basis. To facilitate development of feel-enabled products, we sell specialized microprocessors for controlling the motors in mice, joysticks and steering wheels. We will continue to invest in research and development to improve our technologies, with a particular emphasis on reducing the cost of feel-enabled products.

Expand Software Support for Our Feel Technology. In addition to licensing our technologies to computer peripheral device manufacturers and supporting their product development efforts, we have focused on expanding software support for our feel technology. We have developed software that enables users to automatically feel icons, menus and other objects in software running in Windows 98 applications or on Web pages. We offer specialized authoring tools that simplify adding feel to software applications and Web pages. We also are promoting an efficient file format, called ".ifr," to facilitate the creation and storage of custom feel sensations.

Utilize the Internet to create market demand for feel-enabled products. We believe that adding feel sensations to Web pages will provide on-line advertisers with a new means to attract and keep customers on their sites. We intend to promote this benefit to Web developers and to encourage them to incorporate feel content into their Web pages. When software developers add feel content to a Web site using our FEELtheWEB Designer authoring tool, they are required by license to include an active link from their Web page to our site www.immersion.com. We are modifying our Web site to enable users to buy feel-enabled products by linking our Web site to our licensees' Web sites, such as Logitech's e-commerce site www.buylogitech.com.

Expand Market Awareness. We promote adoption of our feel technology by increasing market awareness among peripheral device manufacturers, software developers and consumers. We devote significant resources to working directly with our licensees to encourage and assist their product development efforts. We encourage software developers to add feel content to their applications by providing them with our authoring tools and technical support. As part of our license agreements, we require our licensees to use our trademarks and logos to create brand awareness among consumers. We intend to devote significant resources in the future to expand market awareness of our feel technology and our brands.

Secure Licensees in New Markets for Feel Technology. We believe that our feel technology can be used in virtually all areas of computing. We initially focused on the computer entertainment market where we have experienced rapid acceptance of our technologies by key licensees. We have recently broadened our focus to include mainstream computing and have licensed our technologies for use in feel-enabled computer mice. We intend to expand our market opportunities by addressing new platforms such as dedicated game consoles and set-top boxes, small computer appliances that plug into a television set enabling it to access the Internet.

Develop and Protect Feel Technology. We hold 37 U.S. patents and have more than 125 patent applications pending in the U.S. and abroad covering our feel technology. Our success depends on our ability to license and commercialize our intellectual property and to continue to expand our intellectual property portfolio. We devote substantial resources to research and development and are engaged in projects focused on expanding the scope and application of our technologies. We have also secured technology by acquisition. We intend to continue to invest in technology development and potential acquisitions and to protect our intellectual property rights.

34

MARKET APPLICATIONS

While we believe that our technologies are broadly applicable, we are focusing our initial marketing and business development activities on the following target markets:

Computer Entertainment. We initially introduced our feel technology for consumer gaming peripherals in 1996 and branded this technology under the name I-FORCE. We have licensed our I-FORCE technology to 16 manufacturers, including Logitech, Microsoft and InterAct. According to PC Data, feel-enabled joysticks accounted for approximately 3% of domestic PC joystick sales by unit volume in 1997 and doubled to approximately 6% of the domestic PC joystick sales by unit volume in 1998. In addition, we have developed I-FORCE technologies for gaming applications in arcade and location-based entertainment markets. We intend to expand our I-FORCE licensing business to include new product categories for the PC platform, such as gamepads, which are hand-held controllers for gaming consoles, and flight yokes, which are game controllers that simulate the controls of an airplane, and to target additional gaming platforms.

Mainstream Computing. In order to bring feel technology to every desktop, we have targeted the computer mouse market. To address this large opportunity, we developed FEELit, a feel technology designed for cursor control products that enables all the basic functionality of a traditional mouse but also presents information to the sense of touch. In 1998, we entered into a license with Logitech under which Logitech will manufacture mice incorporating our feel technology. We plan to expand the FEELit licensing business with new types of controllers and platforms.

Medical and Other Professional Computing. We have identified and addressed demand for our feel technology in various industrial, medical and scientific markets. We currently have both product manufacturing and product licensing business relationships in these markets.

TECHNOLOGY LICENSING AND PRODUCTS

Technology Licensing

We currently license our intellectual property to manufacturers that produce peripheral devices incorporating our feel technology. In general, our licenses permit manufacturers to produce only a particular category of product within a specified field of use. We recently introduced our TouchSense brand which covers all of our feel technologies. We grant licenses for gaming products, such as joysticks, steering wheels and game pads, under the I-FORCE brand. We grant licenses for cursor control products, such as mice or trackballs, and for our medical simulation devices under the FEELit brand. We make our reference designs available to our licensees for an additional fee. A reference design is a package consisting of a technology binder, an electronic database and a hardware prototype that can be used in the development of a feel-enabled product.

Our basic licensing model includes a per unit royalty paid by the manufacturer that is a percentage of the wholesale selling price of the feel-enabled product. In addition, each licensee

35

must abide by a branding obligation. The prominent display of I-FORCE and FEELit logos on retail packaging generates customer awareness for our technologies.

I-FORCE.LOGO FEELit.LOGO
Consumer Products. We license joysticks and steering wheel gaming peripherals targeted at the PC platform. Currently, there are three consumer joysticks sold under the I-FORCE brand: the Wingman Force Feedback Joystick from Logitech, the Sidewinder Force Feedback Joystick from Microsoft and the Force-FX Joystick from CH Products. Currently, there are ten I-FORCE steering wheel gaming peripherals licensed under the I-FORCE brand, including the Wingman Formula Force from Logitech, the Force GT from Thrustmaster, the Sidewinder Force Feedback Wheel from Microsoft and the V4 Force Feedback Racing Wheel and FX Force Feedback Racing Wheel from InterAct.

Logitech has announced that it will ship the first computer mouse incorporating our feel technology in late 1999. This mouse, to be called the Wingman Force Feedback Mouse, will automatically allow users to feel many of the basic desktop controls in Windows 98 and standard interface elements of Web pages and will be marketed with an entertainment focus.

Medical Products. We license our feel technology to HT Medical Systems for use in three medical simulation products, CathSim, PreOp Endoscopic Simulator and PreOp Endovascular Simulator. These devices are used for training purposes and enable clinicians to feel simulations of sensations experienced during medical procedures, such as encountering an unexpected obstruction in an artery.

Arcade and Location-Based Entertainment Products. In order to help increase consumer awareness of feel technology in gaming applications, we license our feel technology to manufacturers of joystick and steering wheel arcade units.

Software and Developer Products

Demand for feel-enabled computer peripheral devices depends on the existence of software applications and Web pages that take advantage of these devices. The development of such software likewise depends on the existence of an installed base of feel-enabled hardware devices. We have addressed this interdependency of hardware and software solutions in two ways. First, we have developed end-user software that is included with the mouse, and which automatically adds feel to many of the basic Windows 98 controls. Second, we have developed and provide to developers and end users software authoring tools that help programmers add feel content to software applications and web pages. We have developed an efficient file format, called an ".ifr" file, for representing, storing and transmitting feel sensations. This file format allows the development of feel sensation libraries that facilitate the development of feel-enabled applications software.

36

Automatic Support

- FEELit Desktop adds feel to many of the basic Windows 98 controls, such as icons, menus, buttons, sliders and windows. It immediately makes any application running under Windows 98 more interesting and enhances productivity during mouse use. It includes a control panel that gives users the ability to customize the feel of their desktop. We expect that this product will be bundled with each feel-enabled mouse.

- FEELtheWEB adds feel to web pages accessed through Internet Explorer and Netscape Navigator. In conjunction with FEELit Desktop, it allows users to feel the standard interface elements of Web pages such as hyperlinks, check boxes and menus. It also allows users to feel custom sensations that have been added to Web pages. We expect that this product will be bundled with each feel-enabled mouse.

Authoring Tools

- I-FORCE Studio is a fully animated graphical environment that allows game developers to design feel sensations for their software titles by adjusting physical parameters and feel sensations. Each software file describing the feel sensation that a developer creates can be saved into an ".ifr" file and then can be quickly inserted into gaming applications and Web pages during the development process. We currently sell I-FORCE Studio to developers for $19.95.

- FEELit Studio is an authoring tool that allows developers of mainstream productivity, Web and gaming software to design feel sensations into their software titles. Like I-FORCE Studio, it employs an intuitive graphical interface that allows feel sensations to be designed rapidly, implemented and saved as ".ifr" files. We currently distribute FEELit Studio to developers and end users free of charge.

- FEELtheWEB Designer is an easy-to-use authoring tool that allows Web developers to add feel sensations to Web pages. They can load any HTML Web page into the tool and modify it to support feel sensations. We currently make FEELtheWEB Designer available to developers and end users free of charge.

Custom Microprocessors

Many feel-enabled peripheral devices utilize commercially available microprocessors which process instructions needed to deliver force sensations to the user. These microprocessors have not been optimized for feel-enabled products. We develop, license and sell custom microprocessors to support the requirements of our feel technology in gaming and PC peripheral products. We believe that these microprocessors are cost-effective components that allow our licensees to reduce their costs of goods and the amount of custom development that they must perform to bring a product to market, speeding their development cycle.

We have invested in this technology because we believe it is important as an enabling technology for low-cost feel-enabled devices. By incorporating commonly used components on a single piece of silicon, our microprocessors reduce the number of discrete components required on a printed circuit board and can help lower overall system costs for our licensees. This level of integration simplifies the manufacture of feel-enabled products while increasing performance and reliability.

Specialty Products

Medical Simulation and Other Medical Equipment. We have developed numerous technologies that can be used for medical training and simulation. By allowing computers to deliver feel sensations to users, our technologies can support realistic simulations that are effective in teaching

37

medical students and doctors what it feels like to perform a given procedure. Currently, we manufacture and sell a number of low volume specialized medical products, including:

- Virtual Laparoscopic Interface, a fully integrated tool designed to let developers, researchers and educators simulate minimally invasive surgical procedures;

- Laparoscopic Impulse Engine, a three-dimensional interface for virtual reality simulations of laparoscopic and endoscopic surgical procedures that allows users to feel actual surgical tools as if they were performing these procedures;

- PinPoint, a stereotactic arm manufactured for Picker International, Inc., which is integrated with Picker CT scanners to enable image-guided biopsies and radiation therapy; and

- Endoscopic Sinus Surgery Simulation Trainer, an electro-mechanical system that recreates an operating room environment to simulate endoscopic procedures.

Arcade and Location-Based Entertainment Products. We manufacture versions of force feedback joysticks and steering wheel products with enhanced durability for the arcade and location-based entertainment markets. We sell these products directly to prominent entertainment companies that operate entertainment centers.

MicroScribe-3D. Our MicroScribe-3D product allows users to create three-dimensional computer models directly from physical objects. It contains sensor and microprocessor technologies that allow users to digitize physical objects simply by tracing their contours with a stylus. The computer records the three-dimensional geometry of the object and reproduces it on the screen as a three-dimensional computer model. MicroScribe-3D is designed to support the needs of game developers, engineers, animators, film makers, industrial designers and other professionals who need to create realistic three-dimensional computer images quickly and easily.

Softmouse. We also manufacture a high performance non-feel-enabled mouse for geographic information systems and the map-making industry. This product has a two-handed interface with ten buttons and a rotary thumbwheel. We currently sell this product to several major manufacturers, including Intergraph, Vision International and LH Systems. End users of Softmouse include the U.S. Geological Survey, NASA and the U.S. Department of Defense.

TECHNOLOGY

Feel simulation, also known as force feedback, haptic feedback or force reflection, refers to the technique of adding feel sensations to computer software by imparting physical forces upon the user's hand. These forces are imparted by actuators, usually motors, that are incorporated into consumer peripheral devices such as mice, joysticks, steering wheels or gamepads, or into more sophisticated interfaces designed for industrial, medical or scientific applications. Feel-enabled peripheral devices can impart to users physical sensations like rough textures, smooth surfaces, viscous liquids, compliant springs, jarring vibrations, heavy masses and rumbling engines.

As a user manipulates a feel-enabled device, such as a mouse, motors within the device apply computer modulated forces that either resist or assist the manipulations. These forces are generated based on mathematical models that simulate the desired sensations. For example, when simulating the feel of a rigid wall with a force feedback mouse, motors within the mouse apply forces that simulate the feel of encountering the wall. As the user moves the mouse to penetrate the wall, the motors apply a force that resists the penetration. The harder the user pushes, the harder the motors push back. The end result is a sensation that feels like a physical encounter with an obstacle.

38

FEEL-ENABLED PRODUCT ARCHITECTURE

[DIAGRAM]

The mathematical models that control the motors may be simple modulating forces based on a function of time, such as jolts and vibrations, or may be more complex modulating forces based on user manipulations such as surfaces, textures, springs and liquids. Complex sensations can be created by combining a number of simpler sensations. For example, a series of simulated surfaces can be combined to give the seamless feel of a complex object like a sports car or a telephone. Textures can be added to these complex surfaces so that the windshield of the sportscar feels smooth and its tires feel rubbery.

To simplify the process of generating feel sensations, we have developed a parallel processing architecture in which a dedicated processor resides within the peripheral device and performs the complex mathematics. The dedicated processor offloads the processing burden from the host computer. This distributed processing architecture, along with specialized software, provides a software developer with an easy-to-use high-level application programming interface that abstracts feel programming into a perceptual rather than mathematical level. The application programming interface allows programmers to define and initiate feel sensations with software routines that have descriptive physical names such as "wall," "vibration" or "liquid." Programmers can easily adjust multiple parameters to customize different types of sensations.

We have developed two application programming interfaces, one for gaming markets and one for productivity markets. The gaming application programming interface is called the I-FORCE API. The productivity application programming interface is called the FEELit API. Both allow software developers to incorporate feel sensations into software applications quickly. In 1997, Microsoft included support for our I-FORCE API into DirectX, Microsoft's standard gaming device application programming interface for the Windows platform.

Most computer interface devices, such as mice and joysticks, are input-only devices, meaning that they track a user's physical manipulations but provide no manual feedback. As a result, information flows in only one direction, from the peripheral to the computer. Feel-enabled devices are input-output devices, meaning that they track a user's physical manipulations (input) and provide realistic physical sensations coordinated with on-screen events (output). The computer and the device need to communicate quickly in order to present realistic sensations.

39

We have developed efficient processing techniques to minimize the amount of information that needs to be communicated between the computer and the peripheral. We use dedicated processors in the device to produce feel sensations in response to high-level commands from the computer. Our control architecture has the added benefit of performing force feedback computations in parallel with the computer's execution of a software application.

SALES, MARKETING AND SUPPORT

We establish licensing relationships and sell a number of our products through our direct sales efforts. We also sell some of our products indirectly through distributors and value-added resellers.

Consistent with our intellectual property licensing strategy, we have focused our marketing activities on developing relationships with potential licensees and on participating with existing licensees in their marketing and sales efforts. To generate awareness of our technologies and our licensees' products, we participate in industry trade shows, maintain ongoing contact with industry press, provide product information over our Web site and advertise in entertainment and game industry publications.

Another focus of our marketing efforts is to promote the adoption of our feel technology by software and Web developers to facilitate the implementation of feel sensations into software applications. We have developed the Feel Foundation Classes Software Development Kits, which contain our software authoring tools, as well as documentation, tutorials and software files containing sample feel sensations. We currently distribute this software to software developers at no cost. Our software support staff also works closely with developers to assist them in developing compelling feel-enabled applications. We provide sample feel sensations to developers through our Web site and through our I-FORCE Studio and FEELtheWEB Designer authoring tools. We intend to devote substantial resources to supporting software developers and Web page designers in the creation of feel-enabled software applications, including hiring additional software engineers and other technical personnel.

We anticipate allocating substantially more resources to sales and marketing to proliferate our technology and to support the sales of our licensed products. To date, we have not focused on marketing to end users of our licensees' products. However, we believe that it is important to increase awareness of our feel technology among potential end users. As part of our strategy to increase our visibility and promote our feel technology, our license agreements generally require our licensees to display the TouchSense, I-FORCE or FEELit logos on licensed products they distribute. In addition, we intend to substantially increase our advertising and marketing efforts to end users.

RESEARCH AND DEVELOPMENT

Our success depends on our ability to improve, and reduce the costs of, our technologies in a timely manner. We have assembled a team of highly skilled engineers who possess experience in the disciplines required for feel technology development, including mechanical engineering, electrical engineering and computer science.

Our research and development expenses were approximately $710,000 in 1996, $1.5 million in 1997, $1.8 million in 1998 and $1.1 million in the six months ended June 30, 1999. Our research and development efforts have been focused on technology development, including hardware, software and designs. We have entered into numerous contracts with government agencies and corporations that help fund advanced research and development. Our government contracts permit us to retain ownership of the technology developed under the contracts, provided that we provide the applicable government agency a license to use the technology for non-commercial purposes. Although we expect to continue to invest substantially in research and development activities, we expect government sponsored research activity to decline.

40

COMPETITION

We are aware of several companies that claim to possess feel technology applicable to the consumer market, but we do not believe that these companies or their licensees have introduced feel-enabled products. Several companies also currently market force feedback products to non-consumer markets and could shift their focus to the consumer market. In addition, our licensees may develop products that compete with products employing our feel technology but are based on alternative technologies. Many of our licensees, including Microsoft and Logitech, and other potential competitors have greater financial and technical resources upon which to draw in developing computer peripheral technologies that do not make use of our feel technology.

Our competitive position is partially dependent on our licensees' competitive positions. Our licensees' markets are highly competitive. We believe that the principal competitive factors in our licensees' markets include price, performance, user-centric design, ease of use, quality and timeliness of products, as well as the manufacturer's responsiveness, capacity, technical abilities, established customer relationships, retail shelf space, advertising, promotion programs and brand recognition. Feel-related benefits may be viewed simply as enhancements, and products incorporating our feel technology might face competition from computer peripheral devices that are not feel-enabled as well as from peripheral devices that use simple vibration technology, sometimes referred to as "dual shock" or "rumble shock."

Semiconductor companies, including Intel and Mitsubishi, manufacture products that compete with the I-FORCE and FEELit processors but which have not been optimized specifically for feel technology. We are not aware of any companies that currently produce optimized feel processors.

There are several companies that currently sell high-end simulation products that compete with our professional and medical products. The principal bases for competition in these markets are technological sophistication and price. We believe we compete favorably on these bases.

INTELLECTUAL PROPERTY

We rely on a combination of patents, copyrights, trade secrets, trademarks, employee and third-party nondisclosure agreements and licensing arrangements to protect our intellectual property. We consider our ability to protect our intellectual property to be critical to our success.

We hold 37 U.S. patents and have more than 125 pending patent applications, both domestic and foreign, covering feel technology. These patents and patent applications cover a variety of hardware and software innovations relating primarily to force feedback. Our current U.S. patents expire between the years 2011 and 2016. Our failure to obtain or maintain adequate protection for our intellectual property rights for any reason could hurt our competitive position. Patents may not issue from the patent applications that we have filed or may file. Our issued patents may be challenged, invalidated or circumvented, and claims of our patents may not be of sufficient scope or strength, or issued in the proper geographic regions, to provide meaningful protection or any commercial advantage.

In addition, others may develop technologies that are similar or superior to our technologies, duplicate our technologies or design around our patents. Effective intellectual property protection may be unavailable or limited in some foreign countries. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy or otherwise use aspects of our methods and devices that we regard as proprietary. If our intellectual property protection is insufficient to protect our intellectual property rights, we could face increased competition in the market for our technologies, or be unable to persuade or require companies to enter into royalty-bearing license arrangements.

We have acquired patents from third parties and also license some technologies from third parties. We must rely upon the owners of the patents or the technologies for information on the origin and ownership of the acquired or licensed technologies. As a result, our exposure to infringement claims may increase. We generally obtain representations as to the origin and ownership of acquired or licensed technology and indemnification to cover any breach of these

41

representations. However, representations may not be accurate and indemnification may not provide adequate compensation for breach of the representations.

From time to time, we have received claims from third parties that our technologies, or those of our licensees, infringe the intellectual property rights of these third parties. Between May 1995 and June 1999, we received four such letters. After examination of these claims and consultation with counsel, we believe that these claims are without merit. To date, none of these companies has filed a legal action against us. However, these or other matters might lead to litigation costs in the future. Intellectual property claims, whether or not they have merit, could be time-consuming to defend, cause product shipment delays, require us to pay damages against us, or require us to cease utilizing the technology unless we can enter into royalty or licensing agreements. Royalty or licensing agreements might not be available on terms acceptable to us or at all. Furthermore, claims could also result in claims from our licensees under the indemnification provisions of their agreements with us.

From time to time, we initiate claims against third parties that we believe infringe our intellectual property rights. To date, these claims have not led to any litigation. However, any litigation to protect and enforce our intellectual property rights could be costly, time-consuming and distracting to management and could result in the impairment or loss of portions of our intellectual property assets.

EMPLOYEES

As of September 30, 1999, we had 54 full-time employees, including 25 in research and development, 11 in sales and marketing and 18 in finance, administration and operations. As of that date, we also employed one independent contractor and five temporary seasonal employees. None of our employees is represented by a labor union, and we consider our employee relations to be good. Competition for qualified personnel in our industry is extremely intense, particularly for engineers and technical staff. Our future success will depend in part on our continued ability to attract, hire and retain qualified personnel.

FACILITIES

We have 16,280 square feet of office space in San Jose, California. Our lease for this building expires on October 31, 2002. We anticipate that we may need to add office space over the next year in order to accommodate new employees.

LEGAL MATTERS

We are not currently involved in any legal or arbitration proceedings, nor have we been involved in any such proceedings during the past 12 months.

42

MANAGEMENT

EXECUTIVE OFFICERS, DIRECTORS AND OTHER KEY EMPLOYEES

The following table sets forth information regarding our executive officers, directors and other key employees as of September 30, 1999:

                  NAME                     AGE                       POSITION
                  ----                     ---                       --------
EXECUTIVE OFFICERS AND DIRECTORS
Louis Rosenberg, Ph.D....................  30    Chairman of the board, President and Chief
                                                 Executive Officer
Victor Viegas............................  42    Vice President, Finance and Chief Financial
                                                 Officer
J. Stuart Mitchell.......................  46    Vice President, Business Development
Bruce Schena.............................  35    Vice President, Chief Technology Officer,
                                                 Secretary and Director
Jennifer Saffo...........................  45    Vice President, Marketing
Kenneth Martin...........................  34    Director of Product Development
Steven Blank.............................  45    Director
Jonathan Rubinstein......................  42    Director

KEY EMPLOYEES
Richard Abramson.........................  43    Director of Litigation and Intellectual Property
Adam Braun...............................  28    Director of Embedded Systems
Dean Chang, Ph.D.........................  32    Director of Platforms and Applications
Craig Factor.............................  31    General Counsel
Timothy Lacey............................  29    Vice President, Operations
Michael Levin............................  34    Director of Professional and Industrial Products

Dr. Louis Rosenberg is a founder of Immersion and has served as Chairman of our board of directors and as President and Chief Executive Officer since May 1993. Since April 1997, Dr. Rosenberg has also served as a manager of MicroScribe LLC, a licensing company in which we hold a membership interest. Dr. Rosenberg holds bachelor of science, master of science and doctorate degrees in mechanical engineering from Stanford University.

Mr. Victor Viegas has served as our Chief Financial Officer and Vice President, Finance since August 1999. From June 1996 to August 1999, he served as vice president, finance and administration and chief financial officer of Macrovision Corporation, a developer and licensor of video and software copy protection technologies. From October 1986 to June 1996, he served as vice president of finance and chief financial officer of Balco Incorporated, a manufacturer of advanced automotive service equipment. He holds a bachelor of science degree in accounting and a master of business administration degree from Santa Clara University. Mr. Viegas is also a certified public accountant in the State of California.

Mr. J. Stuart Mitchell has served as our Vice President, Business Development since August 1999. From February 1987 to February 1999, Mr. Mitchell served as vice president of sales and marketing, systems products division and vice president of worldwide technology licensing business for Adobe Systems, Inc., a technology licensing desktop publishing and graphics software company. From May 1982 to January 1987, Mr. Mitchell served in various sales and marketing management positions for Zentec Corporation, a computer systems and display terminal company and, from April 1977 to April 1982, Mr. Mitchell served in various sales and marketing positions for Xerox Corporation, an information technology and document systems company. Mr. Mitchell holds a bachelor of science degree in engineering physics with a minor in business from the University of Colorado, Boulder.

Mr. Bruce Schena has served as our Vice President, Chief Technology Officer, Secretary, and a member of our board of directors since January 1995. Since April 1997, Mr. Schena has also served

43

as a manager of MicroScribe LLC, a licensing company in which we hold a membership interest. From June 1993 to December 1994, Mr. Schena consulted for Pandemonium Product Development, a product design company owned by Mr. Schena. Mr. Schena holds bachelor of science and master of science degrees in mechanical engineering from Massachusetts Institute of Technology and a degree of engineer in mechanical engineering from Stanford University.

Ms. Jennifer Saffo has served as our Vice President, Marketing since July 1999. From January 1991 to July 1999, Ms. Saffo owned and operated a sole proprietorship marketing company delivering strategic marketing advice to Internet and software companies. From 1987 to 1990, Ms. Saffo served as director of marketing for Adobe Systems, Inc., a technology licensing desktop publishing and graphics software company. From 1984 to 1987, Ms. Saffo was a founder and director of Aldus Corporation, a desktop publishing company and from 1981 to 1984, served as national accounts manager at Microsoft Corporation, a software company. Ms. Saffo holds a bachelor of arts degree in linguistics from University of Colorado, Boulder.

Mr. Kenneth Martin has served as our Director of Product Development since April 1996. From June 1994 to April 1996, Mr. Martin served as a design engineer at IDEO Product Development Inc., a product design company. Since 1994, Mr. Martin also has served as a lecturer in the design division in the mechanical engineering department of Stanford University. Mr. Martin holds a bachelor of applied science degree from the University of Toronto and a master of science degree in manufacturing systems engineering from Stanford University.

Mr. Steven Blank has served as a member of our board of directors since October 1996. From November 1996 to August 1999, Mr. Blank served as executive vice president of marketing for E.piphany Marketing, an enterprise software company which Mr. Blank Co-founded. From February 1993 to October 1996, he served as chief executive officer of Rocket Science Games, a video game software company.

Mr. Jonathan Rubinstein has served as a member of our board of directors since October , 1999. From February 1997 to present, Mr. Rubinstein has served as senior vice president of Hardware Engineering at Apple Computer, Inc., a personal computer company. From August 1993 to August 1997, Mr. Rubinstein was executive vice president and chief operating officer of Fire Power Systems, a developer and manufacturer of Power PC-based computer systems. Mr. Rubinstein has a masters and bachelors of science degree in electrical engineering from Cornell University and a master of science degree in computer science from Colorado State University.

Mr. Richard Abramson has served as our Director of Litigation and Intellectual Property since February 1999. Since 1998, Mr. Abramson also has served as an adjunct professor at the University of California at Berkeley, Boalt Hall School of Law. From September 1991 to February 1999, Mr. Abramson was a litigation partner at the law firm of Heller Ehrman White & McAuliffe, specializing in patent and other intellectual property litigation. From August 1984 to 1991, Mr. Abramson was a litigation associate and partner at the law firm of Irell & Manella. Mr. Abramson holds a bachelor of arts degree from Claremont McKenna College and a juris doctorate degree from the University of California at Berkeley, Boalt Hall School of Law.

Mr. Adam Braun has served as our Director of Embedded Systems since September 1995. From May 1994 to September 1995, Mr. Braun was an embedded systems engineer at Autonomous Effects Inc., a consulting company. Mr. Braun holds a bachelor of science degree in mechanical engineering from Brown University and a master of science degree in mechanical engineering from Stanford University.

Dr. Dean Chang has served as our Director of Platforms and Applications since July 1995. From 1989 to July 1995, Dr. Chang was completing his master of science and doctorate degrees at Stanford University. Dr. Chang holds a bachelor of science degree from the Massachusetts Institute of Technology and master of science and doctorate degrees in mechanical engineering from Stanford University.

44

Mr. Craig Factor has served as our General Counsel since September 1997. From January 1995 to January 1997, Mr. Factor was an associate at the law firm of Wilson Sonsini Goodrich & Rosati. From September 1993 to January 1995, Mr. Factor was an associate at the law firm of Wiley, Rein & Fielding. Mr. Factor holds a bachelor of arts degree in social studies from Harvard University and a juris doctorate degree from the Duke University School of Law.

Mr. Timothy Lacey is a founder of Immersion and has served as our Vice President, Operations since August 1999. From May 1993 to August 1999, Mr. Lacey served as our chief financial officer and from May 1993 to October 1999 as a member of our board of directors. Since April 1997, Mr. Lacey has served as a manager of MicroScribe LLC, a licensing company in which we hold a membership interest. Mr. Lacey holds bachelor of science and master of science degrees in mechanical engineering from Stanford University.

Mr. Michael Levin has served as our Director of Professional and Industrial Products since July 1995. From July 1990 to May 1995, Mr. Levin served as manager of automation at Merck & Co., Inc., a pharmaceutical company. Mr. Levin holds a bachelor of science degree in aeronautics and astronautics and a master of science degree in mechanical engineering from Massachusetts Institute of Technology.

BOARD COMPOSITION

Our board of directors currently consists of four members. Our board of directors is divided into three classes, with each director serving a three-year term and one class being elected at each year's annual meeting of stockholders. Messrs. Blank and Schena will be in the class of directors whose term expires at the 2000 annual meeting of stockholders. Mr. Rubinstein will be in the class of directors whose term expires at the 2001 annual meeting of stockholders. Dr. Rosenberg will be in the class of directors whose term expires at the 2002 annual meeting of stockholders.

ELECTION OF DIRECTORS AND EXECUTIVE OFFICERS

At each annual meeting of the stockholders, the successors to each class of directors will be elected to serve for three year terms from the time of election and qualification until the next annual meeting at which the director's class stands for election.

Executive officers are elected by the board of directors on an annual basis and serve until their successors have been duly elected and qualified. There are no family relationships among any of our directors or officers.

BOARD COMMITTEES

Audit Committee. The board of directors has established an audit committee consisting of Mr. Blank and Mr. Rubinstein. The audit committee reviews with our independent auditors the scope and timing of their audit services and any other services that they are asked to perform, the auditors' report on our consolidated financial statements following completion of their audit, and our policies and procedures with respect to internal accounting and financial controls. In addition, the audit committee makes annual recommendations to our board of directors regarding the appointment of independent auditors for the upcoming year.

Compensation Committee. The board of directors has established a compensation committee consisting of Mr. Blank and Mr. Rubinstein. The compensation committee makes recommendations to the board concerning salaries and incentive compensation for our officers and employees and administers our employee benefit plans.

DIRECTOR COMPENSATION

Our directors do not receive cash compensation for their services as directors. Under our 1997 stock option plan, nonemployee directors are eligible to receive stock option grants at the

45

discretion of the board of directors. In November 1996, we issued an option to purchase 80,700 shares of common stock at an exercise price of $0.17 per share to Mr. Blank. This option contains a provision providing Mr. Blank with the right to maintain his percentage interest of stock in our company. This right will terminate upon the closing of this offering. Pursuant to this provision, we have granted to Mr. Blank additional options to purchase shares of our common stock as follows:

                                           SHARES SUBJECT    EXERCISE PRICE
              DATE OF GRANT                  TO OPTION         PER SHARE
              -------------                --------------    --------------
June 18, 1997                                  18,157            $0.25
December 12, 1997                               6,052             0.37
March 16, 1998                                 20,336             1.24
April 22, 1999                                 20,175             3.66
June 21, 1999                                   3,228             3.66

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION IN COMPENSATION DECISIONS

None of the members of our compensation committee has at any time since our formation been one of our officers or employees. None of our executive officers currently serves or in the past has served as a member of a compensation committee or board of directors of any other entity that has one or more executive officers serving as a member of our board of directors or compensation committee.

EXECUTIVE COMPENSATION

Summary Compensation Table. The following table presents information concerning compensation received during the year ended December 31, 1998 by our chief executive officer and each of our two other executive officers whose total salary and bonus earned during that year exceeded $100,000. In accordance with the rules of the Securities and Exchange Commission, the compensation described in this table does not include perquisites and other personal benefits received by these executive officers that do not exceed the lesser of $50,000 or 10% of the total salary and bonus reported for these officers.

                                                                               LONG-TERM
                                                                              COMPENSATION
                                                                                 AWARDS
                                                                 ANNUAL       ------------
                                                              COMPENSATION     SECURITIES
                                                              ------------     UNDERLYING
                NAME AND PRINCIPAL POSITIONS                     SALARY        OPTIONS(#)
                ----------------------------                  ------------    ------------
Louis Rosenberg, Ph.D. .....................................    $138,615         72,465
  President and Chief Executive Officer
Bruce Schena................................................     121,683         22,819
  Vice President, Chief Technology Officer and Director
Timothy Lacey...............................................     107,628         26,210
  Chief Financial Officer and Director

Mr. Lacey was serving as our chief financial officer as of December 31, 1998. In August 1999, Mr. Lacey resigned as our chief financial officer and was appointed vice president, operations.

46

Option Grants in Fiscal Year Ended December 31, 1998. The following table presents information with respect to stock options granted during 1998 to our executive officers listed in the summary compensation table.

                                                                                          POTENTIAL REALIZABLE
                                                                                            VALUE AT ASSUMED
                           NUMBER OF                                                      ANNUAL RATES OF STOCK
                           SECURITIES   PERCENT OF TOTAL                                 APPRECIATION FOR OPTION
                           UNDERLYING   OPTIONS GRANTED       EXERCISE                            TERM
                            OPTIONS       TO EMPLOYEES         PRICE        EXPIRATION   -----------------------
          NAME             GRANTED(#)    DURING PERIOD       ($/SHARE)         DATE         5%           10%
          ----             ----------   ----------------   --------------   ----------   ---------   -----------
Louis Rosenberg, Ph.D....       605           0.14%            $0.68         02/24/03    $  9,443    $   15,281
                                605           0.14              0.68         03/03/03       9,443        15,281
                              1,210           0.29              1.36         03/24/03      18,064        29,739
                                403           0.10              1.36         03/31/03       6,016         9,905
                              1,210           0.29              1.36         04/15/03      18,064        29,739
                             63,591          15.05              1.36         03/16/08     949,347     1,562,903
                              1,210           0.29              0.41         01/15/03      19,214        30,888
                              3,631           0.86              4.02         11/06/03      44,549        79,582
Bruce Schena.............       605           0.14              0.62         02/24/08       9,480        15,317
                                605           0.14              0.62         03/03/08       9,480        15,317
                             21,004           4.97              1.24         03/16/08     316,088       518,745
                                605           0.14              3.66         11/06/08       7,641        13,478
Timothy Lacey............    26,210           6.20              1.36         03/16/03     391,288       644,174

The potential realizable value represents the hypothetical gains of the options granted based on assumed annual compound stock appreciation rates of 5% and 10% over an assumed initial public offering price of $10.00. The 5% and 10% assumed annual rates of stock price appreciation are required by the rules of the Securities and Exchange Commission and do not represent our estimate or projection of future common stock prices.

In 1998, we granted options to purchase an aggregate of 422,406 shares to employees.

The exercise price of each option granted to Dr. Rosenberg and Mr. Lacey was equal to 110% of the fair market value of the common stock on the date of grant as determined by the board of directors.

Dr. Rosenberg's option to purchase 63,591 shares of common stock vests as to 1/24 of the shares per month for 24 months. Dr. Rosenberg's option to purchase 605 shares with an expiration date of February 24, 2003 and option to purchase 1,210 shares with an expiration of January 15, 2003 are fully vested. His remaining options vest as to 1/12 of the shares per month for 12 months.

Mr. Schena's option to purchase 21,004 shares of common stock vests as to 1/24 of the shares per month for 24 months. His remaining options vest as to 1/12 of the shares per month for 12 months.

Mr. Lacey's option to purchase 26,210 shares of common stock vests as to 1/24 of the shares per month for 24 months.

Aggregated Option Exercises in Last Fiscal Year and Fiscal Year-End Values. The following table presents information for our executive officers listed in the summary compensation table concerning option exercises during 1998 and the value of exercisable and unexercisable options held as of December 31, 1998 by these officers:

                                                                 NUMBER OF SECURITIES
                                                                UNDERLYING UNEXERCISED      VALUE OF UNEXERCISED
                                                                      OPTIONS AT          IN-THE-MONEY OPTIONS AT
                                       SHARES        VALUE       DECEMBER 31, 1998(#)       DECEMBER 31, 1998($)
                                     ACQUIRED ON    REALIZED    -----------------------   ------------------------
               NAME                  EXERCISE(#)      ($)         VESTED      UNVESTED      VESTED       UNVESTED
               ----                  -----------   ----------   ----------    ---------   -----------    ---------
Louis Rosenberg, Ph.D..............    129,120     $1,286,035     985,210       91,089    $9,658,603     $832,384
Bruce Schena.......................     80,700        803,772     399,626       34,909     3,937,199      326,982
Timothy Lacey......................    250,947      2,488,859     150,864       35,684     1,454,034      329,345

47

The value realized upon exercise of options is calculated based on an assumed initial public offering price of $10.00 less the exercise price. It does not necessarily indicate that the option holder sold the stock for the amount listed. The value of unexercised in-the-money options represents the positive difference between the exercise price of the stock options and an assumed initial public offering price of $10.00.

CHANGE OF CONTROL AND EMPLOYMENT ARRANGEMENTS

The options granted to Mr. Viegas may accelerate in the event of a change in our control, if he resigns due to a material reduction in his duties or if we move his principal office more than 60 miles from San Jose. If the event occurs within 18 months of his start date, vesting will be accelerated by 12 months and if the event occurs more than 18 months after his start date, 50% of the unvested shares will become vested. In addition, if we terminate Mr. Viegas' employment other than for cause, we will pay him a severance payment equal to 6 months of base salary (or, if lesser, the number of months before he finds other employment) and his options will also accelerate. If the termination occurs before the first anniversary of his start date, 37.5% of the shares will become vested, and if the termination occurs after his first anniversary but within 18 months of his start date, vesting will be accelerated by 12 months.

The options granted to Mr. Mitchell may accelerate in the event of a change in our control that results in his termination of employment, if he resigns due to a material reduction in his duties or if we move his principal office more than 60 miles from San Jose within 12 months of his start date. If one of the events occurs, vesting will be accelerated by 12 months. In addition, if we terminate Mr. Mitchell's employment other than for cause, we will pay him a severance payment equal to 3 months of base salary (or, if lesser, the number of months before he finds other employment) and the vesting of his options will be accelerated by 3 months.

The options granted to Ms. Saffo may accelerate in the event of a change in our control that results in her termination employment, if she resigns due to a material reduction in her duties or if we move her principal office more than 60 miles from San Jose within 12 months of her start date. If one of the events occurs, vesting will be accelerated by 12 months. In addition, if we terminate Ms. Saffo's employment other than for cause, we will pay her a severance payment equal to 3 months of base salary (or, if lesser, the number of months before she finds other employment) and the vesting of her options will be accelerated by 3 months.

Our 1994 stock option plan provides that, in the event of a change in control, our board of directors may either:

- arrange with the acquiring corporation that outstanding options be assumed or that equivalent options be substituted by the acquiring corporation; or

- provide that any unexercisable or unvested portion of the outstanding option shall be immediately exercisable and vested in full.

The options terminate if they are not assumed, substituted or exercised prior to a change of control.

EMPLOYEE BENEFIT PLANS

1997 Stock Option Plan. Our 1997 stock option plan was adopted by our board of directors in June 1997 and approved by our stockholders in July 1997. The stock option plan was amended in July 1999. We are authorized to issue under this plan up to 3,166,793 shares of common stock. The number of shares may be increased with the approval of our stockholders. In addition, independent of stockholder and board approval, the share reserve will automatically be increased on January 1 of each year beginning on or after January 1, 2001 by an amount equal to 5% of the number of shares of our common stock which were issued and outstanding on the last day of the preceding year. The 1997 option plan is currently administered by the board of directors. The plan allows

48

grants of incentive stock options, within the meaning of Section 422 of the Internal Revenue Code of 1986, to employees, including officers and employee directors. In addition, it allows grants of nonstatutory stock options to employees, non-employee directors and consultants. Incentive stock options may not be granted after June 2007, although the plan may be terminated sooner by the board of directors.

The exercise price of incentive stock options granted under the 1997 stock option plan must not be less than the fair market value of the common stock on the date of grant. In the case of nonstatutory stock options, the exercise price must not be less than 85% of fair market value. With respect to any option holder who owns stock representing more than 10% of the voting power of all classes of our outstanding capital stock, the exercise price of any incentive stock option must be equal to at least 110% of the fair market value of the common stock on the date of grant, and the term of the option may not exceed five years. The terms of all other options may not exceed ten years. The aggregate fair market value of the common stock for which an incentive stock option may become exercisable for the first time may not exceed $100,000 in any calendar year. The fair market value will be determined as of the date of the option grant. The board of directors or any committee administering the 1997 stock option plan has discretion to determine exercise schedules and vesting requirements, if any, of all options granted under the plan. In the event of a change in control, the acquiring or successor corporation may assume or substitute for the outstanding options granted under our 1997 stock option. The outstanding options will terminate to the extent that they are neither exercised nor assumed or substituted for by the acquiring or successor corporation.

As of September 30, 1999, 304,276 shares of common stock had been issued upon exercise of options outstanding under this plan. Options to purchase 2,846,923 shares of common stock, at a weighted average exercise price of $4.76, were outstanding, while 15,594 shares remained available for future grants.

1994 Stock Option Plan. Our 1994 stock option plan was adopted by our board of directors in August 1994 and approved by our stockholders in August 1994. Prior to the adoption of the 1997 stock option plan, a total of 2,381,330 shares of common stock were reserved for issuance under the 1994 stock option plan. In July 1997, upon the adoption of the 1997 stock option plan, our board of directors terminated the 1994 stock option plan. While no additional options will be granted under that plan, options to purchase 1,149,217 shares of common stock are outstanding and remain subject to the provisions of the 1994 stock option plan. The plan is administered by the board of directors.

The 1994 stock option plan allowed the grant of incentive stock options and nonstatutory stock options. The exercise price of incentive stock options granted under the plan had to be at least equal to the fair market value of the common stock on the date of grant. With respect to any option holder who owned stock representing more than 10% of the voting power of all classes of our outstanding capital stock, the exercise price of any stock option had to be at least equal to 110% of the fair market value of the common stock on the date of grant and the term of the option may not exceed five years. The terms of all other options could not exceed ten years. The aggregate fair market value of the common stock for which an incentive stock option may become exercisable for the first time may not exceed $100,000 in any calendar year. In the event of a change in control, our board of directors may either:

- arrange with the acquiring corporation that outstanding options be assumed or that equivalent options be substituted by the acquiring corporation; or

- provide that any unexercisable or unvested position of the outstanding option be immediately exercisable and vested in full.

The outstanding options will terminate to the extent that they are neither exercised nor assumed or substituted for by the acquiring or successor corporation.

49

As of September 30, 1999, 1,232,099 shares of common stock had been issued upon exercise of options outstanding under this plan. Options to purchase 1,149,217 shares of common stock, at a weighted average exercise price of $0.10, were also outstanding.

1999 Employee Stock Purchase Plan. In August 1999, our board of directors adopted, subject to approval by our stockholders, our 1999 employee stock purchase plan. We have reserved a total of 500,000 shares of common stock for issuance under the 1999 employee stock purchase plan, none of which has been issued as of the effective date of this offering. The share reserve will automatically be increased on January 1, 2001 and on each subsequent January 1 through January 1, 2010, by 500,000 shares per year or a lesser number of shares determined by our board of directors.

The employee stock purchase plan is intended to qualify under Section 423 of the Internal Revenue Code. Employees, including officers and employee directors, of us or any subsidiary designated by the board for participation in the plan are eligible to participate in the plan if they are customarily employed for more than 20 hours per week and more than five months per year. Eligible employees may begin participating at the start of any offering period.

The first offering period will run for approximately 24 months and will be divided into four consecutive purchase periods of approximately six months. The first offering period and the first purchase period will commence on the date of this offering. The first offering period will terminate on the last day of January 2002. The first purchase period will terminate on the last day of January 2000. Subsequent purchase periods will generally have a duration of approximately six months. Purchasing periods after the initial purchase period will commence on the first day of February and August of each year. The board may change the dates or duration of one or more offering periods, but no offering period may exceed 27 months. Participants will purchase shares on the last day of each purchase period of the initial offering period and on the last day of each subsequent six month offering period.

The employee stock purchase plan permits eligible employees to purchase common stock through payroll deductions at a price equal to 85% of the lower of the fair market value of the common stock on the first day of the offering period, or the purchase date. Participants generally may not purchase more than 1,000 shares on any purchase date or stock having a value greater than $25,000 in any calendar year as measured at the beginning of the offering period. In the event of a change in control, the board may accelerate the purchase date of the then-current offering period to a date prior to the change in control, unless the acquiring or successor corporation assumes or replaces the purchase rights outstanding under the employee stock purchase plan. Our board of directors may amend or terminate the 1999 employee stock purchase plan at any time, as long as such amendment or termination does not impair outstanding purchase rights.

401(k) Plan. We have a 401(k) retirement and deferred savings plan covering all eligible employees that is intended to qualify as a tax-qualified plan under the Internal Revenue Code. Employees are eligible to participate in the plan after completing one month of service with us. Employees may participate in the plan beginning on the first day of the calendar quarter immediately following satisfaction of the eligibility requirement. The plan provides that each participant may contribute up to 15% of his or her pre-tax gross compensation, up to a statutory limit, which was $10,000 in the 1998 calendar year. All amounts contributed by participants and earnings on these contributions are immediately vested. We may contribute an amount up to 6% of the participant's annual compensation if that amount is less than or equal to the amount of the participant's contribution that will vest on the last day of the plan year for employees employed on that date. We may also make discretionary non-matching contributions. These contributions would vest ratably over six years or seven years depending on the nature of the contribution. Continued employment is a condition of vesting. To date, we have made no contributions to the 401(k) plan.

50

INDEMNIFICATION OF DIRECTORS AND EXECUTIVE OFFICERS AND LIMITATION OF DIRECTORS' LIABILITY

Our certificate of incorporation limits the liability of our directors to the maximum extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except liability for:

- any breach of their duty of loyalty to the corporation or its stockholders;

- acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;

- unlawful payments of dividends or unlawful stock repurchases or redemptions; or

- any transaction from which they derived an improper personal benefit.

This limitation of liability does not apply to liabilities arising under the federal securities laws and does not affect the availability of equitable remedies such as injunctive relief or rescission.

Our certificate of incorporation and bylaws provide that we will indemnify our directors and executive officers and may indemnify other officers and employees and other agents to the fullest extent permitted by law. We believe that indemnification under our bylaws covers at least negligence and gross negligence on the part of indemnified parties. Our bylaws also permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity, regardless of whether Delaware law would permit indemnification.

In addition to indemnification provisions in our bylaws, we have entered into agreements to indemnify our directors and executive officers. These agreements provide for indemnification of our directors and executive officers for some types of expenses, including attorneys' fees, judgments, fines and settlement amounts incurred by persons in any action or proceeding, including any action by or in the right of Immersion, arising out of their services as our director or executive officer. We believe that these provisions and agreements are necessary to attract and retain qualified persons as directors and executive officers.

51

CERTAIN TRANSACTIONS

Since January 1, 1996, there has not been, nor is there currently proposed, any transaction or series of similar transactions to which we were or are a party in which the amount involved exceeds $60,000 and in which any of our directors, executive officers or holders of more than 5% of our capital stock had or will have a direct or indirect material interest other than:

- the agreements that are described in "Management;" and

- the transactions described below.

FINANCING TRANSACTIONS

In November 1996, we issued 394,760 shares of Series B preferred stock to individuals for an aggregate purchase price of $590,004. Of these shares, we issued 20,175 shares to Bruce Paul, a holder of more than 5% of our capital stock. In November 1996, we also issued Mr. Paul a warrant to purchase 32,280 shares of Series B preferred stock at an exercise price of $1.49 per share. In December 1996, we issued Mr. Paul a warrant to purchase 40,350 shares of Series B preferred stock at an exercise price of $1.49 per share. We amended these warrants in September 1998 to extend their term from two years to five years.

In June 1997, we issued 864,642 shares of Series C preferred stock for an aggregate purchase price of $1,500,005. Of these shares, we issued 518,788 shares to Intel, a holder of more than 5% of our capital stock. In connection with this sale of Series C preferred stock to Intel, we issued Intel a warrant to purchase 91,191 shares of common stock at an exercise price of $0.19 per share. In connection with this sale, we agreed to provide the holders of Series C preferred stock with registration rights with respect to the common stock issuable upon conversion of the Series C preferred stock and upon exercise of Intel's warrant.

In April 1998, we issued shares of our Series D preferred stock to Intel and Logitech, each a holder of more than 5% of our capital stock. Intel purchased 179,599 shares and Logitech purchased 1,197,329 shares of our Series D preferred stock at a purchase price of $4.17 per share for an aggregate purchase price of $5,750,002. In connection with this sale, we agreed to provide each of Intel and Logitech with registration rights with respect to the common stock issuable upon conversion of this Series D preferred stock.

OTHER TRANSACTIONS

Share Repurchase. In May 1998, we repurchased 502,014 shares of our common stock at $3.66 per share from stockholders who elected to participate in the repurchase, including:

                                                   NUMBER OF
                  STOCKHOLDER                     SHARES SOLD    CONSIDERATION PAID
                  -----------                     -----------    ------------------
Louis Rosenberg.................................    257,838         $   942,531
Bruce Schena....................................     79,922             292,159
Timothy Lacey...................................    107,190             391,837

Logitech Agreement. In October 1996, we entered into a royalty-based license agreement and a technology product development agreement with Logitech. The license agreement grants Logitech a license under such patents for feel-enabled gaming products. Pursuant to the technology product development agreement, we provided Logitech consulting services with respect to the development of feel-enabled gaming products. Pursuant to these agreements, Logitech is required to mark its products with our relevant patents and abide by our product branding requirements. We derived royalty revenue of $242,000 in 1997 and $149,000 in 1998 from these agreements.

In April 1998, we entered into a royalty-based license agreement and a technology product development agreement with Logitech. The license agreement grants Logitech a license under such patents for feel-enabled cursor control devices. Pursuant to the technology product development agreement, we provided Logitech consulting services with respect to the development of feel-

52

enabled cursor control devices. Pursuant to these agreements, Logitech is required to mark its products with our relevant patents and abide by our product branding requirements. We derived royalty revenue of $161,000 in 1998 and $190,000 for the six months ended June 30, 1999 from these agreements.

MicroScribe Agreements. In July 1997, we entered into an exchange agreement, a patent license agreement and an intellectual property license agreement with MicroScribe LLC. Pursuant to the exchange agreement and the patent license agreement, we assigned certain of our patents to MicroScribe in exchange for a worldwide, royalty-free, exclusive, irrevocable license and all of the class 1 membership interests in MicroScribe. All of the class 2 membership interests of MicroScribe were distributed to shareholders of our company at the time of the exchange agreement. The following table presents information regarding the percentage interest in MicroScribe of each person listed individually in our principal stockholders table on page 54.

                                                   PERCENTAGE INTEREST
           NAME OF BENEFICIAL HOLDER               OWNED IN MICROSCRIBE
           -------------------------               --------------------
Cybernet System Corporation....................              --%
Logitech International S.A.....................              --
Intel Corporation..............................             5.9
Bruce Paul.....................................             7.5
Louis Rosenberg................................            25.9
Bruce Schena...................................             8.6
Jonathan Rubinstein............................              --
Steven Blank...................................             1.0

The aggregate amount paid to these persons in 1999 was approximately $53,000.

Distributable cash from normal business operations of MicroScribe is distributed 99% to the class 2 members and 1% to us, as the sole class 1 member. Pursuant to the terms of the license agreement, MicroScribe granted us rights to use intellectual property of MicroScribe for the development and distribution of 3D digitizing products. We paid MicroScribe $116,487 in 1998 and $67,696 for the six months ended June 30, 1999.

Cybernet Agreements. In March 1999, we acquired patents and in-process technology from Cybernet Systems Corporation in exchange for 1,291,200 shares of our common stock. In addition, we entered into a consulting services agreement with Cybernet, under which we issued Cybernet a warrant to purchase 322,800 shares of common stock at an exercise price of $3.66 and agreed to pay Cybernet $300,000. We paid $150,000 of this amount in March 1999 and must pay $75,000 in January 2000 and $75,000 in January 2001. In connection with this acquisition and consulting arrangement, we agreed to provide Cybernet with registration rights with respect to their common stock and the common stock issuable upon exercise of this warrant.

53

PRINCIPAL STOCKHOLDERS

The following table presents information regarding the beneficial ownership of our common stock as of September 30, 1999, and as adjusted to reflect the sale of the 4,250,000 shares of common stock offered by us, by:

- each stockholder known by us to beneficially own more than five percent of our common stock;

- each of the executive officers listed in our summary compensation table on page 47;

- each director; and

- all executive officers and directors as a group.

                                                    SHARES OF
                                                   COMMON STOCK
                                                   BENEFICIALLY       PERCENTAGE OF COMMON STOCK
                                                      OWNED               BENEFICIALLY OWNED
                                                   ------------    ---------------------------------
            NAME OF BENEFICIAL OWNER                  NUMBER       BEFORE OFFERING    AFTER OFFERING
            ------------------------               ------------    ---------------    --------------
5% STOCKHOLDERS
Cybernet Systems Corporation.....................   1,557,510           13.5%               9.9%
  727 Airport Boulevard
  Ann Arbor, Michigan 48108-1639
Logitech International S.A. .....................   1,197,329           10.7                7.8
  6505 Kaiser Drive
  Fremont, California 94555-3615
Intel Corporation................................     789,578            7.0                5.1
  2200 Mission College Boulevard
  M&A Portfolio Manager, RN 6-46
  Santa Clara, California 95052
Bruce Paul.......................................     781,781            6.9                5.0
  One Hampton Road
  Purchase, NY 10577
EXECUTIVE OFFICERS AND DIRECTORS
Louis Rosenberg, Ph.D. ..........................   2,543,408           20.8               15.4
Bruce Schena.....................................     869,475            7.5                5.5
Steven Blank.....................................     146,093            1.3                0.9
Jonathan Rubinstein..............................      14,795            0.1                0.1
All executive officers and directors as a group
  (8 persons)....................................   3,776,656           29.5               22.1

The principal stockholders and members of the board of directors of Cybernet Systems Corporation exercise dispositive and voting power on behalf of Cybernet Systems Corporation.

As of September 30, 1999, there were 11,191,856 shares of common stock outstanding, assuming conversion of all shares of preferred stock into common stock. Following completion of this offering, there will be 15,441,856 shares of common stock outstanding, assuming no exercise of the underwriters' over-allotment option. The column that shows the percentage of shares outstanding after the offering assumes that the underwriters' over-allotment option is not exercised.

If the over-allotment option is exercised in full, we will sell a total of 137,230 shares of common stock and selling stockholders will sell a total of 500,270 shares of common stock. The following table presents information regarding the beneficial ownership of our common stock as of

54

September 30, 1999, assuming the exercise of the over-allotment option in full, as adjusted to reflect the sale of common stock offered by each selling stockholder:

                                                 SHARES OF COMMON STOCK     SHARES OF COMMON STOCK
                                                   BENEFICIALLY OWNED         BENEFICIALLY OWNED
                                                     BEFORE OFFERING            AFTER OFFERING
                                                 -----------------------   ------------------------
           NAME OF BENEFICIAL OWNER               NUMBER      PERCENTAGE     NUMBER      PERCENTAGE
           ------------------------              ---------    ----------   ----------    ----------
Bernie G. and Linda A. Jackson, and trustees of
  the Regina trust.............................    414,909        3.7%        391,394        2.5%
Adam C. Braun..................................    145,687        1.3         141,652        0.9
C. Gordon Bell Revocable Trust.................     53,802        0.5          41,697        0.3
Scott Curtis...................................     10,087        0.1               0        0.0
Cybernet Systems Corporation...................  1,557,510       13.5       1,396,110        8.8
Craig H. Factor................................    150,550        1.3         142,480        0.9
Alex Goldenberg................................     14,379        0.1          14,218        0.1
David R. Hague.................................     97,160        0.9          89,090        0.6
Christopher J. Hasser..........................     85,783        0.8          85,218        0.5
John Gibson Limited............................    171,486        1.5         163,416        1.0
Patrick H. and Nina J. Lacey...................     30,262        0.3          22,192        0.1
Timothy Lacey..................................  1,083,821        9.5       1,043,512        6.6
Michael D. Levin...............................    129,313        1.2         128,970        0.8
Kenneth Martin.................................    202,885        1.8         194,815        1.2
Nicholas Palevsky..............................     20,175        0.2               0        0.0
Arthur and Marilyn Rosenberg...................     85,541        0.8          71,822        0.5
Louis Rosenberg, Ph.D. ........................  2,543,408       20.8       2,414,288       14.5
Bruce M. Schena................................    869,475        7.5         861,405        5.4
Sia Tan........................................     32,279        0.3          24,209        0.2
Ming-Chang Tsai................................     28,245        0.3               0        0.0

Beneficial ownership is determined under the rules of the Securities and Exchange Commission. All of the shares of common stock subject to options currently exercisable or exercisable within 60 days after September 30, 1999 are treated as outstanding and beneficially owned by the person holding them for the purpose of computing the number of shares beneficially owned by and the percentage of ownership of that person. They are not, however, treated as outstanding and beneficially owned for the purpose of computing the percentage ownership of any other person. Except where indicated and subject to applicable community property laws, based on information provided by the persons named in the table, these persons have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them.

Shares listed as held by Cybernet consist of 1,246,008 shares and 311,502 shares issuable upon exercise of warrants exercisable within 60 days of September 30, 1999.

Shares listed as held by Intel consist of 698,387 shares and 91,191 shares issuable upon exercise of warrants exercisable within 60 days of September 30, 1999.

Shares listed as held by Bruce Paul include 467,051 shares and 72,630 shares issuable upon exercise of warrants exercisable within 60 days of September 30, 1999. In addition, Mr. Paul's shares include 242,100 shares held by Mr. Paul as custodian for his minor children under the California uniform transfers to minors act. Mr. Paul disclaims beneficial ownership of these shares.

55

Shares listed as held by the persons listed in the tables above include shares subject to options exercisable within 60 days of September 30, 1999 as follows:

                                                              SHARES SUBJECT
              EXECUTIVE OFFICERS AND DIRECTORS                  TO OPTIONS
              --------------------------------                --------------
Louis Rosenberg.............................................    1,044,408
Bruce Schena................................................      432,718
Steven Blank................................................       61,358
Jonathan Rubinstein.........................................        6,725
All directors and executive officers as a group (8
  persons)..................................................    1,624,523
SELLING STOCKHOLDERS
------------------------------------------------------------
Adam C. Braun...............................................       46,352
C Gordon Bell Revocable Trust...............................       20,175
Craig H. Factor.............................................       75,002
Alex Goldenberg.............................................          162
David R. Hague..............................................        3,950
Christopher J. Hasser.......................................       10,230
Timothy Lacey...............................................      202,669
Michael D. Levin............................................        1,392
Kenneth Martin..............................................       79,314
Louis Rosenberg.............................................    1,044,408
Bruce M. Schena.............................................      432,718

In addition, Mr. Schena's shares include 2,734 shares held by Rita Schena, as custodian for Mr. Schena's minor child under the California uniform transfers to minors act. Mr. Schena disclaims beneficial ownership of these shares.

56

DESCRIPTION OF CAPITAL STOCK

Our authorized capital stock will consist of 100,000,000 shares of common stock, $0.001 par value per share, and 5,000,000 shares of preferred stock, $0.001 par value per share. The following summary of provisions of the common stock and preferred stock is subject to, and qualified in its entirety by, our certificate of incorporation and bylaws and by the provisions of applicable law.

COMMON STOCK

As of September 30, 1999, there were 11,191,856 shares of common stock outstanding held by approximately 108 stockholders of record. Subject to preferences that may be applicable to any preferred stock outstanding at the time, the holders of outstanding shares of common stock are entitled to receive dividends out of assets legally available at the times and in the amounts that the board from time to time may determine in its sole discretion. Holders of common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders. Cumulative voting for the election of directors is not authorized by our certificate of incorporation, which means that the holders of a majority of the shares voted can elect all of the directors then standing for election. Our common stock is not entitled to preemptive rights and is not subject to conversion or redemption. If we liquidate, dissolve or wind-up our business, the holders of common stock would be entitled to share ratably in all assets remaining after payment of liabilities and the liquidation of any preferred stock. Each outstanding share of common stock is, and all shares of common stock to be outstanding upon completion of this offering upon payment will be, duly and validly issued, fully paid and nonassessable. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of any shares of preferred stock, that we may issue in the future.

PREFERRED STOCK

Before the closing of this offering and in connection with our reincorporation in the state of Delaware, all outstanding shares of preferred stock will be converted into an aggregate of 5,131,100 shares of common stock, and 5,000,000 shares of undesignated preferred stock will be authorized for issuance. Our board of directors will have the authority, without further action by the stockholders, to issue this undesignated preferred stock in one or more series. In addition, the board may:

- fix the designations, powers, preferences, privileges and relative participating, optional or special rights of this preferred stock; and

- set the qualifications, limitations or restrictions of this preferred stock, including dividend rights, conversion rights, voting rights, terms of redemption and liquidation preferences.

Any or all of these rights may be greater than the rights of the common stock. As a result, the board of directors, without stockholder approval, may issue preferred stock with voting, conversion or other rights that could adversely affect the voting power and other rights of the holders of common stock. Preferred stock could thus be issued quickly with terms calculated to delay or prevent a change in our control or make removal of our management more difficult. Additionally, the issuance of preferred stock may have the effect of decreasing the market price of the common stock. We have no present plans to issue any shares of preferred stock.

REGISTRATION RIGHTS

Some of our stockholders have registration rights under the Securities Act.

Piggyback Registration. If we elect to register any of our shares of stock for an underwritten public offering, the holders of 4,505,589 shares of our common stock and 402,693 shares of common stock issuable upon exercise of warrants, or their permitted transferees, will be entitled to include their securities in the registration, subject to the ability of underwriters to limit the number of shares included in the offering.

57

Form S-3 Registration. If we qualify for registration on Form S-3, holders of 2,240,707 shares of our common stock and 91,191 shares of common stock issuable upon exercise of warrants, or their permitted transferees, may request that we register these securities on Form S-3, provided that at least 121,050 shares are to be registered.

Demand Registration. The holders of 2,240,707 shares of our common stock and 91,191 shares of common stock issuable upon exercise of warrants, or their permitted transferees, upon the vote of 50% of these securities, may demand on two occasions that we file a registration statement for an underwritten public offering covering some or all of these securities. The underwriters may reduce the number of shares proposed to be registered in view of market conditions.

We will pay all expenses in connection with any of these registrations, other than underwriting discounts, fees or commissions or fees of legal counsel for the holders.

DELAWARE ANTI-TAKEOVER LAW AND CERTAIN CHARTER AND BYLAW PROVISIONS

Provisions of Delaware law and our certificate of incorporation and bylaws could make more difficult the acquisition of our company by means of a tender offer, a proxy contest or other means, or the removal of incumbent officers and directors. We expect these provisions to discourage certain types of coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of our company to negotiate first with our board of directors. We believe that the benefits provided by our ability to negotiate with the proponent of an unfriendly or unsolicited proposal outweigh the disadvantages of discouraging these proposals. We believe the negotiation of an unfriendly or unsolicited proposal could result in an improvement of its terms.

We are subject to section 203 of the Delaware General Corporation Law. This provision generally prohibits any Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years following the date the stockholder became an interested stockholder, unless:

- prior to that date, the board of directors approved either the business combination or the transaction that resulted in the stockholder's becoming an interested stockholder;

- upon completion of the transaction that resulted in the stockholder's becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock outstanding at the time the transaction began; or

- on or following that date, the business combination is approved by the board of directors and authorized at an annual or special meeting of stockholders by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.

Section 203 defines a business combination to include:

- any merger or consolidation involving the corporation and the interested stockholder;

- any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation in a transaction involving the interested stockholder;

- subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;

- any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and

- the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

58

In general, section 203 defines an interested stockholder as an entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by that entity or person.

Our certificate of incorporation provides that our board of directors will be divided into three classes of directors, with each class serving a three-year term. The term of the first class of directors expires at the 2000 annual meeting. The term of the second class expires at the 2001 annual meeting. The term of the third class expires at the 2002 annual meeting.

We believe that a classified board of directors will help to assure the continuity and stability of the board of directors and our business strategies and policies as determined by the board of directors, since a majority of the directors at any given time will have had prior experience as directors of our company. We believe that this, in turn, will permit the board of directors to represent the interests of stockholders more effectively.

With a classified board of directors, at least two annual meetings of stockholders will generally be required to effect a change in the majority of the board of directors. As a result, a classified board of directors may discourage proxy contests for the election of directors or purchases of a substantial block of our common stock because it could prevent obtaining control of the board of directors in a relatively short period of time. The classification provision could also have the effect of discouraging a third party from making a tender offer or attempting to obtain control of our company in some other manner. Under the Delaware General Corporation Law, a director on a classified board may be removed by the stockholders of the corporation only for cause. Our certificate of incorporation does not provide for cumulative voting in the election of directors. The amendment of the provisions relating to the classified board requires approval by 66 2/3% or more of the outstanding common stock.

Further, provisions of our certificate of incorporation and bylaws prevent our stockholders from taking action by means of written consent and require our stockholders to provide advance notice before nominating directors and bringing stockholder proposals.

TRANSFER AGENT AND REGISTRAR

The transfer agent and registrar for our common stock is BankBoston, N.A.

59

SHARES ELIGIBLE FOR FUTURE SALE

Prior to this initial public offering, there has not been a public market for our common stock. Future sales of substantial amounts of common stock in the public market could adversely affect the trading price of the common stock.

Upon completion of this offering, we will have outstanding 15,441,856 shares of common stock, assuming no exercise of the underwriters' over-allotment option and no exercise of outstanding options or warrants to purchase common stock subsequent to September 30, 1999. Of these shares, the 4,250,000 shares sold in this offering will be freely tradable without restriction or further registration under the Securities Act, except for any shares purchased by our "affiliates" as defined in Rule 144 under the Securities Act, whose sales would be subject to the limitations and restrictions described below.

The remaining 11,191,856 shares of common stock outstanding upon completion of this offering will be "restricted securities" as defined in Rule 144. These securities may be sold in the public market only if registered or if they qualify for an exemption from registration under Rules 144 or 701 under the Securities Act, which are summarized below. Sales of these restricted securities in the public market, or the availability of these shares for sale, could adversely affect the trading price of our common stock.

The number of restricted securities that will be available for sale in the public market, subject in some cases to the volume limitations and other restrictions of Rule 144, will be as follows:

- no shares will be eligible for immediate sale as of the date of this prospectus;

- approximately 8,875,526 additional shares will be eligible for sale beginning 181 days after the date of this prospectus pursuant to Rules 144 and 701 upon expiration of the lock-up agreements; and

- approximately 2,316,330 shares will be eligible for sale beginning one year after the date of this prospectus pursuant to Rule 144, subject in some cases to certain volume, manner of sale and other limitations under Rule 144.

Following the completion of this offering, warrants to purchase 498,593 shares will be outstanding, which, if exercised pursuant to net-exercise provisions, would be immediately salable without restriction upon the expiration of the 180 day lock-up period.

Lock-up Agreements. All of our officers and directors and substantially all of our stockholders have signed lock-up agreements that prohibit them from offering, selling or otherwise disposing of any shares of common stock, options or warrants to acquire shares of common stock or securities exchangeable for or convertible into shares of common stock owned by them without the prior written consent of Hambrecht & Quist LLC during the 180-day period following date of this prospectus. Hambrecht & Quist LLC may choose to release some of these shares from these restrictions prior to the expiration of this 180-day period, although it has no current intention to do so.

Rule 144. In general, under Rule 144, beginning 90 days after the date of this prospectus, a person, or persons whose shares are aggregated, who has beneficially owned restricted securities for at least one year, including the holding period of any prior owner except our affiliates, would be entitled to sell within any three-month period a number of shares not to exceed the greater of:

- one percent of the number of outstanding shares of our common stock, which will equal approximately 154,418 shares immediately after this offering, or

- the average weekly trading volume of the common stock on the Nasdaq National Market during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.

60

Sales under Rule 144 are also subject to certain manner-of-sale and notice requirements, as well as to the availability of current public information about us.

Rule 144(k). Under Rule 144(k), a person who has not been considered our affiliate at any time during the 90 days preceding a sale and who has beneficially owned the shares proposed to be sold for at least two years, including the holding period of any prior owner except our affiliates, is entitled to sell these shares without complying with the manner-of-sale, public information, volume limitation or notice provisions of Rule 144.

Rule 701. Shares issued upon exercise of options granted by us prior to the date of this prospectus will be available for sale in the public market under Rule 701 of the Securities Act. Rule 701 permits resales of these shares in reliance upon Rule 144 but without compliance with various restrictions, including the holding period requirement, imposed under Rule 144.

Stock Options. We have reserved a total of 6,048,123 shares of common stock for issuance pursuant to our stock option plans and our stock purchase plan. As of September 30, 1999, options to purchase a total of 4,379,465 shares of common stock were outstanding under our stock option plans. We intend to file registration statements on Form S-8 under the Securities Act approximately 180 days after the date of this prospectus to register a total of 6,895,058 shares of common stock outstanding and reserved for issuance under the stock option plans and the purchase plan. Shares of common stock issued under these plans after the filing of the registration statement will be freely tradable in the public market, subject to the Rule 144 limitations in the case of our affiliates, the lock-up agreements and vesting restrictions imposed by us.

61

UNDERWRITING

Subject to the terms and conditions of the underwriting agreement, the underwriters named below, through their representatives Hambrecht & Quist LLC, Bear, Stearns & Co. Inc. and BancBoston Robertson Stephens Inc., have severally agreed to purchase from us the following respective numbers of shares of our common stock:

                                                              NUMBER OF
                            NAME                                SHARES
                            ----                              ----------
Hambrecht & Quist LLC.......................................
Bear, Stearns & Co. Inc. ...................................
BancBoston Robertson Stephens Inc. .........................
                                                              ----------
Total.......................................................   4,250,000
                                                              ==========

The underwriting agreement provides that the obligations of the underwriters are subject to conditions, including the absence of any material adverse change in our business and the receipt of certificates, opinions and letters from us, our counsel and our independent auditors. The nature of the underwriters' obligations requires that they purchase all shares of common stock offered in this offering if they purchase any of the shares in this offering.

The underwriters propose to offer the shares of common stock directly to the public at the initial public offering price set forth on the cover page of this prospectus and to dealers at that price less a concession not in excess of $ per share. The underwriters may allow and the dealers may reallow a concession not in excess of $ per share to other dealers. After the public offering of the shares, the underwriters may change the offering price and other selling terms. The representatives have advised us that the underwriters do not intend to confirm discretionary sales in excess of 5% of the shares of common stock offered by this prospectus.

We and certain selling stockholders have granted to the underwriters an option, exercisable no later than 30 days after the effective date of this offering, to purchase up to 637,500 additional shares of common stock at the initial public offering price, less the underwriting discount and commissions set forth on the cover page of this prospectus. To the extent that the underwriters exercise this option, each underwriter will have a firm commitment to purchase approximately the same percentage that the number of shares of common stock to be purchased by it shown in the above table bears to the total number of shares of common stock offered in this offering. We and the selling stockholders will be obligated to sell shares to the underwriters to the extent the option is exercised. The underwriters may exercise the option only to cover over-allotments made in connection with the sale of common stock offered in this offering.

The following table shows the per share and total public offering price, the underwriting discount and commissions and the proceeds before expenses to us.

                                                                                 TOTAL
                                                                         ----------------------
                                                                          WITHOUT       WITH
                                                                           OVER-        OVER-
                                                                         ALLOTMENT    ALLOTMENT
                                                            PER SHARE     OPTION       OPTION
                                                            ---------    ---------    ---------
Public offering price.....................................
Underwriting discount and commissions.....................
Proceeds, before expenses, to Immersion...................

62

We estimate that the total expenses of the offering, excluding underwriting discounts and commissions, will be approximately $1.0 million.

The offering of the shares is made for delivery when, as and if accepted by the underwriters and subject to prior sale and to withdrawal, cancellation or modification of the offering without notice. The underwriters reserve the right to reject an order for the purchase of shares in whole or in part.

We and, if the underwriters' over-allotment option is exercised, the selling stockholders, have agreed to indemnify the underwriters against liabilities connected to this offering, including liabilities under the Securities Act, and to contribute to payments the underwriters may be required to make in respect of those liabilities.

All of our stockholders, including all of our executive officers and directors and the selling stockholders, who will own in the aggregate 11,191,856 shares of common stock after the offering, have agreed that they will not, without the prior written consent of Hambrecht & Quist LLC, offer, sell or otherwise dispose of any shares of common stock, options or warrants to acquire shares of common stock or securities exchangeable for or convertible into shares of common stock owned by them during the 180-day period following the date of this prospectus. We have agreed that we will not, without the prior written consent of Hambrecht & Quist LLC, offer, sell or otherwise dispose of any shares of common stock, options or warrants to acquire shares of common stock or securities exchangeable for or convertible into shares of common stock during the 180-day period following the date of this prospectus, except that we may issue shares upon the exercise of options granted before the date of this prospectus, and may grant additional options under our stock option plans, provided that, without the prior written consent of Hambrecht & Quist LLC, the additional options will not be exercisable during the 180-day period.

Before this offering, there has been no public market for our shares. The initial public offering price will be negotiated among us and the underwriters. Among the factors to be considered in determining the initial public offering price of the shares, in addition to prevailing market conditions, will be our historical performance, estimates of our business potential and earnings prospects, an assessment of management and the consideration of the above factors in relation to market valuations of companies in related businesses. The estimated initial public offering price range set forth on the cover of this preliminary prospectus is subject to change as a result of market conditions and other factors.

We have applied to have our common stock quoted on the Nasdaq National Market under the symbol IMMR.

In connection with the offering, the underwriters may purchase and sell shares of common stock in the open market. These transactions may include short sales, stabilizing transactions and purchases to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering. Stabilizing transactions consist of certain bids or purchases made for the purpose of preventing or retarding a decline in the market price of the common stock while the offering is in progress.

The underwriters also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discounts and commissions received by it because the representatives have repurchased shares sold by or for the account of that underwriter in stabilizing or short-covering transactions.

These activities by the underwriters may stabilize, maintain or affect the market price of the common stock in another manner. As a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued by the underwriters at any time. These transactions may be effected on the Nasdaq National Market, in the over-the-counter market or otherwise.

63

LEGAL MATTERS

Gray Cary Ware & Freidenrich LLP, Palo Alto, California will pass upon the validity of the issuance of the shares of common stock offered by this prospectus. Fenwick & West LLP, Palo Alto, California will pass upon legal matters for the underwriters.

EXPERTS

The consolidated financial statements as of December 31, 1997 and 1998, and for each of the three years in the period ended December 31, 1998, included in this prospectus and the related financial statement schedule included elsewhere in the registration statement have been audited by Deloitte and Touche LLP, independent auditors, as stated in their reports appearing in this prospectus and elsewhere in the registration statement, and have been so included in reliance upon the reports of that firm given upon their authority as experts in auditing and accounting.

WHERE YOU CAN FIND ADDITIONAL INFORMATION

We have filed with the Securities and Exchange Commission a registration statement on Form S-1 under the Securities Act with respect to the common stock offered by this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information contained in the registration statement. Some of that information is contained in exhibits to the registration statement as permitted by the rules and regulations of the Securities and Exchange Commission. For further information with respect to us and our common stock being offered by this prospectus, please see the registration statement and related exhibits. Statements made in this prospectus concerning the contents of any document referred to in this prospectus are not necessarily complete. With respect to each document filed with the Securities and Exchange Commission as an exhibit to the registration statement, please see the exhibit for a more complete description of the matter involved. The registration statement, and related exhibits may be inspected without charge at the principal office of the Securities and Exchange Commission located at 450 Fifth Street, N.W., Washington, D.C. 20549. Copies of all or any part of these documents may be obtained from the Securities and Exchange Commission's public reference rooms at the same location and at the Securities and Exchange Commission's regional offices located at Seven World Trade Center, New York, New York 10048 and Citicorp Center, 5000 West Madison Street, Chicago, Illinois 60661 upon payment of the fees prescribed by them. The Securities and Exchange Commission maintains a web site that contains reports, proxy and information statements and other information regarding registrants that file electronically with them. The address of that web site is http://www.sec.gov.

64

IMMERSION CORPORATION

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

                                                              PAGE
                                                              ----
Independent Auditors' Report................................  F-2
Consolidated Balance Sheets as of December 31, 1997 and 1998
  and June 30, 1999 (unaudited).............................  F-3
Consolidated Statements of Operations for the years ended
  December 31, 1996, 1997 and 1998 and the six months ended
  June 30, 1998 and 1999 (unaudited)........................  F-4
Consolidated Statements of Stockholders' Equity and
  Comprehensive Loss for the years ended December 31, 1996,
  1997 and 1998 and the six months ended June 30, 1999
  (unaudited)...............................................  F-5
Consolidated Statements of Cash Flows for the years ended
  December 31, 1996, 1997 and 1998 and the six months ended
  June 30, 1998 and 1999 (unaudited)........................  F-6
Notes to Consolidated Financial Statements..................  F-7

F-1

INDEPENDENT AUDITORS' REPORT

To the Board of Directors and Stockholders of Immersion Corporation:

We have audited the accompanying consolidated balance sheets of Immersion Corporation and its subsidiary (the Company) as of December 31, 1997 and 1998, and the related consolidated statements of operations, stockholders' equity and comprehensive loss and cash flows for each of the three years in the period ended December 31, 1998. These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Immersion Corporation and its subsidiary at December 31, 1997 and 1998, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 1998, in conformity with generally accepted accounting principles.

San Jose, California
April 2, 1999
(August 31, 1999 as to Note 14)

To the Board of Directors and Stockholders of Immersion Corporation:

The consolidated financial statements included herein have been adjusted to give effect to the reincorporation in Delaware and the related 0.807-for-one reverse common and Series C and D preferred stock split and the 4.035-for-one reverse Series A and B preferred stock split as described in the second paragraph of Note 14 to the consolidated financial statements. The above report is in the form that will be signed by Deloitte & Touche LLP upon effectiveness of such event assuming that, from August 31, 1999 to the effective date of such event, no other events shall have occurred that would affect the accompanying consolidated financial statements or notes thereto.

DELOITTE & TOUCHE LLP

San Jose, California

October 5, 1999

F-2

IMMERSION CORPORATION

CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)

ASSETS

                                                              DECEMBER 31,                     PRO FORMA
                                                            ----------------     JUNE 30,      JUNE 30,
                                                             1997     1998         1999          1999
                                                            ------   -------   ------------   -----------
                                                                               (UNAUDITED)    (UNAUDITED)
Current assets:
  Cash and cash equivalents...............................  $  490   $ 2,592     $ 2,204
  Short-term investments..................................   1,212       402         200
  Accounts receivable (net of allowances for doubtful
    accounts of: 1997, $38; 1998, $92; and 1999, $76).....     519     1,111       1,094
  Inventories.............................................     295       481         606
  Prepaid expenses and other assets.......................      49        99          92
                                                            ------   -------     -------
         Total current assets.............................   2,565     4,685       4,196
Property--net.............................................     334       329         398
Purchased patents and technology..........................      --       945       4,841
Other assets..............................................       1        --         271
                                                            ------   -------     -------
         Total assets.....................................  $2,900   $ 5,959     $ 9,706
                                                            ======   =======     =======
              LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY
Current liabilities:
  Accounts payable........................................  $  288   $   410     $   394
  Accrued compensation....................................     125       171         224
  Other accrued liabilities...............................       5        82         179
  Customer advances.......................................      64        46          59
  Income taxes payable....................................       3         1           1
                                                            ------   -------     -------
         Total current liabilities........................     485       710         857
                                                            ------   -------     -------
Commitments and contingencies (Notes 6 and 13)
Redeemable convertible preferred stock, Series C--$0.001
  par value; 863,778 shares designated; shares issued and
  outstanding: 1997, 864,642; 1998 and 1999, 863,771; pro
  forma, none (liquidation preference $1,500,005).........   1,471     1,476       1,479
                                                            ------   -------     -------
Stockholders' equity:
  Convertible preferred stock, $0.001 par value;
    authorized, 10,215,716 shares actual; pro forma,
    5,000,000:
    Series A--$0.001 par value; 2,495,648 shares
      designated; shares issued and outstanding: 1997,
      2,465,384; 1998 and 1999, 2,495,644; pro forma, none
      (liquidation preference $244,400)...................     976     1,012       1,012
    Series B--$0.001 par value; 467,390 shares designated;
      shares issued and outstanding: 1997, 396,778; 1998
      and 1999, 394,757; pro forma, none (liquidation
      preference $590,004)................................     569       566         566
    Series D--$0.001 par value; 1,388,901 shares
      designated; shares issued and outstanding: 1997,
      none; 1998 and 1999, 1,376,928; pro forma, none
      (liquidation preference $5,750,002).................      --     5,377       5,377
  Common stock--$0.001 par value; 100,000,000 shares
    authorized, actual and pro forma; shares issued and
    outstanding: 1997, 3,418,495; 1998, 4,164,231; 1999,
    5,901,405; pro forma, 11,032,505......................      57       961       7,947        $16,381
  Warrants................................................      33        85         893            893
  Deferred stock compensation.............................      --        --      (2,075)        (2,075)
  Accumulated other comprehensive loss....................       2         1          --             --
  Note receivable from stockholder........................      --       (17)        (17)           (17)
  Accumulated deficit.....................................    (693)   (4,212)     (6,333)        (6,333)
                                                            ------   -------     -------        -------
         Total stockholders' equity.......................     944     3,773       7,370        $ 8,849
                                                            ------   -------     -------        =======
Total liabilities, redeemable convertible preferred stock
  and stockholders' equity................................  $2,900   $ 5,959     $ 9,706
                                                            ======   =======     =======

See notes to consolidated financial statements.

F-3

IMMERSION CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

                                                             YEAR ENDED              SIX MONTHS
                                                            DECEMBER 31,           ENDED JUNE 30,
                                                      -------------------------   ----------------
                                                       1996     1997     1998      1998     1999
                                                      ------   ------   -------   ------   -------
                                                                                    (UNAUDITED)
Revenues:
  Royalty revenue...................................  $   --   $   14   $   321   $    8   $   622
  Product sales.....................................   2,022    2,908     3,725    1,604     2,133
  Development contracts and other...................     715    1,410       975      565       748
                                                      ------   ------   -------   ------   -------
          Total revenues............................   2,737    4,332     5,021    2,177     3,503
                                                      ------   ------   -------   ------   -------
Costs and expenses:
  Cost of product sales.............................     947    1,186     1,507      641       970
  Sales and marketing...............................     422      658       656      361       459
  Research and development..........................     710    1,515     1,817      833     1,057
  General and administrative........................     766    1,550     2,677    1,269     1,548
  Amortization of intangibles and deferred stock
     compensation...................................       1       --       211       21       463
  In-process research and development...............      --       --        --       --     1,190
                                                      ------   ------   -------   ------   -------
          Total costs and expenses..................   2,846    4,909     6,868    3,125     5,687
                                                      ------   ------   -------   ------   -------
Operating loss......................................    (109)    (577)   (1,847)    (948)   (2,184)
Other income........................................      28       50       174       79        66
                                                      ------   ------   -------   ------   -------
Net loss............................................     (81)    (527)   (1,673)    (869)   (2,118)
Redeemable convertible preferred stock accretion....      --        3         6        3         3
                                                      ------   ------   -------   ------   -------
Net loss applicable to common stockholders..........  $  (81)  $ (530)  $(1,679)  $ (872)  $(2,121)
                                                      ======   ======   =======   ======   =======
Basic and diluted net loss per share................  $(0.03)  $(0.17)  $ (0.43)  $(0.23)  $ (0.42)
                                                      ======   ======   =======   ======   =======
Shares used in calculating basic and diluted net
  loss per share....................................   2,825    3,162     3,909    3,839     5,003
                                                      ======   ======   =======   ======   =======
Pro forma basic and diluted net loss per share
  (Note 1)..........................................                    $ (0.19)           $ (0.21)
                                                                        =======            =======
Shares used in calculating pro forma basic and
  diluted net loss per share (Note 1)...............                      8,630             10,134
                                                                        =======            =======

See notes to consolidated financial statements.

F-4

IMMERSION CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE LOSS
(IN THOUSANDS, EXCEPT SHARE AMOUNTS)

                                          CONVERTIBLE                                                       ACCUMULATED
                                        PREFERRED STOCK        COMMON STOCK                   DEFERRED         OTHER
                                       ------------------   ------------------                 STOCK       COMPREHENSIVE
                                        SHARES     AMOUNT    SHARES     AMOUNT   WARRANTS   COMPENSATION   INCOME (LOSS)
                                       ---------   ------   ---------   ------   --------   ------------   -------------
Balances at January 1, 1996..........  2,344,331   $ 910    3,311,334   $  28      $ 12       $    --           $15
 Net loss............................
 Change in net unrealized gains from
   short-term investments............                                                                           (10)
 Comprehensive loss..................
 Issuance of Series B convertible
   preferred stock, net of issuance
   costs of $21......................    396,778     569                             21
 Issuance of warrant.................                 (6)                             6
 Collection of stockholder note
   receivable........................
 Exercise of stock options...........                           2,017      --
 Stock compensation..................                                       1
                                       ---------   ------   ---------   ------     ----       -------           ---
Balances at December 31, 1996........  2,741,109   1,473    3,313,351      29        39            --             5
 Net loss............................
 Change in net unrealized gains from
   short-term investments............                                                                            (3)
 Comprehensive loss..................
 Issuance of warrants in connection
   with issuance of Series C
   redeemable convertible preferred
   stock.............................                                                 6
 Exercise of Series A preferred stock
   warrant...........................    121,050      72                            (12)
 Exercise of stock options...........                         105,144      23
 Issuance of stock options for
   license agreement.................                                       5
 Preferred stock accretion...........
                                       ---------   ------   ---------   ------     ----       -------           ---
Balances at December 31, 1997........  2,862,159   1,545    3,418,495      57        33            --             2
 Net loss............................
 Change in net unrealized gains from
   short-term investments............                                                                            (1)
 Comprehensive loss..................
 Issuance of Series D convertible
   preferred stock, net of issuance
   costs of $374.....................  1,376,928   5,376                             17
 Exercise of Series A preferred stock
   warrants..........................     30,260      36                             (6)
 Exercise of common stock warrants...                          85,945       4
 Extension of Series B preferred
   stock warrants....................                                                41
 Exercise of stock options...........                       1,024,615     114
 Issuance of common stock and options
   for patents.......................                         137,190     720
 Issuance of stock options for
   consulting services...............                                      68
 Repurchase of stock.................     (2,018)     (2)    (502,014)     (2)
 Preferred stock accretion...........
                                       ---------   ------   ---------   ------     ----       -------           ---
Balances at December 31, 1998........  4,267,329   $6,955   4,164,231   $ 961      $ 85       $    --           $ 1
 Net loss*...........................
 Change in net unrealized gains from
   short-term investments*...........                                                                            (1)
 Comprehensive loss*.................
 Issuance of common stock and options
   for services*.....................                           8,070     140
 Exercise of common stock
   warrants*.........................                           7,061       1
 Warrants issued for services*.......                                               808          (808)
 Exercise of stock options*..........                         342,073     151
 Issuance of common stock and options
   for patents*......................                       1,379,970   5,092
 Issuance of stock options for
   license agreement*................                                     129
 Deferred stock compensation*........                                   1,473                  (1,473)
 Amortization of stock
   compensation*.....................                                                             206
 Preferred stock accretion*..........
                                       ---------   ------   ---------   ------     ----       -------           ---
Balances at June 30, 1999*...........  4,267,329   $6,955   5,901,405   $7,947     $893       $(2,075)          $--
                                       =========   ======   =========   ======     ====       =======           ===

                                          NOTE
                                       RECEIVABLE                                TOTAL
                                          FROM       ACCUMULATED             COMPREHENSIVE
                                       STOCKHOLDER     DEFICIT      TOTAL        LOSS
                                       -----------   -----------   -------   -------------
Balances at January 1, 1996..........     $ (6)        $   (82)    $   877
 Net loss............................                      (81)        (81)     $   (81)
 Change in net unrealized gains from
   short-term investments............                                  (10)         (10)
                                                                                -------
 Comprehensive loss..................                                           $   (91)
                                                                                =======
 Issuance of Series B convertible
   preferred stock, net of issuance
   costs of $21......................                                  590
 Issuance of warrant.................                                   --
 Collection of stockholder note
   receivable........................        6                           6
 Exercise of stock options...........                                   --
 Stock compensation..................                                    1
                                          ----         -------     -------
Balances at December 31, 1996........       --            (163)      1,383
 Net loss............................                     (527)       (527)     $  (527)
 Change in net unrealized gains from
   short-term investments............                                   (3)          (3)
                                                                                -------
 Comprehensive loss..................                                           $  (530)
                                                                                =======
 Issuance of warrants in connection
   with issuance of Series C
   redeemable convertible preferred
   stock.............................                                    6
 Exercise of Series A preferred stock
   warrant...........................                                   60
 Exercise of stock options...........                                   23
 Issuance of stock options for
   license agreement.................                                    5
 Preferred stock accretion...........                       (3)         (3)
                                          ----         -------     -------
Balances at December 31, 1997........       --            (693)        944
 Net loss............................                   (1,673)     (1,673)     $(1,673)
 Change in net unrealized gains from
   short-term investments............                                   (1)          (1)
                                                                                -------
 Comprehensive loss..................                                           $(1,674)
                                                                                =======
 Issuance of Series D convertible
   preferred stock, net of issuance
   costs of $374.....................                                5,393
 Exercise of Series A preferred stock
   warrants..........................                                   30
 Exercise of common stock warrants...                                    4
 Extension of Series B preferred
   stock warrants....................                                   41
 Exercise of stock options...........      (17)                         97
 Issuance of common stock and options
   for patents.......................                                  720
 Issuance of stock options for
   consulting services...............                                   68
 Repurchase of stock.................                   (1,840)     (1,844)
 Preferred stock accretion...........                       (6)         (6)
                                          ----         -------     -------
Balances at December 31, 1998........     $(17)        $(4,212)    $ 3,773
 Net loss*...........................                   (2,118)     (2,118)     $(2,118)
 Change in net unrealized gains from
   short-term investments*...........                                   (1)          (1)
                                                                                -------
 Comprehensive loss*.................                                           $(2,119)
                                                                                =======
 Issuance of common stock and options
   for services*.....................                                  140
 Exercise of common stock
   warrants*.........................                                    1
 Warrants issued for services*.......                                   --
 Exercise of stock options*..........                                  151
 Issuance of common stock and options
   for patents*......................                                5,092
 Issuance of stock options for
   license agreement*................                                  129
 Deferred stock compensation*........                                   --
 Amortization of stock
   compensation*.....................                                  206
 Preferred stock accretion*..........                       (3)         (3)
                                          ----         -------     -------
Balances at June 30, 1999*...........     $(17)        $(6,333)    $ 7,370
                                          ====         =======     =======

(* Unaudited)
See notes to consolidated financial statements.

F-5

IMMERSION CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)

                                                                     YEAR ENDED              SIX MONTHS
                                                                    DECEMBER 31,           ENDED JUNE 30,
                                                              -------------------------   -----------------
                                                              1996     1997      1998      1998      1999
                                                              -----   -------   -------   -------   -------
                                                                                             (UNAUDITED)
Cash flows from operating activities:
  Net loss..................................................  $ (81)  $  (527)  $(1,673)  $  (869)  $(2,118)
  Adjustments to reconcile net loss to net cash used in
    operating activities:
    Depreciation and amortization...........................     44       102       142        58        84
    Amortization of intangibles.............................     --        --       211        21       257
    Amortization of deferred stock compensation.............      1        --        --        --       206
    In-process research and development.....................     --        --        --        --     1,190
    Stock and options issued for consulting services and
     other..................................................     --        --        68        23       140
    Stock options issued for license agreement..............     --         5        --        --        --
    Extension of warrants for consulting services...........     --        --        41        --        --
    Changes in assets and liabilities:
      Accounts receivable...................................   (131)     (100)     (592)     (197)       17
      Inventories...........................................    (94)      (25)     (186)      (81)     (125)
      Prepaid expenses and other assets.....................    (38)        2       (50)      (10)        7
      Accounts payable......................................     75       189       122       304       (16)
      Accrued liabilities...................................     14        52       123        55       150
      Customer advances.....................................     --        64       (18)       --        13
      Income taxes payable..................................      2         1        (2)       (2)       --
                                                              -----   -------   -------   -------   -------
        Net cash used in operating activities...............   (208)     (237)   (1,814)     (698)     (195)
                                                              -----   -------   -------   -------   -------
Cash flows from investing activities:
  Purchases of short-term investments.......................   (325)   (1,487)   (2,943)       --        --
  Sales and maturities of short-term investments............    399       538     3,752       382       201
  Purchases of property.....................................   (181)     (205)     (138)      (89)     (153)
  Purchase of patents and technology........................     --        --      (434)     (385)      (70)
  Other assets..............................................     --        --        --        --      (323)
                                                              -----   -------   -------   -------   -------
        Net cash provided by (used in) investing
        activities..........................................   (107)   (1,154)      237       (92)     (345)
                                                              -----   -------   -------   -------   -------
Cash flows from financing activities:
  Issuance of Series D convertible preferred stock and
    warrants, net...........................................     --        --     5,393     5,393        --
  Issuance of Series C redeemable convertible preferred
    stock, net..............................................     --     1,474        (1)       (1)       --
  Issuance of Series B convertible preferred stock, net.....    590        --        --        --        --
  Exercise of stock options.................................     --        23        97        86       151
  Repurchase of stock.......................................     --        --    (1,844)   (1,844)       --
  Exercise of warrants......................................     --        60        34         2         1
  Collection of stockholder note............................      6        --        --        --        --
                                                              -----   -------   -------   -------   -------
        Net cash provided by financing activities...........    596     1,557     3,679     3,636       152
                                                              -----   -------   -------   -------   -------
Net increase (decrease) in cash and cash equivalents........    281       166     2,102     2,846      (388)
Cash and cash equivalents:
  Beginning of year.........................................     43       324       490       490     2,592
                                                              -----   -------   -------   -------   -------
  End of year...............................................  $ 324   $   490   $ 2,592   $ 3,336   $ 2,204
                                                              =====   =======   =======   =======   =======
Supplemental disclosure of cash flow information -
  Cash paid for taxes.......................................  $  --   $    12   $     1   $     1   $     1
                                                              =====   =======   =======   =======   =======
Noncash activities:
  Change in net unrealized gains from short-term
    investments.............................................  $ (10)  $    (3)  $    (1)  $    --   $    (1)
                                                              =====   =======   =======   =======   =======
  Issuance of equity instruments for patents, technology and
    licenses................................................  $  --   $    --   $   720   $   514   $ 5,221
                                                              =====   =======   =======   =======   =======
  Issuance of warrants......................................  $  --   $     6   $    --   $    --   $   808
                                                              =====   =======   =======   =======   =======
  Accretion of redeemable preferred stock...................  $  --   $     3   $     6   $     3   $     3
                                                              =====   =======   =======   =======   =======
  Exercise of stock option for note receivable..............  $  --   $    --   $    17   $    17   $    --
                                                              =====   =======   =======   =======   =======

See notes to consolidated financial statements.

F-6

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

1. SIGNIFICANT ACCOUNTING POLICIES

Description of Business--Immersion Corporation was originally incorporated in May 1993 in California and provides technologies that enable users to interact with computers using their sense of touch.

Principles of Consolidation--The consolidated financial statements include the accounts of Immersion Corporation and its wholly-owned subsidiary (the "Company"). All intercompany transactions and balances have been eliminated in consolidation.

Cash Equivalents--The Company considers all highly liquid debt or equity instruments purchased with an original maturity at the date of purchase of 90 days or less to be cash equivalents.

Short-Term Investments--Short-term investments consist primarily of highly liquid debt instruments purchased with an original maturity at the date of purchase of greater than 90 days and investments in mutual funds. Short-term investments are classified as available for sale securities and are stated at market value with unrealized gains and losses reported as a component of accumulated other comprehensive loss within stockholders' equity.

Inventories--Inventories are stated at the lower of cost (first-in, first-out basis) or market.

Property--Property is stated at cost and is depreciated using the straight-line method over the estimated useful life of the related asset. The estimated useful lives are as follows:

Computer equipment................................  3 years
Machinery and equipment...........................  5 years
Furniture and fixtures............................  5 years

Leasehold improvements are amortized over the shorter of the lease term or their useful life.

Purchased Patents and Technology--Purchased patents and technology are stated at cost and are amortized over the shorter of the remaining life of the patent or the estimated useful life of the technology, generally nine years. Accumulated amortization was none, $221,000 and $426,000 at December 31, 1997 and 1998 and June 30, 1999, respectively.

Long-Lived Assets--The Company reviews for the impairment of a long-lived asset whenever events or changes in circumstances indicate that the carrying amount of that asset may not be recoverable. An impairment loss would be recognized when the sum of the undiscounted future net cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount.

Product Warranty--The Company sells the majority of its products with warranties ranging from three to 12 months. Historically, warranty-related costs have been immaterial.

Note Receivable from Stockholder--The note receivable from stockholder was issued in exchange for common stock, bears interest at 5.39% per annum and is due March 2001.

Revenue Recognition--Revenues from product sales are recorded upon shipment. Revenues from development contracts with the U.S. Government and other commercial customers are derived from either fixed price or reimbursement of costs contracts. Contract revenues are recognized

F-7

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

under the cost-to-cost percentage-of-completion accounting method based on the actual physical completion of work performed and the ratio of costs incurred to total estimated costs to complete the contract. Losses on contracts are recognized when determined. Revisions in estimates are reflected in the period in which the conditions become known. Allowable fees under cost-reimbursement contracts are recognized as costs are incurred. The Company recognizes royalty revenue based on royalty reports or related information received from the licensee.

The Company has no obligation to repay amounts received under development contracts with the U.S. government at June 30, 1999.

Advertising--Advertising costs are expensed as incurred and included in sales and marketing expense. Advertising expense was $129,000, $164,000, $147,000 and $76,000 in 1996, 1997, 1998 and the six months ended June 30, 1999, respectively.

Research and Development--Research and development costs are expensed as incurred. The Company has generated revenues from development contracts with the U.S. Government and other commercial customers that have enabled it to accelerate its own product development efforts. Such development revenues have only partially funded the Company's product development activities, and the Company generally retains ownership of the products developed under these arrangements. As a result, the Company classifies all development costs related to these contracts as research and development expenses.

Income Taxes--The Company provides for income taxes using the asset and liability approach defined by Statement of Financial Accounting Standards ("SFAS") No. 109.

Software Development Costs--Certain of the Company's products include software. Costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized in accordance with SFAS No 86, Computer Software to be Sold, Leased or Otherwise Marketed. The Company considers technological feasibility to be established upon completion of a working model of the software and the related hardware. Because the Company believes its current process for developing software is essentially completed concurrently with the establishment of technological feasibility, no costs have been capitalized to date.

Stock-Based Compensation--The Company accounts for its stock-based awards to employees using the intrinsic value method in accordance with Accounting Principles Board ("APB") Opinion No. 25, Accounting for Stock Issued to Employees.

Comprehensive Income--In June 1997, the Financial Accounting Standards Board ("FASB") issued SFAS No. 130, Reporting Comprehensive Income, which requires that an enterprise report, by major components and as a single total, the change in its net assets during the period from nonowner sources. The Company adopted this statement in 1998 and has presented its total comprehensive loss in the statements of stockholders' equity. Accumulated other comprehensive loss during 1997 and 1998 and the six months ended June 30, 1999 is comprised of unrealized gains on short-term investments of $2,000, $1,000 and none, respectively.

Unaudited Pro Forma Information--Upon the closing of the initial public offering, each of the outstanding shares of Series D convertible preferred stock and Series C redeemable convertible preferred stock will convert into 0.807 shares of common stock and each of the outstanding shares of Series A and Series B convertible preferred stock will convert into 4.035 shares of common stock.

F-8

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

The pro forma balance sheet presents the Company's balance sheet as if this had occurred at June 30, 1999.

Unaudited Interim Financial Information--The interim financial information as of June 30, 1999 and for the six months ended June 30, 1998 and 1999 is unaudited and has been prepared on the same basis as the audited consolidated financial statements. In the opinion of management, this unaudited financial information includes all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the interim information. Operating results for the six months ended June 30, 1999 are not necessarily indicative of the results that may be expected for the year ended December 31, 1999.

Net Loss per Share--Basic net loss per share excludes dilution and is computed by dividing net loss applicable to common stockholders by the weighted average number of common shares outstanding for the period (excluding shares subject to repurchase). Diluted net loss per common share was the same as basic net loss per common share for all periods presented since the effect of any potentially dilutive securities is excluded as they are anti-dilutive because of the Company's net losses.

Pro Forma Net Loss per Share--Pro forma basic and diluted net loss per share is computed by dividing net loss by the sum of the weighted average number of common shares outstanding for the period (excluding shares subject to repurchase) and the weighted average number of common shares resulting from the assumed conversion of outstanding shares of redeemable convertible preferred stock and convertible preferred stock.

Use of Estimates--The preparation of consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These management estimates include the allowance for doubtful accounts and the net realizable value of inventory. Actual results could differ from those estimates.

Concentration of Credit Risks--Financial instruments that potentially subject the Company to a concentration of credit risk principally consist of cash and cash equivalents, short-term investments and accounts receivable. The Company invests primarily in mutual funds of large U.S. securities firms and debt securities of U.S. Government agencies.

The Company sells products primarily to companies in North America, Europe and the Far East. A majority of these sales are to customers in the personal computer industry. To reduce credit risk, management performs periodic credit evaluations of its customers' financial condition. The Company maintains reserves for potential credit losses, but historically has not experienced any significant losses related to individual customers or groups of customers in any particular industry or geographic area.

Certain Significant Risks and Uncertainties--The Company operates in a dynamic industry and, accordingly, can be affected by a variety of factors. For example, management of the Company believes that changes in any of the following areas could have a negative effect on the Company in terms of its future financial position and results of operations: its ability to obtain additional financing; the mix of revenues; the loss of significant customers; fundamental changes in the

F-9

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

technology underlying the Company's products; market acceptance of the Company's and its licensees' products under development; the availability of foundry capacity; development of sales channels; litigation or other claims against the Company; the hiring, training and retention of key employees; successful and timely completion of product and technology development efforts; and new product or technology introductions by competitors.

Fair Value of Financial Instruments--Financial instruments consist primarily of cash equivalents and short-term investments. Cash equivalents and short-term investments are stated at fair value based on quoted market prices.

Recently Issued Accounting Standards--In June 1997, the FASB issued SFAS No. 131, Disclosures About Segments of an Enterprise and Related Information, which establishes annual and interim reporting standards for an enterprise's business segments and related disclosures about its products, services, geographic areas and major customers. The Company currently operates in one reportable segment under SFAS No. 131.

In June 1998, the FASB issued SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. This statement requires companies to record derivatives on the balance sheet as assets or liabilities measured at fair value. Gains or losses resulting from changes in the values of those derivatives would be accounted for depending on the use of the derivative and whether it qualifies for hedge accounting. SFAS No. 133 will be effective for the Company's year ending December 31, 2001. The management believes that this statement will not have a material impact on the Company's financial position or results of operations.

Reclassifications--Certain prior year amounts have been reclassified to conform to the current year presentation. These reclassifications had no effect on net loss or stockholders' equity.

2. PURCHASED PATENTS AND TECHNOLOGY

During 1998, the Company entered into a license agreement and acquired various patents relating to feel technology. In connection with these agreements, the Company paid $434,000, issued 137,190 shares of common stock and issued an option to purchase 242,100 shares of common stock at $3.66 per share (see Note 7). The Company has recorded the estimated fair value of the aggregate consideration of $1,154,000 as purchased patents and technology.

In February 1999, the Company acquired certain patents and related materials pertaining to feel technology from another company in exchange for $25,000 in cash and 88,770 shares of the Company's common stock. In addition, the Company is required to issue an additional 16,140 shares of common stock to the seller if the Company is successful in obtaining either a reissue or a foreign version of at least one of the patents. The Company's stock issued in this transaction is being held in escrow until the successful reissue of at least one of the patents and the earlier to occur of five years or certain defined liquidity events of the Company (such as an initial public offering meeting specified criteria). If such conditions are not met at the end of five years and the stock is therefore still held in escrow, the seller has the right to put the shares back to the Company for $3.72 per share. The existence of the put option has the effect of increasing the value assigned to the shares issued to $3.72 per share. As a result, the estimated value of $355,000 (representing 88,770 shares at $3.72 per share plus $25,000) has been recorded as purchased patents and technology.

F-10

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

In March 1999, the Company acquired certain additional feel patents and in-process research and development from another company in exchange for 1,291,200 shares of the Company's common stock with an estimated fair value of $4,720,000. The seller has the option to put 807,000 of the shares back to the Company after five years and to require the Company to return the patents, subject to the Company's retaining a non-exclusive license to the patents. This put option expires upon an initial public offering meeting certain criteria, a sale of the Company or certain defined changes in control. The Company has included in the aggregate purchase price of the purchased patents and in-process research and development the estimated fair value of $42,000 for the put option and $45,000 of direct acquisition costs. The aggregate purchase price of $4,807,000 has been allocated $3,617,000 to purchased patents and technology and $1,190,000 to acquired in-process research and development. The purchased patents and technology are being amortized over the estimated useful life of nine years. The allocation of the purchase price to the respective intangibles was based on management's estimates of the after-tax cash flows and gave explicit consideration to the Securities and Exchange Commission's views on purchased in-process research and development as set forth in its September 9, 1998 letter to the American Institute of Certified Public Accountants. Specifically, the valuation gave consideration to the following: (i) the employment of a fair market value premise excluding any Company-specific considerations that could result in estimates of investment value for the subject assets; (ii) comprehensive due diligence concerning all potential intangible assets; (iii) the determination that none of the technology development had been completed at the time of acquisition; and (iv) the allocation to in-process research and development based on a calculation that considered only the efforts completed as of the transaction date, and only the cash flow associated with these completed efforts for one generation of the products currently in process. As indicated above, the Company recorded a one-time charge of $1,190,000 upon the acquisition in March 1999 for purchased in-process research and development related to five development projects. The charge related to the portion of these products that had not reached technological feasibility, had no alternative future use and for which successful development was uncertain. Management's conclusion that the in-process development effort had no alternative future use was reached in consultation with the engineering personnel from both the Company and the seller.

The first of these projects, the CYBERIMPACT SDK, is a flexible force feedback development environment that allows developers to choose the level of complexity/functionality that fits their needs. At the time of acquisition, the development was 81% complete and the estimated cost to complete this development was $438,000. Management expects to complete this development of this product and begin shipping it in September 2001. The second of these projects, the CYBERIMPACT 3DOF joystick, gives the operator smooth, intuitive movement and feedback along three axes-roll, pitch and yaw using brushless motor and encoder technology. At the time of acquisition, the development was 36% complete and the estimated cost to complete this development was $109,000. Management expects this product to become available in December 2000. The third of these projects is the CYBERIMPACT 6DOF hand controller is a small back drivable robot that moves in six degrees of freedom, three linear positions and attitudes. At the time of acquisition, the development was 70% completed and the estimated cost to complete this development was $88,000. Management expects to complete development of this product and begin shipping it in June 2001. The fourth project is the CYBERIMPACT, which Flight Yoke provides the intuitive motion and feel of an airplane control yoke. It translates in and out to control the pitch, rotates for roll control, and provides the corresponding feel along these axes of motion. At the time of acquisition, the development was 49% completed and the estimated cost to complete this

F-11

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

development was $175,000. Management expects that the product will become available for sale in fiscal 2001. The fifth development project is the STYLIN 3D, which allows the user to reach inside the computer monitor and feel three-dimensional objects. At the time of acquisition, the development was 11% completed and the estimated cost to complete this development was $248,000. Management expects that the product will become available for sale in fiscal 2001.

The Company will begin to benefit from the acquired research and development of these products once they begin shipping. Failure to reach successful completion of these projects could result in impairment of the associated capitalized intangible assets and could require the Company to accelerate the time period over which the intangibles are being amortized, which could have a material adverse effect on the Company's business, financial condition and results of operation. Significant assumptions used to determine the value of in-process research and development, including the following: (i) forecast of net cash flows that were expected to result from the development effort using projections prepared by the Company's and the seller's management;
(ii) the portion of the projects estimated by considering a number of factors, including the costs invested to date relative to total cost of the development effort and the amount of progress completed as of the acquisition date, on a technological basis, relative to the overall technological achievements required to achieve the functionality of the eventual product. The technological issues were addressed by engineering representatives from both the Company and the seller, and when estimating the value of the technology, the projected financial results of the acquired assets were estimated on a stand-alone basis without any consideration to potential synergistic benefits or "investment value" related to the acquisition. As there were no existing products acquired, separate projected cash flows were prepared for the existing and the in-process projects.

These projected results were based on the number of units sold times the average selling price less the associated costs. After preparing the estimated cash flows from the products being developed, a portion of these cash flows were attributed to the existing technology, which was embodied in the in-process product lines and enabled a quicker and more cost-effective development of these products. When estimating the value of the in-process technologies, a discount rate of 30% was used. The discount rate considered both the status and risks associated with the cash flows at the acquisition date. Projected revenues from the in-process products are expected to begin in 2000 and 2001 as the products are completed and begin to ship. Initial annual revenue growth rates after introduction are projected to exceed 50% and decline to less than 15% by 2005. Gross margins from these products are anticipated to be consistent with the gross margins from its other products.

The technology was acquired in a transaction that was tax-free to the seller and, as a result, the Company has a minimal tax basis in the acquired technology. Accordingly, a deferred tax liability of $1,410,000 has been recorded for the difference in the book and tax bases of the acquired assets. This resulted in the concurrent recognition of previously reserved deferred tax assets of an equal amount. Also, in connection with this acquisition, the Company entered into a consulting arrangement with the seller to provide consulting services related to the development of various platforms of feel technology, and collaboration with Company, in executing development agreements with the U.S. government and other commercial customers for a three year period. In consideration for certain consulting services and rights, the Company granted to the seller a warrant to purchase 322,800 shares of the Company's common stock at $3.66 per share (see Note 7), paid the seller $150,000, and is obligated to pay an additional $75,000 in 2000 and 2001. The consideration for the consulting services is $1,108,000, including the estimated fair value of the

F-12

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

warrant ($808,000) which has been recorded as deferred compensation within stockholders' equity. The cash portion of the services ($300,000) has been paid or accrued, with a corresponding amount included in other assets recorded as other assets. The consideration for the consulting service will be amortized over the two-year estimated period of benefit of the consulting services. The warrants were fully vested at the date of grant. Accordingly, the fair of the warrants was determined at the date of grant using the methods specified by SFAS No. 123, Accounting for Stock-Based Compensation ("SFAS 123") with the following assumptions: expected life, 10 years; risk free interest rate, 5.7%; volatility 50% and no dividends during the expected term.

Also during 1999, in consideration for a technology license agreement, the Company issued an option to purchase 20,175 shares of common stock at an exercise price of $3.66 per share. The Company has recorded the estimated fair value of the option of $129,000 as purchased patents and technology at June 30, 1999 (see Note 7).

3. SHORT-TERM INVESTMENTS

Short-term investments included the following equity securities and gross unrealized holding gains and losses as of December 31, 1997 and 1998 and June 30, 1999 (in thousands):

                                                                        UNREALIZED   UNREALIZED
                                                   AMORTIZED   MARKET    HOLDING      HOLDING
                                                     COST      VALUE      GAINS        LOSSES
                                                   ---------   ------   ----------   ----------
                                                                  (IN THOUSANDS)
DECEMBER 31, 1997
Mutual funds.....................................   $1,210     $1,212      $ 2          $--
                                                    ======     ======      ===          ===
DECEMBER 31, 1998
Mutual funds.....................................   $  401     $  402      $ 1          $--
                                                    ======     ======      ===          ===
JUNE 30, 1999
Mutual funds.....................................   $  200     $  200      $--          $--
                                                    ======     ======      ===          ===

The Company realized gains on the sales of securities of $19,000, $14,000, $56,000 and none in 1996, 1997 and 1998 and the six months ended June 30, 1999, respectively, while realizing losses of $1,000, $1,000, $1,000 and none in 1996, 1997, 1998 and for the six months ended June 30, 1999, respectively.

4. INVENTORIES

Inventories consisted of:

                                                               DECEMBER 31,
                                                              --------------    JUNE 30,
                                                              1997      1998      1999
                                                              ----      ----    --------
                                                                    (IN THOUSANDS)
Raw materials and subassemblies.............................  $223      $378      $504
Work in process.............................................    16        37        38
Finished goods..............................................    56        66        64
                                                              ----      ----      ----
Total.......................................................  $295      $481      $606
                                                              ====      ====      ====

F-13

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

5. PROPERTY

Property consisted of:

                                                                 DECEMBER 31,
                                                                --------------    JUNE 30,
                                                                1997     1998       1999
                                                                -----    -----    --------
                                                                      (IN THOUSANDS)
Computer equipment..........................................    $ 208    $ 314     $ 385
Machinery and equipment.....................................      172      177       195
Furniture and fixtures......................................      110      123       174
Leasehold improvements......................................       --       13        27
                                                                -----    -----     -----
Total.......................................................      490      627       781
Less accumulated depreciation and amortization..............     (156)    (298)     (383)
                                                                -----    -----     -----
Property, net...............................................    $ 334    $ 329     $ 398
                                                                =====    =====     =====

6. LEASE COMMITMENTS

The Company leases its manufacturing and office facilities under a noncancelable operating lease that expires in October 2002.

Minimum future operating lease payments are as follows:

                PERIODS ENDING DECEMBER 31,
                ---------------------------                   (IN THOUSANDS)
1999........................................................       $230
2000........................................................        243
2001........................................................        255
2002........................................................        263
                                                                   ----
Total minimum lease payments................................       $991
                                                                   ====

Rent expense was approximately $94,000, $117,000, $169,000 and $117,000 in 1996, 1997, 1998 and the six months ended June 30, 1999, respectively.

7. REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY

Preferred Stock--During June 1997, the Company issued a total of 864,642 shares of Series C redeemable convertible preferred stock ("Series C preferred stock") to investors for gross proceeds of $1,500,005. At the option of the stockholders, at any time on or after June 4, 2002, the Series C preferred stockholders can require the Company to pay them the price originally paid plus an amount equal to the declared but unpaid dividends. These payments will be made in four equal installments on June 4, 2002 and every six months thereafter. Issuance costs are being amortized over five years to accrete the carrying value of the stock to $1,500,005 on June 4, 2002.

During June 1993 and May 1995, the Company issued a total of 2,344,331 shares of Series A convertible preferred stock to investors for gross proceeds of $922,000. During November 1996, the Company issued 396,778 shares of Series B convertible preferred stock to investors for gross proceeds of $590,004. During April 1998, the Company issued 1,376,928 shares of Series D convertible preferred stock to investors for gross proceeds of $5,750,002.

F-14

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

The significant terms of the redeemable convertible preferred stock and the convertible preferred stock are as follows:

- Each share of preferred stock is convertible into one share of common stock (subject to adjustments for events of dilution).

- Each share of Series A and B preferred stock will automatically convert in the event of a public offering in which the Company receives proceeds equal to or greater than $5,000,000. Each share of Series C and D preferred stock will automatically convert in the event of a public offering in which the Company receives proceeds equal to or greater than $10,000,000.

- Each share of Series A, B, C and D preferred stock has voting rights equivalent to the number of shares of common stock into which it is convertible. In addition, the Series C and D preferred stock have certain protective voting rights with respect to corporate matters.

- In the event of liquidation, dilution or winding up of the Company, the holders of Series C and Series D preferred stock will receive first, and in preference to any distribution to the holders of Series A and Series B preferred stock and common stock, an amount equal to $1.73 per share of Series C preferred stock and $4.18 per share of Series D preferred stock plus all declared but unpaid dividends. Upon satisfaction of the Series C and Series D liquidation preferences, the holders of Series A and Series B preferred stock will receive $0.10 and $1.49 per share plus all declared but unpaid dividends, respectively. Upon satisfaction of the Series A and Series B liquidation preferences, the holders of Series C and Series D preferred stock will receive an additional $1.73 and $2.50 per share, respectively, and will be entitled to receive with the common stock stockholders on a pro rata basis the remaining assets of the Company, based on the number of shares of common stock into which their shares are convertible.

- In the event the Board of Directors declares dividends payable on the then outstanding common stock, Series A, B, C and D preferred stockholders will receive $0.005, $0.01, $0.17 and $0.41 per share, respectively. The right to these dividends is not cumulative.

Preferred Stock Warrants--In connection with the Series A preferred stock offering, the Company issued warrants to purchase 121,050 and 30,260 shares of Series A preferred stock at exercise prices of $0.50 and $0.99, respectively, to a Series A preferred stock investor. During 1997, the warrant to purchase 121,050 shares was exercised. During 1998, the remaining warrant was exercised. The estimated fair values of these warrants of $12,000 and $6,000, respectively, were accounted for as reductions to the Series A preferred stock financing proceeds.

In connection with the Series B offering, the Company issued warrants to purchase 40,350 and 32,280 shares of Series B preferred stock at an exercise price of $6.00 to a Series B preferred stock investor. Such warrants were originally issued with a two-year term, expiring in 1998. The estimated fair values of these warrants of $12,000 and $9,000, respectively, were accounted for as reductions to the Series B preferred stock financing proceeds. During 1998, upon the expiration of the original warrant terms the Company extended the term of these exercisable warrants for three additional years through 2001 in consideration for prior strategic planning consulting services. The estimated fair value of the extension of the warrants of $41,000 was accounted for as a consulting expense. The fair value of the extension of the warrants was determined at the date of the grant extension using the methods specified by SFAS 123 with following assumptions: risk free interest rate, 5.5%;

F-15

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

volatility 50% and no dividends during the expected term. An expected life of three years is based on the remaining contractual life of the warrant agreements.

In connection with the Series D preferred stock offering, the Company issued warrants to purchase 11,972 shares of Series D preferred stock at an exercise price of $4.18 to an investment banker. The estimated fair value of these warrants of $17,000 has been accounted for as a reduction to the Series D preferred stock financing proceeds.

Common Stock Warrants--During 1995, the Company issued to two former employees warrants to purchase 85,945 and 7,061 shares of the Company's common stock, each at an exercise price of $0.04 for past services to the Company. During 1998, the warrant to purchase 85,945 shares was exercised. During 1999, the remaining warrant was exercised. The estimated fair value of these warrants was not considered material.

During June 1997, the Company issued a warrant to purchase 91,191 shares of the Company's common stock at an exercise price of $0.19 per share to a Series C preferred investor. The warrant is exercisable through 2002. The estimated fair value of this warrant of $6,000 has been accounted for as a reduction to the Series C preferred stock financing proceeds.

As discussed in Note 2, during March 1999, the Company issued a warrant to purchase 322,800 shares of the Company's common stock at an exercise price of $3.66 per share for consulting services. The warrant is exercisable through 2009. The estimated fair value of the warrant of $808,000 has been recorded as prepaid consulting services and is being amortized over the service period of two years.

Stock Options--Under the Company's stock option plans, the Company may grant options to purchase up to 5,991,975 shares of common stock to employees, directors and consultants at prices not less than the fair market value on the date of grant for incentive stock options and not less than 85% of fair market value on the date of grant for nonstatutory stock options. These options generally expire ten years from the date of grant. The Company has granted immediately exercisable options as well as options that become exercisable over periods ranging from three months to four years.

F-16

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

Details of activity under the option plans are as follows:

                                                                           WEIGHTED
                                                                NUMBER     AVERAGE
                                                                  OF       EXERCISE
                                                                SHARES      PRICE
                                                              ----------   --------
Outstanding, January 1, 1996................................   1,471,846    $0.06
  Granted (weighted average fair value of $0.01)............     925,629    $0.16
  Exercised.................................................      (2,017)   $0.17
  Canceled..................................................          --    $  --
                                                              ----------
Outstanding, December 31, 1996 (1,620,720 exercisable at a
  weighted average price of $0.10)..........................   2,395,458    $0.10
  Granted (weighted average fair value of $0.04)............   1,022,860    $0.30
  Exercised.................................................    (105,144)   $0.21
  Canceled..................................................        (168)   $0.19
                                                              ----------
Outstanding, December 31, 1997 (2,871,999 exercisable at a
  weighted average price of $0.16)..........................   3,313,006    $0.16
  Granted (weighted average fair value of $0.38)............     721,976    $1.31
  Exercised.................................................  (1,024,615)   $0.11
  Canceled..................................................     (88,484)   $3.59
                                                              ----------
Outstanding, December 31, 1998..............................   2,921,883    $0.36
  Granted (weighted average fair of value $0.47)............     784,167    $3.74
  Exercised.................................................    (342,073)   $0.45
  Canceled..................................................     (19,648)   $1.98
                                                              ----------
Outstanding, June 30, 1999..................................   3,344,329    $1.13
                                                              ==========

F-17

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

Additional information regarding options outstanding as of December 31, 1998 and June 30, 1999 is as follows:

                                           OPTIONS OUTSTANDING
                                  -------------------------------------    OPTIONS EXERCISABLE
                                                  WEIGHTED                ----------------------
                                                  AVERAGE      WEIGHTED                 WEIGHTED
            RANGE OF                             REMAINING     AVERAGE                  AVERAGE
            EXERCISE                NUMBER      CONTRACTUAL    EXERCISE     NUMBER      EXERCISE
             PRICES               OUTSTANDING   LIFE (YEARS)    PRICE     EXERCISABLE    PRICE
--------------------------------  -----------   ------------   --------   -----------   --------
December 31, 1998:
$0.04 - $0.14...................   1,099,568        3.80        $0.07      1,010,500     $0.07
 0.17 - 0.37....................   1,139,540        6.71         0.26      1,059,832      0.26
 0.41 - 1.24....................     545,356        7.72         0.67        545,356      0.67
 1.36 - 4.02....................     137,419        5.91         2.12        106,692      1.67
                                   ---------        ----        -----      ---------     -----
$0.04 - $4.03...................   2,921,883        5.73        $0.35      2,722,380     $0.32
                                   =========        ====        =====      =========     =====
June 30, 1999:
$0.04 - $0.14...................     907,960        5.92        $0.07        877,193     $0.07
 0.17 - 0.37....................   1,018,602        5.90         0.26        969,090      0.27
 0.41 - 1.36....................     628,077        7.89         0.77        628,077      0.77
 3.11 - 4.03....................     789,690        9.80         3.75         83,889      3.71
                                   ---------        ----        -----      ---------     -----
$0.04 - $4.03...................   3,344,329        7.20        $1.13      2,558,249     $0.43
                                   =========        ====        =====      =========     =====

At December 31, 1998 and June 30, 1999, the Company had 754,379 and 1,141,493 shares, respectively, available for future grants under the option plans.

Additional Stock Plan Information--As discussed in Note 1, the Company accounted for its stock-based awards using the intrinsic value method in accordance with APB No. 25, Accounting for Stock Issued to Employees and its related interpretations.

SFAS No. 123, Accounting for Stock-Based Compensation ("SFAS 123"), requires the disclosure of pro forma net loss had the Company adopted the fair value method as of the beginning of fiscal 1996. Under SFAS 123, the fair value of stock-based awards to employees is calculated through the use of option pricing models, even though these models were developed to estimate the fair value of freely tradable, fully transferable options without vesting restrictions, which significantly differ from the Company's stock option awards. These models also require subjective assumptions, including future stock price volatility and expected time to exercise, which greatly affect the calculated values. The Company's calculations were made using the minimum value method with the following weighted average assumptions: expected life, 18 months following vesting; risk free interest rate, 5.5%, 6.0%, 5.3% and 5.2% in 1996, 1997, 1998 and the first six months of 1999, respectively; and no dividends during the expected term. The Company's calculations are based on a multiple option valuation approach and forfeitures are recognized as they occur. If the computed fair values of the awards issued in 1996, 1997, 1998 and the first six months of 1999 had been amortized to expense over the vesting periods of the awards, pro forma net loss would have been $90,000 ($0.04 net loss per share), $545,000 ($0.17 net loss per share), $1,885,000 ($0.48 net loss per share) and $2,202,000 ($0.45 net loss per share) in 1996, 1997 and 1998 and the six months ended June 30, 1999, respectively.

The Company had outstanding nonstatutory stock options to consultants to purchase 104,182, 153,570 and 203,604 shares of common stock at December 31, 1997 and 1998 and June 30, 1999,

F-18

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

respectively. Compensation expense of none, $5,000, $68,000 and $111,000 was recognized as result of these options in 1996, 1997, 1998 and the six months ended June 30, 1999, respectively. The fair value of the unvested portion of these options is being amortized over the vesting period. The fair value attributable to the unvested portion of these options is subject to adjustment based upon the future value of the Company's common stock. The fair values of these options are determined at the date of vesting using the methods specified by SFAS 123 with the following weighted average assumptions during 1996, 1997, 1998 and the six months ended June 30, 1999, respectively: expected life, 10 years; risk free interest rate, 5.5%, 6.0%, 5.3% and 5.2%; volatility, 50% and no dividends during the expected term. Forfeitures are recognized as they occur.

In addition, the Company granted nonstatutory stock options to purchase 242,100 and 20,175 shares of common stock in 1998 and the six months ended June 30, 1999, respectively, in connection with the acquisition of patents and the licensing of technology (see Note 2). The estimated fair value of these options of $219,000 and $129,000, respectively, has been recorded as purchased patents and technology. Such options were fully vested at the date of grant. Accordingly, the fair value of the options was determined at the date of grant using the methods specified by SFAS No. 123, Accounting for Stock-Based Compensation ("SFAS 123"), with the following assumptions during 1998 and 1999, respectively: expected life, 10 years, risk free interest rate, 5.5% and 5.0%; volatility, 25% and 50% and no dividends during the expected term.

Common Stock--Common stock issued to the founders and certain other employees is subject to repurchase agreements under which the Company has the option to repurchase the unvested shares upon termination of employment at the original issue price. The Company's repurchase right generally lapses over four years. At December 31, 1998, 23,537 shares of common stock were subject to repurchase by the Company. At June 30, 1999, the Company's repurchase rights had lapsed.

During 1998, the Company issued 137,190 shares of common stock in connection with purchases of patents. The fair value of the common stock of $501,000 was recorded as purchased patents and technology. During 1999, the Company issued 1,379,970 shares of common stock in connection with purchases of patents and technology (see Note 2).

Deferred Stock Compensation

In connection with grants of certain stock options to employees and directors in the six months ended June 30, 1999, the Company recorded $1,473,000 for the difference between the deemed fair value for accounting purposes and the stock price as determined by the Board of Directors on the date of grant. This amount has been presented as a reduction of stockholders' equity and is being amortized to expense over the vesting period of the related stock options (generally four years). Amortization of deferred stock compensation for the six months ended June 30, 1999 was $66,000.

F-19

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

Common Stock Reserved for Issuance

At December 31, 1998, the Company had reserved shares of common stock for issuance as follows:

Conversion of preferred stock...............................   5,131,100
Exercise of options.........................................   3,676,262
Exercise of warrants........................................     182,854
                                                              ----------
          Total.............................................   8,990,216
                                                              ==========

8. NET LOSS PER SHARE

The following is a reconciliation of the numerators and denominators used in computing basic and diluted net loss per share (in thousands):

                                                         YEAR ENDED           SIX MONTHS ENDED
                                                        DECEMBER 31,              JUNE 30,
                                                  -------------------------   -----------------
                                                   1996     1997     1998      1998      1999
                                                  ------   ------   -------   -------   -------
                                                                                 (UNAUDITED)
Numerator:
  Net loss......................................  $  (81)  $ (527)  $(1,673)  $  (869)  $(2,118)
  Redeemable convertible preferred stock
     accretion..................................      --        3         6         3         3
                                                  ------   ------   -------   -------   -------
Net loss applicable to common stockholders......  $  (81)  $ (530)  $(1,679)  $  (872)  $(2,121)
                                                  ======   ======   =======   =======   =======
Denominator:
  Weighted average common shares outstanding....   3,311    3,338     3,970     3,926     5,003
  Weighted average common shares outstanding
     subject to repurchase......................    (486)    (176)      (61)      (87)       --
                                                  ------   ------   -------   -------   -------
  Shares used in calculating basic and diluted
     net loss per share.........................   2,825    3,162     3,909     3,839     5,003
                                                  ======   ======   =======   =======   =======
Basic and diluted net loss per share............  $(0.03)  $(0.17)  $ (0.43)  $ (0.23)  $ (0.42)
                                                  ======   ======   =======   =======   =======

F-20

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

For the above-mentioned periods, the Company had securities outstanding that could potentially dilute basic earnings per share in the future, but were excluded from the computation of diluted net loss per share in the periods presented since their effect would have been antidilutive. These outstanding securities consisted of the following:

                                                    YEAR ENDED                   SIX MONTHS ENDED
                                                   DECEMBER 31,                      JUNE 30,
                                       ------------------------------------   -----------------------
                                          1996         1997         1998         1998         1999
                                       ----------   ----------   ----------   ----------   ----------
                                                                                    (UNAUDITED)
Redeemable convertible preferred
  stock..............................          --      864,642      863,771      863,771      863,771
Convertible preferred stock..........   2,741,109    2,862,159    4,267,329    4,237,074    4,267,329
Shares of common stock subject to
  repurchase.........................     343,176      125,813       23,537       75,096           --
Outstanding options..................   2,395,458    3,313,006    2,921,883    2,925,425    3,344,329
Warrants.............................     195,899      287,087      182,854      213,117      498,593
                                       ----------   ----------   ----------   ----------   ----------
Total................................   5,675,642    7,452,701    8,259,374    8,314,483    8,974,022
                                       ==========   ==========   ==========   ==========   ==========
Weighted average exercise price of
  options............................  $     0.10   $     0.16   $     0.36   $     0.30   $     1.13
                                       ==========   ==========   ==========   ==========   ==========
Weighted average exercise price of
  warrants...........................  $     0.72   $     0.56   $     0.95   $     0.97   $     2.71
                                       ==========   ==========   ==========   ==========   ==========

9. INCOME TAXES

No provision for federal income taxes was required for the years ended December 31, 1996, 1997 and 1998 due to the Company's net losses in these periods.

Significant components of the net deferred tax assets for federal and state income taxes consisted of:

                                                                DECEMBER 31,
                                                              ----------------
                                                              1997      1998
                                                              -----    -------
                                                               (IN THOUSANDS)
Deferred tax assets:
  Net operating loss carryforwards..........................  $ 173    $   830
  Research and development credits..........................     13        130
  Reserves and accruals recognized in different periods.....     39         75
  Depreciation and amortization.............................     --          2
                                                              -----    -------
Total deferred tax assets...................................    225      1,037
Valuation reserve...........................................   (225)    (1,037)
                                                              -----    -------
Net deferred tax assets.....................................  $  --    $    --
                                                              =====    =======

F-21

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

The Company's effective tax rate differed from the expected benefit at the federal statutory tax rate at December 31 as follows:

                                                                YEAR ENDED DECEMBER 31,
                                                              ---------------------------
                                                              1996       1997       1998
                                                              -----      -----      -----
Federal statutory tax rate..................................  (35.0)%    (35.0)%    (35.0)%
State taxes, net of federal benefit.........................   (6.0)      (6.0)      (6.0)
Other.......................................................    1.7        0.6        0.6
Valuation allowance.........................................   39.3       40.4       40.4
                                                              -----      -----      -----
Effective tax rate..........................................     --%        --%        --%
                                                              =====      =====      =====

Substantially all of the Company's loss from operations for all periods presented is generated from domestic operations.

At December 31, 1998, the Company has federal and state net operating loss carryforwards of approximately $1,926,000 and $967,000, respectively, expiring through 2018 and through 2003, respectively.

Current federal and state tax laws include provisions limiting the annual use of net operating loss carryforwards in the event of certain defined changes in stock ownership. The Company's issuances of common and preferred stock may have resulted in such a change. Accordingly, the annual use of the Company's net operating loss carryforwards would be limited according to these provisions. Management has not yet determined the extent of this limitation, and this limitation may result in the loss of carryforward benefits due to their expiration.

10. SEGMENT INFORMATION, OPERATIONS BY GEOGRAPHIC AREA AND SIGNIFICANT CUSTOMERS

The Company operates in one business segment, which is the design, development, production, marketing and licensing of products based on feel technology. These devices are used in computer entertainment, personal computing, medical and other professional computing applications. The Company operates entirely in North America and does not maintain operations in other countries. The following is a summary of revenues within geographic areas. Revenues are broken out geographically by the ship-to location of the customer.

                                                                                 SIX MONTHS
                                                 YEAR ENDED DECEMBER 31,       ENDED JUNE 30,
                                                --------------------------    ----------------
                                                 1996      1997      1998      1998      1999
                                                ------    ------    ------    ------    ------
                                                                (IN THOUSANDS)
North America.................................  $1,867    $3,325    $3,363    $1,428    $2,494
Europe........................................     533       648       950       425       469
Far East......................................     239       347       597       259       465
Rest of the world.............................      98        12       111        59        75
                                                ------    ------    ------    ------    ------
                                                $2,737    $4,332    $5,021    $2,171    $3,503
                                                ======    ======    ======    ======    ======

F-22

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

Significant Customers

In 1996, one unrelated customer accounted for 11% of total revenues. In 1997, one unrelated customer accounted for 13% of total revenues. In 1998, a preferred stockholder accounted for 11% of total revenues. For the six months ended June 30, 1999, a preferred stockholder accounted for 19% of total revenues.

Receivables due from two unrelated customers were $158,000 and $57,000, respectively, at December 31, 1997. Receivables due from a preferred stockholder were $387,000 at December 31, 1998. Receivables due from two unrelated parties were $215,000 and $184,000, respectively, at June 30, 1999.

11. EMPLOYEE BENEFIT PLAN

The Company has a 401(k) tax-deferred savings plan under which eligible employees may elect to have a portion of their salary deferred and contributed to the 401(k) plan. Contributions may be made by the Company at the discretion of the Board of Directors. No contributions by the Company have been made to the 401(k) plan since its inception.

12. RELATED PARTIES

In July 1997, the Company transferred certain patent rights related to its MicroScribe product to a newly created limited liability corporation, MicroScribe LLC, in exchange for 1,000 Class 1 Units and 98,999 Class 2 Units. This investment represents a 99% ownership of MicroScribe LLC. Subsequently, the Company distributed all Class 2 Units to its then outstanding common, preferred and vested option holders on a pro rata basis. The Company maintains a 1% ownership of MicroScribe LLC subsequent to the distribution of the Class 2 Units. There was no recorded value related to these internally-developed patent agreements, and thus no amount was recognized as a result of the transfer.

During July 1997, the Company also entered into an exclusive ten-year license agreement with MicroScribe LLC (the "Agreement") for the right to manufacture, market and sell the related MicroScribe technology. Under the terms of the Agreement, the Company must pay a royalty to MicroScribe LLC based on a variable percentage of net receipts as defined under the Agreement. Royalty expense under the Agreement was $49,000, $116,000 and $68,000 in 1997 and 1998 and the six months ended June 30, 1999, respectively.

As discussed in Note 10, a preferred stockholder accounted for $249,000 and $462,000 of royalty revenue in 1998 and the six months ended June 30, 1999, respectively, and $316,000 and $222,000 of development contract revenue in 1998 and the six months ended June 30, 1999, respectively.

13. CONTINGENCIES

The Company has received claims from third parties asserting that the Company's technologies, or those of its licensees, infringe on the other parties' intellectual property rights. Management believes that these claims are without merit and, with respect to each, has obtained or is in the process of obtaining written non-infringement and/or patent invalidity opinions from outside patent

F-23

IMMERSION CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
YEARS ENDED DECEMBER 31, 1996, 1997 AND 1998 AND
THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED)

counsel. Accordingly, in the opinion of management, the outcome of such claims will not have a material effect on the financial statements of the Company.

14. SUBSEQUENT EVENTS

In June 1999, the Board of Directors approved, subject to stockholder approval, an amendment to the 1997 Stock Option Plan to increase the number of shares reserved for issuance by 1,149,975.

On August 31, 1999, the Board of Directors approved, subject to stockholder approval, the following:

- Reincorporation of the Company in the state of Delaware and a concurrent 0.807-for-one reverse common and Series C and D preferred stock split and 4.035-for-one reverse Series A and B preferred stock split.

- Adoption of the Company's 1999 Employee Stock Purchase Plan (the "ESPP"). The ESPP becomes effective upon the closing of the Company's initial public offering. Under the ESPP, eligible employees may purchase common stock through payroll deductions. Participants may not purchase more than 1,000 shares in a six-month offering period or stock having a value greater than $25,000 in any calendar year as measured at the beginning of the offering period. A total of 500,000 shares of common stock are reserved for issuance under the ESPP plus an automatic annual increase on January 1, 2000 and on each January 1 thereafter through January 1, 2010 by an amount equal to the lesser of 500,000 shares per year, or a number of shares determined by the Board of Directors.

- Amendment of the Company's 1997 Stock Option Plan to provide for an automatic increase in the shares reserved for issuance on January 1 of each year, beginning on January 1, 2001, by an amount equal to 5% of the number of shares of common stock which were issued and outstanding on the last day of the preceding year.

F-24



4,250,000 SHARES

IMMERSION.LOGO
COMMON STOCK

PROSPECTUS


HAMBRECHT & QUIST
BEAR, STEARNS & CO. INC.

ROBERTSON STEPHENS


, 1999


YOU SHOULD RELY ONLY ON INFORMATION CONTAINED IN THIS PROSPECTUS. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION DIFFERENT FROM THAT CONTAINED IN THIS PROSPECTUS. WE ARE OFFERING TO SELL, AND SEEKING OFFERS TO BUY, SHARES OF COMMON STOCK ONLY IN JURISDICTIONS WHERE OFFERS AND SALES ARE PERMITTED. THE INFORMATION CONTAINED IN THIS PROSPECTUS IS ACCURATE ONLY AS OF THE DATE OF THIS PROSPECTUS, REGARDLESS OF THE TIME OF DELIVERY OF THIS PROSPECTUS OR OF ANY SALE OF OUR COMMON STOCK.
NO ACTION IS BEING TAKEN IN ANY JURISDICTION OUTSIDE THE UNITED STATES TO PERMIT A PUBLIC OFFERING OF THE COMMON STOCK OR POSSESSION OR DISTRIBUTION OF THIS PROSPECTUS IN ANY SUCH JURISDICTION. PERSONS WHO COME INTO POSSESSION OF THIS PROSPECTUS IN JURISDICTIONS OUTSIDE THE UNITED STATES ARE REQUIRED TO INFORM THEMSELVES ABOUT AND TO OBSERVE ANY RESTRICTIONS AS TO THIS OFFERING AND THE DISTRIBUTION OF THIS PROSPECTUS APPLICABLE TO THAT JURISDICTION.
UNTIL , 1999, ALL DEALERS THAT BUY, SELL OR TRADE IN OUR COMMON STOCK, WHETHER OR NOT PARTICIPATING IN THIS OFFERING, MAY BE REQUIRED TO DELIVER A PROSPECTUS. THIS IS IN ADDITION TO THE DEALERS' OBLIGATION TO DELIVER A PROSPECTUS WHEN ACTING AS UNDERWRITERS AND WITH RESPECT TO THEIR UNSOLD ALLOTMENTS OR SUBSCRIPTIONS.



PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

The following table sets forth all costs and expenses, other than the underwriting discounts and commissions payable by the Registrant in connection with the sale and distribution of the Common Stock being registered. All amounts shown are estimates except for the Securities and Exchange Commission registration fee, the NASD filing fee and the Nasdaq National Market application fee.

Securities and Exchange Commission registration fee.........  $   14,946
NASD filing fee.............................................       5,877
Nasdaq National Market application fee......................       1,000
Blue sky qualification fees and expenses....................
Printing and engraving expenses.............................
Legal fees and expenses.....................................
Accounting fees and expenses................................
Director and officer liability insurance....................
Transfer agent and registrar fees...........................
Miscellaneous expenses......................................
                                                              ----------
          Total.............................................  $1,000,000
                                                              ==========

ITEM 14. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

Section 145 of the Delaware General Corporation Law permits indemnification of officers, directors and other corporate agents under certain circumstances and subject to certain limitations. The Registrant's Certificate of Incorporation and Bylaws provide that the Registrant shall indemnify its directors, officers, employees and agents to the full extent permitted by Delaware General Corporation Law, including in circumstances in which indemnification is otherwise discretionary under Delaware law. In addition, the Registrant has entered into separate indemnification agreements (Exhibit 10.3) with its directors and officers which require the Registrant, among other things, to indemnify them against certain liabilities which may arise by reason of their status or service (other than liabilities arising from willful misconduct of a culpable nature). The Registrant also intends to maintain director and officer liability insurance, if available on reasonable terms. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of the Registrant's officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.

The Underwriting Agreement (Exhibit 1.1) provides for indemnification by the Underwriters of the Registrant and its officers and directors for certain liabilities arising under the Securities Act or otherwise.

ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES.

The Registrant has sold and issued the following unregistered securities:

(1) From inception to September 30, 1999, we have issued options to purchase an aggregate of 3,038,372 shares of common stock under the 1994 stock option plan, of which 1,232,099 have been exercised, and 3,254,842 shares of common stock under the 1997 stock option plan, of which 304,276 have been exercised.

II-1


(2) On November 3, 1996, November 4, 1996, November 20, 1996, November 26, 1996 and November 27, 1996, the Registrant sold an aggregate of 396,777 shares of Series B preferred stock to accredited investors for an aggregate purchase price of $590,004.

(3) In November 1996, the Registrant issued an option to purchase 80,700 shares of common stock to Steven Blank at an exercise price of $0.17 per share.

(4) In November 1996, the Registrant issued a warrant to purchase 32,280 shares of Series B preferred stock to Bruce Paul at an exercise price of $1.48 per share.

(5) From November 1996 through June 1999, the Registrant issued options to purchase an aggregate of 154,648 shares of common stock to Steven Blank at exercise prices ranging between $0.173 per share and $3.66 per share. These options may be exercised at any time within ten years after their date of issuance.

(6) In December 1996, the Registrant issued a warrant to purchase 40,350 shares of Series B preferred stock to Bruce Paul at an exercise price of $1.48 per share.

(7) In March 1997, the Registrant issued 121,050 shares of Series A preferred stock to Bruce Paul pursuant to an exercise of a warrant dated April 1995 at an exercise price of $0.49 per share.

(8) On June 3, 1997, the Registrant sold an aggregate of 864,642 shares of Series C preferred stock to accredited investors for an aggregate purchase price of $1,500,005.40.

(9) On June 3, 1997, the Registrant issued a warrant to purchase 91,191 shares of common stock to an accredited investor at an exercise price of $0.19 per share.

(10) In December 1997, the Registrant issued an option to purchase 80,700 shares of common stock to Washington Research Foundation at an exercise price of $0.37 per share in consideration of consulting services. This option may be exercised at any time within ten years after its issuance.

(11) In February 1998, the Registrant issued an option to purchase 20,175 shares of common stock to Asia Pacific Ventures Co. at an exercise price of $0.37 in consideration of consulting services. This option may be exercised at any time within ten years after its issuance.

(12) In March 1998, the Registrant issued an option to purchase 242,100 shares of common stock to Lex Computer Management at an exercise price of $0.62 per share in consideration of consulting services.

(13) In March 1998, the Registrant issued 60,525 shares of common stock to Steven Blank pursuant to an exercise of an option dated November 1996 at an exercise price of $0.17 per share. The consideration was paid by the company in exchange for a promissory note from Mr. Blank.

(14) In March 1998, the Registrant issued 28,245 shares of common stock to Craig Culver with a fair market value of $3.66 per share in consideration for an assignment of a patent.

(15) On April 13, 1998, the Registrant sold an aggregate of 1,376,929 shares of Series D preferred stock to accredited investors for an aggregate purchase price of $5,750,002.

(16) On April 13, 1998, the Registrant issued a warrant to purchase 11,972 shares of Series D preferred stock to BancAmerica Robertson Stephens at an exercise price of $4.18 per share.

II-2


(17) In June 1998, the Registrant issued 80,700 shares of common stock to Digital Equipment Corporation with a fair market value of $3.66 per share in consideration of consulting services and assignment of a patent.

(18) In June 1998, the Registrant issued 85,945 shares of common stock to Bernie G. Jackson pursuant to an exercise of a warrant dated June 1995 at an exercise price of $0.04 per share.

(19) In July 1998, the Registrant issued 28,245 shares of common stock to Ming-Chang Tsai and Gemintek Corporation at a price of $3.66 per share in consideration of an assignment of the patent.

(20) In August 1998, the Registrant issued 30,262 shares of Series A preferred stock to Bruce Paul pursuant to an exercise of a warrant dated August 1996 at an exercise price of $0.99 per share.

(21) In February 1999, the Registrant issued 8,070 shares of common stock to Washington Research Foundation in consideration for a patent license.

(22) In February 1999, the Registrant issued 88,770 shares of common stock to the University of British Columbia for consideration of the sale and transfer of a patent.

(23) On March 4, 1999, the Registrant issued an aggregate of 1,291,200 shares of common stock to Cybernet Systems Corporation with a fair market value of $3.66 pursuant to an Agreement and Plan of Reorganization.

(24) On March 4, 1999, the Registrant issued a warrant to purchase 322,800 shares of common stock to Cybernet Systems Corporation at an exercise price of $3.66 in consideration for certain consulting services.

(25) In May 1999, the Registrant issued 7,061 shares of common stock to Richard Brent Gillespie pursuant to an exercise of a warrant dated August 1995 at an exercise price of $0.04 per share.

(26) In June 1999, the Registrant issued an option to purchase 20,175 shares of common stock at an exercise price of $3.66 per share to Coactive Drive Corporation in consideration for a technology licensing agreement. This option may be exercised at any time within ten years after its issuance.

(27) In July 1999, the Registrant issued 68,595 shares of common stock to Michael Reich and Associates in consideration of services.

There were no underwriters employed in connection with any of the transactions set forth in Item 15.

Certain issuances described in this Item 15 were deemed exempt from registration under the Securities Act in reliance on Section 4(2) of the Securities Act and/or Rules 504, 505 or 506 promulgated under the Securities Act as transactions by an issuer not involving a public offering. Certain issuances described in this Item 15 were deemed exempt from registration under the Securities Act in reliance on Section 4(2) or Rule 701 promulgated thereunder as transactions pursuant to compensatory benefit plans and contracts relating to compensation. The recipients of securities in each of these transaction represented their intention to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the share certificates and other instruments issued in such transactions. All recipients either received adequate information about us or had access, through employment or other relationships, to that information.

II-3


ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

(A) EXHIBITS.

EXHIBIT
NUMBER                       DESCRIPTION OF DOCUMENT
-------                      -----------------------
 1.1       Form of Underwriting Agreement.
 2.1       Agreement and Plan of Reorganization with Cybernet Systems
           Corporation ("Cybernet"), its wholly-owned subsidiary and
           our wholly-owned subsidiary dated March 4, 1999.**
 3.1       Amended and Restated Articles of Incorporation of Immersion,
           as amended to date.**
 3.2       Certificate of Incorporation of Immersion.
 3.3       Form of Amended and Restated Certificate of Incorporation of
           Immersion (to be filed with the Delaware Secretary of State
           prior to the date of this prospectus).
 3.4       Certificate of Designations of Immersion (to be filed with
           the Delaware Secretary of State prior to the date of this
           prospectus).
 3.5       Agreement and Plan of Merger (to be executed prior to the
           date of this prospectus).
 3.6       Certificate of Elimination of Immersion (to be filed with
           the Delaware Secretary of State upon completion of the
           offering).
 3.7       Certificate of Amendment of Restated Certificate of
           Incorporation of Immersion (to be filed with the Delaware
           Secretary of State upon completion of the offering).
 3.8       Bylaws of Immersion.**
 3.9       Form of Bylaws.*
 4.1       Information and Registration Rights Agreement dated April
           13, 1998.**
 4.2       Immersion Corporation Cybernet Registration Rights Agreement
           dated March 5, 1999.**
 4.3       Common Stock Grant and Purchase Agreement and Plan with
           Michael Reich & Associates dated July 6, 1999.**
 4.4       Common Stock Agreement with Digital Equipment Corporation
           dated June 12, 1998.**
 5.1       Opinion of Gray Cary Ware & Freidenrich LLP.
10.1       1994 Stock Option Plan and form of Incentive Stock Option
           Agreement and form of Nonqualified Stock Option Agreement.**
10.2       1997 Stock Option Plan and form of Incentive Stock Option
           Agreement and form of Nonqualified Stock Option Agreement.**
10.3       Form of Indemnity Agreement.*
10.4       Immediately Exercisable Nonstatutory Stock Option Agreement
           with Steven G. Blank dated November 1, 1996.**
10.5       Common Stock Purchase Warrant issued to Cybernet Systems
           Corporation dated March 5, 1999.**
10.6       Consulting Services Agreement with Cybernet Systems
           Corporation dated March 5, 1999.**
10.7       Amendment to Warrant to Purchase Shares of Series B
           Preferred Stock to Bruce Paul amending warrant to purchase
           8,000 shares of Series B Preferred Stock dated September 22,
           1998.**
10.8       Amendment to Warrant to Purchase Shares of Series B
           Preferred Stock to Bruce Paul amending warrant to purchase
           10,000 shares of Series B Preferred Stock dated September
           22, 1998.**
10.9       Operating Agreement with MicroScribe, LLC dated July 1,
           1997.**
10.10      Exchange Agreement with MicroScribe, LLC dated July 1,
           1997.**
10.11      Lease with Spieker Properties, L.P. dated October 26, 1998.*
10.12      Agreement Draft for ASIC Design and Development with
           Kawasaki LSI, U.S.A., Inc., dated October 16, 1997.*+
10.13      Patent License Agreement with Microsoft Corporation dated
           July 19, 1999.*+
10.14      Semiconductor Device Component Purchase Agreement with
           Kawasaki LSI, U.S.A., Inc., dated August 17, 1998.*+
10.15      Amendment No. 1 to Semiconductor Device Component Purchase
           Agreement with Kawasaki LSI, U.S.A., Inc. dated April 27,
           1999.*+

II-4


EXHIBIT
NUMBER                       DESCRIPTION OF DOCUMENT
-------                      -----------------------
10.16      Intercompany Intellectual Property License Agreement with
           MicroScribe, LLC dated July 1, 1997.*+
10.17      Patent License Agreement with MicroScribe, LLC dated July 1,
           1997.*+
10.18      Intellectual Property License Agreement with Logitech, Inc.
           dated [#].*+
10.19      Intellectual Property License Agreement with Logitech, Inc.
           dated [#].*+
10.20      Technology Product Development Agreement with Logitech, Inc.
           dated [#].*+
10.21      1999 Employee Stock Purchase Plan and form of subscription
           agreement thereunder.
21.1       Subsidiaries of Immersion.**
23.1       Consent of Deloitte & Touche LLP (to be filed upon
           subsequent amendment).
23.2       Consent of Gray Cary Ware & Freidenrich LLP (included in
           Exhibit 5.1).
24.1       Power of Attorney (included on page II-5).**
27.1       Financial Data Schedule (EDGAR filed version only).**


** Previously filed with Registrant's Registration Statement on Form S-1 (File No. 333-86361) on September 1, 1999.

* Previously filed with Amendment No. 1 to Registrant's Registration Statement on Form S-1 (File No. 333-86361) on September 13, 1999.

# Certain information has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

+ Confidential treatment is being requested as to a portion of this exhibit.

(B) FINANCIAL STATEMENT SCHEDULES.

The following are filed herewith:

Independent Auditors' Report on Schedule.

Schedule II Valuation and Qualifying Accounts.

Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.

ITEM 17. UNDERTAKINGS

The undersigned Registrant hereby undertakes to provide to the Underwriters at the closing specified in the Underwriting Agreement certificates in such denominations and registered in such names as required by the Underwriters to permit prompt delivery to each purchaser.

Insofar as indemnification by the Registrant for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions referenced in Item 14 of this Registration Statement or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act, and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered hereunder, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

II-5


The undersigned registrant hereby undertakes that:

(1) For purposes of determining any liability under the Securities Act, the information omitted from the form of Prospectus filed as part of this Registration Statement in reliance upon Rule 430A and contained in the form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or
(4) or 497(h) under the Securities Act shall be deemed to be part of this Registration Statement as of the time it was declared effective; and

(2) For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of Prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.

II-6


SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant has duly caused this Amendment No. 2 to the Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Jose, State of California, on the fifth day of October, 1999

IMMERSION CORPORATION

By: /s/ LOUIS ROSENBERG
  ------------------------------------
    Louis Rosenberg, Ph.D.
    Chairman of the Board, Chief
    Executive Officer and President

Pursuant to the requirements of the Securities Act, this Amendment No. 2 to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated:

                  SIGNATURE                                   TITLE                        DATE
                  ---------                                   -----                        ----

             /s/ LOUIS ROSENBERG               Chairman of the Board, President and  October 5, 1999
---------------------------------------------  Chief Executive Officer (Principal
           Louis Rosenberg, Ph.D.              Executive Officer)

             /s/ VICTOR VIEGAS*                Chief Financial Officer (Principal    October 5, 1999
---------------------------------------------  Financial and Accounting Officer)
                Victor Viegas

              /s/ BRUCE SCHENA*                Vice President, Chief Technology      October 5, 1999
---------------------------------------------  Officer, Secretary and Director
                Bruce Schena

              /s/ STEVEN BLANK*                Director                              October 5, 1999
---------------------------------------------
                Steven Blank

           /s/ JONATHAN RUBINSTEIN             Director                              October 5, 1999
---------------------------------------------
             Jonathan Rubinstein

          *By: /s/ LOUIS ROSENBERG
   ---------------------------------------
           Louis Rosenberg, Ph.D.
              Attorney-in-Fact

II-7


INDEPENDENT AUDITORS' REPORT ON SCHEDULE

To the Board of Directors and Stockholders of Immersion Corporation:

We have audited the consolidated financial statements of Immersion Corporation (the Company) as of December 31, 1998 and 1997, and for each of the three years in the period ended December 31, 1998, and have issued our report thereon dated April 2, 1999 (included elsewhere in this Registration Statement). Our audits also included the financial statement schedule listed in Item 16(b) of this Registration Statement. The financial statement schedule is the responsibility of the Company's management. Our responsibility is to express an opinion based on our audits. In our opinion, such financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.

San Jose, California

April 2, 1999

To the Board of Directors and Stockholders

of Immersion Corporation:

The consolidated financial statements included herein have been adjusted to give effect to the reincorporation in Delaware and the related 0.807-for-one reverse common and Series C and D preferred stock split and the 4.035-for-one reverse Series A and B preferred stock split as described in the second paragraph of Note 14 to the consolidated financial statements. The above report is in the form that will be signed by Deloitte & Touche LLP upon effectiveness of such event assuming that, from August 31, 1999 to the effective date of such event, no other events shall have occurred that would affect the accompanying consolidated financial statements or notes thereto.

DELOITTE & TOUCHE LLP

San Jose, California

October 5, 1999

S-1

SCHEDULE II

VALUATION AND QUALIFYING ACCOUNTS
(IN THOUSANDS)

                                               BALANCE AT   CHARGED TO                 BALANCE AT
                                               BEGINNING     COST AND    DEDUCTIONS/     END OF
                                               OF PERIOD     EXPENSES    WRITE-OFFS      PERIOD
                                               ----------   ----------   -----------   ----------
Year ended December 31, 1996
  Allowance for doubtful accounts............     $ 5          $40           $37          $ 8
Year ended December 31, 1997
  Allowance for doubtful accounts............     $ 8          $39           $ 9          $38
Year ended December 31, 1998
  Allowance for doubtful accounts............     $38          $57           $ 3          $92
Six months ended June 30, 1999
  Allowance for doubtful accounts*...........     $92          $ 4           $20          $76


* Unaudited

S-2

INDEX TO EXHIBITS

EXHIBIT
NUMBER                       DESCRIPTION OF DOCUMENT
-------                      -----------------------
 1.1       Form of Underwriting Agreement.
 2.1       Agreement and Plan of Reorganization with Cybernet Systems
           Corporation ("Cybernet"), its wholly-owned subsidiary and
           our wholly-owned subsidiary dated March 4, 1999.**
 3.1       Amended and Restated Articles of Incorporation of Immersion,
           as amended to date.**
 3.2       Certificate of Incorporation of Immersion.
 3.3       Form of Amended and Restated Certificate of Incorporation of
           Immersion (to be filed with the Delaware Secretary of State
           prior to the date of this prospectus).
 3.4       Certificate of Designations of Immersion (to be filed with
           the Delaware Secretary of State prior to the date of this
           prospectus).
 3.5       Agreement and Plan of Merger (to be executed prior to the
           date of this prospectus).
 3.6       Certificate of Elimination of Immersion (to be filed with
           the Delaware Secretary of State upon completion of the
           offering).
 3.7       Certificate of Amendment of Restated Certificate of
           Incorporation of Immersion (to be filed with the Delaware
           Secretary of State upon completion of the offering).
 3.8       Bylaws of Immersion.**
 3.9       Form of Bylaws.*
 4.1       Information and Registration Rights Agreement dated April
           13, 1998.**
 4.2       Immersion Corporation Cybernet Registration Rights Agreement
           dated March 5, 1999.**
 4.3       Common Stock Grant and Purchase Agreement and Plan with
           Michael Reich & Associates dated July 6, 1999.**
 4.4       Common Stock Agreement with Digital Equipment Corporation
           dated June 12, 1998.**
 5.1       Opinion of Gray Cary Ware & Freidenrich LLP.
10.1       1994 Stock Option Plan and form of Incentive Stock Option
           Agreement and form of Nonqualified Stock Option Agreement.**
10.2       1997 Stock Option Plan and form of Incentive Stock Option
           Agreement and form of Nonqualified Stock Option Agreement.**
10.3       Form of Indemnity Agreement.*
10.4       Immediately Exercisable Nonstatutory Stock Option Agreement
           with Steven G. Blank dated November 1, 1996.**
10.5       Common Stock Purchase Warrant issued to Cybernet Systems
           Corporation dated March 5, 1999.**
10.6       Consulting Services Agreement with Cybernet Systems
           Corporation dated March 5, 1999.**
10.7       Amendment to Warrant to Purchase Shares of Series B
           Preferred Stock to Bruce Paul amending warrant to purchase
           8,000 shares of Series B Preferred Stock dated September 22,
           1998.**
10.8       Amendment to Warrant to Purchase Shares of Series B
           Preferred Stock to Bruce Paul amending warrant to purchase
           10,000 shares of Series B Preferred Stock dated September
           22, 1998.**
10.9       Operating Agreement with MicroScribe, LLC dated July 1,
           1997.**
10.10      Exchange Agreement with MicroScribe, LLC dated July 1,
           1997.**
10.11      Lease with Spieker Properties, L.P. dated October 26, 1998.*
10.12      Agreement Draft for ASIC Design and Development with
           Kawasaki LSI, U.S.A., Inc., dated October 16, 1997.*+
10.13      Patent License Agreement with Microsoft Corporation dated
           July 19, 1999.*+
10.14      Semiconductor Device Component Purchase Agreement with
           Kawasaki LSI, U.S.A., Inc., dated August 17, 1998.*+


EXHIBIT
NUMBER                       DESCRIPTION OF DOCUMENT
-------                      -----------------------
10.15      Amendment No. 1 to Semiconductor Device Component Purchase
           Agreement with Kawasaki LSI, U.S.A., Inc. dated April 27,
           1999.*+
10.16      Intercompany Intellectual Property License Agreement with
           MicroScribe, LLC dated July 1, 1997.*+
10.17      Patent License Agreement with MicroScribe, LLC dated July 1,
           1997.*+
10.18      Intellectual Property License Agreement with Logitech, Inc.
           dated [#].*+
10.19      Intellectual Property License Agreement with Logitech, Inc.
           dated [#].*+
10.20      Technology Product Development Agreement with Logitech, Inc.
           dated [#].*+
10.21      1999 Employee Stock Purchase Plan and form of subscription
           agreement thereunder.
21.1       Subsidiaries of Immersion.**
23.1       Consent of Deloitte & Touche LLP (to be filed upon
           subsequent amendment).
23.2       Consent of Gray Cary Ware & Freidenrich LLP (included in
           Exhibit 5.1).
24.1       Power of Attorney (included on page II-5).**
27.1       Financial Data Schedule (EDGAR filed version only).**


** Previously filed with Registrant's Registration Statement on Form S-1 (File No. 333-86361) on September 1, 1999.

* Previously filed with Amendment No. 1 to Registrant's Registration Statement on Form S-1 (File No. 333-86361) on September 13, 1999.

# Certain information has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.

+ Confidential treatment is being requested as to a portion of this exhibit.


EXHIBIT 1.1

IMMERSION CORPORATION

SHARES(1)

COMMON STOCK

UNDERWRITING AGREEMENT

_____ __, 1999

HAMBRECHT & QUIST LLC
Bear, Stearns & Co. Inc.
BancBoston Robertson Stephens Inc.
c/o Hambrecht & Quist LLC
One Bush Street
San Francisco, CA 94104

Ladies and Gentlemen:

Immersion Corporation, a Delaware corporation (herein called the Company), proposes to issue and sell _______ shares of its authorized but unissued Common Stock, $0.001 par value (herein called the Common Stock) (said shares of Common Stock being herein called the Underwritten Stock). The Company and the stockholders of the Company named in Schedule II hereto (herein collectively called the Selling Securityholders) propose to grant to the Underwriters (as hereinafter defined) an option to purchase up to additional shares of Common Stock (herein called the Option Stock and with the Underwritten Stock herein collectively called the Stock). The Common Stock is more fully described in the Registration Statement and the Prospectus hereinafter mentioned.

The Company and the Selling Securityholders severally hereby confirm the agreements made with respect to the purchase of the Stock by the several underwriters, for whom you are acting, named in Schedule I hereto (herein collectively called the Underwriters, which term shall also include any underwriter purchasing Stock pursuant to Section 3(b) hereof). You represent and warrant that you have been authorized by each of the other Underwriters to enter into this Agreement on its behalf and to act for it in the manner herein provided.

1. REGISTRATION STATEMENT. The Company has filed with the Securities and Exchange Commission (herein called the Commission) a registration statement on Form S-1 (No. 33-_____), including the related preliminary prospectus, for the registration under the Securities Act of 1933, as amended (herein called the Securities Act) of the Stock. Copies of such registration statement and of each amendment thereto, if any, including the related preliminary prospectus (meeting the requirements of Rule 430A of the rules and regulations of the Commission) heretofore filed by the Company with the Commission have been delivered to you.

The term Registration Statement as used in this agreement shall mean such registration statement, including all exhibits and financial statements, all information omitted therefrom in reliance upon Rule 430A and contained in the Prospectus referred to below, in the form in which it became effective, and any registration statement filed pursuant to Rule 462(b) of the rules and regulations of the Commission with respect to the Stock (herein called a Rule 462(b) registration statement), and, in the event of any amendment thereto after the effective date of such registration statement (herein called the Effective Date), shall also mean (from and after the effectiveness of such amendment) such registration statement as so amended (including any Rule 462(b) registration statement). The term Prospectus as used in this Agreement shall mean the prospectus relating to the Stock first filed with the Commission pursuant to Rule 424(b) and Rule 430A (or if no such filing is required, as included in the Registration Statement) and, in the event of any supplement or amendment to such prospectus after the Effective Date, shall also mean (from and after the filing with the Commission of such supplement or the effectiveness of such amendment) such prospectus as so supplemented or amended. The term Preliminary Prospectus as used in this Agreement shall mean each preliminary prospectus included in such registration statement prior to the time it becomes effective.

The Registration Statement has been declared effective under the Securities Act, and no post-effective amendment to the Registration Statement has been filed as of the date of this Agreement. The Company has caused to be delivered to you copies of each Preliminary Prospectus and has consented to the use of such copies for the purposes permitted by the Securities Act.


(1) Plus an option to purchase from the Company and the Selling Securityholders up to additional shares to cover over-allotments.

1

2. REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND THE SELLING SECURITYHOLDERS.

(a) The Company and each Class I Selling Securityholder in Schedule II hereto hereby represent and warrant as follows:

(i) Each of the Company and its subsidiaries has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation, has full corporate power and authority to own or lease its properties and conduct its business as described in the Registration Statement and the Prospectus and as being conducted, and is duly qualified as a foreign corporation and in good standing in all jurisdictions in which the character of the property owned or leased or the nature of the business transacted by it makes qualification necessary (except where the failure to be so qualified would not have a material adverse effect on the business, properties, financial condition or results of operations of the Company and its subsidiaries, taken as a whole).

(ii) Since the respective dates as of which information is given in the Registration Statement and the Prospectus, there has not been any materially adverse change in the business, properties, financial condition or results of operations of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, other than as set forth in the Registration Statement and the Prospectus, and since such dates, except in the ordinary course of business, neither the Company nor any of its subsidiaries has entered into any material transaction not referred to in the Registration Statement and the Prospectus.

(iii) The Registration Statement and the Prospectus comply, and on the Closing Date (as hereinafter defined) and any later date on which Option Stock is to be purchased, the Prospectus will comply, in all material respects, with the provisions of the Securities Act and the rules and regulations of the Commission thereunder; on the Effective Date, the Registration Statement did not contain any untrue statement of a material fact and did not omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and, on the Effective Date the Prospectus did not and, on the Closing Date and any later date on which Option Stock is to be purchased, will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that none of the representations and warranties in this subparagraph (iii) shall apply to statements in, or omissions from, the Registration Statement or the Prospectus made in reliance upon and in conformity with information herein or otherwise furnished in writing to the Company by or on behalf of the Underwriters for use in the Registration Statement or the Prospectus.

(iv) The Stock is duly and validly authorized, is (or, in the case of shares of the Stock to be sold by the Company, will be, when issued and sold to the Underwriters as provided herein) duly and validly issued, fully paid and nonassessable and conforms to the description thereof in the Prospectus. No further approval or authority of the stockholders or the Board of Directors of the Company will be required for the transfer and sale of the Stock to be sold by the Selling Securityholders or the issuance and sale of the Stock as contemplated herein.

(v) Except as disclosed in the Prospectus, each of the Company and its subsidiaries owns or possesses adequate rights to use all patents, patent rights or licenses, inventions, collaborative research agreements, trade secrets, know-how, trademarks, service marks, trade names and copyrights which are necessary to conduct its businesses as described in the Registration Statement and Prospectus; the expiration of any patents, patent rights, trade secrets, trademarks, service marks, trade names or copyrights would not result in a materially adverse change in the business, properties, financial condition or results of operations of the Company and its subsidiaries, taken as a whole, that is not otherwise disclosed in the Prospectus; except as disclosed in the Prospectus, the Company has not received any notice of, and has no knowledge of, any infringement of or conflict with asserted rights of the Company by others with respect to any patent, patent rights, inventions, trade secrets, know-how, trademarks, service marks, trade names or copyrights; and, except as disclosed in the Prospectus, the Company has not received any notice of, and has no knowledge of, any infringement of or conflict with asserted rights of others with respect to any patent, patent rights, inventions, trade secrets, know-how, trademarks, service marks, trade names or copyrights which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, might have a materially adverse change in the business, properties, financial condition or results of operations of the Company and its subsidiaries, taken as a whole. Except as disclosed in the Prospectus, there is no claim being made against the Company regarding patents, patent rights or licenses, inventions, collaborative research, trade secrets, know-how, trademarks, service marks, trade names or copyrights. The Company and its subsidiaries do not in the conduct of their business as now or proposed to be conducted as described in the Prospectus infringe or conflict with any right or patent of any third party, or any discovery, invention, product or process which is the subject of a patent application filed by any third party, known to the Company or any of its subsidiaries, which such infringement or conflict is reasonably likely to result in a materially adverse

2

change in the business, properties, financial condition or results of operations of the Company and its subsidiaries, taken as a whole.

(vi) The Company has been advised of the rules and requirements under the Investment Company Act of 1940, as amended (herein called the Investment Company Act). The Company is not, and after receipt of payment for the Shares will not be, an "investment company" or an entity "controlled" by an "investment company" within the meaning of the Investment Company Act.

(vii) The Company has not taken and will not take, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Common Stock to facilitate the sale or resale of the Stock.

(viii) Substantially all outstanding shares of Common Stock, and all securities convertible into or exercisable or exchangeable for Common Stock, are subject to valid, binding and enforceable agreements to the effect that, without the prior written consent of Hambrecht & Quist LLC on behalf of the Underwriters, the holder will not, for a period of 180 days following the commencement of the public offering of the Stock by the Underwriters, directly or indirectly, (i) sell, offer, contract to sell, make any short sale, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exchangeable or exercisable for or any rights to purchase or acquire Common Stock or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences or ownership of Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The Company has provided to counsel for the Underwriters a complete and accurate list of all securityholders of the Company and the number and type of securities held by each securityholder. The Company has provided to counsel for the Underwriters true, accurate and complete copies of all of the lock-up agreements in effect.

(b) Each of the Selling Securityholders, severally and not jointly, hereby represents and warrants as follows:

(i) Such Selling Securityholder has good and marketable title to all the shares of Stock to be sold by such Selling Securityholder hereunder, free and clear of all liens, encumbrances, equities, security interests and claims whatsoever, with full right and authority to deliver the same hereunder, subject, in the case of such Selling Securityholder, to the rights of degrees , as custodian (herein called the Custodian), and that upon the delivery of and payment for such shares of the Stock hereunder, the several Underwriters will receive good and marketable title thereto, free and clear of all liens, encumbrances, equities, security interests and claims whatsoever.

(ii) Such Selling Securityholder has duly authorized, executed and delivered, in the form heretofore furnished to the Underwriters, a Custody Agreement and Power of Attorney (herein called the Custody Agreement and Power of Attorney) appointing ____________ and ____________ as attorneys-in-fact (herein collectively called the "Attorneys" and individually called an "Attorney") and appointing ____________ as Custodian; each of the Custody Agreement and Power of Attorney constitutes a valid and binding agreement on the part of such Selling Securityholder, enforceable in accordance with its terms, except as the enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors' rights generally or by general equitable principles; and each of such Selling Securityholder's Attorneys, acting alone, is authorized to execute and deliver this Agreement on behalf of such Selling Securityholder, to determine the purchase price to be paid by the several Underwriters to such Selling Securityholder as provided in Section 3 hereof, to authorize the delivery of the shares of Stock to be sold by such Selling Securityholder under this Agreement and to duly endorse (in blank or otherwise) the certificate or certificates representing such Stock or a stock power or power with respect thereto, to accept payment therefor, and otherwise to act on behalf of such Selling Securityholder in connection with this Agreement.

(iii) All consents, approvals, authorizations and orders required for the execution and delivery by such Selling Securityholder of the Custody Agreement and Power of Attorney, the execution and delivery by or on behalf of such Selling Securityholder of this Agreement and the sale and delivery of the shares of Stock to be sold by such Selling Securityholder under this Agreement have been obtained and are in full force and effect; such Selling Securityholder, if other than a natural person, has been duly organized and is validly existing in good standing under the laws of the jurisdiction of its organization as the type of entity that it purports to be; and such Selling Securityholder has full legal right, power and authority to enter into and perform its obligations under this Agreement and such Custody Agreement and Power of Attorney, and to sell, assign, transfer and deliver the Stock to be sold by such Selling Securityholder under this Agreement.

3

(iv) Certificates in negotiable form for the shares of the Stock to be sold by such Selling Securityholder have been placed in custody under a Custody Agreement for delivery under this Agreement with the Custodian; such Selling Securityholder specifically agrees that the shares of the Stock represented by the certificates so held in custody for such Selling Securityholder are subject to the interests of the several Underwriters and the Company, that the arrangements made by such Selling Securityholder for such custody, including the Power of Attorney provided for in such Custody Agreement, are to that extent irrevocable, and that the obligations of such Selling Securityholder shall not be terminated by any act of such Selling Securityholder or by operation of law, whether by the death or incapacity of such Selling Securityholder (or, in the case of a Selling Securityholder that is not an individual, the dissolution or liquidation of such Selling Securityholder) or the occurrence of any other event; if any such death, incapacity, dissolution, liquidation or other such event should occur before the delivery of such shares of the Stock hereunder, certificates for such shares of the Stock shall be delivered by the Custodian in accordance with the terms and conditions of this Agreement as if such death, incapacity, dissolution, liquidation or other event had not occurred, regardless of whether the Custodian shall have received notice of such death, incapacity, dissolution, liquidation or other event.

(v) If such Selling Securityholder is a Class I or Class II Selling Securityholder in Schedule II hereto, such Selling Securityholder has reviewed the Registration Statement and Prospectus and, although such Selling Securityholder has not independently verified the accuracy or completeness of all the information contained therein, nothing has come to the attention of such Selling Securityholder that would lead such Selling Securityholder to believe that on the Effective Date, the Registration Statement contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and, on the Effective Date the Prospectus contained and, on the Closing Date and any later date on which Option Stock is to be purchased, contains any untrue statement of a material fact or omitted or omits to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.

[ADD ADDITIONAL REPS OF SELLING SECURITYHOLDERS]

3. PURCHASE OF THE STOCK BY THE UNDERWRITERS.

(a) On the basis of the representations and warranties and subject to the terms and conditions herein set forth, the Company agrees to issue and sell shares of the Underwritten Stock to the several Underwriters and each of the Underwriters agrees to purchase from the Company the respective aggregate number of shares of Underwritten Stock set forth opposite its name in Schedule I. The price at which such shares of Underwritten Stock shall be sold by the Company and purchased by the several Underwriters shall be $___ per share. In making this Agreement, each Underwriter is contracting severally and not jointly; except as provided in paragraphs (b) and (c) of this Section 3, the agreement of each Underwriter is to purchase only the respective number of shares of the Underwritten Stock specified in Schedule I.

(b) If for any reason one or more of the Underwriters shall fail or refuse (otherwise than for a reason sufficient to justify the termination of this Agreement under the provisions of Section 8 or 9 hereof) to purchase and pay for the number of shares of the Stock agreed to be purchased by such Underwriter or Underwriters, the Company shall immediately give notice thereof to you, and the non-defaulting Underwriters shall have the right within 24 hours after the receipt by you of such notice to purchase, or procure one or more other Underwriters to purchase, in such proportions as may be agreed upon between you and such purchasing Underwriter or Underwriters and upon the terms herein set forth, all or any part of the shares of the Stock which such defaulting Underwriter or Underwriters agreed to purchase. If the non-defaulting Underwriters fail so to make such arrangements with respect to all such shares and portion, the number of shares of the Stock which each non-defaulting Underwriter is otherwise obligated to purchase under this Agreement shall be automatically increased on a pro rata basis to absorb the remaining shares and portion which the defaulting Underwriter or Underwriters agreed to purchase; provided, however, that the non-defaulting Underwriters shall not be obligated to purchase the shares and portion which the defaulting Underwriter or Underwriters agreed to purchase if the aggregate number of such shares of the Stock exceeds 10% of the total number of shares of the Stock which all Underwriters agreed to purchase hereunder. If the total number of shares of the Stock which the defaulting Underwriter or Underwriters agreed to purchase shall not be purchased or absorbed in accordance with the two preceding sentences, the Company shall have the right, within 24 hours next succeeding the 24-hour period above referred to, to make arrangements with other underwriters or purchasers satisfactory to you for purchase of such shares and portion on the terms herein set forth. In any such case, either you or the Company and the Selling Securityholders shall have the right to postpone the Closing Date determined as provided in Section 5 hereof for not more than seven business days after the date originally fixed as the Closing Date pursuant to said Section 5 in order that any necessary changes in the Registration Statement, the Prospectus or any other documents or arrangements may be made. If neither the non-defaulting Underwriters nor the Company and the Selling Securityholders shall make arrangements within the 24-hour periods stated above for the purchase of all the shares of the Stock which the

4

defaulting Underwriter or Underwriters agreed to purchase hereunder, this Agreement shall be terminated without further act or deed and without any liability on the part of the Company or the Selling Securityholders to any non-defaulting Underwriter and without any liability on the part of any non-defaulting Underwriter to the Company or the Selling Securityholders. Nothing in this paragraph (b), and no action taken hereunder, shall relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.

(c) On the basis of the representations, warranties and covenants herein contained, and subject to the terms and conditions herein set forth, the Company and the Selling Securityholders grant an option to the several Underwriters to purchase, severally and not jointly, up to shares in the aggregate of the Option Stock from the Company and the Selling Securityholders at the same price per share as the Underwriters shall pay for the Underwritten Stock. Said option may be exercised only to cover over-allotments in the sale of the Underwritten Stock by the Underwriters and may be exercised in whole or in part at any time (but not more than once) on or before the thirtieth day after the date of this Agreement upon written or telegraphic notice by you to the Company setting forth the aggregate number of shares of the Option Stock as to which the several Underwriters are exercising the option. Delivery of certificates for the shares of Option Stock, and payment therefor, shall be made as provided in Section 5 hereof. The number of shares of the Option Stock to be purchased by each Underwriter shall be the same percentage of the total number of shares of the Option Stock to be purchased by the several Underwriters as such Underwriter is purchasing of the Underwritten Stock, as adjusted by you in such manner as you deem advisable to avoid fractional shares. The number of shares of Option Stock to be sold by each Selling Securityholder is set forth in Schedule II opposite the name of each Selling Securityholder.

4. OFFERING BY UNDERWRITERS.

(a) The terms of the initial public offering by the Underwriters of the Stock to be purchased by them shall be as set forth in the Prospectus. The Underwriters may from time to time change the public offering price after the closing of the initial public offering and increase or decrease the concessions and discounts to dealers as they may determine.

(b) The information set forth in the ______, _______ and ______ paragraphs under "Underwriting" in the Registration Statement, any Preliminary Prospectus and the Prospectus (insofar as such information relates to the Underwriters) constitutes the only information furnished by the Underwriters to the Company for inclusion in the Registration Statement, any Preliminary Prospectus, and the Prospectus, and you on behalf of the respective Underwriters represent and warrant to the Company that the statements made therein are correct.

5. DELIVERY OF AND PAYMENT FOR THE STOCK.

(a) Delivery of certificates for the shares of the Underwritten Stock and the Option Stock (if the option granted by Section 3(c) hereof shall have been exercised not later than 7:00 A.M., San Francisco time, on the date two business days preceding the Closing Date), and payment therefor, shall be made at the office of Gray Cary Ware & Freidenrich LLP, 400 Hamilton Avenue, Palo Alto, California 94301-1825, at 7:00 a.m., San Francisco time, on the fourth business day after the date of this Agreement, or at such time on such other day, not later than seven full business days after such fourth business day, as shall be agreed upon in writing by the Company, you and (if Option Stock is to be delivered) the Selling Securityholders. The date and hour of such delivery and payment (which may be postponed as provided in Section 3(b) hereof) are herein called the Closing Date.

(b) If the option granted by Section 3(c) hereof shall be exercised after 7:00 a.m., San Francisco time, on the date two business days preceding the Closing Date, delivery of certificates for the shares of Option Stock, and payment therefor, shall be made at the office of Gray Cary Ware & Freidenrich LLP, 400 Hamilton Avenue, Palo Alto, California 94301-1825, at 7:00 a.m., San Francisco time, on the third business day after the exercise of such option.

(c) Payment for the Stock purchased from the Company shall be made to the Company or its order, and payment for the Stock purchased from the Selling Securityholders shall be made to the Custodian, for the account of the Selling Securityholders, in each case by one or more certified or official bank check or checks or by wire, in either case in same day funds. Such payment shall be made upon delivery of certificates for the Stock to you for the respective accounts of the several Underwriters against receipt therefor signed by you. Certificates for the Stock to be delivered to you shall be registered in such name or names and shall be in such denominations as you may request at least one business day before the Closing Date, in the case of Underwritten Stock, and at least one business day prior to the purchase thereof, in the case of the Option Stock. Such certificates will be made available to the Underwriters for inspection, checking and packaging at the offices of Lewco Securities Corporation, 2 Broadway, New York, New York 10004 on the business day prior to the Closing Date or, in the case of the Option Stock, by 3:00 p.m., New York time, on the business day preceding the date of purchase.

5

It is understood that you, individually and not on behalf of the Underwriters, may (but shall not be obligated to) make payment to the Company and the Selling Securityholders for shares to be purchased by any Underwriter whose check shall not have been received by you on the Closing Date or any later date on which Option Stock is purchased for the account of such Underwriter. Any such payment by you shall not relieve such Underwriter from any of its obligations hereunder.

6. FURTHER AGREEMENTS OF THE COMPANY AND THE SELLING SECURITYHOLDERS. Each of the Company and the Selling Securityholders (where expressly indicated) respectively covenants and agrees as follows:

(a) The Company will (i) prepare and timely file with the Commission under Rule 424(b) a Prospectus containing information previously omitted at the time of effectiveness of the Registration Statement in reliance on Rule 430A and (ii) not file any amendment to the Registration Statement or supplement to the Prospectus of which you shall not previously have been advised and furnished with a copy or to which you shall have reasonably objected in writing or which is not in compliance with the Securities Act or the rules and regulations of the Commission.

(b) The Company will promptly notify each Underwriter in the event of (i) the request by the Commission for amendment of the Registration Statement or for supplement to the Prospectus or for any additional information, (ii) the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, (iii) the institution or notice of intended institution of any action or proceeding for that purpose, (iv) the receipt by the Company of any notification with respect to the suspension of the qualification of the Stock for sale in any jurisdiction, or (v) the receipt by it of notice of the initiation or threatening of any proceeding for such purpose. The Company and the Selling Securityholders will make every reasonable effort to prevent the issuance of such a stop order and, if such an order shall at any time be issued, to obtain the withdrawal thereof at the earliest possible moment.

(c) The Company will (i) on or before the Closing Date, deliver to you a signed copy of the Registration Statement as originally filed and of each amendment thereto filed prior to the time the Registration Statement becomes effective and, promptly upon the filing thereof, a signed copy of each post-effective amendment, if any, to the Registration Statement (together with, in each case, all exhibits thereto unless previously furnished to you) and will also deliver to you, for distribution to the Underwriters, a sufficient number of additional conformed copies of each of the foregoing (but without exhibits) so that one copy of each may be distributed to each Underwriter, (ii) as promptly as possible deliver to you and send to the several Underwriters, at such office or offices as you may designate, as many copies of the Prospectus as you may reasonably request, and (iii) thereafter from time to time during the period in which a prospectus is required by law to be delivered by an Underwriter or dealer, likewise send to the Underwriters as many additional copies of the Prospectus and as many copies of any supplement to the Prospectus and of any amended prospectus, filed by the Company with the Commission, as you may reasonably request for the purposes contemplated by the Securities Act.

(d) If at any time during the period in which a prospectus is required by law to be delivered by an Underwriter or dealer any event relating to or affecting the Company, or of which the Company shall be advised in writing by you, shall occur as a result of which it is necessary, in the opinion of counsel for the Company or of counsel for the Underwriters, to supplement or amend the Prospectus in order to make the Prospectus not misleading in the light of the circumstances existing at the time it is delivered to a purchaser of the Stock, the Company will forthwith prepare and file with the Commission a supplement to the Prospectus or an amended prospectus so that the Prospectus as so supplemented or amended will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances existing at the time such Prospectus is delivered to such purchaser, not misleading. If, after the initial public offering of the Stock by the Underwriters and during such period, the Underwriters shall propose to vary the terms of offering thereof by reason of changes in general market conditions or otherwise, you will advise the Company in writing of the proposed variation, and, if in the opinion either of counsel for the Company or of counsel for the Underwriters such proposed variation requires that the Prospectus be supplemented or amended, the Company will forthwith prepare and file with the Commission a supplement to the Prospectus or an amended prospectus setting forth such variation. The Company authorizes the Underwriters and all dealers to whom any of the Stock may be sold by the several Underwriters to use the Prospectus, as from time to time amended or supplemented, in connection with the sale of the Stock in accordance with the applicable provisions of the Securities Act and the applicable rules and regulations thereunder for such period.

(e) Prior to the filing thereof with the Commission, the Company will submit to you, for your information, a copy of any post-effective amendment to the Registration Statement and any supplement to the Prospectus or any amended prospectus proposed to be filed.

6

(f) The Company will cooperate, when and as requested by you, in the qualification of the Stock for offer and sale under the securities or blue sky laws of such jurisdictions as you may designate and, during the period in which a prospectus is required by law to be delivered by an Underwriter or dealer, in keeping such qualifications in good standing under said securities or blue sky laws; provided, however, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation in any jurisdiction in which it is not so qualified. The Company will, from time to time, prepare and file such statements, reports, and other documents as are or may be required to continue such qualifications in effect for so long a period as you may reasonably request for distribution of the Stock.

(g) During a period of five years commencing with the date hereof, the Company will furnish to you, and to each Underwriter who may so request in writing, copies of all periodic and special reports furnished to stockholders of the Company and of all information, documents and reports filed with the Commission.

(h) Not later than the 45th day following the end of the fiscal quarter first occurring after the first anniversary of the Effective Date, the Company will make generally available to its security holders an earnings statement in accordance with Section 11(a) of the Securities Act and Rule 158 thereunder.

(i) The Company and the Selling Securityholders jointly and severally agree to pay all costs and expenses incident to the performance of their obligations under this Agreement, including all costs and expenses incident to (i) the preparation, printing and filing with the Commission and the National Association of Securities Dealers, Inc. ("NASD") of the Registration Statement, any Preliminary Prospectus and the Prospectus, (ii) the furnishing to the Underwriters of copies of any Preliminary Prospectus and of the several documents required by paragraph (c) of this Section 6 to be so furnished, (iii) the printing of this Agreement and related documents delivered to the Underwriters,
(iv) the preparation, printing and filing of all supplements and amendments to the Prospectus referred to in paragraph (d) of this
Section 6, (v) the furnishing to you and the Underwriters of the reports and information referred to in paragraph (g) of this Section 6 and (vi) the printing and issuance of stock certificates, including the transfer agent's fees. The Selling Securityholders will pay any transfer taxes incident to the transfer to the Underwriters of the shares the Stock being sold by the Selling Securityholders.

(j) The Company and the Selling Securityholders jointly and severally agree to reimburse you, for the account of the several Underwriters, for blue sky fees and related disbursements (including counsel fees and disbursements and cost of printing memoranda for the Underwriters) paid by or for the account of the Underwriters or their counsel in qualifying the Stock under state or international securities or blue sky laws and in the review of the offering by the NASD.

(k) The provisions of paragraphs (i) and (j) of this Section are intended to relieve the Underwriters from the payment of the expenses and costs which the Company and the Selling Securityholders hereby agree to pay and shall not affect any agreement which the Company and the Selling Securityholders may make, or may have made, for the sharing of any such expenses and costs.

(l) The Company and each of the Selling Securityholders hereby agrees that, without the prior written consent of Hambrecht & Quist LLC on behalf of the Underwriters, the Company or such Selling Securityholder, as the case may be, will not, for a period of 180 days following the commencement of the public offering of the Stock by the Underwriters, directly or indirectly, (i) sell, offer, contract to sell, make any short sale, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exchangeable or exercisable for or any rights to purchase or acquire Common Stock or
(ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences or ownership of Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing sentence shall not apply to the Stock to be sold to the Underwriters pursuant to this Agreement. The obligations of the Company under this subsection (l) also shall not apply to (A) shares of Common Stock issued by the Company upon the exercise of options granted under the stock option plans of the Company (the "Option Plans") or upon the exercise of warrants outstanding as of the date hereof, all as described in the introduction to the table under the caption "Capitalization" in the Preliminary Prospectus, (B) options to purchase Common Stock granted under the Option Plans, and (C) shares of Common Stock issued by the Company under its employee stock purchase plan.

(m) The Company agrees to use its best efforts to cause all directors, officers, and stockholders to agree that, without the prior written consent of Hambrecht & Quist LLC on behalf of the Underwriters,

7

such person or entity will not, for a period of 180 days following the commencement of the public offering of the Stock by the Underwriters, directly or indirectly, (i) sell, offer, contract to sell, make any short sale, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exchangeable or exercisable for or any rights to purchase or acquire Common Stock or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences or ownership of Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The Company will not release any of its officers, directors or other stockholders from any lock-up agreements currently existing or hereafter effected without the prior written consent of Hambrecht & Quist LLC.

(n) If at any time during the 25-day period after the Registration Statement becomes effective any rumor, publication or event relating to or affecting the Company shall occur as a result of which in your opinion the market price for the Stock has been or is likely to be materially affected (regardless of whether such rumor, publication or event necessitates a supplement to or amendment of the Prospectus), the Company will, after written notice from you advising the Company to the effect set forth above, forthwith prepare, consult with you concerning the substance of, and disseminate a press release or other public statement, reasonably satisfactory to you, responding to or commenting on such rumor, publication or event.

(o) The Company is familiar with the Investment Company Act of 1940, as amended, and will in the future conduct its affairs, in such a manner to ensure that the Company was not and will not be an "investment company" or a company "controlled" by an "investment company" within the meaning of the Investment Company Act of 1940, as amended, and the rules and regulations thereunder.

7. INDEMNIFICATION AND CONTRIBUTION.

(a) Subject to the provisions of paragraph (f) of this Section 7, the Company and the Selling Securityholders jointly and severally agree to indemnify and hold harmless each Underwriter and each person (including each partner or officer thereof) who controls any Underwriter within the meaning of Section 15 of the Securities Act from and against any and all losses, claims, damages or liabilities, joint or several, to which such indemnified parties or any of them may become subject under the Securities Act, the Securities Exchange Act of 1934, as amended (herein called the Exchange Act), or the common law or otherwise, and the Company and the Selling Securityholders jointly and severally agree to reimburse each such Underwriter and controlling person for any legal or other expenses (including, except as otherwise hereinafter provided, reasonable fees and disbursements of counsel) incurred by the respective indemnified parties in connection with defending against any such losses, claims, damages or liabilities or in connection with any investigation or inquiry of, or other proceeding which may be brought against, the respective indemnified parties, in each case arising out of or based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (including the Prospectus as part thereof and any Rule 462(b) registration statement) or any post-effective amendment thereto (including any Rule 462(b) registration statement), or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Preliminary Prospectus or the Prospectus (as amended or as supplemented if the Company shall have filed with the Commission any amendment thereof or supplement thereto) or the omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that (1) the indemnity agreements of the Company and the Selling Securityholders contained in this paragraph (a) shall not apply to any such losses, claims, damages, liabilities or expenses if such statement or omission was made in reliance upon and in conformity with information furnished as herein stated or otherwise furnished in writing to the Company by or on behalf of any Underwriter for use in any Preliminary Prospectus or the Registration Statement or the Prospectus or any such amendment thereof or supplement thereto, (2) the indemnity agreement contained in this paragraph (a) with respect to any Preliminary Prospectus shall not inure to the benefit of any Underwriter from whom the person asserting any such losses, claims, damages, liabilities or expenses purchased the Stock which is the subject thereof (or to the benefit of any person controlling such Underwriter) if at or prior to the written confirmation of the sale of such Stock a copy of the Prospectus (or the Prospectus as amended or supplemented) was not sent or delivered to such person and the untrue statement or omission of a material fact contained in such Preliminary Prospectus was corrected in the Prospectus (or the Prospectus as amended or supplemented) unless the failure is the result of noncompliance by the Company with paragraph (c) of Section 6 hereof, and (3) each Class III Selling Securityholder shall only be liable under this paragraph with respect to (A) information pertaining to such Selling Securityholder furnished by or on behalf of such Selling Securityholder expressly for use in any Preliminary Prospectus or the Registration Statement or the Prospectus or any such amendment thereof or supplement thereto or (B) facts that would constitute a breach of any representation or warranty of such Selling Securityholder set forth in Section 2(b) hereof. The indemnity agreements of the Company and the Selling Securityholders contained in this paragraph (a) and the representations and warranties of the Company and the Selling Securityholders contained in Section 2

8

hereof shall remain operative and in full force and effect regardless of any investigation made by or on behalf of any indemnified party and shall survive the delivery of and payment for the Stock.

(b) Each Underwriter severally agrees to indemnify and hold harmless the Company, each of its officers who signs the Registration Statement on his own behalf or pursuant to a power of attorney, each of its directors, each other Underwriter and each person (including each partner or officer thereof) who controls the Company or any such other Underwriter within the meaning of Section 15 of the Securities Act, and the Selling Securityholders from and against any and all losses, claims, damages or liabilities, joint or several, to which such indemnified parties or any of them may become subject under the Securities Act, the Exchange Act, or the common law or otherwise and to reimburse each of them for any legal or other expenses (including, except as otherwise hereinafter provided, reasonable fees and disbursements of counsel) incurred by the respective indemnified parties in connection with defending against any such losses, claims, damages or liabilities or in connection with any investigation or inquiry of, or other proceeding which may be brought against, the respective indemnified parties, in each case arising out of or based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (including the Prospectus as part thereof and any Rule 462(b) registration statement) or any post-effective amendment thereto (including any Rule 462(b) registration statement) or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (as amended or as supplemented if the Company shall have filed with the Commission any amendment thereof or supplement thereto) or the omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, if such statement or omission was made in reliance upon and in conformity with information furnished as herein stated or otherwise furnished in writing to the Company by or on behalf of such indemnifying Underwriter for use in the Registration Statement or the Prospectus or any such amendment thereof or supplement thereto. The indemnity agreement of each Underwriter contained in this paragraph (b) shall remain operative and in full force and effect regardless of any investigation made by or on behalf of any indemnified party and shall survive the delivery of and payment for the Stock.

(c) Each party indemnified under the provision of paragraphs (a) and (b) of this Section 7 agrees that, upon the service of a summons or other initial legal process upon it in any action or suit instituted against it or upon its receipt of written notification of the commencement of any investigation or inquiry of, or proceeding against, it in respect of which indemnity may be sought on account of any indemnity agreement contained in such paragraphs, it will promptly give written notice (herein called the Notice) of such service or notification to the party or parties from whom indemnification may be sought hereunder. No indemnification provided for in such paragraphs shall be available to any party who shall fail so to give the Notice if the party to whom such Notice was not given was unaware of the action, suit, investigation, inquiry or proceeding to which the Notice would have related and was prejudiced by the failure to give the Notice, but the omission so to notify such indemnifying party or parties of any such service or notification shall not relieve such indemnifying party or parties from any liability which it or they may have to the indemnified party for contribution or otherwise than on account of such indemnity agreement. Any indemnifying party shall be entitled at its own expense to participate in the defense of any action, suit or proceeding against, or investigation or inquiry of, an indemnified party. Any indemnifying party shall be entitled, if it so elects within a reasonable time after receipt of the Notice by giving written notice (herein called the Notice of Defense) to the indemnified party, to assume (alone or in conjunction with any other indemnifying party or parties) the entire defense of such action, suit, investigation, inquiry or proceeding, in which event such defense shall be conducted, at the expense of the indemnifying party or parties, by counsel chosen by such indemnifying party or parties and reasonably satisfactory to the indemnified party or parties; provided, however, that (i) if the indemnified party or parties reasonably determine that there may be a conflict between the positions of the indemnifying party or parties and of the indemnified party or parties in conducting the defense of such action, suit, investigation, inquiry or proceeding or that there may be legal defenses available to such indemnified party or parties different from or in addition to those available to the indemnifying party or parties, then counsel for the indemnified party or parties shall be entitled to conduct the defense to the extent reasonably determined by such counsel to be necessary to protect the interests of the indemnified party or parties and (ii) in any event, the indemnified party or parties shall be entitled to have counsel chosen by such indemnified party or parties participate in, but not conduct, the defense. If, within a reasonable time after receipt of the Notice, an indemnifying party gives a Notice of Defense and the counsel chosen by the indemnifying party or parties is reasonably satisfactory to the indemnified party or parties, the indemnifying party or parties will not be liable under paragraphs (a) through (c) of this Section 7 for any legal or other expenses subsequently incurred by the indemnified party or parties in connection with the defense of the action, suit, investigation, inquiry or proceeding, except that (A) the indemnifying party or parties shall bear the legal and other expenses incurred in connection with the conduct of the defense as referred to in clause (i) of the proviso to the preceding sentence and (B) the indemnifying party or parties shall bear such other expenses as it or they have authorized to be incurred by the indemnified party or parties. If, within a reasonable time after receipt of the Notice, no Notice of Defense has been given, the indemnifying party or parties shall be responsible for any legal or other expenses incurred by the indemnified party or parties in connection with the defense of the action, suit, investigation, inquiry or proceeding.

9

(d) If the indemnification provided for in this Section 7 is unavailable or insufficient to hold harmless an indemnified party under paragraph (a) or (b) of this Section 7, then each indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in paragraph (a) or (b) of this Section 7 (i) in such proportion as is appropriate to reflect the relative benefits received by each indemnifying party from the offering of the Stock or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of each indemnifying party in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, or actions in respect thereof, as well as any other relevant equitable considerations. The relative benefits received by the Company and the Selling Securityholders on the one hand and the Underwriters on the other shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Stock received by the Company and the Selling Securityholders and the total underwriting discount received by the Underwriters, as set forth in the table on the cover page of the Prospectus, bear to the aggregate public offering price of the Stock. Relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by each indemnifying party and the parties' relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission.

The parties agree that it would not be just and equitable if contributions pursuant to this paragraph (d) were to be determined by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take into account the equitable considerations referred to in the first sentence of this paragraph
(d). The amount paid by an indemnified party as a result of the losses, claims, damages or liabilities, or actions in respect thereof, referred to in the first sentence of this paragraph (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigation, preparing to defend or defending against any action or claim which is the subject of this paragraph (d). Notwithstanding the provisions of this paragraph (d), no Underwriter shall be required to contribute any amount in excess of the underwriting discount applicable to the Stock purchased by such Underwriter. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters' obligations in this paragraph (d) to contribute are several in proportion to their respective underwriting obligations and not joint.

Each party entitled to contribution agrees that upon the service of a summons or other initial legal process upon it in any action instituted against it in respect of which contribution may be sought, it will promptly give written notice of such service to the party or parties from whom contribution may be sought, but the omission so to notify such party or parties of any such service shall not relieve the party from whom contribution may be sought from any obligation it may have hereunder or otherwise (except as specifically provided in paragraph (c) of this Section 7).

(e) Neither the Company nor the Selling Securityholders will, without the prior written consent of each Underwriter, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action, suit or proceeding in respect of which indemnification may be sought hereunder (whether or not such Underwriter or any person who controls such Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act is a party to such claim, action, suit or proceeding) unless such settlement, compromise or consent includes an unconditional release of such Underwriter and each such controlling person from all liability arising out of such claim, action, suit or proceeding.

(f) The liability of each Selling Securityholder under the indemnity and reimbursement agreements contained in the provisions of this Section 7 and
Section 11 hereof shall be limited to an amount equal to the initial public offering price of the stock sold by such Selling Securityholder to the Underwriters less underwriting discounts and commissions. The Company and the Selling Securityholders may agree, as among themselves and without limiting the rights of the Underwriters under this Agreement, as to the respective amounts of such liability for which they each shall be responsible.

8. TERMINATION. This Agreement may be terminated by you at any time prior to the Closing Date by giving written notice to the Company and the Selling Securityholders if after the date of this Agreement trading in the Common Stock shall have been suspended, or if there shall have occurred (i) the engagement in hostilities or an escalation of major hostilities by the United States or the declaration of war or a national emergency by the United States on or after the date hereof, (ii) any outbreak of hostilities or other national or international calamity or crisis or change in economic or political conditions if the effect of such outbreak, calamity, crisis or change in economic or political conditions in the financial markets of the United States would, in the Underwriters' reasonable judgment, make the offering or delivery of the Stock impracticable, (iii) suspension of trading in securities generally or a material adverse decline in value of securities generally on the New York Stock Exchange, the American Stock Exchange, or The Nasdaq Stock Market, or limitations on prices (other than limitations on hours or numbers of days of trading) for securities on either such exchange or system, (iv) the enactment, publication, decree or other promulgation of any federal or state statute, regulation, rule or order of, or

10

commencement of any proceeding or investigation by, any court, legislative body, agency or other governmental authority which in the Underwriters' reasonable opinion materially and adversely affects or will materially or adversely affect the business or operations of the Company, (v) declaration of a banking moratorium by either federal or New York State authorities or (vi) the taking of any action by any federal, state or local government or agency in respect of its monetary or fiscal affairs which in the Underwriters' reasonable opinion has a material adverse effect on the securities markets in the United States. If this Agreement shall be terminated pursuant to this Section 8, there shall be no liability of the Company or the Selling Securityholders to the Underwriters and no liability of the Underwriters to the Company or the Selling Securityholders; provided, however, that in the event of any such termination the Company and the Selling Securityholders agree to indemnify and hold harmless the Underwriters from all costs or expenses incident to the performance of the obligations of the Company and the Selling Securityholders under this Agreement, including all costs and expenses referred to in paragraphs (i) and (j) of Section 6 hereof.

9. CONDITIONS OF UNDERWRITERS' OBLIGATIONS. The obligations of the several Underwriters to purchase and pay for the Stock shall be subject to the performance by the Company and by the Selling Securityholders of all their respective obligations to be performed hereunder at or prior to the Closing Date or any later date on which Option Stock is to be purchased, as the case may be, and to the following further conditions:

(a) The Registration Statement shall have become effective; and no stop order suspending the effectiveness thereof shall have been issued and no proceedings therefor shall be pending or threatened by the Commission.

(b) The legality and sufficiency of the sale of the Stock hereunder and the validity and form of the certificates representing the Stock, all corporate proceedings and other legal matters incident to the foregoing, and the form of the Registration Statement and of the Prospectus (except as to the financial statements contained therein), shall have been approved at or prior to the Closing Date by Fenwick & West LLP, counsel for the Underwriters.

(c) You shall have received from Gray Cary Ware & Freidenrich, counsel for the Company and the Selling Securityholders, and from Hickman, Stephens & Coleman LLP, patent counsel for the Company, opinions, addressed to the Underwriters and dated the Closing Date, covering the matters set forth in Annex A and Annex B hereto, respectively, and if Option Stock is purchased at any date after the Closing Date, additional opinions from each such counsel, addressed to the Underwriters and dated such later date, confirming that the statements expressed as of the Closing Date in such opinions remain valid as of such later date.

(d) You shall be satisfied that (i) as of the Effective Date, the statements made in the Registration Statement and the Prospectus were true and correct in all material respects and neither the Registration Statement nor the Prospectus omitted to state any material fact required to be stated therein or necessary in order to make the statements therein, respectively, not misleading, (ii) since the Effective Date, no event has occurred which should have been set forth in a supplement or amendment to the Prospectus which has not been set forth in such a supplement or amendment, (iii) since the respective dates as of which information is given in the Registration Statement in the form in which it originally became effective and the Prospectus contained therein, there has not been any material adverse change or any development involving a prospective material adverse change in or affecting the business, properties, financial condition or results of operations of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, and, since such dates, except in the ordinary course of business, neither the Company nor any of its subsidiaries has entered into any material transaction not referred to in the Registration Statement in the form in which it originally became effective and the Prospectus contained therein, (iv) neither the Company nor any of its subsidiaries has any material contingent obligations which are not disclosed in the Registration Statement and the Prospectus, (v) there are not any pending or known threatened legal proceedings to which the Company or any of its subsidiaries is a party or of which property of the Company or any of its subsidiaries is the subject which are material and which are not disclosed in the Registration Statement and the Prospectus, (vi) there are not any franchises, contracts, leases or other documents which are required to be filed as exhibits to the Registration Statement which have not been filed as required, (vii) the representations and warranties of the Company herein are true and correct in all material respects as of the Closing Date or any later date on which Option Stock is to be purchased, as the case may be, and
(viii) there has not been any material change in the market for securities in general or in political, financial or economic conditions from those reasonably foreseeable as to render it impracticable in your reasonable judgment to make a public offering of the Stock, or a material adverse change in market levels for securities in general (or those of companies in particular) or financial or economic conditions which render it inadvisable to proceed.

(e) You shall have received on the Closing Date and on any later date on which Option Stock is purchased a certificate, dated the Closing Date or such later date, as the case may be, and signed

11

by the President and the Chief Financial Officer of the Company, stating that the respective signers of said certificate have carefully examined the Registration Statement in the form in which it originally became effective and the Prospectus contained therein and any supplements or amendments thereto, and that the statements included in clauses (i) through (vii) of paragraph (d) of this Section 9 are true and correct.

(f) You shall have received from Deloitte & Touche LLP, a letter or letters, addressed to the Underwriters and dated the Closing Date and any later date on which Option Stock is purchased, confirming that they are independent public accountants with respect to the Company within the meaning of the Securities Act and the applicable published rules and regulations thereunder and based upon the procedures described in their letter delivered to you concurrently with the execution of this Agreement (herein called the Original Letter), but carried out to a date not more than three business days prior to the Closing Date or such later date on which Option Stock is purchased (i) confirming, to the extent true, that the statements and conclusions set forth in the Original Letter are accurate as of the Closing Date or such later date, as the case may be, and (ii) setting forth any revisions and additions to the statements and conclusions set forth in the Original Letter which are necessary to reflect any changes in the facts described in the Original Letter since the date of the Original Letter or to reflect the availability of more recent financial statements, data or information. The letters shall not disclose any change, or any development involving a prospective change, in or affecting the business or properties of the Company or any of its subsidiaries which, in your sole judgment, makes it impractical or inadvisable to proceed with the public offering of the Stock or the purchase of the Option Stock as contemplated by the Prospectus.

(g) You shall have received from Deloitte & Touche LLP a letter stating that their review of the Company's system of internal accounting controls, to the extent they deemed necessary in establishing the scope of their examination of the Company's financial statements as at , 1999, did not disclose any weakness in internal controls that they considered to be material weaknesses.

(h) You shall have been furnished evidence in usual written or telegraphic form from the appropriate authorities of the several jurisdictions, or other evidence satisfactory to you, of the qualification referred to in paragraph (f) of Section 6 hereof.

(i) Prior to the Closing Date, the Stock to be issued and sold by the Company and the Stock to be sold by the Selling Securityholders shall have been duly authorized for listing by the Nasdaq National Market upon official notice of issuance.

(j) On or prior to the Closing Date, you shall have received from all directors and officers and from stockholders holding substantially all of the remaining stock agreements, in form reasonably satisfactory to Hambrecht & Quist LLC, stating that without the prior written consent of Hambrecht & Quist LLC on behalf of the Underwriters, such person or entity will not, for a period of 180 days following the commencement of the public offering of the Stock by the Underwriters, directly or indirectly, (i) sell, offer, contract to sell, make any short sale, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exchangeable or exercisable for or any rights to purchase or acquire Common Stock or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences or ownership of Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise.

All the agreements, opinions, certificates and letters mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if Fenwick & West LLP, counsel for the Underwriters, shall be satisfied that they comply in form and scope.

In case any of the conditions specified in this Section 9 shall not be fulfilled, this Agreement may be terminated by you by giving notice to the Company and to the Selling Securityholders. Any such termination shall be without liability of the Company or the Selling Securityholders to the Underwriters and without liability of the Underwriters to the Company or the Selling Securityholders; provided, however, that (i) in the event of such termination, the Company and the Selling Securityholders agree to indemnify and hold harmless the Underwriters from all costs or expenses incident to the performance of the obligations of the Company and the Selling Securityholders under this Agreement, including all costs and expenses referred to in paragraphs
(i) and (j) of Section 6 hereof, and (ii) if this Agreement is terminated by you because of any refusal, inability or failure on the part of the Company or the Selling Securityholders to perform any agreement herein, to fulfill any of the conditions herein, or to comply with any provision hereof other than by reason of a default by any of the Underwriters, the Company will reimburse the Underwriters severally upon demand for all out-of-pocket expenses (including reasonable fees and disbursements of counsel) that shall have been incurred by them in connection with the transactions contemplated hereby.


10. CONDITIONS OF THE OBLIGATION OF THE COMPANY AND THE SELLING SECURITYHOLDERS. The obligation of the Company and the Selling Securityholders to deliver the Stock shall be subject to the conditions that (a) the Registration Statement shall have become effective and (b) no stop order suspending the effectiveness thereof shall be in effect and no proceedings therefor shall be pending or threatened by the Commission.

In case either of the conditions specified in this Section 10 shall not be fulfilled, this Agreement may be terminated by the Company and the Selling Securityholders by giving notice to you. Any such termination shall be without liability of the Company and the Selling Securityholders to the Underwriters and without liability of the Underwriters to the Company or the Selling Securityholders; provided, however, that in the event of any such termination the Company and the Selling Securityholders jointly and severally agree to indemnify and hold harmless the Underwriters from all costs or expenses incident to the performance of the obligations of the Company and the Selling Securityholders under this Agreement, including all costs and expenses referred to in paragraphs (i) and (j) of Section 6 hereof.

11. REIMBURSEMENT OF CERTAIN EXPENSES. In addition to their other obligations under Section 7 of this Agreement (and subject, in the case of a Selling Securityholder, to the provisions of paragraph (f) of Section 7), the Company and the Selling Securityholders hereby jointly and severally agree to reimburse on a quarterly basis the Underwriters for all reasonable legal and other expenses incurred in connection with investigating or defending any claim, action, investigation, inquiry or other proceeding arising out of or based upon any statement or omission, or any alleged statement or omission, described in paragraph (a) of Section 7 of this Agreement, notwithstanding the absence of a judicial determination as to the propriety and enforceability of the obligations under this Section 11 and the possibility that such payments might later be held to be improper; provided, however, that (i) to the extent any such payment is ultimately held to be improper, the persons receiving such payments shall promptly refund them and (ii) such persons shall provide to the Company, upon request, reasonable assurances of their ability to effect any refund, when and if due.

12. PERSONS ENTITLED TO BENEFIT OF AGREEMENT. This Agreement shall inure to the benefit of the Company, the Selling Securityholders and the several Underwriters and, with respect to the provisions of Section 7 hereof, the several parties (in addition to the Company, the Selling Securityholders and the several Underwriters) indemnified under the provisions of said Section 7, and their respective personal representatives, successors and assigns. Nothing in this Agreement is intended or shall be construed to give to any other person, firm or corporation any legal or equitable remedy or claim under or in respect of this Agreement or any provision herein contained. The term "successors and assigns" as herein used shall not include any purchaser, as such purchaser, of any of the Stock from any of the several Underwriters.

13. NOTICES. Except as otherwise provided herein, all communications hereunder shall be in writing or by telegraph and, if to the Underwriters, shall be mailed, telegraphed or delivered to Hambrecht & Quist LLC, One Bush Street, San Francisco, California 94104; and if to the Company, shall be mailed, telegraphed or delivered to it at its office, 2158 Paragon Drive, San Jose, California 95131, Attention: Chief Executive Officer; and if to the Selling Securityholders, shall be mailed, telegraphed or delivered to the Selling Securityholders in care of at . All notices given by telegraph shall be promptly confirmed by letter.

14. MISCELLANEOUS. The reimbursement, indemnification and contribution agreements contained in this Agreement and the representations, warranties and covenants in this Agreement shall remain in full force and effect regardless of
(a) any termination of this Agreement, (b) any investigation made by or on behalf of any Underwriter or controlling person thereof, or by or on behalf of the Company or the Selling Securityholders or their respective directors or officers, and (c) delivery and payment for the Stock under this Agreement; provided, however, that if this Agreement is terminated prior to the Closing Date, the provisions of paragraphs (l), (m) and (n) of Section 6 hereof shall be of no further force or effect.

This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

This Agreement shall be governed by, and construed in accordance with, the laws of the State of California.


Please sign and return to the Company and to the Selling Securityholders in care of the Company the enclosed duplicates of this letter, whereupon this letter will become a binding agreement among the Company, the Selling Securityholders and the several Underwriters in accordance with its terms.

Very truly yours,

IMMERSION CORPORATION

By

Name:
Title:

SELLING SECURITYHOLDERS:

By:
, Attorney-in-Fact

14

The foregoing Agreement is hereby confirmed and accepted as of the date first above written.

HAMBRECHT & QUIST LLC
BEAR, STEARNS & CO. INC.
BANCBOSTON ROBERTSON STEPHENS INC.

By Hambrecht & Quist LLC

By __________________________
Managing Director

Acting on behalf of the several Underwriters, including themselves, named in Schedule I hereto.

15

SCHEDULE I

UNDERWRITERS

                                                                                 NUMBER OF
                                                                                  SHARES
                                                                                  TO BE
        UNDERWRITERS                                                             PURCHASED
        ------------                                                             ---------
Hambrecht & Quist LLC.......................................................
Bear, Stearns & Co. Inc.....................................................
BancBoston Robertson Stephens Inc...........................................

           Total............................................................
                                                                                 ---------

                                                                                 =========

16

SCHEDULE II

SELLING SECURITYHOLDERS

                          NAME AND CLASS OF                                      NUMBER OF SHARES OF
                       SELLING SECURITYHOLDERS                                 OPTION STOCK TO BE SOLD
                       -----------------------                                 -----------------------
CLASS I

CLASS II

CLASS III

        Total.....................................................
                                                                                         ======

17

ANNEX A

MATTERS TO BE COVERED IN THE OPINION OF GRAY CARY WARE & FREIDENRICH
COUNSEL FOR THE COMPANY
AND THE SELLING SECURITYHOLDERS

(i) Each of the Company and its subsidiaries has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation, is duly qualified as a foreign corporation and in good standing in each state of the United States of America in which its ownership or leasing of property requires such qualification (except where the failure to be so qualified would not have a material adverse effect on the business, properties, financial condition or results of operations of the Company and its subsidiaries, taken as a whole), and has full corporate power and authority to own or lease its properties and conduct its business as described in the Registration Statement; all the issued and outstanding capital stock of each of the subsidiaries of the Company has been duly authorized and validly issued and is fully paid and nonassessable, and, except as disclosed in the Prospectus, is owned by the Company free and clear of all liens, encumbrances and security interests, and to the best of such counsel's knowledge, no options, warrants or other rights to purchase, agreements or other obligations to issue or other rights to convert any obligations into shares of capital stock or ownership interests in such subsidiaries are outstanding;

(ii) the authorized capital stock of the Company consists of shares of Stock, of which there are outstanding shares, and shares of Common Stock, $0.001 par value, of which there are outstanding shares (including the Underwritten Stock plus the number of shares of Option Stock issued on the date hereof); proper corporate proceedings have been taken validly to authorize such authorized capital stock; all of the outstanding shares of such capital stock (including the Underwritten Stock and the shares of Option Stock issued, if any) have been duly and validly issued and are fully paid and nonassessable; any Option Stock purchased after the Closing Date, when issued and delivered to and paid for by the Underwriters as provided in the Underwriting Agreement, will have been duly and validly issued and be fully paid and nonassessable; and no preemptive rights of, or rights of refusal in favor of, stockholders exist with respect to the Stock, or the issue and sale thereof, pursuant to the Certificate of Incorporation or Bylaws of the Company and, to the knowledge of such counsel, there are no contractual preemptive rights that have not been waived, rights of first refusal or rights of co-sale which exist with respect to the Stock being sold by the Selling Securityholders or the issue and sale of the Stock;

(iii) the Registration Statement has become effective under the Securities Act and, to such counsel's knowledge, no stop order suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus is in effect and no proceedings for that purpose have been instituted or are pending or contemplated by the Commission;

(iv) the Registration Statement and the Prospectus (except as to the financial statements and schedules and other financial data contained therein, as to which such counsel need express no opinion) comply as to form in all material respects with the requirements of the Securities Act and with the rules and regulations of the Commission thereunder;

(v) the information required to be set forth in the Registration Statement in answer to Items 9, 10 (insofar as it relates to such counsel) and 11(c) of Form S-1 is to such counsel's knowledge accurately and adequately set forth therein in all material respects or no response is required with respect to such Items, and the description of the Company's stock option plans and the options granted and which may be granted thereunder and the options and warrants granted otherwise than under such plans set forth in the Prospectus accurately and fairly presents the information required to be shown with respect to said plans and options and warrants to the extent required by the Securities Act and the rules and regulations of the Commission thereunder;

(vi) such counsel do not know of any franchises, contracts, leases, documents or legal proceedings, pending or threatened, which in the opinion of such counsel are of a character required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement, which are not described and filed as required;

(vii) the Underwriting Agreement has been duly authorized, executed and delivered by the Company;

(viii) the Underwriting Agreement has been duly executed and delivered by or on behalf of the Selling Securityholders and the Custody Agreement between the Selling Securityholders and ,

18

as Custodian, and the Power of Attorney referred to in such Custody Agreement have been duly executed and delivered by the several Selling Securityholders;

(ix) the issue and sale by the Company of the shares of Stock sold by the Company as contemplated by the Underwriting Agreement will not conflict with, or result in a breach of, the Certificate of Incorporation or Bylaws of the Company or any of its subsidiaries or any agreement or instrument known to such counsel to which the Company or any of its subsidiaries is a party or any applicable law or regulation, or so far as is known to such counsel, any order, writ, injunction or decree, of any jurisdiction, court or governmental instrumentality;

(x) to such counsel's knowledge, all holders of securities of the Company having rights to the registration of shares of Common Stock, or other securities, because of the filing of the Registration Statement by the Company have waived such rights or such rights have expired by reason of lapse of time following notification of the Company's intent to file the Registration Statement;

(xi) valid marketable title to the shares of Stock sold by the Selling Securityholders under the Underwriting Agreement, free and clear of all liens, encumbrances, equities, security interests and claims, has been transferred to the Underwriters who have severally purchased such shares of Stock under the Underwriting Agreement, assuming for the purpose of this opinion that the Underwriters purchased the same in good faith without notice of any adverse claims; and

(xii) based insofar as factual matters with respect to the stock to be sold by the Selling Securityholders are concerned solely upon certificates of the Selling Securityholders, the accuracy of which such counsel have no reason to question, no consent, approval, authorization or order of any court or governmental agency or body is required for the consummation of the transactions contemplated in the Underwriting Agreement, except such as have been obtained under the Securities Act and such as may be required under state securities or blue sky laws in connection with the purchase and distribution of the Stock by the Underwriters.

In addition to the enumerated opinions, such counsel shall also state that such counsel has no reason to believe that the Registration Statement (except as to the financial statements and schedules and other financial data contained therein, as to which such counsel need not express any opinion or belief) at the Effective Date contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading, or that the Prospectus (except as to the financial statements and schedules and other financial data contained or incorporated by reference therein, as to which such counsel need not express any opinion or belief) as of its date or at the Closing Date (or any later date on which Option Stock is purchased), contained or contains any untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading;


Counsel rendering the foregoing opinion may rely as to questions of law not involving the laws of the United States or of the State of California, upon opinions of local counsel satisfactory in form and scope to counsel for the Underwriters. Copies of any opinions so relied upon shall be delivered to the Representatives and to counsel for the Underwriters and the foregoing opinion shall also state that counsel knows of no reason the Underwriters are not entitled to rely upon the opinions of such local counsel.

19

ANNEX B

MATTERS TO BE COVERED IN THE OPINION OF HICKMAN, STEPHENS & COLEMAN
PATENT COUNSEL FOR THE COMPANY

Such counsel are familiar with the technology used by the Company in its business and the manner of its use thereof and have read the Registration Statement and the Prospectus, including particularly the portions of the Registration Statement and the Prospectus referring to patents, trade secrets, trademarks, service marks or other proprietary information or materials and:

(i) such counsel have no reason to believe that the Registration Statement or the Prospectus (A) contains any untrue statement of a material fact with respect to patents, trade secrets, trademarks, service marks or other proprietary information or materials owned or used by the Company or any of its subsidiaries, or the manner of its use thereof, or any allegation on the part of any person that the Company or any of its subsidiaries is infringing any patent rights, trade secrets, trademarks, service marks or other proprietary information or materials of any such person or (B) omits to state any material fact relating to patents, trade secrets, trademarks, service marks or other proprietary information or materials owned or used by the Company or any of its subsidiaries, or the manner of its use thereof, or any allegation of which such counsel have knowledge, that is required to be stated in the Registration Statement or the Prospectus or is necessary to make the statements therein not misleading;

(ii) to the best of such counsel's knowledge and except as set forth in the Prospectus under the caption " ," there are no legal or governmental proceedings pending relating to patent rights, trade secrets, trademarks, service marks or other proprietary information or materials of the Company or any of its subsidiaries, and to the best of such counsel's knowledge no such proceedings are threatened or contemplated by governmental authorities or others;

(iii) such counsel do not know of any contracts or other documents, relating to the Company's or any subsidiary's patents, trade secrets, trademarks, service marks or other proprietary information or materials of a character required to be filed as an exhibit to the Registration Statement or required to be described in the Registration Statement or the Prospectus that are not filed or described as required;

(iv) except as set forth in the Prospectus, to the best of such counsel's knowledge, neither the Company nor any of its subsidiaries is infringing or otherwise violating any patents, trade secrets, trademarks, service marks or other proprietary information or materials of others, and to the best of such counsel's knowledge there are no infringements by others of any of the Company's or any subsidiary's patents, trade secrets, trademarks, service marks or other proprietary information or materials which in the judgment of such counsel could affect materially the use thereof by the Company or any of its subsidiaries; and

(v) to the best of such counsel's knowledge, the Company owns or possesses sufficient licenses or other rights to use all patents, trade secrets, trademarks, service marks or other proprietary information or materials necessary to conduct the business now being or proposed to be conducted by the Company as described in the Prospectus.


EXHIBIT 3.2

CERTIFICATE OF INCORPORATION

OF

IMMERSION CORPORATION DELAWARE

FIRST: The name of this corporation is Immersion Corporation Delaware (hereinafter sometimes referred to as the "Corporation").

SECOND: The address of the registered office of the Corporation in the State of Delaware is Incorporating Services, Ltd., 15 East North Street, in the City of Dover, County of Kent. The name of the registered agent at that address is Incorporating Services, Ltd.

THIRD: The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the General Corporation Law of Delaware.

FOURTH: The Corporation is authorized to issue a total of 25,000,000 shares of stock in two classes designated respectively "Preferred Stock" and "Common Stock." The total number of shares of all series of Preferred Stock that the Corporation shall have the authority to issue is 5,000,000 and the total number of shares of Common Stock that the Corporation shall have the authority to issue is 20,000,000. All of the authorized shares shall have a par value of $0.001.

FIFTH: The name and mailing address of the incorporator is:

Andrea Charvet c/o Gray Cary Ware & Freidenrich LLP 139 Townsend Street, Suite 400 San Francisco, CA 94107-1922

SIXTH: The business and affairs of the Corporation shall be managed by or under the direction of the Board of Directors. In addition to the powers and authority expressly conferred upon them by Statute or by this Certificate of Incorporation or the Bylaws of the Corporation, the

1

directors are hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the Corporation. Election of directors need not be by written ballot unless the Bylaws so provide.

SEVENTH: The Board of Directors is authorized to make, adopt, amend, alter or repeal the Bylaws of the Corporation. The stockholders shall also have power to make, adopt, amend, alter or repeal the Bylaws of the Corporation.

EIGHTH: This Corporation reserves the right to amend or repeal any of the provisions contained in this Certificate of Incorporation in any manner now or hereafter permitted by law, and the rights of the stockholders of this Corporation are granted subject to this reservation.

NINTH: To the fullest extent permitted by the Delaware General Corporation Law, a director of this Corporation shall not be liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. Any repeal or modification of the foregoing provisions of this Article NINTH by the stockholders of the Corporation shall not adversely affect any right or protection of a director of the Corporation existing at the time of such repeal or modification.

I, THE UNDERSIGNED, being the incorporator, for the purpose of forming a corporation under the laws of the State of Delaware, do make, file and record this Certificate of Incorporation, do certify that the facts herein stated are true, and accordingly, have hereto set my hand this 26th day of August, 1999.

 /s/ ANDREA CHARVET
---------------------------------------
Andrea Charvet

2

EXHIBIT 3.3

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

OF

IMMERSION CORPORATION DELAWARE

(Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware)

Immersion Corporation Delaware, a corporation organized and existing under the General Corporation Law of the State of Delaware on August 26, 1999, (the "Corporation") certifies as follows:

1. The Corporation's Amended and Restated Certificate of Incorporation was duly adopted by the Board of Directors and sole stockholder by written consent in accordance with Sections 242 and 245 of the General Corporation Law.

2. The Corporation's Certificate of Incorporation is restated to read in full as follows:

FIRST:    The name of the Corporation is Immersion Corporation Delaware.

SECOND:   The address of the registered office of the Corporation in the
          State of Delaware is Incorporating Services, Ltd., 15 East North
          Street, in the City of Dover, County of Kent. The name of the
          registered agent at that address is Incorporating Services, Ltd.

THIRD:    The purpose of the Corporation is to engage in any lawful act or
          activity for which a corporation may be organized under the
          General Corporation Law of Delaware.

FOURTH:

A.        The Corporation is authorized to issue a total of 110,215,716
          shares of stock in two classes designated respectively "Preferred
          Stock" and "Common Stock". The total number of shares of all
          series of Preferred Stock that the Corporation shall have the
          authority to issue is 10,215,716 and the total number of shares
          of Common Stock that the Corporation shall have the authority to
          issue is 100,000,000. All of the authorized shares shall have a
          par value of $0.001.

          The shares of Preferred Stock may be divided into such number of
          series as the Board of Directors may determine. The Board of
          Directors is authorized to determine and alter the rights,
          preferences, privileges and restrictions granted to and imposed
          upon the Preferred Stock or any series thereof with respect to
          any wholly unissued series of Preferred Stock, and to fix the
          number of shares of any such series of Preferred Stock. The Board
          of Directors, within the limits and restrictions stated in any


              resolution or resolutions of the Board of Directors
              originally fixing the number of shares constituting any
              series, may increase or decrease (but not below the number
              of shares of such series then outstanding) the number of
              shares of any series subsequent to the issue of shares of
              that series.

FIFTH:        The following provisions are inserted for the management
              of the business and the conduct of the affairs of the
              Corporation, and for further definition, limitation and
              regulation of the powers of the Corporation and of its
              directors and stockholders:

A.            The business and affairs of the Corporation shall be
              managed by or under the direction of the Board of
              Directors. In addition to the powers and authority
              expressly conferred upon them by statute or by this
              Certificate of Incorporation or the Bylaws of the
              Corporation, the directors are hereby empowered to
              exercise all such powers and do all such acts and things
              as may be exercised or done by the Corporation.

B.            The directors of the Corporation need not be elected by
              written ballot unless the Bylaws so provide.

C.            On and after the closing date of the first sale of the
              Corporation's Common Stock pursuant to a firmly
              underwritten registered public offering (the "IPO"), any
              action required or permitted to be taken by the
              stockholders of the Corporation must be effected at a duly
              called annual or special meeting of stockholders of the
              Corporation and may not be effected by any consent in
              writing by such stockholders. Prior to such sale, unless
              otherwise provided by law, any action which may otherwise
              be taken at any meeting of the stockholders may be taken
              without a meeting and without prior notice, if a written
              consent describing such actions is signed by the holders
              of outstanding shares having not less than the minimum
              number of votes which would be necessary to authorize or
              take such action at a meeting at which all shares entitled
              to vote thereon were present and voted.

D.            Special meetings of stockholders of the Corporation may
              be called only (1) by the Board of Directors pursuant to a
              resolution adopted by a majority of the total number of
              authorized directors (whether or not there exist any
              vacancies in previously authorized directorships at the
              time any such resolution is presented to the Board for
              adoption) or (2) by the holders of not less than ten
              percent (10%) of all of the shares entitled to cast votes
              at the meeting.

                               2

SIXTH:

A.            The  number  of  directors  shall  initially  be set at
              four (4) and, thereafter, shall be fixed from time to time
              exclusively by the Board of Directors pursuant to a
              resolution adopted by a majority of the total number of
              authorized directors (whether or not there exist any
              vacancies in previously authorized directorships at the
              time any such resolution is presented to the Board for
              adoption). Upon the closing of the IPO, the directors
              shall be divided into three classes with the term of
              office of the first class (Class I) to expire at the first
              annual meeting of the stockholders following the IPO; the
              term of office of the second class (Class II) to expire at
              the second annual meeting of stockholders held following
              the IPO; the term of office of the third class (Class III)
              to expire at the third annual meeting of stockholders; and
              thereafter for each such term to expire at each third
              succeeding annual meeting of stockholders after such
              election. Subject to the rights of the holders of any
              series of Preferred Stock then outstanding, a vacancy
              resulting from the removal of a director by the
              stockholders as provided in Article SIXTH, Section C below
              may be filled at a special meeting of the stockholders
              held for that purpose. All directors shall hold office
              until the expiration of the term for which elected, and
              until their respective successors are elected, except in
              the case of the death, resignation, or removal of any
              director.

B.            Subject to the rights of the holders of any series of
              Preferred Stock then outstanding, newly created
              directorships resulting from any increase in the
              authorized number of directors or any vacancies in the
              Board of Directors resulting from death, resignation or
              other cause (other than removal from office by a vote of
              the stockholders) may be filled only by a majority vote of
              the directors then in office, though less than a quorum,
              and directors so chosen shall hold office for a term
              expiring at the next annual meeting of stockholders at
              which the term of office of the class to which they have
              been elected expires, and until their respective
              successors are elected, except in the case of the death,
              resignation, or removal of any director. No decrease in
              the number of directors constituting the Board of
              Directors shall shorten the term of any incumbent
              director.

C.            Subject to the rights of the holders of any series of
              Preferred Stock then outstanding, any directors, or the
              entire Board of Directors, may be removed from office at
              any time, with or without cause, but only by the
              affirmative vote of the holders of at least a majority of
              the voting power of all of the then outstanding shares of
              capital stock of the Corporation entitled to vote
              generally in the election of directors, voting together as
              a single class. Vacancies in the Board of Directors
              resulting from such removal may be filled by a majority of
              the directors then in office, though less than a quorum,
              or by the stockholders as provided in Article SIXTH,
              Section A above. Directors so chosen shall hold office for
              a term expiring at the next annual meeting of stockholders
              at which the term of office of the class to which they
              have been elected expires, and until their

                               3

              respective successors are elected, except in the case of
              the death, resignation, or removal of any director.

SEVENTH:      The Board of Directors is expressly empowered to adopt,
              amend or repeal Bylaws of the Corporation. Any adoption,
              amendment or repeal of Bylaws of the Corporation by the
              Board of Directors shall require the approval of a
              majority of the total number of authorized directors
              (whether or not there exist any vacancies in previously
              authorized directorships at the time any resolution
              providing for adoption, amendment or repeal is presented
              to the Board). The stockholders shall also have power to
              adopt, amend or repeal the Bylaws of the Corporation. Any
              adoption, amendment or repeal of Bylaws of the Corporation
              by the stockholders shall require, in addition to any vote
              of the holders of any class or series of stock of the
              Corporation required by law or by this Certificate of
              Incorporation, the affirmative vote of the holders of at
              least sixty-six and two-thirds percent (66-2/3%) of the
              voting power of all of the then outstanding shares of the
              capital stock of the Corporation entitled to vote
              generally in the election of directors, voting together as
              a single class.

EIGHTH:       A director of the Corporation shall not be personally
              liable to the Corporation or its stockholders for monetary
              damages for breach of fiduciary duty as a director, except
              for liability (i) for any breach of the director's duty of
              loyalty to the Corporation or its stockholders, (ii) for
              acts or omissions not in good faith or which involved
              intentional misconduct or a knowing violation of law,
              (iii) under Section 174 of the Delaware General
              Corporation Law, or (iv) for any transaction from which
              the director derived an improper personal benefit.

              If the Delaware General Corporation Law is hereafter
              amended to authorize the further elimination or limitation
              of the liability of a director, then the liability of a
              director of the Corporation shall be eliminated or limited
              to the fullest extent permitted by the Delaware General
              Corporation Law, as so amended.

              Any repeal or modification of the foregoing provisions of
              this Article EIGHTH by the stockholders of the Corporation
              shall not adversely affect any right or protection of a
              director of the Corporation existing at the time of such
              repeal or modification.

4

NINTH:        The Corporation reserves the right to amend or repeal any
              provision contained in this Certificate of Incorporation
              in the manner prescribed by the laws of the State of
              Delaware and all rights conferred upon stockholders are
              granted subject to this reservation; provided, however,
              that, notwithstanding any other provision of this
              Certificate of Incorporation or any provision of law which
              might otherwise permit a lesser vote or no vote, but in
              addition to any vote of the holders of any class or series
              of the stock of this Corporation required by law or by
              this Certificate of Incorporation, the affirmative vote of
              the holders of at least 66-2/3% of the voting power of all
              of the then outstanding shares of the capital stock of the
              Corporation entitled to vote generally in the election of
              directors, voting together as a single class, shall be
              required to amend or repeal this Article NINTH, Article
              FIFTH, Article SIXTH, Article SEVENTH or Article EIGHTH.

IN WITNESS WHEREOF, the Corporation has caused this Amended and Restated Certificate to be signed by a duly authorized officer on this ______ day of October, 1999.

IMMERSION CORPORATION DELAWARE

By:

Louis Rosenberg, Ph.D., Chief Executive Officer

5

EXHIBIT 3.4

IMMERSION CORPORATION DELAWARE

CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS
OF THE TERMS OF THE
SERIES A, SERIES B, SERIES C AND SERIES D PREFERRED STOCK

(Pursuant to Section 151 of the General Corporation Law of the State of Delaware)

We, the President and the Secretary, respectively, of Immersion Corporation Delaware, organized and existing under the General Corporation Law of the State of Delaware, in accordance with the provisions of Section 103 thereof, DO HEREBY CERTIFY:

That pursuant to the authority conferred upon the Board of Directors by the Certificate of Incorporation of the said Corporation, the said Board of Directors on August 30, 1999, adopted the following resolution creating (i) a series of 2,495,648 shares of Preferred Stock designated as Series A Preferred Stock, (ii) a series of 467,390 shares of Preferred Stock designated as Series B Preferred Stock (iii) a series of 863,778 shares of Preferred Stock designated as Series C Preferred Stock, and (iv) a series of 1,388,901 shares of Preferred Stock designated as Series D Preferred Stock.

RESOLVED, that pursuant to the authority vested in the Board of Directors of this Corporation in accordance with the provisions of its Certificate of Incorporation, series of Preferred Stock of the Corporation be and they hereby are created, and that the designation and amount thereof and the powers, preferences and relative, participating, optional and other special rights of the shares of such series, and the qualifications, limitations or restrictions thereof are as follows:

Designation and Amount. The first series of Preferred Stock shall be designated Series A Preferred Stock and shall be comprised of 2,495,648 shares. The second series of Preferred Stock shall be designated Series B Preferred Stock and shall be comprised of 467,390 shares. The third series of Preferred Stock shall be designated Series C Preferred Stock and shall be comprised of 863,778 shares. The fourth series of Preferred Stock shall be designated Series D Preferred Stock and shall be comprised of 1,388,901 shares.

Relative rights, preferences, privileges and restrictions granted to or imposed upon the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock (collectively, the "Preferred Stock") are as follows:

Section 1. Voting Rights.

Section 1.1 Except as otherwise required by law or as set forth herein, the shares of Series A, Series B, Series C and Series D Preferred Stock shall be voted equally and together with the shares of the Corporation's Common Stock at any annual or special meeting of shareholders of the Corporation, or may act by written consent in the same manner as the

1

Corporation's Common Stock, upon the following basis: each holder of shares of Series A, Series B, Series C and Series D Preferred Stock shall be entitled to such number of votes for the Series A, Series B, Series C and Series D Preferred Stock held by him on the record date fixed for such meeting, or on the effective date of such written consent, as shall be equal to the whole number of shares of the Corporation's Common Stock into which all of his shares of Series A, Series B, Series C and Series D Preferred Stock are convertible immediately after the close of business on the record date fixed for such meeting or the effective date of such written consent.

Section 2. Protective Provisions.

Section 2.1 If any shares of Series C Preferred Stock are outstanding, the Corporation shall not, without first obtaining the approval by vote or written consent, in the manner provided by law, of the holders of more than fifty percent (50%) of the total number of shares of Series C Preferred Stock then outstanding, voting together as a single class, undertake any of the following actions: (a) amend or change the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of the Series C Preferred Stock; or (b) authorize, create or issue shares of any class of stock having rights, preferences, privileges or powers superior to that of the Series C Preferred Stock; or (c) reclassify any outstanding shares of any class of stock into shares having rights, preferences, privileges or powers as to dividends or assets senior to the preferences, rights, privileges or powers of the Series C Preferred Stock; or (d) amend the Corporation's Restated Articles to adversely affect the rights, preferences, privileges or powers of the Series C Preferred Stock; provided, however, that any amendment to the Corporation's Restated Articles authorizing any class of stock having rights, preferences, privileges or powers on parity with the Series C Preferred Stock shall not be deemed to adversely affect the rights of the Series C Preferred Stock, respectively.

Section 2.2 If any shares of Series D Preferred Stock are outstanding, the Corporation shall not, without first obtaining the approval by vote or written consent, in the manner provided by law, of the holders of more than fifty percent (50%) of the total number of shares of Series D Preferred Stock then outstanding, voting together as a single class, undertake any of the following actions: (a) amend or change the rights, preferences, privileges or powers of, or the restrictions provided for the benefit of the Series D Preferred Stock; or (b) authorize, create or issue shares of any class of stock having rights, preferences, privileges or powers superior to that of the Series D Preferred Stock; or (c) reclassify any outstanding shares of any class of stock into shares having rights, preferences, privileges or powers as to dividends or assets senior to the preferences, rights, privileges or powers of the Series D Preferred Stock; or (d) amend the Corporation's Restated Articles to adversely affect the rights, preferences, privileges or powers of the Series D Preferred Stock; provided, however, that any amendment to the Corporation's Restated Articles authorizing any class of stock having rights, preferences, privileges or powers on parity with the Series D Preferred Stock shall not be deemed to adversely affect the rights of the Series D Preferred Stock, respectively.

2

Section 3. Dividends.

Section 3.1 The holders of the then outstanding Series A, Series B, Series C and Series D Preferred Stock shall be entitled to receive in any fiscal year, prior and in preference to any distribution of dividends to the holders of the Common Stock, when, as and if, declared by the Board of Directors, out of any assets at the time legally available therefor, dividends in cash at the rate of $0.0050, $0.0149, $0.1735, and $0.4089 per annum per share, respectively on a pari passu basis, as adjusted for any consolidations, combinations, stock distributions, stock dividends, stock splits or similar events (each a "Recapitalization Event"). The right to such dividends on the Series A, Series B, Series C and Series D Preferred Stock shall not be cumulative and no right shall accrue to holders of Series A, Series B, Series C or Series D Preferred Stock by reason of the fact that dividends on said shares are not declared in any prior year, nor shall any undeclared or unpaid dividends bear or accrue interest. Dividends may be declared or paid upon shares of Common Stock in any fiscal year of the Corporation only if dividends shall have been paid to or declared and set apart upon, as the case may be, all shares of Series A, Series B, Series C and Series D Preferred Stock at such annual rate for each quarter of such fiscal year of the Corporation including the quarter in which such dividends upon common shares are declared. No dividends shall be paid on any Common Stock unless an equal dividend is paid with respect to all outstanding shares of Series A, Series B, Series C and Series D Preferred Stock in an amount for each such share of Series A, Series B, Series C and Series D Preferred Stock equal to the aggregate amount of such dividends for all Common Stock into which each such share of Series A, Series B, Series C and Series D Preferred Stock could then be converted.

Section 3.2 Each holder of Series A, Series B, Series C or Series D Preferred Stock shall be deemed to have consented, for purposes of Sections 502, 503 and 506 of the General Corporation Law of the State of California, to (i) distributions made by the Corporation in connection with the repurchase of Common Stock issued to or held by employees or consultants upon termination of their employment or services pursuant to agreements providing for such repurchase and (ii) the use of up to two million dollars ($2,000,000) from the sale of Series D Preferred Stock to purchase outstanding shares of the Company's Common Stock or Preferred Stock at the fair market value of the Common Stock as determined by the Board of Directors of the Company.

Section 4. Redemption Rights

Section 4.1 At any time on or after June 4, 2002, this Corporation shall, upon receipt of the written request (the "Redemption Request") of the holders of at least a majority of the Series C Preferred Stock then outstanding, redeem for cash out of any funds legally available therefor ratably from holders thereof, on or before each of the relevant Redemption Dates (as defined below), that number of shares of Series C Preferred Stock equal to one-fourth of the number of such shares outstanding on the first Redemption Date. Redemptions of each share of Series C Preferred Stock pursuant to this Section 4.1 shall be made at the price originally paid by the holders of Series C Preferred Stock (and without interest as adjusted for any Recapitalization Event) for such Series C Preferred Stock, plus an amount equal to the amount of all declared but unpaid dividends as of the relevant Redemption Date payable in accordance with
Section 3.1

3

above on each such share to be redeemed. The total amount to be paid with respect to each share of Series C Preferred Stock is hereinafter referred to as the "Redemption Price."

Section 4.2 The Redemption Request shall set forth the requested date of the redemption, which date in no event shall be fewer than twenty (20) days nor more than sixty (60) days after the date of the Redemption Request, or such later date as the holders of at least a majority of the then outstanding Series C Preferred Stock agree to in writing. Such date and the six (6) month, twelve
(12) month, and eighteen (18) month anniversaries thereof are referred to herein collectively as the "Redemption Dates" and individually as a "Redemption Date." Within ten (10) days of the Redemption Request, this Corporation shall give written notice by mail, postage prepaid, to each holder of record (at the close of business on the business day next preceding the day on which notice is deposited in the mail) of the Series C Preferred Stock to be redeemed, at the address last shown on the records of this corporation for such holder or given by the holder to this Corporation for the purpose of notice, or if no such address appears or is given, at the place where the principal executive office of this Corporation is located, notifying such holder of the redemption to be effected, specifying the number of shares to be redeemed from such holder, the applicable Redemption Date, the applicable Redemption Price, the place at which payment may be obtained and the date on which such holder's Conversion Rights as to such shares terminate and calling upon such holder to surrender to this Corporation, in the manner and at the place designated, his certificate or certificates representing the shares to be redeemed (the "Redemption Notice"). On or after such Redemption Date, each holder of Series C Preferred Stock to be redeemed shall surrender to this corporation the certificate or certificates representing such shares, in the manner and at the place designated in the Redemption Notice, and thereupon the applicable Redemption Price of such shares shall be payable to the order of the person whose name appears on such certificate or certificates as the owner thereof and each surrendered certificate shall be canceled. In the event fewer than all the shares represented by any such certificate are redeemed, a new certificate shall be issued representing the unredeemed shares.

Section 4.3 From and after the applicable Redemption Date, unless there shall have been a default in payment of the applicable Redemption Price, all dividends on the Series C Preferred Stock designated for redemption in the Redemption Notice shall cease to accrue, all rights of the holders of such shares as holders of the Series C Preferred Stock (except the right to receive the Redemption Price without interest upon surrender of their certificate or certificates) shall cease with respect to such shares, and such shares shall not thereafter be transferred on the books of this corporation or be deemed to be outstanding for any purpose whatsoever. If the funds of the corporation legally available for redemption of Series C Preferred Stock on any Redemption Date are insufficient to redeem the total number of Series C Preferred Stock to be redeemed on such date, those funds which are legally available will be used to redeem the maximum possible number of such shares ratably among the holders of such shares to be redeemed. The shares of Series C Preferred Stock not redeemed shall remain outstanding and entitled to all the rights and preferences provided herein. At any time thereafter when additional funds of the corporation are legally available for the redemption of the Series C Preferred Stock, such funds will immediately be used to redeem the balance of the shares which the corporation has become obligated to redeem on any Redemption Date but which it has not redeemed.

4

Section 5. Liquidation Preference.

Section 5.1 In the event of the liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary, distributions to the shareholders of the Corporation shall be made in the following manner:

(a) The holders of Series C and Series D Preferred Stock then outstanding shall be entitled to be paid out of the assets of the Corporation, on a pari passu basis, for each share of Series C or Series D Preferred Stock then held by them, first, prior and in preference to any distribution to the holders of the Series A and Series B Preferred Stock, and the Common Stock, an amount equal to $1.7348 per share of Series C Preferred Stock and $3.37 per share of Series D Preferred Stock (as adjusted for Recapitalization Events) plus an amount equal to all declared and unpaid dividends with respect thereto. If upon the occurrence of such event, the assets and funds available for distribution are insufficient to permit the payment to the holders of Series C and Series D Preferred Stock the full preferential amount, then the entire assets and funds of the Corporation legally available for distribution to shareholders will be distributed among the holders of the Series C and Series D Preferred Stock ratably in proportion to the full preferential amount which they would be entitled to receive pursuant to the preceding sentence of this Section 5.1(a).

(b) After payment has been made to the holders of Series C and Series D Preferred Stock of the full preferential amounts to which they shall be entitled, if any, as aforesaid, the holders of the Series A and Series B Preferred Stock then outstanding shall be entitled to be paid, pari passu, out of the assets of the Corporation, for each share of Series A or Series B Preferred Stock then held by them, first, prior and in preference to any distribution to the holders of the Common Stock, and amount equal to (A) $0.0991 per share for the Series A Preferred Stock and $1.4870 per share for the Series B Preferred Stock (as adjusted for Recapitalization Events) plus (B) an amount equal to all declared and unpaid dividends with respect thereto.

(c) After payment has been made to the holders of the Series A, Series B, Series C and Series D Preferred Stock of the full preferential amounts to which they shall be entitled, if any, as aforesaid and until the holders of the Series C and Series D Preferred Stock then outstanding have received an additional $1.7348 and $2.5031 per share of Series C and Series D Preferred Stock, respectively (as adjusted for Recapitalization Events), the holders of the Common Stock and the Series C and Series D Preferred Stock shall be entitled to receive, pro rata, the remaining assets of the Corporation available for distribution to shareholders, based on the number of shares of Common Stock then held, with each share of Series C and Series D Preferred Stock treated as the number of shares of Common Stock into which such share of Preferred Stock is then convertible.

(d) After payment has been made to the holders of the Series C and Series D Preferred Stock and holders of Common Stock pursuant to
Section 5.1(c), the holders of Common Stock shall be entitled to receive, pro rata, the remaining assets of the Corporation

5

available for distribution to shareholders, based on the number of shares of Common Stock then held.

Section 5.2 Events Deemed to be Liquidation.

(a) For the purposes of this Section 5 and with respect to the Series A and Series B Preferred Stock, (i) a consolidation or merger of the Corporation with or into any other corporation or corporations (other than a wholly-owned subsidiary) in which the shareholders of the Corporation immediately prior to such transaction hold fifty percent (50%) or less of the total voting power for the election of directors of the acquiring or surviving entity immediately following the transaction, or (ii) the sale, transfer or other disposition of all or substantially all of the assets of the Corporation or (iii) the consummation of any transaction or series of related transactions which results in the Corporation's shareholders immediately prior to such transaction holding fifty percent (50%) or less of the voting power of the acquiring or surviving entity immediately following the transaction (each such event is hereinafter defined as a "Corporate Sale") shall not be deemed to be a liquidation, dissolution or winding up.

(b) For purposes of this Section 5 and with respect to the Series C and Series D Preferred Stock, a Corporate Sale shall be deemed a liquidation, dissolution or winding up.

Section 6. Conversion Rights.

Section 6.1 Conversion of Series A and Series B Preferred Stock.

(a) Optional Conversion. Each share of Series A and Series B Preferred Stock will be convertible, at the option of the holder thereof, at the office of the Corporation or any transfer agent for the Series A and Series B Preferred Stock, into Common Stock. The number of shares of Common Stock into which each share of Series A Preferred Stock will be converted will be equal to $0.0991 divided by the Series A Conversion Price (as hereafter defined) such conversion ratio being referred to as the "Series A Conversion Rate." The initial Series A Conversion Price will be $0.0991 and the initial Series A Conversion Rate shall be one-to-one. The number of shares of Common Stock into which each share of Series B Preferred Stock will be converted will be equal to $1.4870 divided by the Series B Conversion Price (as hereafter defined) such conversion ratio being referred to as the "Series B Conversion Rate." The initial Series B Conversion Price will be $1.4870 and the initial Series B Conversion Rate shall be one-to-one. Any decrease or increase of the Series A Conversion Price or Conversion Rate, or the Series B Conversion Price or Conversion Rate as described in this Section F will cause an increase or decrease in the conversion rate or conversion price accordingly.

(b) Automatic Conversion of the Series A and Series B Preferred Stock. Each share of Series A and Series B Preferred Stock will be converted into shares of Common Stock at the then effective Series A Conversion Rate or Series B Conversion Rate:

6

(i) immediately upon the closing of the sale of stock pursuant to a registration statement under the Securities Act of 1933, as amended, (the "Securities Act") for an underwritten public offering (other than a registration on Form S-8, Form S-4 or comparable or successor forms) covering the Corporation's Common Stock which results in aggregate cash proceeds (prior to underwriters' commissions and expenses) to the Corporation of more than $5,000,000, and which has a public offering price of not less than $0.720 per share (as appropriately adjusted for stock splits, combinations, reclassifications and the like);

(ii) immediately upon the affirmative vote or written consent of the holders of a majority of the then outstanding shares of Series A Preferred Stock and Series B Preferred Stock, voting together as a class; or

(iii) on the date that less than twenty percent (20%) of the highest number of the total number of shares of Series A Preferred Stock and Series B Preferred Stock that have been outstanding at any time remain outstanding.

(c) Adjustment for Dividends, Distributions, Subdivisions or Combinations of Common Stock. In the event the Corporation at any time or from time to time after the date hereof (a) effects a subdivision or combination of its outstanding Common Stock into a greater or lesser number of shares without a proportionate and corresponding subdivision or combination of its outstanding Series A Preferred Stock and its outstanding Series B Preferred Stock or (b) issues a dividend or other distribution of additional shares of Common Stock or other securities or rights (collectively hereinafter referred to as "Common Stock Equivalents") convertible into or entitling the holder thereof to receive additional shares of Common Stock without payment of any consideration by such holder for such Common Stock Equivalents or the additional shares of Common Stock, then the existing Series A Conversion Price and Series B Conversion Price will be decreased or increased proportionately.

(d) Recapitalizations. If at any time or from time to time there shall be a recapitalization of the Common Stock (other than a subdivision, combination or merger or sale of assets transaction provided for in Section 5), provision shall be made so that the holders of the Series A and Series B Preferred Stock will thereafter be entitled to receive upon conversion of the Series A and Series B Preferred Stock the number of shares of stock or other securities or property of the Corporation or otherwise, to which a holder of Common Stock deliverable upon conversion would have been entitled on such recapitalization. In any such case, appropriate adjustment shall be made in the application of the provisions of this Section 6.1 with respect to the rights of the holders of the Series A and Series B Preferred Stock after the recapitalization to the end that the provisions of this Section 6.1 (including adjustment of the Series A and Series B Conversion Price then in effect and the number of shares issuable upon conversion of the Series A or Series B Preferred Stock) shall be applicable after that event in as nearly an equivalent manner as may be practicable.

(e) Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment of the Series A Conversion Rate or Series B Conversion Rate pursuant to this Section 6, the Corporation at its expense promptly will compute such adjustment

7

or readjustment in accordance with the terms hereof and prepare and furnish to each holder of Series A or Series B Preferred Stock, a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation, upon the written request at any time of any holder of Series A or Series B Preferred Stock, will furnish or cause to be furnished to such holder a like certificate setting forth (i) such adjustments and readjustments, (ii) the Series A or Series B Conversion Rate at the time in effect, and (iii) the number of shares of Common Stock and the amount, if any, of other property which at the time would be received upon the conversion of the Series A or Series B Preferred Stock held by such holder.

Section 6.2 Conversion of Series C and Series D Preferred Stock.

(a) Conversion. The holders of the Series C and Series D Preferred Stock have conversion rights as follows (the "Conversion Rights"):

(i) Right to Convert Series C Preferred. Each share of Series C Preferred Stock shall be convertible, at the option of the holder thereof, at any time after the date of issuance of such share into the number of fully paid and nonassessable shares of Common Stock which results from dividing the Series C Conversion Value (as defined below) by the Series C Conversion Price (as defined below) per share in effect for such series at the time of conversion. The initial Series C Conversion Price per share of the Series C Preferred shall be $1.7348, and the Series C Conversion Value per share of the Series C Preferred shall be $1.7348. The initial Series C Conversion Price per share of the Series C Preferred Stock shall be subject to adjustment from time to time as provided in Section 6.2(a)(iv) hereof. Upon conversion, all declared and unpaid dividends on the Series C Preferred Stock shall be paid in cash, to the extent legally permitted.

(ii) Right to Convert Series D Preferred. Each share of Series D Preferred Stock shall be convertible, at the option of the holder thereof, at any time after the date of issuance of such share into the number of fully paid and nonassessable shares of Common Stock which results from dividing the Series D Conversion Value (as defined below) by the Series D Conversion Price (as defined below) per share in effect for such series at the time of conversion. The initial Series D Conversion Price per share of the Series D Preferred shall be $4.1760 and the Series D Conversion Value per share of the Series D Preferred shall be $4.1760. The initial Series D Conversion Price per share of the Series D Preferred Stock shall be subject to adjustment from time to time as provided in Section 6.2(a)(iv) hereof. Upon conversion, all declared and unpaid dividends on the Series D Preferred Stock shall be paid in cash, to the extent legally permitted.

(iii) Automatic Conversion of Series C and Series D Preferred Stock. Each share of Series C and Series D Preferred Stock will be converted into shares of Common Stock at the then effective Series C Conversion Price and Series D Conversion Price, respectively, immediately upon the closing of the sale of stock pursuant to a registration statement under the Securities Act for an underwritten public offering (other than a registration on Forms S-8, Form S-4 or comparable or successor forms) covering the Corporation's Common

8

Stock (an "Offering") which results in aggregate cash proceeds to the Corporation of more than $10,000,000 and which has a public offering price of not less than $8.6741 per share (as adjusted for Recapitalization Events).

(iv) Adjustments to Conversion Price of Series C and Series D Preferred Stock.

(1) Special Definitions. For purposes of this Section 6.2(a)(iii), the following definitions shall apply:

(A) "Options" shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire either Common Stock or Convertible Securities.

(B) "Convertible Securities" shall mean any evidences of indebtedness, shares or other securities convertible into or exchangeable for Common Stock.

(C) "Additional Shares of Common" shall mean all shares of Common Stock issued (or, pursuant to Section 6.2(a)(iv)(3) below, deemed to be issued) by the Corporation after the Original Issue Date, other than shares of Common Stock issued or issuable:

(I) upon conversion of shares of Series A, Series B, Series C and Series D Preferred Stock;

(II) upon exercise of warrants to purchase an aggregate of (i) 228,250 shares of Common Stock, (ii) 7,500 shares of Series A Preferred Stock, and (iii) 18,000 shares of Series C Preferred Stock outstanding as of the Original Issue Date (as adjusted for Recapitalization Events);

(III) to officers, directors or employees of, or consultants to, the Corporation pursuant to a stock grant, option plan or purchase plan or other employee stock incentive program or agreement approved by the Board, not to exceed 5,971,800 shares, inclusive of the 3,549,596 shares subject to outstanding options and the 1,101,693 shares issued upon exercise of outstanding options but net of repurchases, cancellations, terminations and expirations, since the Original Issue Date (as adjusted for Recapitalization Events);

(IV) in connection with the acquisition by the Company of another business entity or majority ownership thereof, provided that (A) such entity is not an affiliate (any person or entity controlling, controlled by or under common control with the Company, an "Affiliate") of any director, officer or other natural person who is an Affiliate of the Company (a "Control Person") other than in such Control Person's capacity as an officer, director or shareholder of the Company and such Control Person does not have a material interest in such entity other than as an officer, director or shareholder of the Company, or

9

(B) such issuances of Common Stock issued or issuable are made in a bona fide arm's length transaction as determined by the Board of Directors of the Company;

(V) in an amount up to 605,250 shares of Common Stock (as adjusted for Recapitalization Events), in connection with any lease financing transaction approved by the Company's Board of Directors;

(VI) as a dividend or distribution on Series A, Series B, Series C or Series D Preferred Stock;

(VII) upon exercise of nonqualified stock options outstanding as of the Original Issue Date to purchase 80,700 shares of Common Stock (as adjusted for Recapitalization Events);

(VIII) by way of dividend or other distribution on shares of Common Stock excluded from the definition of Additional Shares of Common by the foregoing clauses (I) through (VII) or this clause (VIII); or

(IX) solely for purposes of calculating adjustments to the Series D Conversion Price, Additional Shares of Common shall also exclude all shares of Common Stock issued or issuable in an amount up to 645,600 shares of Common Stock (as adjusted for Recapitalization Events), issued in connection with strategic investment and/or the acquisition of technology approved by the Company's Board of Directors.

(D) "Original Issue Date" shall mean October __, 1999.

(2) No Adjustment of Conversion Price. No adjustment in the Series C or Series D Conversion Price shall be made in respect of the issuance of Additional Shares of Common unless the consideration per share for an Additional Share of Common issued or deemed to be issued by the Corporation is less than the Series C or Series D Conversion Price, as applicable, in effect on the date of, and immediately prior to, such issue.

(3) Deemed Issue of Additional Shares of Common.

(A) Options and Convertible Securities. In the event the Corporation at any time or from time to time after the Original Issue Date shall issue any Options or Convertible Securities or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number of shares (as set forth in the instrument relating thereto without regard to any provisions contained therein for a subsequent adjustment of such number) of Common Stock issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the exercise of such Options and conversion or exchange of such Convertible Securities shall be deemed to be Additional Shares of Common issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date, provided that Additional Shares of Common shall not be deemed to have been issued unless the

10

consideration per share (determined pursuant to Section 6.2(a)(iv)(5) hereof) of such Additional Shares of Common would be less than the Series C or Series D Conversion Price in effect on the date of and immediately prior to such issue, or such record date, as the case may be, and provided further that in any such case in which Additional Shares of Common are deemed to be issued:

(I) except as provided in Section 6.2(a)(iv)(3)(II) below, no further adjustment in the Series C or Series D Conversion Price shall be made upon the subsequent issue of Convertible Securities or shares of Common Stock upon the exercise of such Options or conversion or exchange of such Convertible Securities;

(II) if such Options or Convertible Securities by their terms provide, with the passage of time or otherwise, for any change in the consideration payable to the Corporation, or change in the number of shares of Common Stock issuable, upon the exercise, conversion or exchange thereof (other than under or by reason of provisions designed to protect against dilution), a Conversion Price computed upon the original issue thereof (or upon the occurrence of a record date with respect thereto) and any subsequent adjustments based thereon, shall, upon any such increase or decrease becoming effective, be recomputed to reflect such increase or decrease insofar as it affects such Options or the rights of conversion or exchange under such Convertible Securities; and

(III) no readjustment pursuant to clause (II) above shall have the effect of increasing the Series C or Series D Conversion Price to an amount which exceeds the lower of (1) the Series C or Series D Conversion Price on the original adjustment date or (2) the Series C or Series D Conversion Price that would have resulted from any issuance of Additional Shares of Common between the original adjustment date and such readjustment date.

(B) Stock Dividends and Subdivisions. In the event the Corporation at any time or from time to time after the Original Issue Date shall declare or pay any dividend on the Common Stock payable in Common Stock, or effect a split or subdivision of the outstanding shares of Common Stock into a greater number of shares of Common Stock (by reclassification or otherwise than by payment of a dividend in Common Stock), then and in any such event, Additional Shares of Common shall be deemed to have been issued:

(I) in the case of any such dividend, immediately after the close of business on the record date for the determination of holders of any class of securities entitled to receive such dividend, or

(II) in the case of any such subdivision, at the close of business on the date immediately prior to the date upon which such corporate action becomes effective.

(4) Adjustment of Conversion Price Upon Issuance of Additional Shares of Common. In the event this Corporation shall issue Additional Shares of

11

Common (including Additional Shares of Common deemed to be issued pursuant to
Section 6.2(a)(iv)(3)) without consideration or for a consideration per share less than the Series C or Series D Conversion Price in effect on the date of and immediately prior to such issue (such issuance price being referred to herein as the "Dilution Price"), then and in each such event the Series C or Series D Conversion Price, as applicable, shall be reduced to a price (calculated to the nearest cent) determined by multiplying such Series C or Series D Conversion Price by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the number of shares of Common Stock which the aggregate consideration received by the Corporation for the total number of Additional Shares of Common so issued would purchase at such Series C or Series D Conversion Price; and the denominator of which shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the number of such Additional Shares of Common so issued; provided that, for the purposes of this Section 6.2(a)(iv)(4), all shares of Common Stock issuable upon conversion of all outstanding Preferred Stock, and other Convertible Securities and all outstanding Options (provided such Options have an exercise price below the Series C or Series D Conversion Price immediately prior to such issue) shall be deemed to be outstanding, and, immediately after any Additional Shares of Common are deemed issued pursuant to
Section 6.2(a)(iv)(3), such Additional Shares of Common shall be deemed to be outstanding.

(5) Determination of Consideration. For purposes of this Section 6.2(a)(iv), the consideration received by the Corporation for the issue of any Additional Shares of Common shall be computed as follows:

(A) Cash and Property: Such consideration shall:

(I) insofar as it consists of cash, be computed at the aggregate amount of cash received by the Corporation;

(II) insofar as it consists of property other than cash, be computed at the fair value thereof at the time of such issue, as determined by Board in the good faith exercise of its reasonable business judgment; and

(III) in the event Additional shares of Common are issued together with other shares or securities or other assets of the Corporation for consideration which covers both, be the proportion of such consideration so received, computed as provided in clauses (A) and (B) above, as determined in good faith by the Board.

(B) Options and Convertible

(I) the total amount, if any, received or receivable by the Corporation as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the

12

instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the Corporation upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, by

(II) the maximum number of shares of Common Stock (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities.

(C) Stock Dividends and Stock Subdivisions. Any Additional Shares of Common deemed to have been issued, relating to stock dividends and stock splits or subdivisions, shall be deemed to have been issued for no consideration.

(6) Other Adjustments to Series C and Series D Conversion Price.

(A) Subdivisions, Combinations, or Consolidations of Common Stock. In the event the outstanding shares of Common Stock shall be subdivided, combined or consolidated, by stock split, stock dividend, combination or like event, into a greater or lesser number of shares of Common Stock after the Original Issue Date, the Series C and the Series D Conversion Price in effect immediately prior to such subdivision, combination, consolidation or stock dividend shall, concurrently with the effectiveness of such subdivision, combination or consolidation, be proportionately adjusted.

(B) Distributions Other Than Cash Dividends Out of Retained Earnings. In case the Corporation shall declare a cash dividend upon its Common Stock payable otherwise than out of retained earnings or shall distribute to holders of its Common Stock shares of its capital stock (other than Common Stock), stock or other securities of other persons, evidences of indebtedness issued by the Corporation or other persons, assets (excluding cash dividends) or options or rights (excluding options to purchase and rights to subscribe for Common Stock or other securities of the Corporation convertible into or exchangeable for Common Stock), then, in each such case, the holders of shares of Series C and Series D Preferred Stock shall, concurrently with the distribution to holders of Common Stock, receive a like distribution based upon the numbers of shares of Common Stock into which the Series C and Series D Preferred Stock is then convertible.

(C) Reclassifications. In the case, at any time after the date hereof, of any capital reorganization or any reclassification of the stock of the Corporation (other than as a result of a stock dividend or subdivision, split-up or combination of shares), or Corporate Sale (other than a consolidation or merger in which the Corporation is the continuing entity and which does not result in any change in the Common Stock), the shares of the Series C and Series D Preferred Stock shall, after such reorganization, reclassification or Corporate Sale, be convertible into the kind and number of shares of stock or other securities or property of the Corporation or otherwise to which such holder would have been entitled if

13

immediately prior to such reorganization, reclassification or Corporate Sale, the holder had converted the holder's shares of the Series C and Series D Preferred Stock into Common Stock. The provisions of this Section 6.2(a)(iv)(6)(C) shall similarly apply to successive reorganizations, reclassifications, consolidations or Corporate Sales.

(b) Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment of the Series C or Series D Conversion Price pursuant to this Section 6.2, the Corporation at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to each holder of Series C and/or Series D Preferred Stock a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Corporation shall, upon the written request at any time of any holder of Series C or Series D Preferred Stock, furnish or cause to be furnished to such holder a like certificate setting forth (i) such adjustments and readjustments, (ii) the Conversion Price of the Series C or Series D Preferred Stock at the time in effect, and (iii) the number of shares of Common Stock and the amount, if any, of other property which at the time would be received upon the conversion of the Series C or Series D Preferred Stock.

Section 6.3 No Fractional Shares. No fractional shares of Common Stock will be issued upon conversion of Series A, Series B, Series C or Series D Preferred Stock and any fractional share which otherwise would result from conversion by a holder of all of his shares of Series A, Series B, Series C or Series D Preferred Stock will be redeemed by payment in an amount equal to such fraction of the then effective Series A, Series B, Series C or Series D Conversion Price as promptly as funds legally are available therefor.

Section 6.4 Mechanics of Conversion. Before any holder of Series A, Series B, Series C or Series D Preferred Stock will be entitled to convert the same into shares of Common Stock, he will surrender the certificate or certificates therefor, duly endorsed, at the office of the Corporation or of any transfer agent for the Series A, Series B, Series C or Series D Preferred Stock, and he will give written notice to the Corporation stating the name or names in which he wishes the certificate or certificates for shares of Common Stock to be issued. The Corporation, as soon as practicable thereafter, will issue and deliver at such office to such holder of Series A, Series B, Series C or Series D Preferred Stock or to his nominee or nominees, a certificate or certificates for the number of shares of Common Stock to which he will be entitled as aforesaid. Such conversion will be deemed to have been made, in the event of automatic conversion, immediately prior to the close of business on the date of the event of conversion or, in the event of voluntary conversion, immediately prior to the close of business on the date when the Corporation receives a holder's certificate or certificates for Series A, Series B, Series C or Series D Preferred Stock and any other documents or instruments required hereunder or by applicable law, and the person or persons entitled to receive the shares of Common Stock issuable upon conversion will be treated for all purposes as the record holder or holders of such shares of Common Stock on such date.

Section 6.5 No Impairment. The Corporation, whether by amendment of its Articles of Incorporation or through any reorganization, transfer of assets, merger, dissolution, issue or

14

sale of securities or any other voluntary action, will not avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Corporation, but at all times in good faith will assist in the carrying out of all of such action as may be necessary or appropriate in order to protect the conversion rights pursuant to this Section 6 of the holders of Series A, Series B, Series C and Series D Preferred Stock against impairment.

Section 6.6 Notices of Record Date. In the event of any taking by the Corporation of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend) or other distribution, any Common Stock Equivalents or any right to subscribe for, purchase or otherwise acquire any shares of stock of any class or any other securities or property, or to receive any other right, the Corporation will mail to each holder of Series A, Series B, Series C or Series D Preferred Stock at least ten (10) days prior to the date specified therein, a notice specifying the date on which any such record is to be taken for the purpose of such dividend, distribution or rights, and the amount and character of such dividend, distribution or right.

Section 6.7 Reservation of Stock Issuable Upon Conversion. The Corporation at all times will reserve and keep available out of its authorized but unissued shares of Common Stock solely for the purpose of effecting the conversion of the shares of Series A, Series B, Series C or Series D Preferred Stock such number of its shares of Common Stock as from time to time will be sufficient to effect the conversion of all then outstanding shares of Series A, Series B, Series C and Series D Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock is not sufficient to effect the conversion of all then outstanding shares of Series A, Series B, Series C and Series D Preferred Stock, in addition to such other remedies as may be available to the holders of Series A, Series B, Series C and Series D Preferred Stock for such failure, the Corporation will take such corporate action as, in the opinion of its counsel, may be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as will be sufficient for such purpose.

1. Section 6.8 Notices. Any notices required by the provisions of this Section 6 to be given to the holders of shares of Series A, Series B, Series C or Series D Preferred Stock must be in writing and will be deemed given upon personal delivery, one day after deposit with a reputable overnight courier service for overnight delivery or after transmission by facsimile telecopier with confirmation of successful transmission, or five days after deposit in the United States mail, by registered or certified mail postage prepaid, or upon actual receipt if given by any other method, addressed to each holder of such record at his address appearing on the books of the Corporation.

15

IN WITNESS WHEREOF, we have executed and subscribed this Certificate and do affirm the foregoing as true under the penalties of perjury this _____ day of ________________, 1999.


Louis Rosenberg, Chief Executive Officer


Bruce Schena, Secretary

16

EXHIBIT 3.5

CERTIFICATE OF ELIMINATION OF

SERIES A, SERIES B, SERIES C AND SERIES D PREFERRED STOCK OF

IMMERSION CORPORATION

(Pursuant to Section 151 of the General

Corporation Law of the State of Delaware)

Immersion Corporation, a corporation organized and existing under the General Corporation Law of the State of Delaware (the "Corporation"), certifies as follows:

FIRST: Article FOURTH of the Certificate of Incorporation of the Corporation authorizes the issuance of 10,215,716 shares of Preferred Stock, par value $0.001 per share (the "Preferred Stock"), of which 2,495,647 shares have been designated Series A Preferred Stock, 467,390 shares have been designated Series B Preferred Stock, 863,778 shares have been designated Series C Preferred Stock and 1,388,901 shares have been designated Series D Preferred Stock pursuant to a Certificate of Designations filed pursuant to Section 151 of the General Corporation Law of the State of Delaware.

SECOND: The following resolution was adopted on August 30, 1999 by the Board of Directors of the Corporation as required by Section 151(g) of the General Corporation Law of the State of Delaware:

RESOLVED, that none of the authorized shares of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock are outstanding and no shares of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock will be issued subject to the Certificate of Designations previously filed with respect to such Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock.

THIRD: Pursuant to the provisions of Section 151(g) of the General Corporation Law of the State of Delaware, all matters set forth in the Certificate of Designations with respect to such Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock are hereby eliminated from the Certificate of Incorporation.

IN WITNESS WHEREOF, the Corporation has caused this Certificate to be signed by its duly authorized officer this ____ day of October, 1999.

IMMERSION CORPORATION

By:

Its:



EXHIBIT 3.6

AGREEMENT AND PLAN OF MERGER

THIS AGREEMENT AND PLAN OF MERGER (the "Merger Agreement") is entered into as of ____________________, 1999 by and between Immersion Corporation a California corporation ("Immersion California"), and Immersion Corporation Delaware, a Delaware corporation ("Immersion Delaware").

WITNESSETH:

WHEREAS, Immersion Delaware is a corporation duly organized and existing under the laws of the State of Delaware;

WHEREAS, Immersion California is a corporation duly organized and existing under the laws of the State of California;

WHEREAS, on the date of this Merger Agreement, Immersion Delaware has authority to issue 100,000,000 shares of Common Stock, par value $0.001 per share (the "Immersion Delaware Common Stock"), of which 100 shares are issued and outstanding and owned by Immersion California and 10,215,717 shares of Preferred Stock, par value $0.001 per share (the "Immersion Delaware Preferred Stock), of which no shares are issued or outstanding;

WHEREAS, on the date of this Merger Agreement, Immersion California has authority to issue 100,000,000 shares of Common Stock (the "Immersion California Common Stock"), of which ________ shares are issued and outstanding, and 5,000,000 shares of Preferred Stock (the "Immersion California Preferred Stock"), of which 3,492,923 shares are issued and outstanding;

WHEREAS, the respective Boards of Directors for Immersion Delaware and Immersion California have determined that, for the purpose of effecting the reincorporation of Immersion California in the State of Delaware, it is advisable and to the advantage of said two corporations and their shareholders that Immersion California merge with and into Immersion Delaware upon the terms and conditions herein provided; and

WHEREAS, the respective Boards of Directors of Immersion Delaware and Immersion California, the shareholders of Immersion California, and the sole stockholder of Immersion Delaware have adopted and approved this Merger Agreement;

NOW, THEREFORE, in consideration of the mutual agreements and covenants set forth herein, Immersion California and Immersion Delaware hereby agree to merge as follows:

1. Merger. Immersion California shall be merged with and into Immersion Delaware, and Immersion Delaware shall survive the merger ("Merger"), effective upon the date when this Merger Agreement is made effective in accordance with applicable law (the "Effective Date").

2. Governing Documents. The Amended and Restated Certificate of Incorporation of Immersion Delaware (the "Certificate of Incorporation") shall continue to be the Certificate of Incorporation of Immersion Delaware as the surviving Corporation. Article FIRST of the Restated Certificate of Incorporation of Immersion Delaware shall be amended to read as follows:

1

FIRST: The name of the Corporation is Immersion Corporation.

The Bylaws of Immersion Delaware, in effect on the Effective Date, shall continue to be the Bylaws of Immersion Delaware as the surviving Corporation without change or amendment until further amended in accordance with the provisions thereof and applicable laws.

3. Directors and Officers. The directors and officers of Immersion California shall become the directors and officers of Immersion Delaware upon the Effective Date and any committee of the Board of Directors of Immersion California shall become the members of such committees for Immersion Delaware.

4. Succession. On the Effective Date, Immersion Delaware shall succeed to Immersion California in the manner of and as more fully set forth in Section 259 of the General Corporation Law of the State of Delaware.

5. Further Assurances. From time to time, as and when required by Immersion Delaware or by its successors and assigns, there shall be executed and delivered on behalf of Immersion California such deeds and other instruments, and there shall be taken or caused to be taken by it such further and other action, as shall be appropriate or necessary in order to vest, perfect or confirm, of record or otherwise, in Immersion Delaware the title to and possession of all the property, interests, assets, rights, privileges, immunities, powers, franchises and authority of Immersion California, and otherwise to carry out the purposes of this Merger Agreement and the officers and directors of Immersion Delaware are fully authorized in the name and on behalf of Immersion California or otherwise to take any and all such action and to execute and deliver any and all such deeds and other instruments.

6. Stock of Immersion California.

a. Common Stock. Upon the Effective Date, by virtue of the Merger and without any action on the part of the holder thereof, each one (1) share of Immersion California Common Stock outstanding immediately prior thereto shall be changed and converted into 0.807 fully paid and nonassessable share of Immersion Delaware Common Stock.

b. Preferred Stock. Upon the Effective Date, by virtue of the Merger and without any action on the part of the holder thereof, (i) each one
(1) share of Immersion California Series A Preferred and Series B Preferred outstanding immediately prior thereto shall be changed and converted into 4.035 fully paid and nonassessable equivalent shares of Immersion Delaware Series A Preferred or Series B Preferred Stock and (ii) each one share of Series C Preferred Stock and Series D Preferred Stock outstanding immediately prior thereto shall be changed and converted into 0.807 fully paid and nonassessable equivalent share of Immersion Delaware Series C or Series D Preferred Stock.

c. Fractional Shares. No fractional shares which a Immersion Delaware stockholder would otherwise be entitled to receive by reason of the exchange of Immersion California stock for Immersion Delaware stock shall be issued. In lieu of any fractional shares to which a holder would otherwise be entitled, Immersion Delaware shall pay cash equal to such fraction multiplied by the fair market value of the Common Stock on the Effective Date as determined by the Board of Directors of Immersion Delaware and for the Preferred Stock, such

2

fraction multiplied by the Conversion Prices as defined in Article FOURTH, subparagraph 4(a) of this Certificate of Incorporation.

7. Stock Certificates. On and after the Effective Date, all of the outstanding certificates which prior to that time represented shares of Immersion California stock shall be deemed for all purposes to evidence ownership of and to represent the shares of Immersion Delaware stock into which the shares of Immersion California stock represented by such certificates have been converted as herein provided. The registered owner on the books and records of Immersion Delaware or its transfer agent of any such outstanding stock certificate shall, until such certificate shall have been surrendered for transfer or otherwise accounted for to Immersion Delaware or its transfer agent, have and be entitled to exercise any voting and other rights with respect to and to receive any dividend and other distributions upon the shares of Immersion Delaware stock evidenced by such outstanding certificate as above provided.

8. Options and Warrants. Upon the Effective Date, (i) each outstanding option, warrant to purchase common Stock, Series C Preferred Stock or Series D Preferred Stock or other right to purchase Common Stock, Series C Preferred Stock or Series D Preferred Stock of Immersion California, including those options granted under the 1994 Stock Option Plan and 1997 Stock Option Plan (collectively, the "Option Plan") of Immersion California, shall be converted into and become an option, warrant, or right to purchase the number of shares of Immersion Delaware stock determined by multiplying the number of shares of Immersion California subject to the option, warrant or right to purchase by 0.807, rounded down to the nearest whole number, at a price per share equal to the exercise price of the option, warrant or right to purchase Immersion California stock divided by 0.807, rounded down to the nearest whole cent, and upon the same terms and subject to the same conditions as set forth in the Option Plan and other plan or agreement entered into by Immersion California pertaining to such options, warrants, or rights and (ii) each outstanding warrant to purchase Series A or Series B Preferred Stock of Immersion California shall be converted into and become a warrant to purchase the equivalent number of shares of Series A Preferred Stock or Series B Preferred Stock of Immersion Delaware stock determined by multiplying the number of shares of Immersion California subject to the warrant by 4.035 rounded down to the nearest whole number, at a price per share equal to the exercise price of the warrant divided by 4.035, rounded down to the nearest whole cent, and upon the same terms and subject to the same conditions as set forth in the agreements entered into by Immersion California pertaining to the warrant. A number of shares of Immersion Delaware stock of the relevant class and series shall be reserved for purposes of (i) the options, warrants, and rights described in clause (i) of the preceding sentence equal to the number of shares of Immersion California stock so reserved as of the Effective Date multiplied by 0.807 and (ii) of the warrants described in clause (ii) of the preceding sentence equal to the number of shares of Immersion California stock of the relevant class and series so reserved as of the Effective Date multiplied by 4.035. As of the Effective Date, Immersion Delaware shall assume all obligations of Immersion California under agreements pertaining to such options, warrants and rights, including the Option Plans, and the outstanding options, warrants or other rights, or portions thereof, granted pursuant thereto.

9. Other Employee Benefit Plans. As of the Effective Date, Immersion Delaware hereby assumes all obligations of Immersion California under any and all employee benefit plans

3

in effect as of said date or with respect to which employee rights or accrued benefits are outstanding as of said date.

10. Outstanding Common Stock of Immersion Delaware. Forthwith upon the Effective Date, the One Hundred (100) shares of Immersion Delaware Common Stock presently issued and outstanding in the name of Immersion California shall be canceled and retired and resume the status of authorized and unissued shares of Immersion Delaware Common Stock, and no shares of Immersion Delaware Common Stock or other securities of Immersion Delaware shall be issued in respect thereof.

11. Covenants of Immersion Delaware. Immersion Delaware covenants and agrees that it will, on or before the Effective Date:

a. Qualify to do business as a foreign corporation in the State of California, and in all other states in which Immersion California is so qualified and in which the failure so to qualify would have a material adverse impact on the business or financial condition of Immersion Delaware. In connection therewith, Immersion Delaware shall irrevocably appoint an agent for service of process as required under the provisions of Section 2105 of the California Corporations Code and under applicable provisions of state law in other states in which qualification is required hereunder.

b. File any and all documents with the California Franchise Tax Board necessary to the assumption by Immersion Delaware of all of the franchise tax liabilities of Immersion California.

12. Amendment. At any time before or after approval and adoption by the stockholders of Immersion California, this Merger Agreement may be amended in any manner as may be determined in the judgment of the respective Boards of Directors of Immersion Delaware and Immersion California to be necessary, desirable or expedient in order to clarify the intention of the parties hereto or to effect or facilitate the purposes and intent of this Merger Agreement.

13. Abandonment. At any time before the Effective Date, this Merger Agreement may be terminated and the Merger may be abandoned by the Board of Directors of either Immersion California or Immersion Delaware or both, notwithstanding approval of this Merger Agreement by the sole stockholder of Immersion Delaware and the shareholders of Immersion California.

14. Counterparts. In order to facilitate the filing and recording of this Merger Agreement, the same may be executed in any number of counterparts, each of which shall be deemed to be an original.

4

IN WITNESS WHEREOF, this Merger Agreement, having first been duly approved by resolution of the Board of Directors of Immersion California and Immersion Delaware, is hereby executed on behalf of each of said two corporations by their respective officers thereunto duly authorized.

IMMERSION CORPORATION DELAWARE, a Delaware

corporation

By:

Louis Rosenberg, Chief Executive Officer

IMMERSION CORPORATION, a California
corporation

By:


Louis Rosenberg, Chief Executive Officer

5

EXHIBIT 3.7

CERTIFICATE OF AMENDMENT

OF

RESTATED CERTIFICATE OF INCORPORATION

OF

IMMERSION CORPORATION

Immersion Corporation, a Delaware corporation (the "Corporation"), hereby certifies:

1. That the Corporation's Board of Directors has duly adopted the following resolutions:

RESOLVED, that the first paragraph of Article FOURTH of the Restated Certificate of Incorporation is hereby amended to read in full as follows:

FOURTH:The Corporation is authorized to issue a total of 105,000,000 shares of stock in two classes designated respectively "Preferred Stock" and "Common Stock." The total number of shares of all series of Preferred Stock that the Corporation shall have the authority to issue is 5,000,000 and the total number of shares of Common Stock that the Corporation shall have the authority to issue is 100,000,000. All of the authorized shares shall have a par value of $0.001.

2. That the proposed amendment has been duly adopted by the Corporation's Board of Directors and sole stockholder in accordance with the provisions of Sections 242 and 228 of the General Corporation Law of the State of Delaware.

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment of Restated Certificate of Incorporation to be signed by a duly authorized officer on this _____ day of ___________, 1999.

IMMERSION CORPORATION


Louis Rosenberg, Ph.D., Chief Executive

Officer


EXHIBIT 5.1

[Gray Cary Ware & Freidenrich LLP Letterhead]

400 Hamilton Avenue, Palo Alto, CA 94301-1825 Phone 650-833-2000 Fax 650-327-3699 www.graycary.com

Our File No: 1090369-900000

______________, 1999

Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549

RE: IMMERSION CORPORATION REGISTRATION STATEMENT ON FORM S-1

Ladies and Gentlemen:

As counsel to Immersion Corporation (the "Company"), we are rendering this opinion in connection with a proposed sale of those certain shares of the Company's newly-issued Common Stock as set forth in the Registration Statement on Form S-1 to which this opinion is being filed as Exhibit 5.1 (the "Shares"). We have examined all instruments, documents and records which we deemed relevant and necessary for the basis of our opinion hereinafter expressed. In such examination, we have assumed the genuineness of all signatures and the authenticity of all documents submitted to us as originals and the conformity to the originals of all documents submitted to us as copies.

We express no opinion with respect to (i) the availability of equitable remedies, including specific performance, or (ii) the effect of bankruptcy, insolvency, reorganization, moratorium or equitable principles relating to or limiting creditors' rights generally.

Based on such examination, we are of the opinion that the Shares identified in the above-referenced Registration Statement will be, upon effectiveness of the Registration Statement and receipt by the Company of payment therefor, validly authorized, legally issued, fully paid, and nonassessable.

We hereby consent to the filing of this opinion as an exhibit to the above-referenced Registration Statement and to the use of our name wherever it appears in said Registration Statement, including the Prospectus constituting a part thereof, as originally filed or as subsequently amended.

Respectfully submitted,

/s/ Gray Cary Ware & Freidenrich LLP

GRAY CARY WARE & FREIDENRICH LLP

SILICON VALLEY SAN DIEGO SAN FRANCISCO AUSTIN SACRAMENTO
LA JOLLA IMPERIAL VALLEY MEXICO


EXHIBIT 10.21
IMMERSION CORPORATION
1999 EMPLOYEE STOCK PURCHASE PLAN

1. ESTABLISHMENT, PURPOSE AND TERM OF PLAN.

1.1 ESTABLISHMENT. This 1999 Employee Stock Purchase Plan (the "PLAN") is hereby established effective as of the effective date of the initial registration by the Company of its Stock under Section 12 of the Securities Exchange Act of 1934, as amended (the "EFFECTIVE DATE").

1.2 PURPOSE. The purpose of the Plan is to advance the interests of Company and its shareholders by providing an incentive to attract, retain and reward Eligible Employees of the Participating Company Group and by motivating such persons to contribute to the growth and profitability of the Participating Company Group. The Plan provides such Eligible Employees with an opportunity to acquire a proprietary interest in the Company through the purchase of Stock. The Company intends that the Plan qualify as an "employee stock purchase plan" under
Section 423 of the Code.

1.3 TERM OF PLAN. The Plan shall continue in effect until the earlier of its termination by the Board or the date on which all of the shares of Stock available for issuance under the Plan have been issued.

2. DEFINITIONS AND CONSTRUCTION.

2.1 DEFINITIONS. Any term not expressly defined in the Plan but defined for purposes of Section 423 of the Code shall have the same definition herein. Whenever used herein, the following terms shall have their respective meanings set forth below:

(a) "BOARD" means the Board of Directors of the Company. If one or more Committees have been appointed by the Board to administer the Plan, "Board" also means such Committee(s).

(b) "CODE" means the Internal Revenue Code of 1986, as amended, and any applicable regulations promulgated thereunder.

(c) "COMMITTEE" means a committee of the Board duly appointed to administer the Plan and having such powers as shall be specified by the Board. Unless the powers of the Committee have been specifically limited, the Committee shall have all of the powers of the Board granted herein, including, without limitation, the power to amend or terminate the Plan at any time, subject to the terms of the Plan and any applicable limitations imposed by law.

(d) "COMPANY" means Immersion Corporation, a California corporation, or any successor corporation thereto.

1

(e) "COMPENSATION" means, with respect to any Offering Period, base wages or salary, commissions, overtime, bonuses, annual awards, other incentive payments, shift premiums, and all other compensation paid in cash during such Offering Period before deduction for any contributions to any plan maintained by a Participating Company and described in Section 401(k) or Section 125 of the Code. Compensation shall not include reimbursements of expenses, allowances, long-term disability, workers' compensation or any amount deemed received without the actual transfer of cash or any amounts directly or indirectly paid pursuant to the Plan or any other stock purchase or stock option plan, or any other compensation not included above.

(f) "ELIGIBLE EMPLOYEE" means an Employee who meets the requirements set forth in Section 5 for eligibility to participate in the Plan.

(g) "EMPLOYEE" means a person treated as an employee of a Participating Company for purposes of Section 423 of the Code. A Participant shall be deemed to have ceased to be an Employee either upon an actual termination of employment or upon the corporation employing the Participant ceasing to be a Participating Company. For purposes of the Plan, an individual shall not be deemed to have ceased to be an Employee while such individual is on any military leave, sick leave, or other bona fide leave of absence approved by the Company of ninety (90) days or less. In the event an individual's leave of absence exceeds ninety (90) days, the individual shall be deemed to have ceased to be an Employee on the ninety-first (91st) day of such leave unless the individual's right to reemployment with the Participating Company Group is guaranteed either by statute or by contract. The Company shall determine in good faith and in the exercise of its discretion whether an individual has become or has ceased to be an Employee and the effective date of such individual's employment or termination of employment, as the case may be. For purposes of an individual's participation in or other rights, if any, under the Plan as of the time of the Company's determination, all such determinations by the Company shall be final, binding and conclusive, notwithstanding that the Company or any governmental agency subsequently makes a contrary determination.

(h) "ENTRY DATE" means (i) the Offering Date of an Offering Period, or (ii) with respect to persons who first become Eligible Employees after the commencement of the Initial Offering Period (as defined in Section 6.1 below) but prior to the commencement of the final Purchase Period of the Initial Offering Period, the first day of the Purchase Period following the date on which such person becomes an Eligible Employee. Notwithstanding the foregoing, in the event that the Fair Market Value of a share of Stock on the first, second or third Purchase Date of the Initial Offering Period is less than the Fair Market Value of a share of Stock on the Entry Date for a Participant who was participating in the Offering as of such Purchase Date, the Entry Date for such Participant for the remainder of the Offering shall be the first day of the next Purchase Period immediately following such Purchase Date.

(i) "FAIR MARKET VALUE" means, as of any date, if there is then a public market for the Stock, the closing price of a share of Stock (or the mean of the closing bid and asked prices if the Stock is so quoted instead) as quoted on the Nasdaq National Market, The Nasdaq SmallCap Market or such other national or regional securities exchange or market system constituting the primary market for the Stock, as reported in The Wall Street Journal or such other source as the Company deems reliable. If the relevant date does not fall on a day on

2

which the Stock has traded on such securities exchange or market system, the date on which the Fair Market Value shall be established shall be the last day on which the Stock was so traded prior to the relevant date, or such other appropriate day as shall be determined by the Board, in its discretion. If, as of any date, there is then no public market for the Stock, the Fair Market Value on any relevant date shall be as determined by the Board. Notwithstanding the foregoing, the Fair Market Value per share of Stock on the Effective Date shall be deemed to be the public offering price set forth in the final prospectus filed with the Securities and Exchange Commission in connection with the initial public offering of the Stock.

(j) "OFFERING" means an offering of Stock as provided in Section 6.

(k) "OFFERING DATE" means, for any Offering, the first day of the Offering Period with respect to such Offering.

(l) "OFFERING PERIOD" means a period established in accordance with
Section 6.1.

(m) "PARENT CORPORATION" means any present or future "parent corporation" of the Company, as defined in Section 424(e) of the Code.

(n) "PARTICIPANT" means an Eligible Employee who has become a participant in an Offering Period in accordance with Section 7 and remains a participant in accordance with the Plan.

(o) "PARTICIPATING COMPANY" means the Company or any Parent Corporation or Subsidiary Corporation designated by the Board as a corporation the Employees of which may, if Eligible Employees, participate in the Plan. The Board shall have the sole and absolute discretion to determine from time to time which Parent Corporations or Subsidiary Corporations shall be Participating Companies.

(p) "PARTICIPATING COMPANY GROUP" means, at any point in time, the Company and all other corporations collectively which are then Participating Companies.

(q) "PURCHASE DATE" means the last day of (i) any Purchase Period during the Initial Offering Period, or (ii) an Offering Period which begins after the Initial Offering Period.

(r) "PURCHASE PERIOD" means a period established in accordance with
Section 6.2.

(s) "PURCHASE PRICE" means the price at which a share of Stock may be purchased under the Plan, as determined in accordance with Section 9.

(t) "PURCHASE RIGHT" means an option granted to a Participant pursuant to the Plan to purchase such shares of Stock as provided in Section 8, which the Participant may or may not exercise during the Offering Period in which such option is outstanding. Such option arises from the right of a Participant to withdraw any accumulated

3

payroll deductions of the Participant not previously applied to the purchase of Stock under the Plan and to terminate participation in the Plan at any time during an Offering Period.

(u) "STOCK" means the common stock of the Company, as adjusted from time to time in accordance with Section 4.2.

(v) "SUBSCRIPTION AGREEMENT" means a written agreement in such form as specified by the Company, stating an Employee's election to participate in the Plan and authorizing payroll deductions under the Plan from the Employee's Compensation.

(w) "SUBSCRIPTION DATE" means the last business day prior to an Entry Date or such other date as the Company shall establish.

(x) "SUBSIDIARY CORPORATION" means any present or future "subsidiary corporation" of the Company, as defined in Section 424(f) of the Code.

2.2 CONSTRUCTION. Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term "or" is not intended to be exclusive, unless the context clearly requires otherwise.

3. ADMINISTRATION.

3.1 ADMINISTRATION BY THE BOARD. The Plan shall be administered by the Board. All questions of interpretation of the Plan, of any form of agreement or other document employed by the Company in the administration of the Plan, or of any Purchase Right shall be determined by the Board and shall be final and binding upon all persons having an interest in the Plan or the Purchase Right. Subject to the provisions of the Plan, the Board shall determine all of the relevant terms and conditions of Purchase Rights granted pursuant to the Plan; provided, however, that all Participants granted Purchase Rights pursuant to the Plan shall have the same rights and privileges within the meaning of Section 423(b)(5) of the Code. All expenses incurred in connection with the administration of the Plan shall be paid by the Company.

3.2 AUTHORITY OF OFFICERS. Any officer of the Company shall have the authority to act on behalf of the Company with respect to any matter, right, obligation, determination or election that is the responsibility of or that is allocated to the Company herein, provided that the officer has apparent authority with respect to such matter, right, obligation, determination or election.

3.3 POLICIES AND PROCEDURES ESTABLISHED BY THE COMPANY. The Company may, from time to time, consistent with the Plan and the requirements of
Section 423 of the Code, establish, change or terminate such rules, guidelines, policies, procedures, limitations, or adjustments as deemed advisable by the Company, in its sole discretion, for the proper administration of the Plan, including, without limitation, (a) a minimum payroll deduction amount required for participation in an Offering, (b) a limitation on the frequency or number of changes permitted in the rate of payroll deduction during an Offering, (c) an exchange ratio applicable to amounts withheld in a currency other than United States dollars, (d) a payroll

4

deduction greater than or less than the amount designated by a Participant in order to adjust for the Company's delay or mistake in processing a Subscription Agreement or in otherwise effecting a Participant's election under the Plan or as advisable to comply with the requirements of Section 423 of the Code, and (e) determination of the date and manner by which the Fair Market Value of a share of Stock is determined for purposes of administration of the Plan.

4. SHARES SUBJECT TO PLAN.

4.1 MAXIMUM NUMBER OF SHARES ISSUABLE. Subject to adjustment as provided in Section 4.2, the maximum aggregate number of shares of Stock that may be issued under the Plan shall be five hundred thousand (500,000), cumulatively increased on January 1, 2001 and each January 1 thereafter until and including January 1, 2010 by an amount equal to the lesser of (a) five hundred thousand (500,000) shares, or (b) a lesser amount of shares determined by the Board, and shall consist of authorized but unissued or reacquired shares of Stock, or any combination thereof. If an outstanding Purchase Right for any reason expires or is terminated or canceled, the shares of Stock allocable to the unexercised portion of such Purchase Right shall again be available for issuance under the Plan.

4.2 ADJUSTMENTS FOR CHANGES IN CAPITAL STRUCTURE. In the event of any stock dividend, stock split, reverse stock split, recapitalization, combination, reclassification or similar change in the capital structure of the Company, or in the event of any merger (including a merger effected for the purpose of changing the Company's domicile), sale of assets or other reorganization in which the Company is a party, appropriate adjustments shall be made in the number and class of shares subject to the Plan and each Purchase Right and in the Purchase Price. If a majority of the shares which are of the same class as the shares that are subject to outstanding Purchase Rights are exchanged for, converted into, or otherwise become (whether or not pursuant to an Ownership Change Event) shares of another corporation (the "NEW SHARES"), the Board may unilaterally amend the outstanding Purchase Rights to provide that such Purchase Rights are exercisable for New Shares. In the event of any such amendment, the number of shares subject to, and the Purchase Price of, the outstanding Purchase Rights shall be adjusted in a fair and equitable manner, as determined by the Board, in its sole discretion. Notwithstanding the foregoing, any fractional share resulting from an adjustment pursuant to this Section 4.2 shall be rounded down to the nearest whole number, and in no event may the Purchase Price be decreased to an amount less than the par value, if any, of the stock subject to the Purchase Right. The adjustments determined by the Board pursuant to this
Section 4.2 shall be final, binding and conclusive.

5. ELIGIBILITY.

5.1 EMPLOYEES ELIGIBLE TO PARTICIPATE. Each Employee of a Participating Company is eligible to participate in the Plan and shall be deemed an Eligible Employee, except the following:

(a) Any Employee who is customarily employed by the Participating Company Group for less than twenty (20) hours per week; or

5

(b) Any Employee who is customarily employed by the Participating Company Group for not more than five (5) months in any calendar year.

5.2 EXCLUSION OF CERTAIN SHAREHOLDERS. Notwithstanding any provision of the Plan to the contrary, no Employee shall be granted a Purchase Right under the Plan if, immediately after such grant, such Employee would own or hold options to purchase stock of the Company or of any Parent Corporation or Subsidiary Corporation possessing five percent (5%) or more of the total combined voting power or value of all classes of stock of such corporation, as determined in accordance with Section 423(b)(3) of the Code. For purposes of this Section 5.2, the attribution rules of Section 424(d) of the Code shall apply in determining the stock ownership of such Employee.

6. OFFERINGS.

6.1 OFFERING PERIODS.

(a) INITIAL OFFERING PERIOD. The Plan shall be implemented by sequential Offerings (an "OFFERING PERIOD"). The first Offering Period shall commence on the Effective Date and end on the last day of January, 2002 (the "INITIAL OFFERING PERIOD").

(b) SUBSEQUENT OFFERING PERIODS. After the completion of the Initial Offering Period, subsequent Offerings shall commence on the first day of February and August of each year and end on the last day of July and January, respectively, occurring thereafter, and will have a duration of approximately six (6) months.

6.2 PURCHASE PERIODS. The Initial Offering Period shall consist of four (4) consecutive Purchase Periods of approximately six (6) months duration. Purchase Periods shall commence on the Effective Date, August 1, 2000, February 1, 2001 and August 1, 2001. Purchase Periods beginning on the first day of February and August shall end on the last day of July and January, respectively, occurring thereafter. The Purchase Period commencing on the Effective Date shall end on July 31, 2000.

6.3 DISCRETION TO VARY DURATION. Notwithstanding the foregoing, the Board may establish a different duration for one or more Offering Periods or Purchase Periods or different commencing or ending dates for such periods; provided, however, that no Offering Period may have a duration exceeding twenty-seven (27) months. If the first or last day of an Offering Period or a Purchase Period is not a day on which the national securities exchanges or Nasdaq Stock Market are open for trading, the Company shall specify the trading day that will be deemed the first or last day, as the case may be, of the period.

7. PARTICIPATION IN THE PLAN.

7.1 INITIAL PARTICIPATION. An Eligible Employee may become a Participant in an Offering Period by delivering a properly completed Subscription Agreement to the Company not later than the close of business for such office on the Subscription Date established by the Company for the applicable Entry Date. An Eligible Employee who does not deliver a properly completed Subscription Agreement to the Company's designated office on or before the Subscription Date shall not participate in that Offering Period or any subsequent Offering Period

6

unless such Eligible Employee subsequently delivers a properly completed Subscription Agreement to the appropriate office of the Company on or before the Subscription Date for such subsequent Offering Period. An Employee who becomes an Eligible Employee after the Offering Date of an Offering Period (other than the Initial Offering Period) shall not be eligible to participate in such Offering Period but may participate in any subsequent Offering Period provided such Employee is still an Eligible Employee as of the Offering Date of such subsequent Offering Period.

7.2 CONTINUED PARTICIPATION. A Participant shall automatically participate in the next Offering Period commencing immediately after the final Purchase Date of each Offering Period in which the Participant participates provided that such Participant remains an Eligible Employee on the Offering Date of the new Offering Period and has not either (a) withdrawn from the Plan pursuant to Section 10.7 or (b) terminated employment as provided in Section 13. A Participant who may automatically participate in a subsequent Offering Period, as provided in this Section, is not required to deliver any additional Subscription Agreement for the subsequent Offering Period in order to continue participation in the Plan. However, a Participant may deliver a new Subscription Agreement for a subsequent Offering Period in accordance with the procedures set forth in Section 7.1 if the Participant desires to change any of the elections contained in the Participant's then effective Subscription Agreement.

8. RIGHT TO PURCHASE SHARES.

8.1 GRANT OF PURCHASE RIGHT. Except as set forth below, on the Offering Date of each Offering Period, each Participant in such Offering Period shall be granted automatically, on his or her Entry Date, a Purchase Right consisting of an option to purchase, on each Purchase Date within such Offering Period, that number of whole shares of Stock determined by dividing the aggregate payroll deductions collected from the Participant by the applicable Purchase Price on such Purchase Date; provided, that no Participant may purchase more than two thousand (2,000) shares of Stock on any Purchase Date.

8.2 CALENDAR YEAR PURCHASE LIMITATION. Notwithstanding any provision of the Plan to the contrary, no Participant shall be granted a Purchase Right which permits his or her right to purchase shares of Stock under the Plan to accrue at a rate which, when aggregated with such Participant's rights to purchase shares under all other employee stock purchase plans of a Participating Company intended to meet the requirements of Section 423 of the Code, exceeds Twenty-Five Thousand Dollars ($25,000) in Fair Market Value (or such other limit, if any, as may be imposed by the Code) for each calendar year in which such Purchase Right is outstanding at any time. For purposes of the preceding sentence, the Fair Market Value of shares purchased during a given Offering Period shall be determined as of the Entry Date for such Offering Period. The limitation described in this Section shall be applied in conformance with applicable regulations under Section 423(b)(8) of the Code.

9. PURCHASE PRICE.

The Purchase Price at which each share of Stock may be acquired in an Offering Period upon the exercise of all or any portion of a Purchase Right shall be established by the Board; provided, however, that the Purchase Price shall not be less than eighty-five percent

7

(85%) of the lesser of (a) the Fair Market Value of a share of Stock on the Participant's Entry Date of the Offering Period or (b) the Fair Market Value of a share of Stock on the Purchase Date. Unless otherwise provided by the Board prior to the commencement of an Offering Period, the Purchase Price for that Offering Period shall be eighty-five percent (85%) of the lesser of (a) the Fair Market Value of a share of Stock on the Participant's Entry Date of the Offering Period, or (b) the Fair Market Value of a share of Stock on the Purchase Date.

10. ACCUMULATION OF PURCHASE PRICE THROUGH PAYROLL DEDUCTION.

Shares of Stock acquired pursuant to the exercise of all or any portion of a Purchase Right may be paid for only by means of payroll deductions from the Participant's Compensation accumulated during the Offering Period for which such Purchase Right was granted, subject to the following:

10.1 AMOUNT OF PAYROLL DEDUCTIONS. Except as otherwise provided herein, the amount to be deducted under the Plan from a Participant's Compensation on each payday during an Offering Period (after the Participant's Entry Date) shall be determined by the Participant's Subscription Agreement. The Subscription Agreement shall set forth the percentage of the Participant's Compensation to be deducted on each payday during an Offering Period (after the Participant's Entry Date) in whole percentages of not less than one percent (1%) (except as a result of an election pursuant to Section 10.3 to stop payroll deductions made effective following the first payday during an Offering after the Participant's Entry Date) or more than ten percent (10%). Notwithstanding the foregoing, the Board may change the limits on payroll deductions effective as of any future Offering Date.

10.2 COMMENCEMENT OF PAYROLL DEDUCTIONS. Payroll deductions shall commence on the first payday following the Entry Date and shall continue to the end of the Offering Period unless sooner altered or terminated as provided herein.

10.3 ELECTION TO CHANGE OR STOP PAYROLL DEDUCTIONS. During an Offering Period, a Participant may elect to increase or decrease the rate of or to stop deductions from his or her Compensation by delivering to the Company an amended Subscription Agreement authorizing such change on or before the "Change Notice Date." The "CHANGE NOTICE DATE" shall be a date prior to the beginning of the first pay period for which such election is to be effective as established by the Company from time to time and announced to the Participants. A Participant who elects to decrease the rate of his or her payroll deductions to zero percent (0%) shall nevertheless remain a Participant in the current Offering Period unless such Participant withdraws from the Plan as provided in Section 12.1.

10.4 ADMINISTRATIVE SUSPENSION OF PAYROLL DEDUCTIONS. The Company may, in its sole discretion, suspend a Participant's payroll deductions under the Plan as the Company deems advisable to avoid accumulating payroll deductions in excess of the amount that could reasonably be anticipated to purchase the maximum number of shares of Stock permitted during a calendar year under the limit set forth in Section 8.2. Payroll deductions shall be resumed at the rate specified in the Participant's then effective Subscription Agreement at the beginning of the next Purchase Period the Purchase Date of which falls in the following calendar year.

8

10.5 PARTICIPANT ACCOUNTS. Individual bookkeeping accounts shall be maintained for each Participant. All payroll deductions from a Participant's Compensation shall be credited to such Participant's Plan account and shall be deposited with the general funds of the Company. All payroll deductions received or held by the Company may be used by the Company for any corporate purpose.

10.6 NO INTEREST PAID. Interest shall not be paid on sums deducted from a Participant's Compensation pursuant to the Plan.

10.7 VOLUNTARY WITHDRAWAL FROM PLAN ACCOUNT. A Participant may withdraw all or any portion of the payroll deductions credited to his or her Plan account and not previously applied toward the purchase of Stock by delivering to the Company a written notice on a form provided by the Company for such purpose. A Participant who withdraws the entire remaining balance credited to his or her Plan account shall be deemed to have withdrawn from the Plan in accordance with Section 12.1. Amounts withdrawn shall be returned to the Participant as soon as practicable after the withdrawal and may not be applied to the purchase of shares in any Offering under the Plan. The Company may from time to time establish or change limitations on the frequency of withdrawals permitted under this Section, establish a minimum dollar amount that must be retained in the Participant's Plan account, or terminate the withdrawal right provided by this Section.

11. PURCHASE OF SHARES.

11.1 EXERCISE OF PURCHASE RIGHT. On each Purchase Date, each Participant who has not withdrawn from the Plan and whose participation in the Offering has not terminated before such Purchase Date shall automatically acquire pursuant to the exercise of the Participant's Purchase Right the number of whole shares of Stock determined by dividing (a) the total amount of the Participant's payroll deductions accumulated in the Participant's Plan account during the Purchase Period and not previously applied toward the purchase of Stock by (b) the Purchase Price. No shares of Stock shall be purchased on a Purchase Date on behalf of a Participant whose participation in the Offering or the Plan has terminated before such Purchase Date.

11.2 PRO RATA ALLOCATION OF SHARES. In the event that the number of shares of Stock which might be purchased by all Participants in the Plan on a Purchase Date exceeds the number of shares of Stock available in the Plan as provided in Section 4.1, the Company shall make a pro rata allocation of the remaining shares in as uniform a manner as shall be practicable and as the Company shall determine to be equitable. Any fractional share resulting from such pro rata allocation to any Participant shall be disregarded.

11.3 DELIVERY OF CERTIFICATES. As soon as practicable after each Purchase Date, the Company shall arrange the delivery to each Participant, as appropriate, of a certificate representing the shares acquired by the Participant on such Purchase Date; provided that the Company may deliver such shares to a broker that holds such shares in street name for the benefit of the Participant. Shares to be delivered to a Participant under the Plan shall be registered in the name of the Participant, or, if requested by the Participant, in the name of the Participant and his or her spouse, or, if applicable, in the names of the heirs of the Participant.

9

11.4 RETURN OF CASH BALANCE. Any cash balance remaining in a Participant's Plan account following any Purchase Date shall be refunded to the Participant as soon as practicable after such Purchase Date. However, if the cash to be returned to a Participant pursuant to the preceding sentence is an amount less than the amount that would have been necessary to purchase an additional whole share of Stock on such Purchase Date, the Company may retain such amount in the Participant's Plan account to be applied toward the purchase of shares of Stock in the subsequent Purchase Period or Offering Period, as the case may be.

11.5 TAX WITHHOLDING. At the time a Participant's Purchase Right is exercised, in whole or in part, or at the time a Participant disposes of some or all of the shares of Stock he or she acquires under the Plan, the Participant shall make adequate provision for the foreign, federal, state and local tax withholding obligations of the Participating Company Group, if any, which arise upon exercise of the Purchase Right or upon such disposition of shares, respectively. The Participating Company Group may, but shall not be obligated to, withhold from the Participant's compensation the amount necessary to meet such withholding obligations.

11.6 EXPIRATION OF PURCHASE RIGHT. Any portion of a Participant's Purchase Right remaining unexercised after the end of the Offering Period to which the Purchase Right relates shall expire immediately upon the end of the Offering Period.

11.7 REPORTS TO PARTICIPANTS. Each Participant who has exercised all or part of his or her Purchase Right shall receive, as soon as practicable after the Purchase Date, a report of such Participant's Plan account setting forth the total payroll deductions accumulated prior to such exercise, the number of shares of Stock purchased, the Purchase Price for such shares, the date of purchase and the cash balance, if any, remaining immediately after such purchase that is to be refunded or retained in the Participant's Plan account pursuant to
Section 11.4. The report required by this Section may be delivered in such form and by such means, including by electronic transmission, as the Company may determine.

12. WITHDRAWAL FROM OFFERING OR PLAN.

12.1 VOLUNTARY WITHDRAWAL FROM THE PLAN. A Participant may withdraw from the Plan by signing and delivering to the Company a written notice of withdrawal on a form provided by the Company for such purpose. Such withdrawal may be elected at any time prior to the end of an Offering Period; provided, however, that if a Participant withdraws from the Plan after the Purchase Date of a Purchase Period, the withdrawal shall not affect shares of Stock acquired by the Participant on such Purchase Date. A Participant who voluntarily withdraws from the Plan is prohibited from resuming participation in the Plan in the same Offering from which he or she withdrew, but may participate in any subsequent Offering by again satisfying the requirements of Sections 5 and 7.1. The Company may impose a requirement that the notice of withdrawal from the Plan be on file with the Company for a reasonable period prior to the effectiveness of the Participant's withdrawal.

12.2 RETURN OF PAYROLL DEDUCTIONS. Upon a Participant's voluntary withdrawal from the Plan pursuant to Section 12.1, the Participant's accumulated payroll deductions which have not been applied toward the purchase of shares of Stock shall be refunded to the Participant as soon as practicable after the withdrawal, without the payment of any

10

interest, and the Participant's interest in the Plan or the Offering, as applicable, shall terminate. Such accumulated payroll deductions to be refunded in accordance with this Section may not be applied to any other Offering under the Plan.

13. TERMINATION OF EMPLOYMENT OR ELIGIBILITY.

Upon a Participant's ceasing, prior to a Purchase Date, to be an Employee of the Participating Company Group for any reason, including retirement, disability or death, or the failure of a Participant to remain an Eligible Employee, the Participant's participation in the Plan shall terminate immediately. In such event, the payroll deductions credited to the Participant's Plan account since the last Purchase Date shall, as soon as practicable, be returned to the Participant or, in the case of the Participant's death, to the Participant's legal representative, and all of the Participant's rights under the Plan shall terminate. Interest shall not be paid on sums returned pursuant to this Section 13. A Participant whose participation has been so terminated may again become eligible to participate in the Plan by again satisfying the requirements of Sections 5 and 7.1.

14. CHANGE IN CONTROL.

14.1 DEFINITIONS.

(a) An "OWNERSHIP CHANGE EVENT" shall be deemed to have occurred if any of the following occurs with respect to the Company: (i) the direct or indirect sale or exchange in a single or series of related transactions by the shareholders of the Company of more than fifty percent (50%) of the voting stock of the Company; (ii) a merger or consolidation in which the Company is a party;
(iii) the sale, exchange, or transfer of all or substantially all of the assets of the Company; or (iv) a liquidation or dissolution of the Company.

(b) A "CHANGE IN CONTROL" shall mean an Ownership Change Event or a series of related Ownership Change Events (collectively, the "TRANSACTION") wherein the shareholders of the Company immediately before the Transaction do not retain immediately after the Transaction, in substantially the same proportions as their ownership of shares of the Company's voting stock immediately before the Transaction, direct or indirect beneficial ownership of more than fifty percent (50%) of the total combined voting power of the outstanding voting stock of the Company or the corporation or corporations to which the assets of the Company were transferred (the "TRANSFEREE CORPORATION(S)"), as the case may be. For purposes of the preceding sentence, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting stock of one or more corporations which, as a result of the Transaction, own the Company or the Transferee Corporation(s), as the case may be, either directly or through one or more subsidiary corporations. The Board shall have the right to determine whether multiple sales or exchanges of the voting stock of the Company or multiple Ownership Change Events are related, and its determination shall be final, binding and conclusive.

14.2 EFFECT OF CHANGE IN CONTROL ON PURCHASE RIGHTS. In the event of a Change in Control, the surviving, continuing, successor, or purchasing corporation or parent corporation thereof, as the case may be (the "ACQUIRING CORPORATION"), may assume the

11

Company's rights and obligations under the Plan. If the Acquiring Corporation elects not to assume the Company's rights and obligations under outstanding Purchase Rights, the Purchase Date of the then current Purchase Period shall be accelerated to a date before the date of the Change in Control specified by the Board, but the number of shares of Stock subject to outstanding Purchase Rights shall not be adjusted. All Purchase Rights which are neither assumed by the Acquiring Corporation in connection with the Change in Control nor exercised as of the date of the Change in Control shall terminate and cease to be outstanding effective as of the date of the Change in Control.

15. NONTRANSFERABILITY OF PURCHASE RIGHTS.

A Purchase Right may not be transferred in any manner otherwise than by will or the laws of descent and distribution and shall be exercisable during the lifetime of the Participant only by the Participant.

16. COMPLIANCE WITH SECURITIES LAW.

The issuance of shares under the Plan shall be subject to compliance with all applicable requirements of federal, state and foreign law with respect to such securities. A Purchase Right may not be exercised if the issuance of shares upon such exercise would constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any securities exchange or market system upon which the Stock may then be listed. In addition, no Purchase Right may be exercised unless (a) a registration statement under the Securities Act of 1933, as amended, shall at the time of exercise of the Purchase Right be in effect with respect to the shares issuable upon exercise of the Purchase Right, or (b) in the opinion of legal counsel to the Company, the shares issuable upon exercise of the Purchase Right may be issued in accordance with the terms of an applicable exemption from the registration requirements of said Act. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company's legal counsel to be necessary to the lawful issuance and sale of any shares under the Plan shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition to the exercise of a Purchase Right, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation, and to make any representation or warranty with respect thereto as may be requested by the Company.

17. RIGHTS AS A SHAREHOLDER AND EMPLOYEE.

A Participant shall have no rights as a shareholder by virtue of the Participant's participation in the Plan until the date of the issuance of a certificate for the shares purchased pursuant to the exercise of the Participant's Purchase Right (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date such certificate is issued, except as provided in Section 4.2. Nothing herein shall confer upon a Participant any right to continue in the employ of the Participating Company

12

Group or interfere in any way with any right of the Participating Company Group to terminate the Participant's employment at any time.

18. LEGENDS.

The Company may at any time place legends or other identifying symbols referencing any applicable federal, state or foreign securities law restrictions or any provision convenient in the administration of the Plan on some or all of the certificates representing shares of Stock issued under the Plan. The Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to a Purchase Right in the possession of the Participant in order to carry out the provisions of this Section. Unless otherwise specified by the Company, legends placed on such certificates may include but shall not be limited to the following:

"THE SHARES EVIDENCED BY THIS CERTIFICATE WERE ISSUED BY THE CORPORATION TO THE REGISTERED HOLDER UPON THE PURCHASE OF SHARES UNDER AN EMPLOYEE STOCK PURCHASE PLAN AS DEFINED IN SECTION 423 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED. THE TRANSFER AGENT FOR THE SHARES EVIDENCED HEREBY SHALL NOTIFY THE CORPORATION IMMEDIATELY OF ANY TRANSFER OF THE SHARES BY THE REGISTERED HOLDER HEREOF. THE REGISTERED HOLDER SHALL HOLD ALL SHARES PURCHASED UNDER THE PLAN IN THE REGISTERED HOLDER'S NAME (AND NOT IN THE NAME OF ANY NOMINEE)."

19. NOTIFICATION OF SALE OF SHARES.

The Company may require the Participant to give the Company prompt notice of any disposition of shares acquired by exercise of a Purchase Right within two
(2) years from the date of granting such Purchase Right or one (1) year from the date of exercise of such Purchase Right. The Company may require that until such time as a Participant disposes of shares acquired upon exercise of a Purchase Right, the Participant shall hold all such shares in the Participant's name (or, if elected by the Participant, in the name of the Participant and his or her spouse but not in the name of any nominee) until the lapse of the time periods with respect to such Purchase Right referred to in the preceding sentence. The Company may direct that the certificates evidencing shares acquired by exercise of a Purchase Right refer to such requirement to give prompt notice of disposition.

20. NOTICES.

All notices or other communications by a Participant to the Company under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.

21. INDEMNIFICATION.

In addition to such other rights of indemnification as they may have as members of the Board or officers or employees of the Participating Company Group, members of the

13

Board and any officers or employees of the Participating Company Group to whom authority to act for the Board or the Company is delegated shall be indemnified by the Company against all reasonable expenses, including attorneys' fees, actually and necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan, or any right granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such person is liable for gross negligence, bad faith or intentional misconduct in duties; provided, however, that within sixty (60) days after the institution of such action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at its own expense to handle and defend the same.

22. AMENDMENT OR TERMINATION OF THE PLAN.

The Board may at any time amend or terminate the Plan, except that (a) such termination shall not affect Purchase Rights previously granted under the Plan, provided that the Board may terminate the Plan (and any Offering thereunder) on any Purchase Date if the Board determines that such termination is in the best interests of the Company and its shareholders except as permitted under the Plan, and (b) no amendment may adversely affect a Purchase Right previously granted under the Plan (except to the extent permitted by the Plan or as may be necessary to qualify the Plan as an employee stock purchase plan pursuant to
Section 423 of the Code or to obtain qualification or registration of the shares of Stock under applicable federal, state or foreign securities laws). In addition, an amendment to the Plan must be approved by the shareholders of the Company within twelve (12) months of the adoption of such amendment if such amendment would authorize the sale of more shares than are authorized for issuance under the Plan or would change the definition of the corporations that may be designated by the Board as Participating Companies.

14

IMMERSION CORPORATION

1999 EMPLOYEE STOCK PURCHASE PLAN

SUBSCRIPTION AGREEMENT

NAME (Please print): __________________________________________________________
(Last) (First) (Middle)

ADDRESS: _________________________________________________________________

MY SOCIAL SECURITY NUMBER: ____________________________________________________

[ ] Original Application for the Offering Period beginning ____________________, 199__.

[ ] Change in Payroll Deduction rate effective with the pay period ending ____________________, 199__.

I hereby elect to participate in the 1999 Employee Stock Purchase Plan (the "PLAN") of Immersion Corporation (the "COMPANY") and subscribe to purchase shares of the Company's Stock in accordance with this Subscription Agreement and the Plan.

I hereby authorize payroll deductions in the amount of ________ percent (in whole percentages not less than 1% or more than 10%) of my "Compensation" on each payday throughout the "OFFERING PERIOD" in accordance with the Plan. I understand that these payroll deductions will be accumulated for the purchase of shares of Stock at the applicable purchase price determined in accordance with the Plan. I understand that, except as otherwise provided by the Plan, I will automatically purchase shares on each Purchase Date under the Plan unless I withdraw from the Plan by giving written notice on a form provided by the Company or unless my employment terminates.

I understand that I will automatically participate in each subsequent Offering that commences immediately after the last day of an Offering in which I am participating until I withdraw from the Plan by giving written notice on a form provided by the Company or my employment terminates.

Shares I purchase under the Plan should be issued in the name(s) set forth below. (Shares may be issued in the participant's name alone or together with the participant's spouse as community property or in joint tenancy.)

NAME(S):________________________________________________________________

[ ] In my name alone [ ] Community Property [ ] Joint Tenancy

I agree to make adequate provision for the federal, state, local and foreign tax withholding obligations, if any, which may arise upon my purchase of shares under the Plan and/or my disposition of such shares. The Company may, but will not be obligated to, withhold from my compensation the amount necessary to meet such withholding obligations.

I agree that while I hold shares acquired under the Plan, unless otherwise permitted by the Company, I will hold such shares in the name(s) entered above (and not in the name of any nominee). This restriction only applies to the name(s) in which shares are held and does not affect my ability to dispose of Plan shares.

THE TAX TREATMENT OF A DISPOSITION OF PLAN SHARES (INCLUDING A GIFT) DEPENDS ON WHEN THE DISPOSITION OCCURS. I AGREE THAT I WILL NOTIFY THE CHIEF FINANCIAL OFFICER OF THE COMPANY IN WRITING WITHIN 30 DAYS AFTER ANY DISPOSITION OF PLAN SHARES THAT OCCURS WITHIN 2 YEARS AFTER THE ENTRY DATE OR 1 YEAR AFTER THE PURCHASE DATE (A "DISQUALIFYING DISPOSITION"). I FURTHER AGREE THAT IF I DO NOT RESPOND WITHIN 30 DAYS TO A COMPANY SURVEY DELIVERED TO ME REQUESTING INFORMATION ABOUT A POSSIBLE DISQUALIFYING DISPOSITION, THE COMPANY MAY (1) TREAT MY NONRESPONSE AS MY NOTICE TO THE COMPANY THAT A DISQUALIFYING DISPOSITION OCCURRED, AND (2) REPORT THE ORDINARY INCOME I MUST RECOGNIZE AS A RESULT OF THE DISQUALIFYING DISPOSITION TO THE INTERNAL REVENUE SERVICE.

I am familiar with the provisions of the Plan and agree to participate in the Plan subject to all of its provisions. I understand that the Board of Directors of the Company reserves the right to terminate the Plan or to amend the Plan and my right to purchase stock under the Plan to the extent provided by the Plan. I understand that the effectiveness of this Subscription Agreement is dependent upon my eligibility to participate in the Plan.

Date:________________ Signature:__________________________________


IMMERSION CORPORATION

1999 EMPLOYEE STOCK PURCHASE PLAN

NOTICE OF WITHDRAWAL

NAME (Please print): __________________________________________________________
(Last) (First) (Middle)

I hereby elect to withdraw from the Offering under Immersion Corporation 1999 Employee Stock Purchase Plan (the "PLAN") which began on _________________________, 19____ and in which I am currently participating (the
"CURRENT OFFERING").

ELECT EITHER A OR B BELOW:

[ ] A. I elect to terminate immediately my participation in the Current Offering and in the Plan.

I request that the Company cease all further payroll deductions from my Compensation under the Plan (provided that I have given sufficient notice prior to the next payday). I request that all payroll deductions credited to my account under the Plan (if any) not previously used to purchase shares under the Plan shall not be used to purchase shares on the next Purchase Date of the Current Offering. Instead, I request that all such amounts be paid to me as soon as practicable. I understand that this election immediately terminates my interest in the Current Offering and in the Plan.

[ ] B. I elect to terminate my participation in the Current Offering and in the Plan following my purchase of shares on next Purchase Date of the Current Offering.

I request that the Company cease all further payroll deductions from my Compensation under the Plan (provided that I have given sufficient notice prior to the next payday). I request that all payroll deductions credited to my account under the Plan (if any) not previously used to purchase shares under the Plan shall be used to purchase shares on the next Purchase Date of the Current Offering to the extent permitted by the Plan. I understand that this election will terminate my interest in the Current Offering and in the Plan immediately following such purchase. I request that any cash balance remaining in my account under the Plan after my purchase of shares be paid to me as soon as practicable.

I understand that by making this election I am terminating my interest in the Plan and that no further payroll deductions will be made (provided that I have given sufficient notice prior to the next payday) unless I elect in accordance with the Plan to become a participant in another Offering under the Plan by filing a new Subscription Agreement with the Company.

Date:_______________________ Signature:________________________________